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ABSTRACT
Post-genomic biomedical science requires quantitative proteomics. In most cases this 
involves differential protein expression analysis using matched pairs o f simultaneously 
detectable labelling reagents for specific protein amino acids. In this thesis the 
development and optimisation o f a novel cysteine labelling strategy, that is based on the 
use o f  iodoacetyl derivatives o f Cy3 and Cy5 (ICy3/5) and 2D-difference gel 
electrophoresis (2D-DIGE) is described. The differentially labelled samples are separated 
on a single 2D gel and detected by multi-wavelength fluorescence scanning. The method 
is used to analyse standard proteins and then cell lysates to define the stoichiometry, 
sensitivity and specificity o f  this labelling technique. A comparative study o f  this new 
proteomic ICy dye protocol with the current NHS-Cy dye labelling system and methods 
that employ commonly used protein staining methods is described. The method is then 
used for cysteine labelling o f proteins in non-reduced, denatured biological samples 
allowing accurate monitoring and sensitive detection o f redox-dependent thiol 
modifications and expression level changes. The method is shown to be compatible with 
the use o f MALDI mass spectrometry to identify proteins by analysis o f trypsinised ICy 
labelled peptide digests. Using parallel sample analysis within single gels, the ICy-dye 
reagents were used to detect redox-, ErbB-2- and growth factor-dependent changes in a 
human mammary luminal epithelial cell system which was exposed to hydrogen peroxide 
or to growth factor stimulation. The conventional lysine labelling 2D-DIGE technique 
was also used in parallel to assess the new ICy labelling strategy for determination o f  the 
effects o f oxidative stress on protein isoform levels. This study has revealed the identity 
o f proteins involved in the response to oxidative stress and growth factor stimulation in 
the context o f ErbB-2 growth factor receptor over-expression. In addition, this labelling 
strategy was also used to detect changes in thiol reactivity that follow the UV irradiation 
o f plasma proteins as part o f a study designed to evaluate the effect o f UV disinfection on 
plasma product safety for clinical use.
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Chapter 1 INTRODUCTION
1.1 Overview on proteomics
After the human genome was sequenced, the understanding o f protein function has 
become the most important issue in the post-genomic era and proteomics is the field uses 
protein analysis tools to globally study the behaviours o f  gene products. Proteomics has 
benefited from the development o f accurate high-throughput technologies allowing 
global protein analysis. Despite the fact that the main techniques used in proteomic 
analysis were developed in the early 1970s (Kenrick and Margolis, 1970), this new 
terminology, proteomics, was first mentioned in 1994 at a “2-D Electrophoresis” 
Symposium held in Siena, Italy. The study o f  the proteome represents the large-scale 
analysis o f proteins expressed in a genome. Differential proteome analysis is the 
comparison o f protein expression profiles between two or more samples on a large scale. 
It was mainly in the 1990s, with the emergence o f high-sensitivity analytical chemistry 
for protein identification using mass spectrometry, that the field o f proteomics really 
became useful for biological studies. Major improvements in mass spectrometry have 
replaced the former method o f choice for protein identification by Edman degradation, an 
approach which although powerful, was time consuming and required larger amounts o f 
sample. The field o f proteomics has rapidly developed and the study o f  the proteome 
now includes methods that evaluate not only changes in protein expression between 
biological samples, but also the examination o f protein-protein interactions, activity 
status, post-translational modifications and protein sub-cellular localization on a large 
scale.
1.1.1 Principles of two-dimensional gel electrophoresis
The most commonly used approach for the study o f proteomics is a combination o f two- 
dimensional gel electrophoresis (2DE) for protein separation with detection by staining or 
protein labelling and mass spectrometry for protein identification. Two-dimensional 
polyacrylamide gel electrophoresis (2D-PAGE) was first developed in the early 1970s 
(Kenrick et al., 1970) and was optimised using denaturing isoelectrofocusing (Klose and
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Spielmann, 1975;0'Farrell, 1975;Scheele, 1975). The technique was greatly improved 
with the development o f  immobilised pH gradient (IPG) gels, which gave increased 
protein resolution in the first dimension (Bjellqvist et al., 1982). Subsequently, pre-cast 
IPG strips were made commercially available, making 2D-PAGE a more reproducible 
technique which could be easily applied by many users. Moreover, with the application 
o f highly sensitive mass spectrometry techniques, 2D-PAGE became even more widely 
used for proteomic analysis.
The main challenge o f 2D-PAGE is to achieve high-resolution protein separation and 
detection in order to provide pure samples for mass spectrometric analysis and for high- 
sensitively differential protein expression analysis. In principle, 2DE relies on the 
separation o f proteins in the first dimension according to their charge and then in the 
second dimension according to their relative molecular weight (Figure 1-1). In the first 
dimension, denatured proteins are separated by isoelectrofocusing (IEF) in a pH gradient 
and focus when they acquire a zero net charge at their isoelectric point (pi). Proteins are 
then separated in the second dimension according to their mass by conventional SDS- 
PAGE. Full descriptions o f  current methodologies and optimised techniques have been 
reported (Rabilloud et al., 1994a;Gorg et al., 1999;Gorg et al., 2000a). In order to reduce 
the complexity in protein samples and the problem o f multiple proteins migrating at the 
same coordinates, the use o f narrow range IPG strips (Gorg et al., 1999; W estbrook et al., 
2001a) and large format gels (Klose, 1999) are utilised for improved separation o f  larger 
amounts o f protein sample. In addition, improvements have been made in the 
solubilisation o f proteins using detergents that are compatible with isoelectrofocusing and 
gel electrophoresis, thereby, providing a means to increase sample loading and improve 
the resolution o f membrane proteins (Rabilloud et al., 1994a;Rabilloud, 1998;Rabilloud 
et al., 1999;Herbert, 1999). Different sample application methods can also be performed 
to improve the entry o f proteins into the first dimension. For example, cup-loading has 
made possible the analysis o f up to 1 mg o f  proteins loaded on to an IPG-strip (Hanash et 
al., 1991).
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(Figure 1-1) Two-dimensional electrophoresis. Protein samples (epithelial cell lysates) are 
separated by isoelectric focusing (IEF) electrophoresis according to the isoelectric point of the 
proteins and then separated by SDS-polyacrylamide gel electrophoresis according to their 
molecular weight.
Despite the benefits o f 2DE for global protein expression analysis, the technique suffers 
from several drawbacks. Most notable is the poor resolution o f basic proteins (Figure 1- 
1). These proteins represent a large fraction o f the proteome and include membrane, 
nuclear proteins and other positively charged proteins that are poorly resolved due to the 
inadequate buffering by ampholytes at basic pHs and also because o f a loss o f reductive 
capacity and concentration (electro-endo-osmosis) resulting in spurious disulphide bond 
reformation and protein precipitation. This can be partially remedied by using stronger 
detergents, high pH range IPG strips, and additives such as isopropanol and DTT to 
improve protein solubility. Thus, for maximal resolution several different 2DE gels must 
be run to separate the acidic and basic fractions o f the proteome, although this is often not 
a practical solution.
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After electrophoretic separation, it is necessary to detect and quantitate proteins in order 
to select proteins o f interest for identification. The challenge is to achieve the detection o f 
the complete proteome and to visualise and accurately quantitate the low- as well as high- 
abundance proteins on the same gel. This means that the detection method used has to 
cover a broad linear range o f detection. Other issues such as high-abundant spots co- 
migrating with low-abundant ones masking the detection o f potentially regulated low- 
abundant proteins and compatibility o f the stain with downstream identification methods 
must also be considered.
Several reviews have outlined the different methods o f choice for detection o f gel- 
separated proteins (Patton, 2000;Rabilloud, 2000;Patton and Beechem, 2002). The most 
commonly used approaches rely on in-gel staining o f proteins subsequent to 
electrophoretic separation. This post-electrophoretic staining o f proteins can be achieved 
by noncovalent staining with organic dyes which rely on the affinity between the dye and 
proteins. For instance, protein staining with a coomassie brilliant blue (CCB R-250) 
solution in methanol and acetic acid is commonly used. Although this method is rapid 
and provides a uniform staining o f  proteins across gels, it is relatively insensitive with a 
detection limit o f 100-200 ng. In addition, the method requires the extensive destaining 
o f gels, which can create variations in background staining from gel-to-gel. This method 
has been further improved with the use o f colloidal coomassie blue G-250 (CCB G-250), 
a dimethylated form o f CCB used in an acidic solution containing ammonium sulphate 
(N euhoff et al., 1988). The limit o f detection o f colloidal CCB G-250 staining is around 
10-20 ng. Another advantage o f colloidal coomassie blue staining is that it does not 
require de-staining o f the gels compared to conventional CCB staining, providing 
increased reproducibility in protein detection from gel-to-gel. Both CCB R-250 and 
colloidal CCB G-250 are commonly used for the analysis o f abundant proteins or those 
that have been overexpressed for post-translational modification analysis, since these 
dyes are compatible with downstream mass spectrometric analysis as they can be easily 
removed (Scheler et al., 1998).
The most commonly used high sensitivity detection method relies on the precipitation o f 
silver with proteins under acidic or alkaline conditions, a method that can show up to 50- 
fold higher sensitivity compared with conventional CCB R-250 staining. With such
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approaches, gels are usually fixed and washed in order to remove excess SDS or salts 
which can react with silver and produce a high background. Numerous silver staining 
protocols have been described, although the most sensitive approach uses aldehyde-based 
fixatives which interfere with subsequent protein identification by mass spectrometry or 
Edman sequencing due to covalent cross-linking o f proteins to the gel preventing 
efficient elution and due to heterogeneous protein modification by the aldehyde. Other 
silver staining methods have been developed to overcome these problems which do not 
use such harsh fixatives (Shevchenko et al., 1996;Yan et al., 2000). However, these 
methods provide less sensitivity in protein detection as only surface staining o f  gels is 
achieved. A major problem with these silver staining methods is that staining from gel- 
to-gel tends to be variable since it is not an end-point staining method. In addition, some 
proteins show a higher affinity for silver staining than others, making it a poor 
quantitative approach (Rabilloud et al., 1994b;Lopez et al., 2000). Thus, although silver 
staining is a sensitive method, it is not really suitable for accurate differential expression 
analysis by gel-to-gel comparison.
So-called reverse staining has also been applied for protein visualisation, using potassium 
chloride, zinc chloride or copper chloride. These methods rely on the precipitation o f 
salts, which occurs faster in the gel areas with no proteins. Therefore this method stains 
the gel only, leaving proteins as transparent spots which can be viewed with appropriate 
back illumination. The most sensitive reverse staining uses zinc chloride-imidazole 
where 10 to 20 ng o f  protein has been detected (Ortiz et al., 1992;Castellanos-Serra et al., 
1999). Although this method is rapid, the extent o f  reverse staining is not fixed and the 
reverse image tends to fade quickly. In addition, the linear range o f detection is limited 
(Castellanos-Serra et a l , 1999) and so zinc chloride-imidazole staining is also unsuitable 
for quantitative proteomic analyses.
The most promising protein visualisation methods use fluorescent dyes which can be 
detected under a standard 300 nm UV light or using an imaging device equipped with the 
appropriate lasers and wavelength filters. The main advantage in the use o f fluorescent 
stains is that fluorescence gives a very broad and linear dynamic range o f detection. This 
greatly enhances protein quantitation o f biological samples where protein abundance can 
range over seven or eight orders o f  magnitude. Hydrophobic dyes such as 1, 8-ANS (1-
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anilinonaphthalene 8-sulfonate) and bis-ANS (bis (8-p-toluidino-l- 
naphthalenesulfonate)) have been used and display a sensitivity level similar to 
conventional CCB R-250 (Hartman and Udenfriend, 1969;Pina et al., 1985;Horowitz and 
Bowman, 1987). Nile red staining was more recently described as a hydrophobic probe 
interacting with SDS-protein complexes in the gel (Daban et al., 1991;Daban, 2001). 
Consequently, this method requires the use o f  low concentrations o f  SDS for the gel 
electrophoresis to avoid increased fluorescent background. The method shows good 
sensitivity and detection o f  as little as 10 ng o f protein has been reported. However, the 
stain is relatively insoluble in water (Daban, 2001).
More recently, Molecular Probes developed a panel o f fluorescent dyes, the 
SYPRO®dyes (Steinberg et al., 1996;Steinberg et al., 2000;Berggren et al., 2002). The 
SYPRO Orange, Red and Tangerine dyes also interact with SDS-protein complexes 
similarly to Nile red dye and the sensitivity reported was similar, although these dyes are 
more water-soluble. Two transition metal chelate stains have also been developed, 
SYPRO Ruby and SYPRO Rose stains. The most attractive for use in quantitative 
proteomics is SYPRO Ruby, a ruthenium-based metal chelate stain showing high 
sensitivity down to 1 ng o f protein (Lopez et a l , 2000;Berggren et al., 2002). The 
fluorophore reacts directly with proteins via lysine, arginine and histidine residues, 
enabling the sensitive and specific detection o f  all gel-separated proteins (Patton, 2000). 
Importantly, this method was shown to be compatible with downstream mass 
spectrometric analysis (Steinberg et al., 2000;Gharbi et al., 2002). SYPRO Ruby staining 
is also rapid and is performed in a single step followed by minimal washing to remove 
excess dye, and is an end-point stain allowing consistent staining from gel-to-gel. 
Consequently, SYPRO Ruby staining represents a considerable improvement in the 
detection o f gel-separated proteins for proteomic analysis, although gel-to-gel variation 
still remains an obstacle for both statistical and accurate differential analysis.
Amongst all the detection methods described, fluorescence labelling appears to be the 
best method due to its high sensitivity and wide linear dynamic range. Historically, the 
main method for visualisation o f fluorescently labelled proteins required the use o f UV 
trans-illumination and direct visual detection. However, many fluorphores are excited 
optimally outside the UV range and detection systems have been developed which use
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specific lasers for excitation. A single laser source cannot provide the appropriate 
excitation over the entire wavelength range o f different fluorophores and so some devices 
use a broadband visible light source in combination with narrow band filters enabling the 
selection o f a specific wavelength adequate for each fluorophore o f interest. Similarly, 
the detection device can be equipped with a selection o f emission filters, allowing the 
detection o f fluorescence emission for a range o f  different fluorophores. Several types o f 
detectors can be used, such as a cooled charged-coupled device (CCD) or photomultiplier 
tube (PMT), as exemplified by the 2920 2D-Masterlmager and Typhoon 9400, 
respectively. These devices, commercialised by GE Healthcare (U.K.), enable optimal 
excitation and detection o f a broad range o f  fluorescent dyes and were used in the work 
presented in this thesis. The 2920 2D-M asterlmager fluoroimager has a high intensity 
xenon arc lamp source equipped with filter wheels enabling the selection o f  narrow range 
wavelengths and is combined with a cooled CCD camera providing sensitive detection o f 
fluorescent signals. Using this device, the gel is scanned directly between glass plates 
using edge illumination. The Typhoon 9400 relies on a multiple laser source and 
photomultiplier detection device providing improved fluorescent detection and high 
image resolution.
Protein detection can also be achieved by covalent labelling pre- or post-electrophoretic 
separation. Perhaps the most sensitive covalent labelling method used prior to 
electrophoresis is radioactive labelling which provides the widest linear dynamic range o f 
detection. Radiolabelling is mainly accomplished by incorporation o f  radioactive 
metabolites during the growth o f  cells. For instance, H, S, P or P can be 
incorporated into proteins by addition o f growth media containing isotopically labelled 
nutrients. Proteins can also be radiolabelled post-lysis for example by in vitro kinase 
assay or through the use o f radiolabelled protein tags, such as alkylating agents. 
Radiolabelled proteins are then detected in-gel by exposure to film (autoradiography) or 
using a phosphorimager. The latter imaging method provides a wider dynamic range 
than autoradiography enabling better quantitative analysis. However, concerns remain as 
to the effects o f addition o f radioactive compounds to cells. Indeed, DNA damage can 
occur, as well as elevation o f p53 levels leading to cell cycle arrest and apoptosis. 
Another important issue and drawback in the use o f radioactive compounds is their
25
hazardous nature and their higher cost. Limitations in the use of radioactive compounds 
now represents a high priority for many laboratories and finding alternative methods is 
favoured.
Fluorescent tags have also been used to covalently label proteins. Most covalent labelling 
has been performed on gel-separated proteins, and several fluorophores, such as 
fluorescamine, fluorescein isocyanate, N-(7-di-methylamino-4-methylcoumarinyl) 
maleimide and dansyl chloride, have been used for this purpose. Dyes such as 5-(4, 6- 
dichlorotriazin) aminofluorescein, monobromobimane, 2-methoxy-2, 4-diphenyl-3 (2H) 
furanone (MDPF) and dansyl chloride have also been used for covalent labelling prior to 
gel electrophoresis, although low sensitivity and poor resolution on 2DE gels was 
reported (as reviewed in (Patton, 2000;Rabilloud, 2000)). Indeed, the major problem 
faced was that most o f  the dyes possess a charge which affects the electrophoretic 
properties o f proteins. In addition, covalent protein modification can also dramatically 
affect the ability to subsequently identify the proteins by mass spectrometry.
Unlu et al. recently described a new covalent lysine labelling approach for differential 
protein detection, known as difference gel electrophoresis (DIGE) (Unlu et al., 1997b). 
A combination o f two fluorescent cyanine protein tags, were used together enabling 
differential labelling o f  two samples prior to their electrophoretic separation on the same 
2D gel. Cyanine dyes were first described by Mujumdar et al. (Mujumdar et al., 
1989;Mujumdar et al., 1993). These fluorophors have a structure which can be modified 
to create a panel o f reactive fluorescent tags. The dyes developed by Unlu et al. are N- 
hydroxy-succinimidyl (NHS)-ester derivatives o f  the fluorescent cyanines 3 and 5 (NHS- 
propyl-Cy3, NHS-methyl-Cy5) (Figure 1-2A). A third cyanine dye, NHS-Cy2 is now 
commercially available and all three dyes have distinct and non-overlapping excitation 
and emission spectra (Figure 1-2B) enabling their specific detection with a multi­
wavelength fluorescent detection device. Using these dyes, proteins are covalently 
labelled on lysine s-amino groups (s-NFL-lys) by nucleophilic attack resulting in the loss 
o f the NHS group (Figure 1-2C). The advantage o f using lysine labelling is that almost 
all proteins contain at least one lysine residue and so most proteins can be labelled. The 
labelling reaction appears to be specific for s-NFU-lys lysine groups, although the NHS- 
ester could also react with the N-terminal a-am ino groups o f proteins (a-N H 2-Nterm).
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Conceptually, the dyes should be mass and charge matched and the dye modification 
should not perturb the electrophoretic mobility o f  labelled proteins. For this reason, the 
size o f the aliphatic chain (Figure 1-2A) was originally modulated to maintain a similar 
molecular weight between each dye and the dyes possess a positive charge which 
matches the positively charged amino groups they modify. Low stoichiometry labelling 
conditions were established for covalent labelling without adversely affecting protein 
mobility, but keeping the sensitivity o f detection high and linear over a wide dynamic 
range. This approach was then further optimised and commercialised by GE Healthcare 
and the method was originally evaluated and applied by Tonge et al. and Gharbi et al. 
(Tonge et al., 2001;Gharbi et al., 2002). Tonge et al. used the NHS-cyanine dyes Cy2, 
Cy3 and Cy5 to label liver homogenates from pools o f  untreated and paracetamol-treated 
mice and separated these labelled liver proteins by 2DE. After normalisation o f the 
individual fluorescent images, quantitative protein differences were determined between 
the samples from replicate gels. A number o f  the significantly changing features was 
identified by mass spectrometry and some o f these identified proteins could be 
rationalised based on available information on the mechanism o f paracetamol 
hepatotoxicity. Gharbi et al. also evaluated this technique using a model cell system to 
study the effects o f ErbB-2 overexpression, an oncogenic receptor tyrosine kinase 
implicated in breast cancer progression. A Cy2-labelled pool o f samples was used as a 
standard and run on all gels for comparison with the Cy3- and Cy5- labelled sample pairs 
for improved cross-gel quantitative analysis (Figure 1-3). Decyder software (GE 
H ealthcare) was used to distinguish clear statistical differences in protein expression 
over time and between the cell lines. This internal standard method was also 
subsequently described by Alban et al. (Alban et al., 2003).
1.1.2 Problems and limitations of current two-dimensional gel based 
proteomics
As mentioned previously, 2DE-based proteomic studies are somewhat limited since only 
a fraction o f the proteome can be visualised (Corthals et al., 2000). One o f the limitations 
is in protein separation due to the physico-chemical properties o f proteins. Very basic or 
hydrophobic proteins, such as membrane proteins, are not well separated in the first
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(Figure 1-2) Characteristics of the NHS-Cy-dyes. (A) Structure of the NHS-Cyanine dyes.
CyljS-^-carboxymethyOphenylmethyO-S’-ethyloxacarbocyanine halide jV-hydroxy-succinimidyl
ester; Cy3, l-(5-carboxypentyl)-l’-propylindocarbocyanine halide iV-hydroxysuccinimidyl 
ester, Cy5; l-(5-carboxypentyl)-r-methylindodicarbocyanine halide N-hydroxysuccinimidyl. 
Each dye has a similar molecular weight and single positive charge matching the charge of the 
modified primary amino group. (B) Each dye displays a distinct emission spectra enabling the 
individual detection of differentially labelled proteins at the appropriate wavelength without 
overlap of signals. (C) The dyes have an iV-hydroxysuccinimidyl ester reactive group triggering 
covalent interaction with the primary amine groups of lysine residues or the N-terminus.
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(Figure 1-3) The principle of NHS-CyDye Lysine-labelling 2D-difference gel electrophoresis 
(2D-DIGE). Up to three samples can be covalently labelled with a distinct fluorescent cyanine 
dye (Cy2, Cy3 or Cy5) which are mixed prior to protein separation by 2DE. Proteins are 
visualised by fluorescence imaging using a multi-wavelength fluorescence detection device 
generating three single, but directly super-imposable images of the three samples analysed. In this 
scheme, Cy2 is used to label a pool of all samples and used as an internal standard on every gel to 
aid spot matching and provide more accuracy in quantitation.
dimension or are poorly transferred to the second dimension. It may also be difficult to 
detect low molecular weight proteins as they are more difficult to stain. It is estimated 
that o f the tens o f thousands of genes expressed in a human cell, only a small fraction can 
be routinely resolved and visualised on a 2DE gel. This subset o f proteins represents the 
most highly abundant and soluble proteins. Moreover, each protein expressed may have 
different splice variants, proteolysis products or be post-translationally modified, 
therefore increasing the number o f protein features which are resolved. Thus the number
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o f different gene products is much higher than the ~3 thousand protein products that are 
routinely detected by 2DE. The dynamic range o f  expression o f proteins is also very high 
in biological samples, extending over seven or eight orders o f magnitude, with a small 
proportion o f the most abundant proteins making up a high percentage o f the total mass, 
and potentially masking the low abundance proteins (Wilkins et al., 1996). According to 
theoretical studies, to analyse a protein expressed at 1 0 0 0  copies/cell, it would be 
necessary to load 1 0  mg o f total lysate, assuming that proteins can be visualised at the 
low nanogram level on a gel. Since high loading precludes high-resolution separation, 
the lower copy number proteins will be masked or not detected on an average 2DE gel 
stained with the most sensitive stain. Gygi et al. showed in previous work that the 
combination o f 2DE and mass spectrometry only detected the most abundant proteins in 
the yeast Saccharomyces cerevisiae (Gygi et al., 2000). In a small genome such as the 
yeast genome, it is possible to estimate the level o f expression o f a protein according to 
its propensity to use only one o f several codons to incorporate a specific amino acid into 
the polypeptide chain. This is known as codon bias. According to this estimation, 
proteins which are largely expressed appear to have a higher codon bias (>0.2). The 
authors evaluated the protein abundance based on codon bias and showed that the 
majority o f proteins visualised on a 2DE and identified by MALDI-TOF-MS, were 
proteins expressed at high copy number. This study inferred the need for the 
development o f different techniques which could make possible the detection o f  low- 
abundance proteins, for instance using pre-gel enrichment techniques such as sub-cellular 
fractionation or using liquid-chromatography fractionation for enrichment. Thus, the 
most important issue in the use o f 2D-DIGE, and other 2DE-based separation methods, 
remains the limitations in proteome coverage. Due to the wide dynamic range in protein 
expression o f biological samples, proteomic analyses favour the characterisation o f 
highly abundant proteins with masking o f potentially important changes in low-abundant 
proteins. Therefore, highly abundant proteins such as heat shock proteins or cytokeratins 
are often cited as targets o f differential protein expression, although these proteins may 
still represent important markers in biological processes and disease. Improvements in 
2DE analysis have enabled increased sample loads, protein solubility and separation 
through the use o f narrow-range pH strips (Gorg et al., 2000b;W estbrook et al., 2001b),
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whilst sample pre-fractionation via liquid chromatography (Cooper et al., 2004), or the 
isolation o f organelles and sub-proteomes can increase detection and sensitivity o f a 
subset o f proteins when combined with conventional gel-based methods (Bardel et al., 
2002;Schirmer and Gerace, 2002). Protein separation and analysis have also been 
improved using non-gel based methods such as chromatographic separation coupled to 
mass spectrometric analysis. For instance, multi-dimensional protein identification 
technology (MudPIT) (Washburn et al., 2001), which can be coupled to differential 
isotope tagging methods such as SILAC (Ong et al., 2002;Blagoev et al., 2003) for 
quantitation have received a lot o f attention lately and appear to be applicable for in vivo 
incorporation o f specific amino acids into all mammalian proteins and capable o f using as 
quantitative proteomic analysis o f different cell culture systems.
A further disadvantage o f conventional 2DE-based analysis o f differential protein 
expression is its variability and hence only semi-quantitative nature. Indeed, even minor 
variations in temperature, polymerization, current, or batch-to-batch variation in the IPG 
strips used can cause variations between and within multiple gel runs. Although various 
proteomic studies have shown successful results in the comparison o f  multiple samples 
and enabled the identification o f various protein targets (Lewis et al., 2000;Benvenuti et 
al., 2002;Chen et al., 2002), these kind o f studies are labour intensive as many replicate 
gels need to be run, and complex and time consuming image analysis is required for 
statistical validity. In addition, commonly used staining methods such as silver stain are 
non-end point methods and protein detection is somewhat variable from gel-to-gel, 
obligating the need for comparison o f many replicate gels.
The ability to run different samples on the same gel such as in 2D-DIGE, so that proteins 
are subjected to the same physical microenvironments during gel electrophoresis is 
therefore a huge technical advance. Covalent labelling with the set o f fluorescent Cy dye 
tags described by Unlu et al. (Unlu et al., 1997b) and further developed and evaluated by 
Tonge et al. and Gharbi et al. (Tonge et al., 2001;Gharbi et al., 2002), therefore 
represents an attractive tool for improved reproducibility for the comparison o f multiple 
samples. Moreover, fluorescence detection using this method offers a high sensitivity 
and broader linear dynamic range for improved quantitation o f  biological samples.
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1.1.3 Mass spectrometry in proteomics
Mass spectrometry is an analytical tool allowing the determination o f the mass o f a 
molecule with high accuracy. Mass spectrometers are composed o f an ion source where 
the sample is applied, a mass analyser which measures the mass-to-charge ratio (m/z) o f 
ionised particles and a detector. The two major types o f approach used in the study o f 
proteins and peptides are matrix-assisted laser-desorption/ionisation mass spectrometry 
(MALDI-TOF-MS) (Karas and Hillenkamp, 1988) and electrospray ionisation mass 
spectrometry (ESI-MS) (Whitehouse et al., 1985;Fenn et al., 1989) which rely on distinct 
methods o f ionisation (Figure 1-4). MALDI-TOF-MS relies on ions generated from a 
solid phase using laser pulses. The sample is usually applied in a matrix solution that 
facilitates the ion formation by absorption o f  photon energy from a laser source (Figure
1-4A, left). The most commonly used matrices for protein/peptide analysis are 2, 5- 
dihydroxybenzoic acid (DHB) and a-cyano-4-hydroxycinnamic acid (CHCA). ESI-MS 
generates ions from a liquid phase. The sample, in a solvent mixture is directly sprayed 
into the mass spectrometer where an electrostatic field is formed between the capillary 
and the walls o f the mass spectrometer. As the droplets form and travel, they evaporate 
and the resulting charged particles enter into the gas phase (Figure 1-4A, right). Both 
ionisation methods can be performed either in the positive or negative ion mode, although 
typically for peptide mass analysis, ionisation scans are performed in the positive ion 
mode. Each ion is separated in the mass spectrometer according to its m/z ratio and 
several mass analysers have been developed for improved ion separation, resolution and 
mass accuracy. For protein/peptide sample analysis, these include single time-of-flight 
(TOF) methods (Figure 1-4B, left) and tandem-mass spectrometers such as TOF-TOF, 
triple quadrupole, or quadrupole-TOF (Figure 1-4B, right).
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(Figure 1-4) Principles of mass spectrometry and instrumentation (adapted from(Aebersold 
et a l , 2003). (A) Two main ionisation methods can be applied for protein identification and 
characterisation. These are matrix assisted laser desorption/ionisation mass spectrometry 
(MALDI-TOF-MS) and electrospray ionisation mass spectrometry (ESI-MS). (B) Several mass 
analysers have been developed and they can be combined for improved mass resolution and 
sensitivity.
Protein identification by mass spectrometry can be carried out by peptide mass mapping 
using MALDI-TOF MS or by further peptide fragmentation to generate sequence data 
using tandem mass spectrometry (MS/MS). Peptide mass mapping, also called peptide 
mass fingerprinting (PMF), has been the common method of choice for proteomic 
analysis (Henzel et al., 1993;James et al., 1993;Mann et al., 1993;Yates, III et al., 1993). 
A protein o f interest usually separated by methods such as 2DE is first picked from gels 
and then proteolysed using a specific protease to generate a peptide mixture.
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Subsequently, the masses o f the peptides in the mixture are accurately measured in a 
mass spectrometer. The list o f peptide masses is then matched against theoretical masses 
for all known proteins using a database search. Several databases can be used which 
contain theoretical protein cleavages according to the enzyme o f choice and possible 
post-translational modifications and known chemical modifications. A list o f potential 
matches is given and ranked according to a scoring system depending on the probability 
o f a match being real. Confidence in the identification then depends on the species 
studied, the mass and p /  o f the protein observed on a gel, the number o f peptides 
matching the theoretical masses, the mass accuracy o f detection, the protein sequence 
coverage reached, the number o f  missed cleavages during the proteolysis process and 
also the type o f modifications observed, which reflects the process o f sample handling. 
Protein identification by peptide mass fingerprinting was carried out in this study and its 
application is further described in Chapters 2 ,4 , 5 and 6 .
The MALDI-TOF-MS ionisation method generates predominantly singly charged ions 
[M+H]+ and mass spectra are therefore easier to interpret in terms o f  the peptide mass 
profile. The other method o f choice for protein/peptide analysis is peptide fragmentation 
by tandem mass spectrometry (MS/MS). In addition to accurate information on the 
sequence o f a peptide and thus the identification o f a protein, tandem mass spectrometry 
is also an important tool for the analysis o f post-translational modifications, such as 
glycosylation, phosphorylation or acetylation. In tandem mass spectrometry, selected 
parent peptide ions are selected and fragmented in the mass spectrometer to generate 
daughter ions with the loss o f amino acids (Biemann and Scoble, 1987;Hunt et al., 
1987;Wilm et al., 1996). Two main approaches have been used for this fragmentation, 
post source decay (PSD) in a MALDI-TOF-MS instrument, and collision-induced 
dissociation (CID) in an ESI-MS/MS instrument. The common principle o f these 
methods is that peptide ions will fragment along the peptide backbone o f the molecule at 
high energy, inducing the formation o f a series o f smaller daughter ions. According to the 
bond fragmented, the ions are given an annotation as shown in Figure 1-5. Generally, the 
ions most likely to be generated are the “b” and “y” ion series, which represent 
fragmentations at the amino bond from the N- and C- terminus, respectively (Figure 1-5). 
In MS/MS, peptide mixtures are first analysed in the mass analyser and selected parent
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ions o f interest are focused and fragmented in a collision cell, where the necessary energy 
is provided through collision with inert gas molecules. The resulting daughter ions are 
subsequently analysed in a second mass analyser with the sequence o f “b” and “y” ions 
resulting from the loss o f a single amino acid per peptide backbone allowing partial 
sequence to be deduced by comparison o f  masses in the series. Again, the list o f 
fragments is matched against a database o f theoretical fragmentation pattens, although 
manual interpretation o f data is often needed for improved confidence in the analysis. 
Tremendous progress has been made in recent years in the development o f optimised 
instrumentation for increased mass accuracy, sensitivity, yield o f detection and 
automation. The size o f instruments has also decreased and several mass analysers have 
been combined, providing elaborate and compact analytical instruments for high 
sensitivity and high-resolution biological mass spectrometry. In addition, high- 
throughput automation is constantly pushing the detection and identification limits 
further, allowing a promising future for global proteomic analyses.
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(Figure 1-5) Representation of the fragment ions generated from a peptide by MS/MS (from 
(Biemann, 1990)). A series of daughter ions is generated upon fragmentation at high collision 
energy. According to the ionisation method applied, the fragment ion pattern will vary. 
Commonly, in a collision-induced dissociation, the bond most likely to fragment will be the 
amino bond, therefore generating mainly b and y ions. On the other hand, in post-source decay 
(PSD), other ions are observed such as a and x ions.
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1.2 Cell signalling and cancer
In multi-cellular organisms, cells have to communicate with each other in order to control 
their proliferation, differentiation, survival and to perform diverse physiological 
functions. Cells release and receive signals to induce these different states o f growth 
either by direct cell-to-cell interaction or via secreted molecules. This communication is 
elicited through so-called signalling molecules such as transmembrane receptors that are 
embedded in the cell membrane and which can activate intracellular signal transduction 
cascades which ultimately lead to gene activation or repression and a cellular response. 
According to the specificity, strength and duration o f the signal received, the cell will 
proliferate, differentiate, change shape, migrate, enter into growth arrest or undergo 
apoptosis. Signalling pathways are o f  great complexity and although major routes have 
been elucidated, the spatio-temporal organisation and components o f intracellular 
machinery are still poorly understood (reviewed in (Hunter, 2000)). Although a large 
number o f proteins are involved in specific signalling event, this can be simplified 
somewhat by their classification according to their protein structure or functional domain 
content. Indeed, the major events dominating signal transduction involve cascades o f 
protein-protein or protein-lipid interactions that occur through specific domains, although 
these interactions can be regulated by post-translational modifications such as 
phosphorylation. Many protein interaction domains have been classified such as the 
SH2, PTB, SH3, LIM and PDZ domains, and have been shown to play a central role in 
many diverse signalling pathways (Pawson, 1995).
These complex signalling networks are highly regulated and alterations o f the normal 
intracellular signals can lead to the development o f  diseases such as cancer. It is now 
known that a series o f genetic mutations is required for the progressive conversion o f 
normal human cells into cancerous cells. Hanahan and Weinberg have proposed a model 
o f tumourigenesis, whereby several physiological conditions are required by cells before 
they become tumourigenic (Hanahan and Weinberg, 2000). These are self-sufficiency in 
growth signals, insensitivity to growth-inhibitory signals, evasion o f programmed cell 
death (apoptosis), limitless replicative potential, sustained angiogenesis, and tissue 
invasion and metastasis. In proliferative signalling pathways for example, numerous
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proto-oncogenes or tumour suppressors have been identified, the mutation o f which cause 
amplification o f signalling or loss o f  negative regulation resulting in over-proliferation 
and eventual tumour formation. Unlike normal cells, which tightly regulate extracellular 
ligand levels, receptor expression and secondary signalling molecules, cancer cells often 
lose the ability to regulate these signalling events. For example, overexpression o f  RTKs 
(Libermann et al., 1985), mutation o f Ras (Marshall, 1996) or the overexpression o f  PI3K 
(phosphatidylinositol 3-kinase) (Sulis and Parsons, 2003) are thought to lead to cell 
transformation.
RTKs (receptor tyrosine kinases) are able to bind extracellular mitogenic growth factors 
and transduce these growth signals to intracellular second messengers to directly regulate 
specific gene expression. Many different RTKs can activate common pathways such as 
the Ras/RafTMAPK (mitogen activated protein kinase) signalling pathway, the PI3K/Akt 
signalling pathway and the Jak/STAT (Janus kinase/ signal transducers and activators o f 
transcription) signalling pathways that lead to increased E2F and Myc mediated 
transcription and subsequent proliferation (Bell and Ryan, 2005).
In contrast to the highly complex signalling molecular network, most mitogenic signals 
converge on a small number o f nuclear proteins that regulate cell-cycle progression and 
gene expression. One o f these proteins is the retinoblastoma protein (pRb), which 
inhibits cell cycle progression in resting cells, but following mitogen stimulation is 
phosphorylated by cyclin/CDK (cyclin dependent kinase) complexes, releasing its 
inhibition o f the E2F family o f transcription factors to induce the expression o f  genes 
involved in traversing the G1 to S phase transition o f the cell cycle (Sherr and 
McCormick, 2002;Bell and Ryan, 2004). Many intracellular factors can regulate the 
function o f pRb which is inactivated in the vast majority o f human cancers (Sherr et al., 
2002). In addition, viral oncoproteins such as the E7 protein o f human papilloma viruse 
(Dyson et al., 1989) or SV40 large T antigen (Jha et al., 1998) can inhibit pRb function 
and lead to cellular immortalisation and tumour formation.
Another well characterised tumour suppressor is p53, the most frequently mutated and 
inactivated gene in human cancer (Ryan et al., 2001). p53 exists at low levels in normal 
cells, but when stabilised and activated by various forms o f cellular stress or DNA 
damage, it can activate genes such as p 2 1 , inducing cell cycle arrest and
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Bax/PUMA/NOXA to induce apoptosis. In addition, Mdm2, a negative regulator o f p53, 
mediates the degradation o f p53 via ubiquination (Kubbutat et al., 1997) and the E6  
protein o f human papilloma virus also binds to and induces ubiquitin-mediated 
proteolysis o f p53 (Scheffner et al., 1990). Thus, inactivation o f p53 is a major 
determinant o f cellular transformation.
Tumour cells also need to overcome a hypoxic environment in order to survive and 
hypoxia-inducible factor l a  (H IF -la ) is a major factor that activates a wide variety o f 
genes responsible for angiogenesis and glucose metabolism (Bardos and Ashcroft, 2004). 
H IF -la  has been observed to be upregulated in many human cancers including breast 
cancer and is closely correlated with patient mortality (Harris, 2002). Indeed, many 
signalling defects associated with cancer have been shown to increase H IF -la  activity, 
including aberrant signalling by ErbB-2 overexpression (Laughner et al., 2001), PI3K & 
MAPK (Fukuda et al., 2002), Src (Jiang et al., 1997) and loss o f p53 function (Ravi et al., 
2000).
Although several markers o f cancer progression are already well characterised, there is 
still a need to better understand the function o f these molecules and their relationship 
with other cellular components. Indeed, attempting to target one signalling molecule o f a 
pathway needs to be done with caution as such an approach often neglects other 
signalling processes which may be affected. Therefore, in order to better understand the 
molecular mechanisms associated with tumourigenesis, it is necessary to identify all 
affected components and to characterise the changes in as much detail as possible. This 
is one o f the aims o f  proteomics and other global screening methods.
1.2.1 The ErbB receptor tyrosine kinase family
As previously mentioned, one o f the major mechanisms used to mediate transmembrane 
signalling is the ligand induced tyrosine phosphorylation o f receptors that generate 
intracellular binding motifs for interaction with downstream signalling molecules. A 
large family o f  receptor tyrosine kinases (RTK) have been identified and characterised 
(Schlessinger, 2000). These receptors can be classified into 14 different sub-groups 
according to their structural organisation. They generally share a single transmembrane 
hydrophobic domain that connects an extracellular ligand binding domain and an
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intracellular kinase domain. Signal transfer requires the binding o f specific ligands to the 
extracellular domain, which induces preferential dimerisation o f receptor molecules and 
activation o f the tyrosine kinase activity. This results in auto-phosphorylation and cross­
phosphorylation o f specific tyrosine residues in the cytoplasmic domains and tyrosine 
phosphorylation o f specific signalling molecules that induce a complex series o f 
downstream signalling events, ultimately resulting in the regulation o f diverse cellular 
processes such as proliferation, differentiation and cell motility through regulated gene 
expression, protein turnover, localisation and changes in enzyme activity status. RTKs 
also play an important role in development as shown by gene knock-out studies (Lee et 
al., 1995;Chan et al., 2002) and are known to play a role in the progression o f  major 
diseases particularly cancers (Schlessinger, 2000;Zwick et al., 2002).
One o f  the best-studied sub-families o f  RTKs is the epidermal growth factor receptor 
(EGFR) family. The ErbB receptor tyrosine kinase family is composed o f  four members: 
E rbB l/H ER l (EGF receptor), ErbB-2/HER2, ErbB3/HER3 and ErbB4/HER4. Each o f 
these receptors can bind a specific subset o f  ligands (Peles and Yarden, 1993;Riese and 
Stem, 1998;01ayioye et al., 2000b;Yarden et a l , 2001). These ligands are the epidermal 
growth factor (EGF)-related peptides, which fall into three main groups according to 
receptor specificity: EGF, amphiregulin (AR) and transforming growth factor-a, which 
specifically bind to EGFR (ErbB-1); betacellulin, epiregulin and heparin binding EGF- 
like growth factor which bind to both the EGFR and ErbB-4 receptors, and the Neu 
differentiation factors or heregulins (Hrg) which are specific ligands for the ErbB-3 and 
ErbB-4 receptors. The ErbB-2 receptor has no known ligands (Figure 1-6).
Each receptor o f the EGFR family has the ability to be activated by homodimerisation 
upon ligand binding, but heterodimers with other members o f the ErbB family appear to 
be preferred. Several studies have shown that the way in which the receptors dimerise 
within a particular cell type, determines the specificity o f downstream signalling events 
(Riese et al., 1998). Importantly, although the ErbB-2 receptor does not itself have a 
specific ligand, it is the preferred heterodimerisation partner for the other ErbB family 
members (Tzahar et al., 1996;Graus-Porta et al., 1997). It has also been reported to form 
homodimers in ErbB-2 overexpressing cell systems, and could therefore lead to 
constitutive, ligand-independent signalling (Lindberg et al., 2002). In addition, ErbB-2
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heterodimerisation with ErbB-3 is required for signalling, since ErbB-3 receptors lack 
intrinsic tyrosine kinase activity (Guy et al., 1994;Kim et al., 1998) (Figure 1-7). Thus, 
the specificity o f signalling in a particular cell type is determined by a combination of 
factors: the presence o f a specific ligand, the availability of co-receptors for dimerisation 
and the surface expression level o f the dimerisation partners.
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(Figure 1-6) Binding specificities of the EGF-related peptide growth factors (from (Olayioye 
et a l 2000a)). There are four types of ligands that bind ErbB family receptors. EGF, 
amphiregulin (AR) and transforming growth factor-a (TGF-a) bind ErbBl; betacellulin (BTC), 
heparin-binding EGF (HB-EGF) and epiregulin (EPR) bind ErbBl and ErbB4; neuregulin-1 
(NRG-1) and neuregulin-2 (NRG-2) bind ErbB3 and ErbB4; and neuregulin-3 (NRG-3) and 
neuregulin-4 (NRG-4) bind ErbB4.
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(Figure 1-7) ErbB-2 is the preferred dimerization partner for the other ErbB receptors 
(from (Olayioye et a l 2000a)). Ligand binding to ErbB-1 (EGF), ErbB-3 (NRG-1) or ErbB-4 
(NRG-1, BTC) induces the formation of receptor homodimers and ErbB-2-containing 
heterodimers. ErbB-3 homodimers do not signal (indicated by the X), since the receptor has 
impaired kinase activity. Only some of the possible ligand-receptor-induced combinations are 
indicated.
Each receptor possesses a number o f shared and distinct phosphorylation sites which are 
phosphorylated following receptor activation. These phosphorylated tyrosine residues 
are essential for the recruitment and activation o f downstream signal molecules such as 
those involved in PI3K and MAPK signalling. The consensus tyrosine phosphorylation 
sites of each ErbB family members has been determined and the substrates which are 
recruited to these specific sites identified (reviewed by (Weiss and Schlessinger, 
1998;01ayioye et a l , 2000b;Yarden et a l , 2001) (Figure 1-8). Three main classes o f 
substrates are recruited by activated ErbB receptors (Figure 1-8): adaptor proteins, 
including She, Grb2, Grb7 and G abl; kinases, such as phosphatidylinositol 3-kinase 
(PI3K) through its p85 subunit, Src and Chk and tyrosine phosphatases, such as Shpl and 
Shp2. All ErbB receptors possess at least one docking site for the recruitment o f She, 
which binds via its protein tyrosine binding (PTB) domain or its src homology-2 (SH2) 
domain and which is additionally able to recruit the adaptor Grb2 (Shoelson, 1997). 
However, other effector proteins are more specific, and for instance EGFR is the only 
ErbB member able to recruit the E3 ubiquitin ligase c-Cbl or Shpl. In addition, ErbB-3 
possesses six known phosphorylation sites able to recruit the regulatory subunit o f PI3K, 
p85, via its SH2 domains and is therefore thought to be the most potent activator o f 
downstream PI3K signalling (Cantley et al., 1991;Songyang et al., 1993).
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(Figure 1-8) Summary of known ErbB family consensus phophotyrosine residues and 
reported recruitment of signalling molecules (from (Olayioye et a l 2000a)).
Autophosphorylation sites are shown in yellow and Src kinase phosphorylation sites are shown in 
black.
This diversity in recruitment, together with preferential heterodimerisation reveals the 
complexity of the signalling that can be generated through the activation of this family of 
receptor tyrosine kinases. As shown in Figure 1-9, many o f the recruited molecules are 
also receptor substrates and/or substrates for recruited kinases such as Src. The 
recruitment and activation of effector proteins is an important step in the initiation of 
various downstream signalling cascades. For example, two o f these signal cascades 
include the mitogen-activated protein kinase (MAPK) and the PI3K pathways (Neve et 
al., 2002). Both o f them display distinct activation profiles in response to growth factor 
treatment (such as HRG or EGF), with obvious differences in both the intensity and 
duration o f signal output. Through inhibition o f each of these pathways it is apparent that 
each pathway is necessary, yet insufficient alone, to stimulate proliferation. Each 
pathway regulates distinct subsets o f essential cell cycle regulators and integration of 
these signal networks is required for the timely expression of these components, which 
culminates in cell cycle progression. The MAPK pathway is activated downstream o f the
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ErbB family members via the recruitment o f Shc, Grb2 and SOS (an exchange factor 
required for the activation o f the small GTPase Ras). In turn, activated Ras at the plasma 
membrane can recruit and activate a kinase signalling cascade consisting o f Raf, MEK, 
ERK and Rsk that leads to the activation o f  downstream transcription factors such as AP- 
1, Elk-l/p62TCF, c-Myc and C/EBPp (Johnson et al., 1996;01ayioye et al., 2001). The 
PI3K pathway is also activated downstream o f ErbB-3/ErbB-2 heterodimer formation 
thus leading to activation o f  Akt/PKB dependent signalling (Vanhaesebroeck et al., 
1997), required for proliferation, survival and cellular migration. Furthermore, each 
signalling cascade does not work alone, but can interact with other pathways (such as the 
cytokine signalling pathway) to affect the amplitude and duration o f the signals 
transmitted and therefore determine the quality o f the output signal and hence the 
biological response o f a particular cell type.
Importantly, ErbB signalling is rapidly down-regulated and so the signals they generate 
are transient. This has been shown to involve the recruitment o f protein phosphatases 
such as PTP-1B resulting in receptor dephosphorylation and so inhibition or knock-out o f 
PTP-1B leads to the sustained activation o f RTKs such as EGFR and PDGFR (Ostman 
and Bohmer, 2001 ;Haj et al., 2003). In addition, receptor down-regulation occurs by 
rapid endocytosis via clathrin coated-pits and subsequent intracellular degradation 
(Sorkin and Waters, 1993;Sorkina et al., 2002). This process appears to be tightly 
controlled and varies for each ErbB receptor. For example, EGFR is rapidly endocytosed 
and degraded via the ubiquitin-proteasome pathway, due to its ability to recruit c-Cbl, a 
ubiquitin E3 ligase (Levkowitz et al., 1998;Levkowitz et al., 1999), whilst ErbB-2 
appears to have impaired ligand-mediated endocytosis (Sorkin et a l , 1993;Baulida et al., 
1996;Levkowitz et al., 1999).
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(Figure 1-9) The ErbB signalling network (from (Yarden et al., 2001)). This figure summarises 
the complexity of the ErbB signalling network. It can be described as several layers of activation. 
From an array of specific ligands, ErbB receptors are activated in combinations of dimers 
subsequently leading to the recruitment of various specific and overlapping effector proteins. 
Kinase activation enables further cascade activation of signalling molecules. Amongst those, the 
best studied pathways activated downstream of the ErbB family members are the mitogen- 
activated protein kinase (MAPK) pathway via the recruitment of Shc, Grb2 and Sos and the 
phosphatidylinositol 3-kinase (PI3K) pathway leading to the activation of Akt and S6Kinase. The 
next layer of this cascade activation results in the activation of specific transcription factors such 
as Myc, activated protein-1 (AP-1) (consisting of Jun, Fos), and Elk leading to gene expression 
and ultimately the alteration of cellular phenotype.
1.2.2 R o le  o f  E r b B  r e c e p to r  e x p re s s io n  in  c a n c e r
EGFR was the first ErbB receptor to be cloned (Ullrich et al., 1984), has been found to be 
overexpressed in several different types o f human cancer such as non-small cell lung 
carcinoma, bladder, cervical and ovarian cancers and in squamous cell carcinomas of the 
head and neck (Nicholson et al., 2001). Increased EGFR signalling due to 
overexpression is thought to play a critical role in tumourigenesis. Several tyrosine 
kinase inhibitors have been developed in order to specifically target this receptor for 
prospective therapies, such as the compound ZD 1839 (Iressa) (Ciardiello, 2000), or the 
monoclonal antibody directed against EGFR, cetuximab (C225) (Baselga, 2001). These
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EGFR targeted therapies were both designed for preventing the activation o f the receptor 
(Overholser et al., 2 0 0 0 ).
ErbB-2 is known to be a potent activator o f downstream signalling in response to a 
variety o f EGF family ligands (Wang and Hung, 2001). Moreover, ErbB-2 also plays an 
important role in the progression o f some human cancers. Specifically, ErbB-2 has been 
reported to be an important marker in invasive breast cancer (Bange et al., 2001) and 
through gene amplification and its protein overexpression has been observed in 1 0 % to 
30% o f invasive breast cancers and in 40 to 60% o f intraductal breast carcinomas 
(Slamon et al., 1987). ErbB-2 overexpression is also correlated with the reduced survival 
o f patients with breast cancer (Slamon et al., 1987). Thus, ErbB-2 protein expression 
level can therefore be a useful diagnostic marker. For this reason, breast cancer research 
has been focused on the molecular and cellular events associated with ErbB-2 
overexpression and in determining its role in cancer progression.
1.2.3 Cellular model of ErbB-2 dependent breast cancer
In the study for new-targeted therapies against cancers, the use o f cancer cell models can 
be advantageous as it enables the accurate and reproducible study o f the various 
properties o f human cancer mechanisms. Despite clinical cancer biopsies obtained from 
patients more accurately reflecting the real state o f  the illness, these samples are usually 
very heterogeneous, difficult to purify and often cannot be obtained in sufficient 
quantities for study. The prerequisite for a good cancer cell model is that it should mimic 
to the best extent the biological behaviour o f an in situ cancer. However, this criterion is 
not always evident as model cancer cell systems are prone to genetic instability during 
culture, and lack the appropriate cellular or tissue environment. For a single disease, 
multiple models can be used, however, there is no perfect model and the most appropriate 
way to choose the model for study is carefully matching it to the experimental question 
that is being asked.
Many breast cancer cell lines such as SKBr3 BT474 and the SUM cell lines have been 
derived from pleural effusions o f patients with metastatic disease, therefore they 
represent more the final stages o f the tumour and thus little is known about the earlier 
stages o f  tumour formation. In contrast, cell lines can be derived from the modification
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of normal cells allowing the study o f early events in cancer development. It is now well 
understood that for a normal cell to be transformed into a cancerous cell, several genetic 
events need to occur (Hanahan et al., 2000). Thus, to efficiently convert normal primary 
cells into tumourigenic cells, the alteration o f  several oncogenes or tumour suppressors 
needs to be carried out (Land et al., 1983). For example, the expression o f the simian 
virus 40 (SV40) large T antigen (LT) can be used to immortalised primary human 
epithelial or fibroblast cells, which can then be transformed in conjunction with ectopic 
activation o f the telomerase catalytic subunit QiTERT) and an oncogenic allele o f  H-ras 
(Hahn et al. 1999).
In the present study, a cellular model o f breast cancer was chosen to investigate the role 
o f ErbB-2 overexpression in cellular transformation and signalling. Stamps et al. 
developed an immortalised luminal epithelial cell line, HB4a, derived from reduction 
mammoplasty tissue o f a normal subject by flow-sorting (Stamps et al., 1994). As most 
breast cancers arise from the luminal epithelium o f the mammary gland (Bartek et al., 
1991), this cell type is ideal for the study o f  the early stages o f breast cancer. Indeed, the 
cells display several markers o f the luminal epithelial cell type and have a characteristic 
luminal epithelial cellular morphology in culture. These cells were immortalised with a 
temperature-sensitive mutant o f SV40 large T antigen (ts A58-U19) (Jat and Sharp, 
1989). This process o f immortalisation involves the sequestration and inactivation o f the 
tumour suppressor proteins pRb and p53 by the SV40 large T antigen. These proteins 
normally block the cell cycle, and also act as sensors o f cell damage inducing cell cycle 
arrest and apoptosis, given the appropriate stimuli.
In order to better understand the role o f ErbB-2 overexpression in transformation, this 
model human mammary luminal epithelial cell system was engineered to stably 
overexpress ErbB-2 (Harris et al., 1999). In detail, HB4a cell lines were stably 
transfected with a human ErbB-2 cDNA construct and clones were selected by 
fluorescence activated cell sorting (FACS) based on the level o f surface ErbB-2 
expression they showed. A panel o f  cell lines was generated which overexpressed 
various levels o f ErbB-2 (Harris et al., 1999). In this thesis, the parental cell line, HB4a 
and one o f the ErbB-2 overexpressing clones, C3.6, were used to establish the differential 
protein expression profile relating to ErbB-2 overexpression. The C3.6 clone has been
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shown to overexpress surface levels o f ErbB-2 similar to those observed in breast cancers 
(Harris et al., 1999). The C3.6 cells display an altered morphology compared to HB4a 
indicating a loss o f cell-to-cell contact inhibition. In addition, the ErbB-2 overexpressing 
cell lines were shown to display an increased proliferative capacity and showed enhanced 
growth responsiveness to EGF and Hrgp 1, growth factors that are specific for EGFR and 
ErbB-3, respectively. The C3.6 cells were also found to display an increase in 
anchorage-independent growth, as measured by their ability to form colonies on soft agar. 
However, these cells can not form tumours after inoculation into nude or SC ID mice, 
showing that they do not display the phenotype o f a fully transformed cell line (Harris et 
al., 1999). This system is currently being used in our laboratory for biochemical, 
proteomic and microarray analyses in an attempt to establish the cellular defects 
associated with ErbB-2 overexpression.
This model cell system was also used to study the effect o f ErbB-2 overexpression on 
mitogenic signalling and cell cycle progression (Timms et al., 2002). This work showed 
that the C3.6 and HB4a cells were able to activate downstream signalling via the MAPK 
and the PI3K signalling pathways in response to EGF and H rgpl treatment and that the 
ErbB-2 overexpressing cells had enhanced MAPK signalling, but not PI3K signalling. In 
addition, both EGF and H rgpi could induce myc, cyclin D l, cdk6  and cyclin E, known 
activators o f the cell cycle, and this effect was more prominent in the ErbB-2 
overexpressing cells. The cell cycle inhibitor p27kip was also suppressed in the C3.6 
cells, which has been previously shown in other models o f ErbB-2 overexpression (Lane 
et al., 2000;Lenferink et al., 2001). These combined changes induced an increase in cdk2 
activity that promotes more rapid progression through the cell cycle. Together, this prior 
work showed that this cellular model is a valid system for the study o f breast cancer and 
was therefore used here to examine the effects o f  ErbB-2 overexpression on overall 
protein expression and on the response o f luminal epithelial cells to oxidative stress.
1.3 Stress Signalling, ROS and redox regulation
Originally, reactive oxygen species (ROS) were recognised as products o f the 
mammalian host defence mechanism, and early studies focused on the characterisation o f 
the so-called respiratory burst in neutrophils (SBARRA and KARNOVSKY, 1959) and
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the role o f the NADPH oxidase complex, which is now recognised as a primary source o f 
intracellular ROS (Babior, 1999). Apart from this defensive role in phagocytic cells, ROS 
have also been shown to play a role in cell signalling in many diverse biological systems. 
Indeed, ROS can induce programmed cell death (apoptosis) or necrosis, induce or 
suppress the expression o f many genes and activate/inactivate cell signalling cascades, 
such as the mitogen-activated protein kinase pathways (Torres and Forman, 2003). 
Moreover, ROS are believed to play a pivotal role in aging, degenerative diseases, 
immuno-defence and cancer. Based on these reasons, it is important to study the roles and 
mechanisms o f cellular ROS.
1.3.1 Formation of cellular Reactive Oxygen Species (ROS)
ROS are species o f oxygen which are in a more reactive state than molecular oxygen, and 
in which the oxygen is reduced to varying degrees. ROS comprise several species such as 
hydrogen peroxide (H2O2), the hydroxyl radical ( OH), superoxide ( ’ 0 2 ~) and singlet 
oxygen ( O). * 0 2 ~ can be generated by the action o f such enzymes as NADPH oxidase, 
lipoxygenase, cyclooxygenase, cytochrome P450 or through UV irradiation and can be 
converted into H2O2 and O2 by the action o f  superoxide dismutases (SOD) (Figure 1-10). 
H2O2 can be also further converted to OH (a very reactive ROS) in the presence o f Fe2+. 
ROS have been widely reported to play an important role in promoting apoptosis and 
tumourigenesis. For example, ROS have been shown to induce apoptotic proteins, 
whereas antioxidants inhibited this apoptotic effect (Rollet-Labelle et al., 1998;Tanaka et 
al., 1998). However, ROS-induced tumourgenesis has been linked to oxidative DNA 
damage through the generation o f  the DNA oxidative product 8 -oxo-deoxyguanosine, a 
highly mutagenic agent (Floyd, 1990). ROS are also thought to contribute to cancer 
through interference with various signal cascade systems including pathways involving 
nuclear transcription factor kappa B (NFkB), activated protein-1 (AP-1), phospholipase 
A2 (PLA2), mitogen-activated protein kinases (MAPKs), Akt and Jun kinase (Guyton et 
al., 1996a;Bae et al., 1997;Musonda and Chipman, 1998;Manna et al., 1998) (see 1.3.3).
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(Figure 1-10) Metabolic pathways and mechanisms of cellular ROS production and its 
effect on cellular proteins.
Several enzymes are able to produce ROS; the most important o f these is NADPH 
oxidase. NADPH oxidase was first discovered in neutrophils, which following 
stimulation with microorganisms undergo a respiratory burst, with the release of 
superoxide ions into the phagosome (Babior, 1999). In resting cells, NADPH oxidase is a 
heterodimeric plasma membrane-associated protein complex consisting o f two 
polypeptides, p22-phox and gp91-phox, which together make up the flavocytochrome 
b558- gp91-phox contains a FAD group and two haem groups, which together comprise an 
electron transfer module which enables the transfer of electrons from cytosolic NADPH 
to molecular oxygen. However, no NADPH oxidase activity is seen in resting cells and
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other components o f the enzyme must be recruited. These cytoplasmic components are 
p47-phox, p67-phox and p40-phox. Upon stimulation, these polypeptides are 
translocated to the inner surface o f the plasma membrane to form a fully active enzyme 
complex (Babior, 1999). Two small GTPases, Rap and Rac/p21, are also associated with 
NADPH oxidase and are involved in its activation. Rac in the resting state is in 
association with a GDP-dissociation inhibition factor, Rho-GDI, but upon stimulation, 
dissociation takes place and Rac translocates to the plasma membrane where it aids in the 
activation o f the NADPH oxidase complex (Bokoch, 2000).
Whilst NADPH oxidase was first characterized in neutrophils, it is also present in other 
cell types that have no role in host defence. For example, NADPH oxidase components 
have been reported in fibroblasts (Meier et al., 1991), mesangial cells (Radeke et al., 
1991), endothelial cells (Jones et al., 1996), osteoclasts (Steinbeck et al., 1994) and 
chondrocytes (Hiran et al., 1997;Moulton et al., 1997). However, the rate o f  ROS 
generation by NADPH oxidase in many o f these cell types is very low compared with 
that in neutrophils, but such a disparate expression pattern for this enzyme implies a role 
other than in host defence. Indeed, recent work suggests it may play a more general role 
in signal transduction (Torres et al., 2003).
Another source o f ROS is xanthine oxidoreductase or xanthine oxidase (Harrison, 2002) 
(Figure 1-10). This molybdenum- and iron-containing flavoprotein catalyses the 
oxidation o f hypoxanthine to xanthine and then to uric acid. Molecular oxygen is the 
oxidant, and products include superoxide and H2O2 . This enzyme can also produce NO ’ , 
suggesting that it might have a dual role in cellular signalling.
The electron transport system o f mitochondria also produce ROS. Electron transport 
through the mitochondrial respiratory chain is extraordinarily efficient, and normally the 
vast majority o f O2 is consumed. However, 1-2%  o f electrons are leaked to generate ’ 0 2  
in reactions mediated by coenzyme Q and ubiquinone and its complexes. Thus, 
mitochondria are believed to be a major site o f ROS production in vivo (Boveris and 
Chance, 1973). Similarly electron transport in the endoplasmic reticulum generates *0 2 _ 
by the leakage o f electrons from NADPH cytochrome P450 reductase (Cross and Jones, 
1991). Finally, * O2-  is also generated by lipoxygenase, cyclooxygenase and UV
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irradiation o f molecular O2 , whilst cells may also be exposed to extracellular sources o f 
ROS (Figure 1-10).
1.3.2 ROS-dependent protein modifications
Several chemical moieties have been found to be potential regulators o f  cellular redox 
status. One o f these, the free thiol group (RSH) o f cysteine residues is a potent 
nucleophilic agent and can undergo a number o f  redox-induced modifications under 
physiological conditions. Oxidative modifications o f RSH groups other than disulphide 
formation include the formation o f the sulfenic acid (RSOH), sulfinic acid (RSO2H) and 
sulfonic acid (RSO3H) depending upon the oxidative capacity o f  the oxidant ((Schafer 
and Buettner, 2001) and see Figure 1-10). Oxidation o f  RSH groups to sulfinic and 
sulfonic acids is irreversible under physiologic conditions, whilst sulfenic acids were 
thought to exist only as transient intermediates (Hamann et al., 2002). Recently however, 
it has been shown that the formation o f relatively stable protein sulfenates can occur, and 
that these intermediates may play a role in the regulation o f  biochemical pathways and in 
cellular physiology (Willett and Copley, 1996). For example, the crystal structure o f  the 
flavoprotein NADH peroxidase revealed that the protein possesses an active site cysteine 
in the form o f a sulfenic acid (Yeh et al., 1996). It was proposed that stabilization o f the 
active site Cys-SOH was derived from electronic interaction with the flavin moiety, 
coupled with weak interactions with other active site proximal residues. In another 
example, the protein tyrosine phosphatase (PTP-1B) was shown to be inhibited by 
exposure to relatively low concentration o f  hydrogen peroxide, and that this inhibition 
was due to formation o f Cys-SOH at the catalytic Cys residue ((Denu and Tanner, 1998) 
and (Figure 1-10)). Moreover, this Cys-SOH could be shown in vitro to be subject to 
glutathionylation, which protected the Cys-SOH from further oxidation to sulfinic or 
sulfonic acids (Lee et al., 1998) (Figure 1-11).
The cellular redox buffer glutathione (GSH) is present within most cells at a millimolar 
concentration and acts as a first line o f  defense to detoxify ROS (Kosower and Kosower, 
1978). Glutathione peroxidase catalyzes the reduction o f ROS via the oxidation o f the 
GSH thiol to glutathione disulphide (GSSG) and then the GSSG is restored to GSH by 
GSH reductase, an enzyme which uses NADPH for reducing potential (Meister, 1994)
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and (Figure 1-10). In addition, glutathione peroxidase can reduce ROS via the oxidation 
o f the reduced cysteine on various proteins to form mixed disulphides (RSSG) and RSSG 
is restored to RSH by protein disulphide isomerase, glutaredoxin or thioredoxin (Arscott 
et al., 2000) (Figure 1-11). The antioxidative molecule, thioredoxin, is a small 
multifunctional protein that has a redox active disulphide within the conserved active site 
sequence (Holmgren, 1989a;Nakamura et al., 1997). Thioredoxin is capable o f  reducing 
some ROS, including H2O2 , as well as reducing oxidized proteins (Mitsui et al., 1992). 
Oxidized thioredoxin is in turn restored to its reduced form by thioredoxin reductase 
which uses NADPH as a source o f  electrons. In addition, all cells possess the protective 
enzymes, catalase which can degrade H 2O2 to O2 plus H2O. Another family o f  enzymes, 
the peroxiredoxins (Prxns) are required to reduce intracellular peroxides and have been 
shown to suppress tumour formation (Neumann et al., 2003). In humans, the family 
consists o f 6  members, comprising the classical cytosolic 2-Cys peroxiredoxins (Prxns 1- 
5) and the 1-Cys, Prxn-6 . The 2-Cys Prxns contain a redox-sensitive cysteine at the active 
site (Choi et al., 1998) and another conserved cysteine (Hirotsu et al., 1999;Declercq et 
al., 2001). The active site cysteine is oxidized to cysteine sulfenic acid (Choi et al., 1998) 
or to a disulphide with the other conserved cysteine (Chae et al., 1994) when peroxide 
levels are reduced. In order to complete the enzymic catalytic cycle, the peroxiredoxins 
are reduced back to their active thiol form via the thioredoxin/thioredoxin reductase 
system (Chae et al., 1994). Very recently, 2-Cys Prxn has been found to play a signalling 
related role in yeast where it regulates the peroxide induced oxidation and activation o f a 
stress-activated MAP kinase (Sty 1) by forming an intermolecular disulphide bridge (Veal 
et al., 2004).
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(Figure 1-11) Thiol-dependent redox modifications. Cellular thiol containing proteins can be 
modified to different oxidative states which can be revesible or irreversible reactions. The 
reversible redox regulations are always enzyme-dependent. These redox regulatory reactions 
involve the following catalytic enzymes: peroxiredoxins/thioredoxin, glutathione
peroxidase/glutathione S-transferase, protein disulphide isomerase/glutaredoxin/thioredoxin and 
glutathione reductase which are responsible for catalysing the indicated reactions 1, 2, 3 and 4, 
respectively.
1.3.3 R e d o x  re g u la t io n  o f  c e l lu la r  s ig n a llin g
ROS are ideally suited to be signalling molecules as they are small and can diffuse 
quickly through cells. Moreover, there are a number of mechanisms for ROS production, 
some of which are rapid and controllable. In addition, ROS can be also rapidly removed 
through various mechanisms. Many studies have indicated a role for ROS in the 
induction or inhibition o f cell proliferation, in the activation or inhibition o f apoptosis and 
in the induction of necrosis at high concentrations (Gamaley and Klyubin, 1999). 
Reversible protein phosphorylation is a key biochemical event in many cell signalling 
pathways and numerous studies have shown that ROS can significantly affect this protein 
phosphorylation process. For example, several reports have shown that the proteins 
Erkl/2, Akt , p38 and JNK are activated by H2O2 in animal cells (Fialkow et al., 
1994;Guyton et al., 1996b;Blanc et al., 2003;Ruffels et al., 2004), leading to the 
modulation o f gene expression. Importantly, H2O2 has been shown to inhibit 
phosphatases by the direct oxidation o f the active site cysteine in these molecules
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(Sullivan et al., 1994;Wu et al., 1998). For example, the protein-tyrosine phosphatase IB 
(PTP-1B) which can regulate the phosphorylation state o f signalling proteins was found 
to be a target o f H2O2 in cells. Modification o f the catalytic cysteine residue by H2O2 
renders PTP1B inactive leading to increased tyrosine phosphorylation (Lee and 
Esselman, 2002). Thus, H2O2 is now recognized as a secondary signalling molecule in 
cells through its regulation o f protein phosphorylation (Barrett et al., 1999;Finkel, 2000). 
Recent studies have also shown that PTEN plays an important role in redox signalling. 
PTEN normally functions as a PIP3 3'-phosphatase which negatively modulates the PI3K 
signalling pathway to inhibit the proliferation o f cells and promote apoptosis (Maehama 
et al., 2001) and (Figure 1-10). It was shown that cysteine-124 in the active site o f 
human PTEN is a target for exogenous oxidants (such as H2O2) and forms a disulphide 
bridge with Cys-71 (Lee et al., 2002). Moreover, when cells are stimulated with peptide 
growth factors (such as EGF or PDGF), part o f the cellular pool o f PTEN was found to be 
transiently oxidised to the inactive form (Kwon et al., 2004). It was suggested that this 
was due to the generation o f endogenous H2O2 through the activation o f the PI3K 
pathway and subsequent NADPH oxidase via Racl activation. Thus, activation o f PI3K 
by growth factors might not be sufficient to accumulate enough PIP3 for downstream 
signalling due to the antagonistic activity o f PTEN and H2O2 might be needed to inhibit 
PTEN activity to permit PIP3 accumulation. Since PTEN is a known tumour suppressor, 
the modulation o f  PTEN by ROS could be one mechanism by which ROS promotes 
survival and proliferation o f cancer cells (Figure 1-10).
ROS can induce gene expression, and many studies have shown that the expression o f a 
wide range o f genes is regulated by oxidative stress (Allen and Tresini, 2000). For 
example, addition o f H2O2 to cells stimulates expression o f  transcription factors such as 
c-fos, c-jun (AP-1), c-myc, myb and Ets (Amstad et al., 1990;Nose et al., 1991;Myrset et 
al., 1993;Wasylyk and Wasylyk, 1993;Rao et al., 1996) and results in activation o f NF- 
kB through dissociation o f the factor from its inhibitor Ik-B (Schreck et al., 1991). Thus, 
by activating various transcription factors, ROS have the potential to affect the 
expression o f many genes. This response, at least in part, appears to play a cytoprotective 
role since many ROS induced genes are redox protective enzymes such as GST, catalase 
and thioredoxin reductase. Whilst these transcription factor activation events are likely to
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be due to activation o f upstream signalling pathways, perhaps due to protein and lipid 
phosphatase inhibition, some mechanisms o f transcription factor activation by ROS 
appear to be more direct. For example, STAT pathways in animal cells are activated by 
H2O2 (Simon et al., 1998), showing how H2O2 can transduce its message directly into the 
nuclei o f cells. In yeast, the peroxidatic cysteine o f Gpx3 was found to directly induce the 
activation o f the transcriptional factor Y apl in response to H2O2 through the transient 
formation o f an intermolecular disulphide bond with Y apl (Delaunay et al., 2002). Also,
2-Cys Prxn regulates the peroxide induced oxidation and activation o f a stress-activated 
MAP kinase (S ty l) by forming an intermolecular disulphide bridge in yeast (Veal et al., 
2004).
Extracellular growth factors can transduce signals into cells through different signalling 
pathways using RTKs, serine/threonine kinases, phospholipases, Ca2+ and other 
mechanisms (see Section 1.1). Similarly, when cells are exposed to ROS, signals are 
transferred through many o f the same signalling pathways (Kamata and Hirata, 1999). 
Oxidants can activate RTKs (Aslan and Ozben, 2003) and downstream signalling 
molecules such as MAP kinases (Torres et al., 2003), Ras (Lander et al., 1995), PI-3 
kinase and Akt (Park et al., 2004), protein kinase C (PKC) (Inoguchi et al., 2003), 
phospholipase C (Gonzalez-Pacheco et al., 2002) and molecules involved in Ca2+ 
signalling (Mikoshiba, 1997). The activation o f  phospholipase-y by oxidative stress 
increases the cytosolic Ca2+ levels by altering the flux from intracellular Ca2+ pools, such 
as the ER or the extracellular space (Poli et al., 2004). In turn a number o f transcription 
factors become activated, thereby affecting gene expression (Rahman et al., 2004).
It is through their effects on signalling that ROS molecules appear to play the roles o f  
secondary messenagers. Indeed cells activated by extracellular stimuli, are known to 
produce ROS, which in turn modulate diverse signalling pathways. Thus, there is a cross­
talk between signalling systems and the cellular redox state (Poli et al., 2004). The 
current model for ROS production as secondary messengers is that receptor tyrosine 
kinases activated by growth factors cause the activation o f PI3K, the product o f  which, 
namely PtdIns(3 ,4 ,5 )P3, then bind to the PH domain o f  guanine nucleotide exchange 
factors (GEFs) (e.g. Sos, V avl and (3Pix) and stimulate the GDP-GTP exchange activity 
o f GEFs. The activated GEF can convert Rac 1-GDP to Racl-GTP, which binds directly
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to and recruit components o f membrane-bound NADPH oxidase. Thus, the activated 
NADPH oxidase can promote the electron transfer from NADPH to molecular oxygen 
and subsequently mediate the production o f superoxide anions (O2') (Bae et al., 1997;Bae 
et al., 2000;Di-Poi et al., 2001;Price et al., 2002;Park et a l, 2004). These superoxide 
anions (O2 ), or H2O2 produced by superoxide dismutase, can then activate signalling 
kinases through unknown mechanisms, possibly through phosphatase inhibition or direct 
activation by peroxidases, leading to the activation o f downstream transcription factors 
which then regulate gene expression to promote cell survival and proliferation (Guyton et 
al., 1996b). Conversely, other studies have shown that oxidative stress promotes 
apoptosis (Curtin et al., 2002) and can occur through the production o f  ceramide (Verheij 
et al., 1996) that can activate JNK (Ishikawa et al., 1997) and p53 (Yin et al., 1998). 
Thus, the role o f ROS in inducing cell death or survival is uncertain and the end effects 
rely on the cross-talk and balanced regulation o f many signalling pathways.
With regard to tumour development, ROS have been considered as DNA-damaging 
agents that increase the mutational rate and promote oncogenic transformation (Jackson 
and Loeb, 2001). In addition, an elevated oxidative status has been found in many types 
o f cancer cells, with ROS activating signalling cascades that induce and maintain the 
oncogenic phenotype (Behrend et al., 2003). ROS may also lead to the stabilisation and 
activation o f H IF -la , a transcription factor controlling tumour angiogenesis under 
normoxic or hypoxic conditions via the p42/p44 MAPK pathway (Richard et al., 1999). 
Interestingly, the elimination o f excessive ROS by chemical (Mukhopadhyay-Sardar et 
al., 2000) or enzymatic (Lam and Reprecht, 1994) antioxidants decreases the 
tumourigenicity o f various types o f cancer cells, possibly offering new strategies for 
cancer therapy. One o f  the antioxidant enzymes with anti-tumour activity is the 
mitochondrial protein, MnSOD, which has been shown to retard the growth o f tumours 
when overexpressed in rat glioma cells and human oral carcinoma cells (Zhong et al., 
1996;Liu et al., 1997). Moreover, MnSOD expression is found to be lowered in cancer 
cells compared with normal control cells (Oberley and Oberley, 1988). This infers that 
tumour cells have the capacity to produce more superoxide radical, the substrate for 
MnSOD and this may be a general characteristic o f  tumour cells.
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1.4 Redox proteomics
A wealth o f knowledge exists, which indicates that ROS play critical roles in regulating 
cell behavior through the modification o f protein molecules (Moran et al., 2001). 
However, compared with the knowledge accumulated from extensive proteomic studies 
on phosphorylation, relatively little is known about the extent o f redox modifications o f 
proteins. As outlined above, reactive oxygen species (ROS) and reactive nitrogen species 
(RNS) cause various types o f chemical modifications to proteins. Such modifications are 
often irreversible (sulphonation, carbonylation, nitration or protein-protein cross-linking), 
are associated with permanent loss o f protein function and may lead to the accumulation, 
degradation or aggregation o f the damaged or modified proteins. Some modifications are 
reversible (S-nitrosylation or glutathionylation), and appear to play a role in protecting 
cysteines from irreversible oxidation and in regulating the redox status o f  cells (Ghezzi 
and Bonetto, 2003). In the following paragraphs, the techniques available for identifying 
proteins based on their redox status is described, in particular methods for identifying 
changes in the thiol-disulphide chemistry o f  cysteine residues and for identifying protein 
glutathionylation.
Most redox studies have made use o f maleimide or iodoacetyl derivatives o f fluorescent 
or biotinylated reagents which react with free thiol groups to covalently tag the protein. 
Such reagents include: monobromobimane (Berggren et al., 2001), (4-iodobutyl) 
triphenyl-phosphonium (Lin et al., 2002), maleimidobutyrylbiocytin (Garant et al., 1999), 
Oregon green maleimide (Essex et al., 2001), N-biotinoylaminoethyl 
methanethiosulfonate (Ennion and Evans, 2002), N-biotinoyl-N-(maleimidihexanoyl) 
hydrazine (Hare and Lee, 1989), fluorescein-5-maleimide (Birge et al., 1991), N- 
(biotinoyl)-N-(iodoacetyl) ethylendiamine (Kim et al., 2000), NEM-biotin (Lind et al., 
2002) and N-(6-(biotinamido)hexyl)-39-(29-pyridyldithio) propionamide (Jaffrey et al., 
2001a) and maleimide derivates (Yamamoto and Sekine, 1978;Jaffrey et al., 2001b). 
Since oxidation o f a thiol would prevent its labelling by these reagents, they can be used 
in comparative 2DE studies to detect loss o f free thiols due to oxidation. To detect 
disulphides, one approach has been to block all free thiols with iodoacetamide or NEM, 
then to reduce the disulphides and detect the new free thiols with the thiol reactive 
reagents described above. In addition, by using different reductants, the specific form o f
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oxidation (thiolation, S-nitrosylation or glutathionylation) has been inferred. For 
example, ascorbate can reduce S-NO (Jaffrey et al., 2001a), whilst thioredoxin can be 
used to reduce protein disulphide bonds (Yano et al., 2001).
Formation o f mixed disulphides in cell systems can occur by sulfhydryl oxidation or by 
thiol-disulphide exchange (e.g. glutathionylation). The reactions below show the 
formation o f a mixed disulphide:
Protein-SH + GSH + H2O2 (or NO) Protein-S-S-G + H2O 
Protein-SH + GSSG-^  Protein-S-S-G + GSH
Whilst intra- or intermolecular disulphides can be reduced by thioredoxin, the 
glutathionylated disulphide complexes (Protein-S-S-G) are reduced by glutaredoxins 
(Holmgren, 1989b). Many proteins including enzymes, transcription factors and 
cytoskeletal proteins have been identified as glutathionylated proteins and the activity o f 
some o f these appears to be regulated by glutathionylation (Cotgreave and Gerdes, 
1998;Klatt and Lamas, 2000). Although glutathionylation often occurs during oxidative 
stress, many proteins may be glutathionylated under normal physiological conditions. In 
fact, the amount o f glutathione present as a mixed disulphide with proteins is 20-30 
nmol/g in liver tissue (approximately 4-6% o f total protein) (Brigelius et al., 1983). 
Several methods have been used to identify glutationylated proteins in living cell 
systems. One method involves metabolically labelling cells with 35S-cysteine in the 
presence o f high concentrations o f cycloheximide (Rokutan et al., 1991). This technique 
allows labelling o f the intracellular GSH pool, but avoids the incorporation 35S-cysteine 
into newly synthesized proteins. Labelled cell lysates can then be resolved by 2DE for 
further analysis. Another method to analyse glutathionylated proteins is by alkylation o f 
free thiols with NEM, specific reduction o f protein-glutathione mixed disulphides by 
glutaredoxin and then labelling the newly formed thiols with NEM-biotin. Proteins can 
then be enriched by affinity purification and analysed by 2DE (Lind et al., 2002). 
Glutathionylated proteins have also been enriched on GSH or GSNO-sepharose columns 
(Klatt et al., 2000) and have been detected by immunostaining with specific antibodies 
(Wang et al., 2001).
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S-nitrosylation o f proteins is also an important mechanism o f redox regulation and is a 
means by which NO can modulate the activity o f proteins (Jaffrey et al., 2001a). This 
modification is reversible and can be reduced in vitro by ascorbic acid, GSH (Kashiba- 
Iwatsuki et al., 1997) or thioredoxin (Nikitovic and Holmgren, 1996). S-nitrosylation o f 
proteins has been detected by blocking free thiols with methanethiosulfonate, which 
cannot react with nitrosothiols; then nitrosothiols are reduced to thiols with ascorbate and 
the newly formed thiols are derivatized with a biotinylated thiol reagent for detection by 
immunoblotting o f 2D gels (Jaffrey et al., 2001a).
ROS-mediated protein carbonylation is an important marker o f oxidative damage. 
Carbonyl groups may be introduced into a protein at different sites and its extent has been 
correlated with neurodegenerative diseases and aging (Stadtman and Berlett, 
1997;Butterfield and Kanski, 2001). Protein carbonylation occurs via direct oxidation o f 
the protein backbone leading to fragmentation producing polypeptides with an N-terminal 
alpha-ketoacyl amino acid residue (Stadtman et al., 1997) which can be detected in a 
colorimetric assay using 2, 4-dinitrophenylhydrazine (DNPH) (Levine et al., 1990).
The nitration o f tyrosine residues to form 3-nitrotyrosine (3-NT) is the most studied case 
o f protein nitration and is considered as a marker o f irreversible protein modification by 
peroxynitrite (Beckman, 1996). Increased levels o f 3-NT have been shown in various 
diseases such as Alzheimer’s disease, Parkinson’s disease and atherosclerosis and can be 
detected by immunoblotting with specific anti-3-NT antibodies (Ye et al., 1996).
1. 5 Aims of this study
The aim o f this study was to develop a method to detect cysteine-labelling changes for 
use in protein expression profiling and to apply 2D-DIGE to study redox regulation o f 
proteins. In order to apply the cysteine specific ICy dye technique to 2D-DIGE, it was 
first necessary to establish the optimal labelling conditions (temperature, denaturant, 
reductant and so on) using standard proteins and total cell lysate samples. After 
optimising these labelling conditions, the cysteine labelling strategy would then used to 
probe for targets o f cellular oxidative stress (H2O2 treatment) in human luminal epithelial 
cells expressing normal levels o f the receptor tyrosine kinase ErbB-2 and a derivative 
overexpressing this receptor. These experiments would therefore test the effects o f
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overexpression o f an oncogenic RTK on redox stress responses which may be linked to 
tumour progression. It is expected that any changes in labelling are caused either by 
differential protein expression or from the exchange o f reactive thiol groups into higher 
oxidative states that prevent reactivity with the ICy dyes. Proteins displaying differential 
labelling would then be picked from 2D gels for identified by MALDI-TOF-MS with 
further validation o f  changes, carried out by 1-D and 2-D immunoblotting. In addition, 
identification o f labelled peptides by MS would be used to identify sites o f modifications. 
Finally, the cysteine labelling 2D-DIGE strategy will be applied to the study o f EGF 
induced alteration in thiol reactivity and to study the effects o f UV on thiol reactivity in 
purified human serum samples.
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Chapter 2: MATERIALS AND METHODS
All chemicals, solvent and reagents were purchased from Sigma-Aldrich Company Ltd., 
UK, unless otherwise stated.
2.1 Cy dyes
The NHS-Cyanine dyes (Cy2, Cy3, Cy5) were purchased from GE Healthcare. 
Subsequently NHS-Cy3/Cy5 and ICy3/ICy5 were synthesised “in-house” by Dr. P. 
Gaffney (Appendix A). Cyanine dye stock solutions o f 1 mM in dimethyl formamide 
(DMF) could be kept at -20°C for at least 4 months without loss o f labelling efficiency. 
Cyanine dye dilutions for labelling were made fresh in DMF and kept in the dark and on 
ice prior to use.
2.2 Tissue Culture
2.2.1 Cell Growth
HB4a, C3.6 and other clones derived from the HB4a cell line, were obtained from Dr. 
M. O ’Hare as described (Harris et al., 1999). They were maintained in 1640 RPMI 
media containing 10% (v/v) foetal calf serum (FCS), supplemented with L-glutamine (2 
mM), streptomycin (100 pg/ml), penicillin (100 IU/ml) (all purchased from Gibco- 
Invitrogen Corp. , UK), insulin (5 |ig/ml) and hydrocortisone (5 pg/ml) in tissue culture 
dishes at 37°C in a 10% CO2 humidified incubator. Cells were passaged when they 
reached 70 to 80% confluence by trypsinisation according to standard procedures.
Stocks o f luminal epithelial cells were stored in liquid nitrogen and new batches o f  low 
passage cells were used after 25 passages in order to avoid potential genetic drift, which 
can occur during prolonged passaging o f  cells. For freezing, trypsinised cells were 
pelleted and resuspended in 10% (v/v) DMSO in 90% (v/v) FCS. Cells were slowly 
taken to -70°C  in a propanol container and then transferred to liquid nitrogen for long­
term storage. Rapid thawing was carried out in a 37°C water bath and excess DMSO was 
removed by centrifugation prior to plating. Cells were allowed to recover for three 
passages prior to sampling.
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2.2.2 Cell treatment with EGF and hydrogen peroxide
For EGF treatment, cells were first serum-starved in 0.1% (v/v) FCS in 1640 RPMI 
media supplemented with L-glutamine (2 mM), hydrocortisone (5 pg/ml) and antibiotics 
for 48 hours. They were then treated with 1 nM ( 6  ng/ml) o f EGF (R&D system) for 15 
min.
For hydrogen peroxide treatment, cells in 10 cm dishes at -80%  confluence were treated 
with hydrogen peroxide (H2O2) at 0.5 mM final concentration by addition to the growth 
media. Cells were harvested after the indicated times.
2.3Sample preparation
2.3.1 Labelling of standard proteins
Standard proteins used in this study were: bovine serum albumin (BSA); chicken 
ovalbumin (Ova); S. japonicum glutathione S-transferase (GST); bovine a-crystallin ( a  - 
Crys) A and B chains; and horse myoglobin (Myo). All proteins were from Sigma except 
GST, which a gift from Dr. Ivan Gout (LICR). It was expressed in E. coli and purified 
on glutathione sepharose beads according to standard procedures. Standard proteins were 
solubilised in denaturing ICy 2D lysis buffer (4% (w/v) CHAPS, 8  M urea, 10 mM Tris- 
HC1, pH 8.3, 1 mM EDTA) as an equimolar mixture containing 2 pmol o f each protein. 
Labelling with ICy3/5 was carried out at the indicated dye to protein ratios for 1 h on ice 
in the dark, after which the samples were reduced with dithiothreitol (DTT) at 65 mM 
prior to gel analysis. In some cases, samples were first reduced with DTT, acetone 
precipitated and resolubilised in 2D lysis buffer prior to ICy labelling. For NHS-Cy dye 
labelling, routinely, standard proteins prepared in denaturing NHS-Cy dye 2D lysis buffer 
( 8  M urea, 2 M thiourea, 4% (w/v) CHAPS, 0.5% NP-40 (w/v), 10 mM Tris-HCl pH 8.3) 
were “minimally” labelled with dye to protein ratios o f normally 4 pmol o f dye/pg o f 
protein unless otherwise stated. Labelling was performed on ice in the dark for 1 h and 
reactions were quenched with a 2 0 -fold molar excess o f free lysine to dye for 1 0  min on 
ice in the dark.
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2.3.2 Labelling of total cell lysates
Cells were washed twice in 0.5X PBS (Invitrogen), drained well and lysed in ICy 2D 
lysis buffer (see above) without reductant. Samples were homogenized by passage 
through a 25-gauge needle ( 6  times) and insoluble material removed by centrifugation 
(13, 000 rpm/10 min/4°C). Protein concentration was determined using the Coomassie 
Protein Assay Reagent (Pierce). Typically, 2 pi o f protein sample is mixed in 200 pi o f 
the assay reagent, followed by measuring the absorbance at 595 nm. The sample 
concentation is further calculated by comparing the values from standard proteins. For 
labelling, extracts were labelled with 80 pmol/pg o f ICy3/5 on ice in the dark for 1 h and 
reactions quenched with DTT at a final concentration o f 65 mM. For NHS-Cy labelling, 
4 pmol/pg o f dye were used, and reactions were quenched with a 20-fold molar excess o f 
lysine to dye, prior to addition o f DTT. For 2D-DIGE redox experiments, cells were 
lysed in the presence o f ICy dye for rapid labelling and to limit post-lysis thiol 
modification. Since ICy dye interferes with the protein assay, protein concentrations 
were determined on replica lysates not containing dye. Test samples (control or H2O2 
treated) were labelled with ICy5 and mixed with an equal amount o f ICy3-labelled 
standard pool, prepared by mixing equal amounts o f protein from all samples. 
Experiments were also performed where the dye labelling was swapped. Volumes were 
adjusted to 350 pi with lysis buffer containing DTT (65 mM final) and carrier 
Ampholines/Pharmalytes (50/50 V/V) (GE H ealthcare) (pH 3-10) added to a final 
concentration o f 2%. Labelled samples were mixed prior to protein separation by gel 
electrophoresis. All gels were cast and run at the same time.
2.4 One- and Two-dimensional Gel Electrophoresis
Cy dye-labelled proteins in Laemmli sample buffer (50 mM Tris pH 6 .8 , 10% (v/v) 
glycerol, 2% SDS (w/v), 0.1% (w/v) bromophenol blue) were separated by IDE 
according to standard procedures, except that samples in urea-containing buffer were not 
boiled and low-fluorescence glass plates were used. For 2D SDS-PAGE, 18 cm, non­
linear pH 3-10 Immobilised pH gradient (IPG) strips (GE Healthcare) were rehydrated 
with Cy-labelled samples in the dark at room temperature overnight, in a reswelling tray 
according to the manufacturer’s guidelines. Isoelectric focusing was performed on a
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Multiphor II (GE H ealthcare) apparatus for a total o f 80 kVh at 20 °C. Strips were 
equilibrated for 10 min in 50 mM Tris-HCl pH 6 .8 , 6 M urea, 30% (v/v) glycerol and 2 % 
(w/v) SDS containing 65 mM DTT and then for 10 min in the same buffer containing 240 
mM iodoacetamide (IAM). Equilibrated IPG strips were then transferred onto 1.5 mm 
thick 18 X 20 cm 12% polyacrylamide gels cast between low-fluorescence glass plates. 
In some experiments, gels were bonded to the inner surface o f one plate at casting by pre­
treatment with bind-silane solution (80% ethanol, 2% acetic acid, 0.08% Plus One Bind- 
Silane (GE Healthcare)) according to the manufacturer's protocol. Strips were overlaid 
with 0.5% (w/v) low-melting point agarose in running buffer with bromophenol blue. 
Gels were run in Protean II tanks (BioRad) at 10 mA per gel at 10°C until the dye front 
had run off the bottom. All steps were carried out in a dedicated clean room.
2.5 Detection of Dye-labelled Proteins
IDE and 2DE were scanned between low-fluorescence glass plates using either a CCD- 
based 2920 2DMaster Imager with PixCel software or a Typhoon™ 9400 multicolour 
fluorescence scanner using ImageQuant software (both (GE Healthcare)). Excitation and 
emission wavelengths used are shown in Table 2.1. The exposure time 
(2DMasterImager™) or photomultiplier tube voltage (Typhoon™) was adjusted on each 
channel (Cy2, Cy3 and Cy5) for preliminary low-resolution scans (1000 pm) to give 
maximum pixel values within 10% for each Cy image but below the saturation level. 
These settings were then used for high-resolution (100 pm) scans. Images were exported 
as tif  files for image analysis.
2.6 Image analysis
Images were curated and analysed using Melanie IV (Swiss Institution o f Bioinformatics) 
or DeCyder™ software (GE Healthcare). Differences were also detected by overlaying 
psedo-coloured images in Adobe Photoshop (Adobe Systems Inc.) which were used for 
display purposes only. For DeCyder analysis, the DIA module was first used to define 
spot boundaries and to measure normalised spot volumes o f ICy3- and ICy5-labelled 
features for calculation o f difference ratios for samples run on the same gel. Features 
resulting from non-protein sources (e.g. dust particles and scratches) were filtered out as
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much as possible using the exclusive filter based on low-area, volume and shape. The 
BVA mode o f DeCyder was then used to match all pair-wise image comparisons from 
DIA for comparative cross-gel statistical analysis. User intervention was required at this 
stage to set landmarks on gels for accurate cross-gel matching and to match as many 
spots as possible. Comparison o f test spot volumes with the corresponding standard spot 
volumes gave a standardised abundance for each matched spot and values were averaged 
across triplicates for each experimental condition and data plotted graphically within 
BVA. Stastical analysis was performed and spots displaying a >1.5 average-fold increase 
or decrease in abundance and with p  values <0.05 from a student T-test were selected for 
analysis.
Excitation (nm) Emission (nm)
Cy2 480 530
Cy3/ICy3 540 590
Cy5/ICy5 620 680
CCB 620 680
(Table 2-1) Excitation and emission wavelengths used for the detection of each cyanine dye 
and Colloidal Commassie blue stain.
2.7 Protein-staining
Silver staining and colloidal Coomassie blue G-250 staining (CCB) were used to 
visualise gel separated Cy dye-labelled proteins. For silver staining o f non-bonded gels, 
a mass spectrometry-compatible method was used (Shevchenko et al., 1996). Briefly, 
gels were fixed for >3 h in fix solution (40 % methanol, 7.5 % (v/v) acetic acid) and 
washed twice for 15 min each in ddFUO. Gels were sensitised in 0.02% (w/v) sodium 
thiosulphate for 1 min and washed twice in ddFhO for 1 min each. Gels were then 
incubated for 30 min in 0.15% (w/v) silver nitrate at 4°C and washed twice in ddFhO for 
1 min each before developing in 2 % (w/v) sodium carbonate with 0 .0 2 % (v/v)
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formaldehyde. Staining was quenched with 5% (v/v) acetic acid and gels were stored in 
1% (v/v) acetic acid at 4°C for spot picking and MS.
For CCB staining, a modified version o f the protocol by (Neuhoff et al., 1988) was used. 
Bonded gels were fixed in 35% (v/v) ethanol with 2% (v/v) phosphoric acid for >3 h on a 
shaking platform and washed three times for 30 min each in ddFkO. They were then 
incubated in 34% (v/v) methanol, 17% (w/v) ammonium sulphate and 3% (v/v) 
phosphoric acid for 1 h prior to the addition o f 0.5 g/L Coomassie G-250 (Merck) and left 
to stain for 2-3 days. No destaining step was required. Post-stained gels were imaged on 
a BioRad GS-800 calibrated densitometer (silver and CCB) or Typhoon™ 9400 scanner 
using the red laser and no emission filters (CCB).
2.8 Spot Picking and In-gel Digestion
Post-stained images were matched with Cy dye images using DeCyder or Melanie IV 
software and a pick list o f coordinates created for spots o f interest relative to a pair o f 
reference markers fixed to the glass plates at casting. Spots were excised using an Ettan 
automated spot picker (GE H ealthcare) with a 2 mm picking head from gels submerged 
under 1-2 mm o f ddH2 0 . Spots were collected in 96-well plates, drained and stored at - 
20°C prior to MS analysis. In some experiments, spots were picked without post-staining 
using coordinates from the ICy-labelled image.
For in-gel digestion, gel pieces were washed three times in 50% acetonitrile, dried in a 
SpeedVac for 10 min, reduced with 10 mM DTT in 5 mM ammonium bicarbonate pH 8 . 
0 (AmBic) for 45 min at 50°C and then alkylated with 50 mM IAM in 5 mM AmBic for 1 
h at room temperature in the dark. Gel pieces were then washed three times in 50% 
acetonitrile and vacuum-dried before reswelling with 50 ng o f modified trypsin 
(Promega) in 5 mM AmBic. The pieces were then overlaid with 10 jul o f 5 mM AmBic 
and trypsinised for 16 h at 37°C. Supernatant was collected and peptides were further 
extracted twice with 5% trifluoroacetic acid in 50% acetonitrile and the supernatants 
pooled. Peptide extracts were vacuum-dried and resuspended in 5 pL ddH 2<3 and stored 
at -20°C prior to MS analysis.
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2.9 Protein Identification by MALDI-TOF-MS
Matrix-assisted laser desorption/ionization (MALDI) MS with peptide mass mapping was 
used for protein identification. Typically, 0.5 pi o f the tryptic digest was mixed with 1 pi 
o f matrix solution (saturated aqueous 2, 5-dihydroxybenzoic acid) and spotted onto a 
sample target plate and dried. MALDI mass spectra were acquired using an Ultraflex 
TOF/TOF mass spectrometer (Bruker Daltonics) in the reflector mode. The mass 
spectrometer was calibrated using a standard mixture o f peptides (calibration mixture 2  
from the Sequazyme kit, Applied Biosystems). Internal calibration o f  each spectrum was 
carried out using the trypsin autolysis peaks at m/z 842.51 and m/z 2211.10. Prominent 
peaks in the mass range m/z 500-5000 were used to generate a peptide mass fingerprint 
which was matched against the updated NCBI database using Protein Prospector version 
3.4.1 MS-Fit (University o f California, San Francisco, USA) and Mascot (Matrix 
Sciences L td .). A positive identification was accepted when a MOWSE score value o f a 
protein is higher than the threshold MOWSE value (p<0.05) with mass error o f ±50 ppm 
allowing 1 missed cleavage and a minimum o f  6  peptide masses matched to a particular 
protein. The protein hit also had to be in agreement with the molecular weight o f the 
detected gel spot and the searched masses o f Cy dye labelled motifs and be the human 
sequence.
2.10 Immunoblotting
Immunoblotting was used to validate expression differences and protein identities where 
antibodies were available. Briefly, cell extracts were separated by IDE or 2DE and 
electro-blotted onto polyvinylidene fluoride membrane (Immobilon P, Millipore) in a 
transfer tank using transfer buffer (195 mM glycine, 25 mM Tris, 20% (v/v) methanol). 
Membranes were blocked for lh  with 5% (w/v) low fat milk in Tris buffered saline (50 
mM Tris pH 8 , 150 mM NaCl) with 0.1% Tween-20 (TBS-T). Membranes were 
incubated for > 1 h in primary antibody solution in TBS-T. All o f antibodies used in this 
thesis listed in Table 2-2. Membranes were washed in TBS-T (3X 10 min) and then 
probed with the appropriate horseradish peroxidase-coupled secondary antibody (GE 
H ealthcare). After further washes in TBS-T, immunoprobed proteins were visualised 
using enhanced chemiluminescence (PerkinElmer Life Sciences Inc). Films were
67
scanned on a BioRad GS-800 densitometer and matched to ICy dye images using Adobe 
Photoshop.
Primary antibody
molecular
weights
(rainbow
markers)
company
monoclonal/poly
clonal
working 
conc. for 
WB
14-3-3 O (Ab-1) 28 Oncogene rab pAb 1 2000
Akt 60 CST/NEB rab pAb 1 2000
Akt anti-phospho(Ser473) 60 Cell Signaling Technology mo mAb 1 2000
Cyclophilin A 19 Upstate rab pAb 1 5000
Cytokeratin 10 59 Progen mo mAb 1 2000
Cytokeratin 6 53 Sunhil Lakhani mo mAb 1 10000
Cytokeratin 7 51 Progen mo mAb 1 10000
GST (B-14) sc-138 26 St Cruz mo mAb 1 2000
HSP-27 27 Stressgen Biotech. mo mAb 1 3000
HSP-60 60 Stressgen Biotech. mo mAb 1 10000
HSP-70 70 sigma mo mAb 1 10000
Ly-Rho GDI 28 St Cruz goat pAb 1 1000
MEK1/2 45 CST/NEB rab pAb 1 2000
MEK1/2 (anti-phospho Ser217/221) 45 CST/NEB rab pAb 1 2000
Mn SOD 20 Upsate rab pAb 1 2000
p38 MAPK 38 CST/NEB rab pAb 1 2000
p38 MAPK (anti-phosphoT180/Y182) 38 CST/NEB rab pAb 1 1000
PDI 57 Stressgen Biotech. rab pAb 1 5000
Peroxiredoxin 2 29 Ewald Schroder rab pAb 1 5000
Peroxiredoxin 6 25 Ewald Schroder rab pAb 1 5000
Peroxiredoxin Kit (I-VI) 17-27 Lab Frontier rab pAb all 1:2000
Phospho-tyrosine, clone 4G10 N/A UBI mo mAb 1 5000
Prohibitin 30 LAB VISION mo mAb 1 5000
Ran (Gor) 24 Gorlich Lab rab pAb 1 20000
SAPK/JNK 54 CST/NEB rab pAb 1 2000
SAPK/JNK( anti-phosphoT183/Y185) 54 CST/NEB rab pAb 1 1000
TCP-1 beta 57 Stressgen Biotech. rat mAb 1 5000
(Table 2-2) List of antibodies used in this thesis for the validation of differential protein 
expression analysis.
2.11 Quantitative determination of free thiols (Ellman’s test)
Measurement o f free thiols was determined using the Ellman test (Riddles et al., 1979) 
with minor modifications. Briefly, DTNB buffer was prepared by dissolving 40 mg o f 
DTNB (5, 5-dithiobis-2-nitrobenzoate) in 10 ml o f 0. 1 M sodium phosphate buffer (pH 
8.0) i.e. 10 mM final concentration. 100 pi o f each freshly prepared sample were diluted 
with 2800 pi o f 0. 1 M sodium phosphate buffer (pH 8.0) and 100 pi o f lOmM DTNB 
reagent added and left to incubate at RT in the dark for 15 min and then the absorbance
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measured at 412 nm using a 1 cm cuvette in spectrophotometer CE-2041 (CECIL C o .). 
For preparing a reference solution, 100 pi o f DTNB buffer was added to 2900 pi o f 0.1 
M sodium phosphate buffer (pH 8.0) and the absorbance measured. The concentration o f 
sulfhyalryl groups was calculated using the following equation; [SH] = [A412 (sample)- 
A412 (reference)] / 13650.
2.12 Cell proliferation assay (MTT assay)
HB4a and C3.6 cells growing exponentially were chosen for trypsinisation and counted 
using a heamocytometer. Cells (200 pl/well) were seeded into 96-well plates at 2.5*104 
and lxlO4 cells/ml for HB4a and C3.6, respectively, to control for the faster growth o f 
the C3.6. The cultures were then incubated for 24 h before treated with 0.5 mM H2O2 for 
20, 60, 240, 480 and 720 min or left untreated. After removal o f the medium, 50 pi o f 
MTT working solution (1 mg/ml) (Sigma) was added to the cells in each well, followed 
by a further incubation at 37 °C for 4 h. The supernatant was carefully removed, 100 pL 
o f DMSO was added to each well and the plates vibrated for 20 min. The absorbance o f 
samples was then measured at a wavelength o f 540 nm in multiplate reader (Molecular 
Devices) and data ploted using Excel (Microsoft Co.).
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Chapter 3 OPTIMISATION AND CHARACTERISATION  
OF CYSTEINE LABELLING 2D-DIGE
3.1 Introduction
Global differential protein expression analysis is a powerful tool for defining protein 
changes between two or more cellular states and has been used to identify proteins 
involved in various diseases and cellular functions. Traditionally, 2DE has been used for 
large-scale protein separation and comparison o f protein expression across different 
biological samples. In conventional 2DE, gel-separated features are visualised mainly 
using post-electrophoretic staining methods such as silver staining, coomassie blue 
staining or non-covalent fluorescent staining. However, many protein detection methods 
have problems such as poor linear dynamic range o f  detection (silver staining and 
coomassie blue staining), variable staining from gel to gel (silver stain) or are hazardous 
to use (metabolic radio isotope labelling). To overcome these problems, Unlu and co­
workers described a novel strategy for differential protein expression analysis using 
covalent modification o f protein lysine residues with fluorescent tags (Unlu et al., 
1997b). In their original study, this new approach allowed the direct comparison o f two 
samples on the same 2D gel through differential labelling with spectrally distinct 
fluorescent dyes. This strategy produced directly superimposable images to facilitate 
comparison o f spot intensities and eliminate gel-to-gel variation. Another advantage o f 
this strategy was that these fluorescent tags have a broader linear dynamic range o f 
detection that is superior to non-fluorescent protein detection methods such as silver 
staining or coomassie blue staining (Patton, 2000). Therefore, the use o f these covalent 
fluorescent dyes should increase the sensitivity o f detection, as well as allowing accurate 
quantification o f low-abundance and high-abundance proteins in the same gel. This 
methodology was later commercialised by GE Healthcare as difference gel 
electrophoresis (DIGE) which was evaluated in two published studies (Tonge et al., 
2001;Gharbi et al., 2002). This lysine labelling strategy uses three fluorescent dyes 
(NHS-Cy3, -Cy5 and -Cy2) to label experimental samples. A Cy2-labelled pool o f all 
samples is typically used as an internal standard which is run on all gels for comparison 
with Cy3- and Cy5-labelled test sample pairs to facilitate cross-gel quantitative analysis.
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This labelling strategy uses a low dye to protein stoichiometry (4 pmol dye/pg protein) to 
reduce alterations in electrophoretic mobility and to prevent losses due to sample 
insolubility. Figure 3-1 shows the heterogeneous labelling o f standard proteins using 
NHS Cy dye lysine labelling at increasing dye to protein ratio. As more protein is 
labelled, multiple molecular weight isoforms appear, which would complicate 2D spot 
patterns. Thus, the sensitivity o f the minimal labelling method is limited and has been 
reported to be lower than conventional silver staining (Tonge et al., 2001;Patton et al., 
2002). Furthermore, as only approximately 4% o f protein is labelled, the other 96% runs 
with a slightly higher mobility during SDS-PAGE (-500 Da). For low molecular weight 
proteins, this creates a problem for spot excision for MS analysis; therefore, post-staining 
and further spot matching between the fluorescent image and the post-stained image are 
required. To facilitate direct spot picking and to improve sensitivity, it would be 
preferable to label an alternative, less prevalent amino acid residue at higher 
stoichiometry. One such amino acid is cysteine, which has the chemistry amenable to 
chemical modification through reaction with its thiol group. Although fluorescent 
biotinylated or radiolabelled thiol alkylating reagents have been used in various studies, 
their potential as DIGE reagents had not yet been realized and so the primary goal o f this 
project was to develop a 2D-DIGE strategy for optimal labelling o f free thiol groups. 
Toward this goal, Dr. Piers Gaffney (Imperial College London) synthesized a pair o f 
iodoacetylated derivates o f the fluorescent cyanine dyes, termed ICy3 and ICy5 (Figure 
3-2 and see Appendix A). These dyes are spectrally distinct, but charge and size matched 
allowing specific fluorescence detection o f differentially labelled, but co-migrating 
proteins on the same 2DE. Since the target o f  the ICy dyes is the thiol group o f  cysteine 
residues and because these alkylating reagents should not be able to label oxidized forms 
o f the thiol group, these dyes also have potential use as probes to monitor changes in 
cysteine thiol oxidation in response to oxidative stress or growth factor induced ROS 
production. In this chapter, a description o f the optimisation and characterisation o f ICy 
cysteine labelling is presented. A workflow is established for further application in the 
examination o f proteomic changes in a model system o f ErbB-2 dependent breast cancer.
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(Figure 3-1) NHS-Cy dye labelling at increasing dye to protein ratios. Labelling of a standard 
mixture of proteins at increasing molar ratios of NHS-Cy5 dye to standard proteins. An equimolar 
mixture (2 pmol each for IDE; 200 pmol each for 2DE (dye to protein ratio 5:1))  of BSA, Ova, 
GST, a-Crys A/B and Myo in 2D lysis buffer was labelled at the indicated molar ratios for 1 h on 
ice. Reactions were quenched with free lysine and proteins resolved by 12% IDE (left panels) 
and 2DE (middle and right panels). Also the corresponding coomassie blue stained 1DE and the 
silver stained 2DE are shown in the bottom left and right panels, respectively.
ICy3
c 34h 45n 3o i
MW: 638.26 
Ex/Em: 553/572 nm
ICy5
C34H43N3OI \
MW: 636.26 I
Ex/Em: 648/669 nm 0
(Figure 3-2) Structure of the matched lCy3 and ICy5 iodoacetylated cyanine dyes.
Chemical formulas, molecular weights and excitation/emission wavelengths are shown. (The 
synthesis of these reagent is outlined in Appendix A).
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3.2 Optimisation of an ICy dye-labelling strategy for proteomics
3.2.1 Effect of time and temperature on ICy dye-labelling
ICy dye labelling was first characterised on standard proteins and total lysates from 
m ammary luminal epithelial cells. Preliminary 1D-SDS-PAGE experiments revealed that 
labelling with ICy3 or ICy5 at 80 pmol/p,g protein (a molar ratio o f  -5 :1  for a 60 kDa 
protein) in non-reducing 2DE lysis buffer ( 8  M  urea, 4%  CHAPS, 10 m M  Tris pH 8.3, 1 
m M  EDTA) reached a plateau within 5-10 min at 0 °C. Two o f  the ICy3/5 labelled bands 
from total cell lysates w ere quantified using ImageQuant 5.2 (GE Healthcare) (Figure 3- 
3A). A bout 80% and 95% o f saturation was reached in 5 min and 10 min, respectively, 
and both ICy3 and ICy5 behaved with the same labelling kinetics. A lthough the signal 
was more intense for ICy5, these images were not normalised.
The effect o f  tem perature on ICy dye labelling was investigated in total cell lysates using 
a dye to protein ratio o f  5:1 over a timecourse (Figure 3-3B). This experiment again 
showed that protein labelling occurred within minutes, and did not increase significantly 
w ith longer incubations. Although incubation at 30°C did increase the overall labelling 
slightly, tem perature appears not to be a major factor that can improve o f  labelling. Since 
lower tem peratures are preferable to reduce potential side reactions (eg. carbamylation 
from the breakdown products o f urea in the buffer), a tem perature o f  0°C was chosen for 
all future ICy-dye labelling experiments.
3.2.2 Effect of denaturants and reductants on ICy dye-labelling
Denaturants are reagents that alter proteins by unfolding their tertiary structure. In an ICy 
dye labelling experiment, it is expected that overall labelling will be increased if  proteins 
are first denatured. To test this, labelling was compared using 8  M urea/4%  CHAPS as a 
denaturant versus 1% CHAPS alone (native) (Figure 3-3C). The result indicated that 
more intense labelling was achieved in buffers containing urea. In addition, a different 
pattern o f  bands was observed in the two conditions with fewer bands in the native 
labelling conditions. This experiment also shows that significant numbers o f  cellular 
proteins possess reduced thiols which can be detected under denatured and native 
conditions. This raises the possibility that the dyes could be used to probe for changes in 
thiol accessibility due to protein association and dissociation following a test stimulus in
73
addition to monitoring protein level or thiol oxidation. Thiourea, another denaturant that 
has been used to improve protein solubility in 2DE experiments, significantly interfered 
with labelling efficiency (right panel o f Figure 3-3C). This is likely to result from 
reaction o f the ICy dye with thiourea, as reported for other alkylating agents (Galvani et 
al., 2001) and would decrease the amount o f reactive ICy dye available for protein 
labelling.
IC y3  IC y 5
Sec Min Sec Min
— I Cy 3  
—=— ICy 5
T im  e  ( M in )
—  ICy 3
— ICY-i
T im  0  (M h )
(Figure 3-3A) Optimisation of ICy dye protein labelling. The kinetics of ICy dye labelling. 
HB4a cells were lysed in 4%CHAPS/10mM Tris(pH 8.3)/ 8M urea and then labelled with 80 
pmol of ICy dye per pg of protein on ice for the indicated times. After quenching with 65mM 
DTT, 10 pg of each ICy dye labelled lysate was loaded and analysed by IDE and fluorescence 
imaging.
The effect o f commonly used reductants on labelling was also investigated. The addition 
of reductants in 2DE samples is used to reduce disulphide bonds between peptide chains 
enabling the analysis of single peptide, but also to prevent the formation o f mixed 
disulphide induced precipitation. However, the reductant will also compete with protein 
for ICy dye alkylation prior to labelling. Therefore, finding an optimal concentration of 
reductant is important in determining optimal labelling conditions. In the case o f adding
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DTT to the labelling buffer, as expected the higher the concentration o f DTT the lower 
the labelling efficiency between protein and ICy dye (Figure 3-3D). This phenomenon 
was found to be even worse in labelling buffer containing tris-carboxy ethyl phosphine 
(TCEP) and may be due to TCEP dramatically lowering the pH of the buffer thus 
inhibiting the labelling reaction. It is important to note that concentrations of reductants 
that do not significantly inhibit labelling are unlikely to fully reduce proteins in a cell 
lysate.
B
+4% CHAPS 
+ 10mMTris 
+8M urea
0°C 30°C
Min:
4% CHAPS 4% CHAPS
lOmMTris 1% CHAPS 4% CHAPS 10mMTris
8M urea lOmMTris lOmMTris 8M urea
— — > f  K  \  8M urea 2M Thiourea
Min: 2 10 30 60 2 10 30 60
.
D
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______________ a __________________ a ______________/ r \
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(Figure 3-3B, C and D) Optimisation of ICy dye protein labelling. (B) Effect of temperature 
on ICy dye labelling. Total cell lysates were prepared in 4%CHAPS/10mM Tris buffer (pH 8.3) 
containing 8M urea. An estimated dye to protein molar ratio of 5:1 (80 pmol dye/pg protein) was 
used for labelling at 0°C and 30°C over a time course. Proteins (10 pg) were resolved by 12% 
IDE and fluorescent images captured. (C) Comparison of denatured versus native labelling. 
HB4a cell lysates in 2D lysis buffer (left panel) with or without 2M thiourea (right panel) or in 
1% CHAPS/10 mM Tris pH 8.3 (middle panel) were labelled with ICy3 at 80 pmol/pg for the 
indicated times, and quenched by addition of Laemmli sample buffer. Proteins (10 pg) were 
resolved by 12% IDE and fluorescent images captured. (D) Effect of reductants on ICy dye 
labelling. Total cell lysates in 4%CHAPS/10mM Tris (pH 8.3)/8M urea buffer were labelled with 
80 pmol dye/pg protein for 1 hr at 0°C in the presence of the indicated concentrations of DTT or 
TCEP. Protein (10 pg) was resolved by SDS-PAGE and labelling monitored by fluorescent 
imaging.
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3.2.3 Effect of pre-reduction on ICy dye-labelling
A previous study showed that saturated labelling of thiols with an alkylating reagent 
could be achieved by first reducing samples, and then removing the reductant prior to 
labelling (Smolka et al., 2001). Briefly, DTT was applied to reduce disulphide bonds and 
then the reduced protein was precipitated with cold ethanol, acetone and acetic acid to 
remove DTT prior to ICy dye labelling. This modified method was applied to a standard 
protein, BSA, which has one free thiol and 17 disulphides (Figure 3-3E). Reduced BSA 
protein could be highly labelled with dye even at low dye to cysteine ratios (1:1) and 
much better than the control without DTT at higher dye to cysteine ratios. The BSA 
protein shifted to a higher molecular weight as dye molecules became conjugated to it, as 
shown by silver staining. However, complete saturation was never achieved since not all 
the protein was shifted to the highest molecular weight. Also, protein recovery from the 
precipitation was variable among individual experiments which would be undesirable for 
2D expression profiling. In addition, the smearing of the modified protein indicates that 
there is a heterogeneous mixture of dye-labelled species which would over-complicate 
spot patterns. Furthermore, precipitation o f protein-dye complexes was also apparent at 
higher molar ratios of dye to cysteine which resulted in a loss of protein (lane 8, Figure 3- 
3E). This precipitation may occur as a result o f the increased hydrophobicity o f multiply 
labelled molecules. Therefore, pre-reduction o f samples for ICy-dye labelling was not the 
chosen route in future studies where the dyes were optimized for redox proteomic 
analysis rather than total protein expression.
Label with ICy 3 Label with ICy5
______________A ._________________ A ___________
-DTT -HDTT -DTT TDTT
Molar Ratio (ICy : t------- A------ w---------*------w------- * w -------*-----\
 ► 0 1 10 50 0 1 10 50 0 1 10 50 0 1 10 50Cys in BSA)
(17 disulfide bonds . «  I f l f  ICy31 ,
+1 free cysteine) J
H i H  *• ICy5
Silver Stain
(Figure 3-3E) Optimisation of ICy dye protein labelling. Effect of pre-reduction on ICy3 and 
ICy5 dye labelling. The BSA standard was reduced with 65mM DTT, precipitated with 
EtOH/Acetone to remove DTT then resuspended in 4%CHAPS/10mM Tris (pH 8.3)/8M urea 
buffer and labelled with ICy dye at the indicated molar ratios of ICy3 or ICy5 to the number of 
cysteines in BSA, of which there are 35.
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3.2.4 Optimisation of the dye to protein ratio for ICy dye-labelling
In order to apply the ICy dye technique in labelling, establishing an optimal molar ratio 
of dye to protein is crucial. To assess this, different molar ratios of ICy dye to BSA were 
used for the labelling reaction. The results (Figure 3-3F) together with previous data 
indicate that a molar ratio of dye to protein between 5:1 and 10:1 is optimal for 
"saturation" labelling of non-reduced BSA with either ICy3 or ICy5. As estimation of the 
free thiol content o f cell lysates made using Ellman's reagent (see Appendix B) showed 
that there were -6  mol/mol o f free thiol/ protein in total cell lysates, a result made using 
the average molecular weight o f a human protein which was then calculated to be 48 
kDa, by averaging the predicted molecular weights of all known human sequences in the 
SwissProt/ TrEMBL & NCBI databases accessed using the international protein index 
(IPI) (calculated by Richard Jacob, LICR, UCL)(http://www.ebi.ac.uk/IPI). Thus, the 
ratio o f dye to thiol used is roughly equal to 1. However, higher dye to protein ratios 
resulted in significant precipitation o f labelled proteins. Therefore, a 5:1 ratio (i.e. -80  
pmol dye per pg o f protein) was chosen for future labelling experiments.
F
Molar Ratio of 
ICy : Cys o f BSA
ICy3
ICy5
(Figure 3-3F) Optimisation of ICy dye protein labelling. Saturation test of ICy3 and ICy5. 
Different molar ratios of ICy dyes to the number of cysteines on BSA were applied for the 
labelling reaction. A mixture of equal amounts of ICy3 and ICy5 labelled BSA (1 pg) of each 
was resolved by SDS-PAGE and fluorescence images captured.
1 jig o f BSA per well
A
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3.3 Characterisation of ICy dye-labelling
3.3.1 Comparison of cysteine- and lysine-labelling of standard proteins
Following the previous study to determine the optimal molar ratio o f dye to protein for 
ICy dye labelling, additional standard proteins with different number o f free cysteines 
and different molecular weights were selected to examine the efficiency o f labelling and 
to compare this with the lysine labelling method using the NHS-Cy dyes. An equimolar 
mixture o f standard proteins was prepared containing: BSA - 1 free thiol/17 disulphides; 
Ova - 4 free thiols/1 disulphide; GST - 4 free thiols; a-C rys A chain - 1 free thiol; a-Crys 
B chain - no thiols; and Myo - no thiols. The protein mixture was labelled at increasing 
dye to protein ratios in a non-reducing, 2DE ICy lysis buffer. Proteins containing free 
thiols were labelled with ICy dye, although a-Crys A chain could only be seen at 
extended scan time (Figure 3-4A). However, the fluorescence intensities varied between 
proteins. For example, GST with 4 free thiols was detected at higher intensity than Ova, 
also with 4 free thiols, whilst BSA with one free thiol was labelled to the greatest extent. 
Since these samples were denatured in 8  M urea, this data suggests that free cysteine 
thiols have variable reactivity for the dyes or that these samples are already partially 
oxidised. In support o f this, an Ellman's test was performed (see Apendix B), which 
indicated that BSA contains 0.61 mol/mol free thiol/protein, ovalbumin 1.67 mol/mol and 
a -C ry s t 0.53 mol/mol. Although this does suggest partial oxidation, it cannot account for 
the differences in labelling between the standards, indicating that free cysteine thiols do 
indeed have variable reactivity for the dyes even in 8  M urea. Although alkylation should 
be specific for thiol groups, the possibility o f labelling on reactive lysine groups, 
particularly at higher dye concentrations, cannot be ruled out. In addition, it appeared that 
saturation labelling was not reached for any o f the targets, even at dye to protein ratios o f 
1600:1 (Figure 3-4B).
Under these non-reduced conditions, lysine labelling was more sensitive than cysteine 
labelling, but resulted in significant and heterogeneous molecular weight increases to all 
proteins (at ratios >5:1), presumably as more dye molecules react with the greater number 
o f lysines on each protein (Figure 3-4A and B). 2DE gel analysis o f the samples labelled 
at ratios o f  5:1 generated a higher isoform complexity o f lysine- versus cysteine-labelled 
proteins (Figure 3-4C). For example, unlabelled and cysteine-labelled a-C rys A chain
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ran as 3 isoforms on 2DEs, whereas at least 12 lysine-labelled isoforms were detected. 
These results obviously reflect the relative numbers of lysine and cysteine residues in 
target proteins, but indicate the advantage o f stoichiometric cysteine labelling, which for 
most proteins would generate only a minimal number of labelled isoforms. Despite the 
charge on ICy dyes, there was no apparent shift in pi when comparing dye-labelled and 
unlabelled standards. Importantly, there was significant protein precipitation at higher 
dye to protein ratios using both labelling strategies, evidenced by higher MW 
precipitation in the gels. For this reason, an optimal dye to protein ratio of 5 to 1 was used 
for further 2D-DIGE optimisation to avoid unwanted protein loss, but to still provide a 
reasonable level of sensitivity for the detection of free thiol-containing proteins.
Labelling was also examined after pre-reduction of disulphide bonds with DTT, which 
was removed by acetone precipitation and resuspesion of proteins prior to labelling. For 
these reduced samples, ICy labelling became more extensive as free thiols were made 
available for labelling and as expected these alternations did not affect lysine-labelling 
(Figure 3-4D). The data also indicated that GST and a-Crys A chain may indeed be 
partially oxidised, since they were detected at higher sensitivity after reduction, despite 
containing free thiols only. Heterogeneous labelling was apparent and protein recovery 
from the precipitation was variable, and so only the analysis of free thiol-containing 
proteins was pursued.
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(Figure 3-4A) Characterisation of ICy dye labelling. Labelling of a standard mixture of 
proteins at increasing molar ratios of ICy3 or NHS-Cy3 to protein. An equimolar mixture (2 
pmol each) of BSA, Ova, GST, a-Crys A/B and Myo in 2D lysis buffer was labelled at the 
indicated molar ratios for 1 h on ice. Reactions were quenched with DTT for ICy dye or free 
lysine for NHS-Cy dye and proteins resolved by 12% IDE after addition of Laemmli sample 
buffer containing (3-mercaptoethanol. The resulting fluorescent image is shown in the left panel 
and the corresponding colloidal coomassie blue stained gel is shown in right panel.
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(Figure 3-4 B, C and D) Characterisation of ICy dye labelling. (B) Labelling of the standard 
mixture was carried out as above, except that higher ratios of ICy5 and NHS-Cy5 were used. A 
CCB post-stained gel is shown below. (C) Comparison of cysteine labelling ICy-3 and lysine 
labelling NHS-Cy5 by 2DE. The standard proteins were labelled with a 5-fold molar excess of 
ICy3 or NHS-Cy5 without reductant and were resolved on pH 3-10, 12% 2D gels. Unlabelled 
sample was also run for comparison, and gels were post-stained with silver to visualise proteins. 
(D) Effect of pre-reduction on ICy and NHS-Cy dye labelling. The standards were labelled with 
ICy5 or NHS-Cy5 at the indicated dye:protein ratios without reductant, or after reduction with 65 
mM DTT. DTT was removed prior to labelling by acetone precipitation of proteins and 
resuspend in 2D lysis buffer. A CCB post-stained gel is shown below.
80
3.3.2 Sensitivity o f ICy dye-labelling
The sensitivity of ICy labelling of BSA was next compared with MS-compatible silver 
staining (Shevchenko et al., 1996) and colloidal Coomassie blue G-250 (CCB) staining 
(Neuhoff et a l., 1988). Results in Figure 3-5 show that as little as 2 ng of this single free 
thiol-containing protein could be detected with ICy3 or ICy5 using a 5:1 molar excess of 
dye (-80  pmol dye to pg o f protein). This detection level result is better than that 
achieved with silver (-10  ng) or CCB staining (-50 ng). In addition, the dynamic range 
of detection was identical for the two ICy dyes and was broader and more linear 
compared to silver or CCB staining; these are essential pre-requisites for quantifying low 
and high abundant proteins on the same 2D-DIGE gels.
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(Figure 3-5) Sensitivity test of ICy dyes. BSA was labelled at a 5:1 molar ratio (-80 pmol 
dye/pg protein) of ICy3 and ICy5, and the indicated amounts of labelled BSA resolved on a ID 
gel. Gels were post-stained with either CCB or silver (left panel) and relative band intensities 
from fluorescent images and densitometry were plotted against protein amounts (right panel).
3.3.3 Specificity o f ICy dye-labelling
The specificity o f the ICy dyes was also tested by competition experiments using 
iodoacetamide (IAM). Non-reduced lysates from a human epithelial cell line were 
treated with 80 and 400 pmol IAM per pg protein or left untreated, and then labelled with 
ICy dye at 80 pmols/pg protein. Proteins were resolved by IDE and 2DE and 
fluorescence images compared (Figure 3-6). As expected, the results show that IAM is an 
effective competitor for reagent in ICy-labelling, since no protein labelling could be 
detected when a 5-fold molar excess of IAM was used. Given the known reactivity of 
IAM for thiol groups, this shows that the ICy dyes specifically react with reduced protein
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thiols. Moreover, this is supported by the previous data showing that DTT effectively 
inhibits protein labelling when present in the labelling mixture.
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(Figure 3-6) Specificity of labelling assessed by competition with IAM. Total cell lysate 
(HB4a) was pre-treated with IAM at 0, 80 and 400 pmol/pg, and then labelled with 80 pmol/pg 
of ICy3 or ICy5. Samples were separated by IDE (10 pg; upper panel) and 2DE (50 pg; lower 
panel), and fluorescent images captured at the same PMT voltage. Gels were post-stained with
CCB and silver, respectively. The symbols indicate significant shifts in protein mobility after 
ICy dye labelling.
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3.3.4 Co-migration of ICy dye-labelled proteins with NHS dye-labelled, 
colloidal coomassie blue and silver-stained proteins in 2D gels
Comparison o f 2-D ICy images o f cell lysates with the composite silver-stained images 
showed that a significant number o f  protein features were detected at a higher sensitivity 
with fluorescence ICy-labelling than with silver staining (Figure 3-7A). Whilst the total 
number o f spots detected was similar, a number o f  spots labelled with the dye pair did not 
comigrate. To explore this phenomenon further and to test the labelling properties o f the 
ICy dyes for 2D-DIGE application, a detailed 2DE analysis was carried out comparing 
ICy dye labelling with NHS-Cy labelling, and with silver, CCB and Sypro Ruby post- 
staining. Total cell lysates were labelled with ICy3 and NHS-Cy5 and separated on the 
same 2D gel. In addition, replicated ICy-labelled total cell lysate samples were run on 
gels and post-stained with silver, CCB or Sypro Ruby. Spots were matched across 
images using Melanie software. The matched spots were marked with green tags and the 
unmatched ones were labelled with red tags (figure 3-7B). This analysis revealed that 
similar numbers o f protein features could be detected with ICy dyes (903-1034 spots) as 
with NHS lysine labelling (956) and CCB-staining (900); with silver staining performing 
slightly better (1205 ± 78). Interestingly, only -50%  of ICy-labelled features co-migrated 
with features detected using the other methods. This difference is partly attributed to 
proteins lacking free thiols which are revealed by the other staining/labelling methods or 
proteins that silver-stain poorly. However, since the total number o f detected spots was 
similar, it is likely that a significant subset o f  proteins with reactive thiols are only 
detectable by ICy labelling (as implied from Figure 3-7A) which indicates an important 
advantage in sensitivity for detection o f free thiol containing proteins by this method. 
However, there is a further level o f complexity in that the ICy dyes are positively 
charged, such that labelled proteins may shift to more basic pis. In contrast, if  saturation 
labelling could be reached, all o f  the labelled protein should shift to their maximum p/s 
without heterogenous charge chains but this is probably not the case. It is noteworthy that 
SyproRuby post-staining yielded poor images and intense ICy-labelled features appeared 
as ‘inverse spots’ on a high background (Figure 3-7C). Thus, ICy dye labelling appears 
to interfere with SyproRuby staining, despite the fact that these reagents interact with 
different protein residues (cysteine residues in the case o f  the ICy dyes, but lysine and
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arginine residues in the case of SyproRuby). A possible explanation for this interference 
may be that the ICy dye fluorescence may quench the SyproRuby signal.
A
y
B
ICy Dye
ICy Im age  
NHS Cy Dye ICy Dye
Silver stain  
Silver Stain ICy Dye C oom assie
• . ^
«• • ' *
* V.
r
t e
G I
• m
:0
• i V i
' 1
■ \ • ■ *
■S'
•
-
Com parison of ICy, NHS -Cy, silver and CCB labelling/staining
No. spo ts 
on ICy 
Image
No. spo ts  
NHS/Silver/ 
CCB
No. spo ts 
co-migrating % Match
(A) NHS-Cv dve 980 956 551 56.2%
(B1 Silver 1034±245 1205t78 470±56 45.5%
(C) CCB 903 900 414 45.8%
ICy dye SyproRuby
■ •- -c
— *•
ir
„ .. 
* ak_
(Figure 3-7) Comparison of co-migrating spot-intensities. (A) HB4a cell lysate (200 pg) was 
labelled with 16 nmol of ICy3 (80 pmol/pg) and separated by 2DE and the gel post-stained with 
silver for comparison of spot migration. ‘Landmark’ features are circled and arrows indicate 
features detected with higher intensity by ICy labelling. (B) Comparative 2DE analysis of ICy 
and NHS-Cy labelling, silver and CCB. HB4a cell lysates (200 pg) were labelled with ICy3 and 
NHS-Cy5 in the ratios of 80 pmol/pg and 4 pmol/pg respectively, and then separated on the same 
2D gel. Replicate ICy-labelled samples were also resolved by 2DE and subsequently post-stained 
with silver or CCB. Images were analysed with Melanie IV software and gel spots matched to 
the corresponding NHS-Cy-labelled or silver-stained or CCB-stained spots on each gel (marked 
with green tags). In contrast, the unmatched ones were marked with red tags. Total numbers of 
spots were taken for each detection method, and the number of co-migrating spots and the % 
match calculated. The ICy3-silver stained pair was repeated three times and average spot 
numbers ± the standard deviations are shown. All of the “thumbnail” images in (B) are presented 
in Appendix H as enlarged images. (C) Images of the ICy dye and SyproRuby post-stained gel 
are shown.
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3.3.5 Examination of differential labelling and dye bias
It is important that the ICy3/ICy5 dyes behave identically for their optimised use in 2D- 
DIGE. In this technique, two different protein samples are labelled with dyes that have 
different emission wavelengths, so that relative protein abundance can be compared in 
the same gel and consequently it would be disadvantageous if fluorescence quenching 
occurred between the two dye molecules. To test if quenching occurs, dual labelling of a 
standard protein GST was first carried out. A constant amount o f ICy3 labelled GST (dye 
to protein ratio of 10:1) was mixed with the same amount of GST labelled with 
increasing amounts o f ICy5 and vice versa  (Figure 3-8). The results show that the 
fluorescence signal from ICy3 labelled GST was not significantly affected by increasing 
the proportion of ICy5-labelled GST in the labelling mixture. The reverse was also true. 
This data thus suggests that ICy3 and ICy5 do not significantly quench one another's 
signals and fluorescence can therefore be used for quantitative proteomic analysis.
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at 0°C for 1 hr
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(Figure 3-8) Quench test between ICy3 and ICy5. A constant amount of ICy3 labelled GST 
(dye to protein ratio of 10:1) was mixed with the same amount of GST labelled with increasing 
amounts of ICy5. The reciprocal labelling experiment was also performed
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3.3.6 Preferential labelling by ICy3 and ICy5
Having established conditions for 2DE labelling, the performance o f the ICy dyes for 2D- 
DIGE experiments was next assessed. Initially, a comparison was made o f ICy3-labelled 
lysates o f HB4a, an immortalised human mammary luminal epithelial cell line, with 
ICy5-labelled lysates from the C3.6 cell line, which in an ErbB-2 overexpressing 
derivative o f HB4a (Figure 3-9A). Many high-intensity ICy-labelled protein features 
were detected (700-800 spots) indicating that a significant number o f cellular proteins 
and isoforms possess reduced, reactive thiols in these exponentially growing epithelial 
cells. Some charge trains were also observed at higher MWs. Since the ICy dyes are 
positively charged, these basic shift charge trains may reflect partial labelling o f proteins 
with multiple reactive thiols. Importantly, clear differences in the expression o f some 
proteins indicating ErbB-2 dependent expression changes were apparent between the cell 
lines (see Chapter 4). To test and control for differences in labelling by ICy3 and ICy5, 
lysate from the same cells (HB4a) was labelled with ICy3 and ICy5 and the mixed 
samples separated by 2DE. Image comparison, using DeCyder software, suggested that a 
small subset o f proteins (8 % over a 1.5-fold threshold; 1% over a 2-fold threshold) were 
preferentially labelled by one dye over the other (Figure 3-9B). Since it is unlikely that 
ICy3 and ICy5 would display different reactivities under denaturing conditions, several 
other possible explanations may account for this observation. These include 
intermolecular fluorescence resonance energy transfer (FRET) between the dyes on 
colocalised proteins which could result in fluorescence quenching. Such quenching could 
also be due to signals from multiple dye moieties on the same molecule. However, 
overlaying images o f reciprocally-labelled HB4a and C3.6 lysates showed that most o f  
this apparent dye bias resulted from separation o f ICy3- and ICy5-labelled proteins into 
doublets (specifically in the 25-30 kDa range), with the ICy3-labelled proteins migrating 
faster than those labelled with ICy5 (Figure 3-9C). Although this apparent dye bias 
would be problematic for 2D-DIGE analysis, it is important to note that in further 2D- 
DIGE experiments (Chapters 4, 5 and 6 ), these "false" differences will be automatically 
filtered out by labelling test samples with the same ICy dye and running them against a 
standard pool o f all samples labelled with the other dye, as used for the NHS-Cy dyes 
(Gharbi et al., 2002;Alban et al., 2003).
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(Figure 3-9) Differential ICy3 and ICy5 labelling. (A) HB4a and C3.6 cell lysates were 
labelled with ICy3 and ICy5, respectively. The samples were mixed and resolved by 2DE. 
Images were captured at the appropriate excitation and emission wavelengths and pseudo­
coloured (HB4a in red; C3.6 in blue) and overlaid in Adobe Photoshop. (B) Analysis of 
preferential ICy dye labelling. The same lysate was labelled with ICy3 and ICy5 and the sample 
were mixed and resolved by 2DE and analysed using DeCyder DIA software with a 1.5 fold cut­
off applied for changes in abundance. A section of the image and spot statistics are shown. Green 
denotes no significant difference between co-migrating spots, whilst blue and red denote 
increased and decreased intensity, respectively, above the threshold. (C) Dye bias and spot 
splitting revealed by reciprocal labelling. HB4a and C3.6 lysates were reciprocally labelled with 
ICy3 and ICy5, mixed appropriately and resolved by 2DE. Images were captured, pseudo- 
coloured and overlaid in Adobe Photoshop for comparison. Black-circled spots represent real 
differences between HB4a and C3.6 cells whilst white-circled spots indicate dye bias and spot 
splitting in the 25-30 kDa range of the gels.
87
3.3.7 Initial investigation of the effects of oxidation on ICy dye labelling
Since the ICy dyes specifically label reduced cysteinyl thiol groups and not their oxidised 
derivatives, they could potentially be used in redox proteomic studies, for example to 
identify changes in thiol reactivity following oxidative stress. To test this application, the 
standard proteins, human serum albumin (HSA) and bovine serum albumin (BSA) were 
treated with 0.5 mM H2O2 for 20 min and then labelled with ICy dye and compared to the 
untreated labelled proteins. The results demonstrated that H2O2 treatment of HSA or 
BSA significantly reduces ICy labelling (Figure 3-10A). In addition, the free thiol content 
o f treated BSA was significantly reduced (-50% ) as demonstrated using the Ellman’s test 
(Figure 3-1 OB). This indicates that free thiols on these proteins are directly modified by 
H2O2 perhaps being converted to the sulfenic, sulfinic or sulfonic acid forms, or forming 
new disulphide bonds that prevent efficient reaction o f ICy dye with the target proteins. 
This suggests that the ICy dyes can be used to monitor thiol-oxidation status.
A 500 na 200 na B
0.5 mM H202: 
kDa 
75 ►
35'
g
HSA
g
BSA
+ - + -
• - ICy dye 
Image
CCB
Image
0.7
0.6 
1 0.5
CM
s  04
s  0.3 
<
0.2 BSA
BSA + H202
80 100 1200 20 40 60
(Figure 3-10) Effect of H20 2 on thiol reactivity of standard proteins. (A) The indicated 
amount of standard proteins (HSA and BSA) in urea lysis buffer were treated with 0.5mM H20 2 
for 20 min or left untreated. Samples were labelled with ICy dye, resolved by 1DE, detected by 
fluorescence scanning and post-stained with CCB. (B) Ellman's test of thiol content. The 
indicated amounts of BSA or 0.5mM H20 2-treated BSA in 2.9 ml of 0.1 M sodium phosphate 
buffer (pH 8.0) were prepared and 100 pi of 0.01 M DTNB (Ellman’s reagent) in sodium 
phosphate buffer added. The mixture were left to stand in the dark for 15 min and then the 
absorbance measured at 412 nm
3.4 Conclusions
The goal o f this project was to develop an alternative fluorescent labelling strategy to 
improve on the existing 2D-DIGE expression profiling technology. Thus instead o f 
labelling lysine residues at low stoichiometry, the target was to label cysteine thiols at 
higher stoichiometry to improve sensitivity without adversely affecting protein solubility 
or migration behaviour in 2DEs. In addition, it was assessed whether these dyes could be 
used to probe for inducible changes in the reactivity o f protein thiols, allowing one to 
monitor redox modification events such as disulphide bond formation/breakage, 
glutathionylation, S-nitrosylation or oxidation to the sulphenic (RSOH), sulphinic 
(RSO2H) and sulphonic (RSO3H) acids and to investigate changes in thiol accessibility in 
native samples caused by protein association or dissociation.
In this chapter, I present a description o f the optimisation and characterisation o f cysteine 
labelling using the ICy dyes. It was shown that ICy3/5 labelling o f protein lysate was 
rapid and that saturation was reached within 5-10 min in non-reducing, denaturing 2DE 
lysis buffer. A significant, but lesser number o f protein bands were detected in lysates 
labelled in native buffer, suggesting that thiol reactivity could be monitored under more 
physiological conditions. In terms o f specificity, the target o f the ICy dyes would appear 
to be reduced cysteine thiols as shown by the IAM competition assay. Moreover, the 
commonly used reductant DTT competed with free thiols on proteins for labelling with 
the ICy dyes, whilst TCEP reduced dye labelling probably caused by its ability to lower 
the pH. Thus, DTT and TCEP are not suitable components to include in the labelling 
reaction. An alternative strategy is to pre-reduce protein samples with DTT and to 
remove the reductant before labelling. However, I found that protein recovery from this 
process was variable among individual experiments and I did not use this in further 2D- 
DIGE experiments. I found that ICy dye labelling could detect as low as 2 ng or less o f 
BSA protein using a 5:1 molar excess o f dye to protein which was better than the silver 
(-10  ng) or CCB (-20 ng) detection methods. In addition, the dynamic range o f 
detection o f the ICy dyes was broader and more linear compared to silver and CCB 
staining and was identical for the two ICy dyes; these were essential pre-requisites for 
quantifying low and high abundant proteins on the same 2DE. As for dye to protein ratio 
in labelling, 80 pmol o f dye per pg o f total cell lysate which was chosen for 2D-DIGE
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experiments gave a reasonably high sensitivity o f labelling without compromising sample 
solubility or resulting in heterogeneous labelling and formation o f over-complex spot 
patterns.
Comparison o f 2DE ICy images o f cell lysates with the composite silver-stained images 
also revealed that a significant number o f protein features could be detected with higher 
sensitivity using ICy-labelling. Co-migration o f ICy labelled spots with silver-stained or 
CCB-stained spots were 45.5% and 45.8%, respectively. Although some proteins may 
not stain well with silver or CCB and some proteins do not contain free thiols, the data 
suggest detect thiol-containing proteins at higher sensitivity than with silver and CCB 
stains. In addition, I showed that many cellular proteins in epithelial cells possess 
reduced thiols under exponential growth conditions. My study o f the reproducibility o f 
labelling with ICy3 versus ICy5 showed that a small percentage o f protein features 
displayed apparent dye bias when the same sample was labelled with ICy3 and ICy5. 
This was mostly due to splitting o f some spots in the 25-30 kDa region, with the ICy3- 
labelled pool migrating faster in the pair (Figure 3-9C). This effect could be caused by 
slightly different affinities o f SDS for the Cy3 and Cy5 labelled moieties on the protein, 
thereby affecting their migration in gels. Although a potential problem, this apparent dye 
bias was overcome when test samples were labelled with one dye and compared to a 
reference sample labelled with the other dye as in the procedure used for the NHS Cy 
dyes (Gharbi et al., 2002;Alban et al., 2003).
In summary, the results in this chapter demonstrate the conditions and the properties o f 
using ICy dyes for protein labelling and expression profiling in 2D-DIGE. The 
application o f the cysteine labelling 2D-DIGE technique for analysis o f redox regulation 
and growth factor stimulation o f  HB4a and C3.6 cells and UV irradiation-induced thiol 
changes in plasma samples are discussed in the following Chapters.
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Chapter 4 CYSTEINE LABELLING 2D-DIGE TO 
PROBE FOR CELLULAR TARGETS OF 
OXIDATION
4.1 Introduction
The iodoacetylated Cy dyes whose utility for 2D-DIGE was described in the previous 
chapters react with the reduced thiol groups on proteins which can be the targets for 
oxidation by ROS. These modifications have been shown to be biologically important 
(see introduction) and their study is relevant to current proteomics in biomedical 
research. Since the ICy dyes do not react with the oxidised forms o f the thiol groups, 
these reagents should be useful as probes for experiments designed to accurately monitor 
changes in cysteine oxidation and for the identification o f cellular targets o f oxidation in 
response to oxidative stress or growth factor-induced ROS production. This use o f  the 
ICy dye 2D-DIGE strategy to study this area o f  biology is a major aim o f this thesis.
In the previous Chapter, the characterisation and optimisation o f cysteine labelling using 
ICy3/5 dyes was reported (Chapter 3). However, its real usefulness as a proteomic 
technique needed to be tested in a biological context. Thus, ICy dye 2D-DIGE cysteine 
labelling was used to probe protein targets o f  oxidative stress following H2O2 treatment 
of human mammary luminal epithelial cells. This study was also designed to investigate 
the effects o f overexpression o f the oncogenic receptor tyrosine kinase ErbB-2 on the 
stress response, and also to allow the simultaneous assessment o f basal proteomic 
changes which are caused by ErbB-2 overexpression. This analysis was carried out by 
2D-DIGE comparison o f a parental breast luminal epithelial cell line HB4a and an ErbB- 
2 overexpressing derivative, C3.6 (detailed in Chapter 1) in the absence and prescence o f 
exogenous H2O2 . It was expected that changes in labelling would be caused either by 
differential protein expression or from the conversion o f reactive thiol groups to higher 
oxidative states that cannot react with the ICy dyes. The identities o f differentially 
labelled proteins were then determined by MALDI-TOF-MS and peptide mass 
fingerprinting o f excised and trypsinised gel pieces. Furthermore, the biochemical 
changes o f some o f the identified proteins were validated by ID and 2D immunoblotting.
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4.2 The effect of H2C>2 treatment on HB4a and C3.6 cells
As H2O2 is a major form o f ROS in cells (Rhee et al., 2003), it was chosen here as a 
model ROS to treat HB4a and C3.6 cells and to investigate changes in protein expression, 
thiol oxidation and intracellular signalling. First o f all, treatment conditions were 
determined that would induce an oxidative stress response in HB4a and C3.6 cells 
following hydrogen peroxide treatment. According to some signalling studies which have 
used H2O2 treatment o f human or epithelial cells, a concentration range between 0.1 mM 
and 1 mM H2O2 was used to elicit a cellular response (Nishida et al., 2000;Kim et al., 
2002;Fratelli et al., 2002;Bamouin et al., 2002;Zhang et al., 2003;Garg and Chang, 
2003;Kim et al., 2003a;Kim et al., 2003b;Pelaia et al., 2004;Young et al., 2004). Initially, 
HB4a or C3.6 cells were treated with high concentrations o f hydrogen peroxide (10 mM) 
which lead to rapid cell death with most the cells detaching from the substratum after 2 0  
minutes. In contrast, low concentrations o f hydrogen peroxide (10 pM) did not stimulate 
a significant cellular response (such as Akt, p38, JNK stimulations) for the 
phosphorylated and activated forms o f these signalling kinases (data not shown). A 
concentration o f 0.5 mM H2 O2 was therefore chosen and was found to stimulate cellular 
signalling without causing immediate cell death.
Immunoblotting was used to monitor protein tyrosine phosphorylation, since this protein 
modification has been reported to be affected by ROS due to inhibition o f 
phosphotyrosine phoshatases. In agreement with previous work in other cell systems, 
H2O2 produced a robust, but transient increase in total tyrosine phosphorylation (Figure 4- 
1). Interestingly, more proteins were tyrosine phosphorylated to a greater degree in the 
HB4a cells than in C3.6 cells, suggesting that ErbB-2 can affect this response. The 
stress-activated protein kinase, p38, was found to be more rapidly activated after 
hydrogen peroxide treatment o f HB4a cells than o f C3.6 cells, whilst FbCh-induced JNK 
activation was only apparent in the C3.6 cells at longer times. In addition, both the ERK 
and PI3K pathways were activated, with ERK 1/2 activation being more intense in the 
HB4a cells and Akt activation similar in both cell types (Figure 4-1). Interestingly, 
MnSOD, which generates cellular hydrogen peroxide from superperoxide, exhibited 
lower expression in the C3.6 cells. Together these observations indicate that ErbB-2
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overexpression affects proliferative and survival signalling in response to oxidative 
stress, although the details o f this mechanism are unclear.
The effects o f H2O2 on cell proliferation were next examined using an MTT assay (Figure
4-2). This assay is a quantitative colorimetric method for determining cell number and
viability. It utilises the yellow tetrazolium salt MTT as a substrate, which is metabolised
by the mitochondrial respiratory chain enzyme, succinate dehydrogenase, to yield a
purple formazan reaction product in actively proliferating cells. Comparison of the value
to control cells provides a relative increase in cellular proliferative activity. Conversely,
in cells that were undergoing apoptosis or necrosis, MTT conversion was decreased,
reflecting the loss o f cell proliferation. Using this assay, the proliferation of both the
HB4a and C3.6 cells was decreased following hydrogen peroxide treatment. The results
(Figure 4-2) show that approximately 80%, 50% and 30% of proliferative activity was
maintained after treatment with 0.5 mM o f H2O2 for 20, 60 and 240 min, respectively.
Interestingly, the C3.6 cells retained their proliferative capacity better than HB4a at
longer timepoints suggesting that ErbB-2 dependent signalling plays a role in providing
cellular resistance to redox stress. This may be linked to the previously observed delayed
activation o f p38 or JNK in C3.6 cells (Figure 4-1).
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(Figure 4-1) Effect o f hydrogen peroxide treatment on signalling events in HB4a and C3.6 
cells. Total cell lysates were prepared from HB4a and C3.6 cells treated with 0.5 mM hydrogen 
peroxide for the indicated times. Total proteins (30 pg) were separated by SDS-PAGE, 
electrophoretically transferred to Immobilon P membrane (Millipore) and probed with specific 
antibodies to the indicated proteins and phosphorylation motifs.
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On a gross scale, the free thiol content o f the HB4a and C3.6 cells prior to H2 O2 treatment 
was similar with approximately 6  moles o f free thiols per mole o f protein as measured 
using Ellman’s reagent (Appendix B). Hydrogen peroxide has found to induce a 
significant drop in the cellular free thiol content o f both cell types; the free thiol content 
dropping by 45% and 23% in HB4a cells and C3.6 cells, respectively, within 2 min o f 
treatment (Figure 4-3). Following this drop, the free thiol content recovered to 
approximately 80% in both cell lines after 20 min. This result likely indicates a loss o f 
reduced glutathione (GSH) in the cells which acts as a “buffer” to neutralise the influx o f 
H2O2 , but also presents the oxidation o f free thiols on proteins. The recovery may be due 
to the regeneration o f GSH by glutaredoxin or reduction o f oxidised protein thiols by 
peroxiredoxins. Importantly, these results show that ErbB-2 affects the cellular response 
to H2 0 2 , seemingly providing more resistance through the provision o f greater anti­
oxidant activity. This may explain the overall higher survival rate o f C3.6 cells (Figure 
4-2) and the delayed activation o f the ERK and p38 MAPK pathways (Figure 4-1). To 
explore these differences further, and to identify cellular targets o f  oxidative stress, ICy 
dye 2D-DIGE was used to study H20 2 treated HB4a and C3.6 cells.
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(Figure 4-2) The effect of H20 2 on cell proliferation by MTT assay. (A) HB4a and C3.6 cells 
were inquintriplicately plated into 96-well plates at a density of 5000 and 2000 cells/well, 
respectively, in RPMI 1640 medium containing 10% FBS. After 36 hrs, the cells were treated 
with 0.5 mM H20 2 for 20 min and 1, 4, 8 and 12 hr or left untreated. After removing the medium, 
50 pi of MTT working solution (1 mg/ml in culture medium) was added to each well, followed 
by further incubation at 37 °C for 4 h. The medium was then carefully removed and 100 pL of 
DMSO was added and the plates shaken for 20 min. The absorbance of the samples was 
measured at a wavelength of 540 nm in a multiplate reader and values plotted against time. (B) 
Plot of % viability versus time. % viability was calculated as the ratio of the absorbance at each 
timepoint versus the untreated sample.
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(Figure 4-3) Quantitative determination of free thiols (Ellman test). Lysates from untreated 
and H20 2 treated HB4a and C3.6 cells for the indicated times were freshly prepared and 200 pg of 
total protein assayed for thiol content as described above.
4.3 Differential protein expression and thiol-reactivity analysis using 
ICy 2D-DIGE
The cysteine labelling strategy outlined in Chapter 3 was applied in a detailed 2D-DIGE 
and MALDI-TOF-MS analysis to accurately identify changes in thiol reactivity and 
protein expression in response to H2O2 treatment o f mammary luminal epithelial cells. 
These studies were aimed at identifying cellular targets o f oxidative stress and the 
protective mechanisms that respond to redox insult. It was also used to simultaneously 
screen for targets o f ErbB-2-mediated growth factor signalling and assess the effect o f 
H2O2 treatment on the redox response.
In a preliminary timecourse experiment, HB4a and C3.6 cells were treated with 0.5 mM 
H2O2 for 2, 20 and 240 min or left untreated. These conditions were sufficient to induce 
an increase in total cellular tyrosine phosphorylation (likely through inhibition o f  protein 
tyrosine phosphatases), and trigger activation o f the p38 stress-activated protein kinase, 
ERK1/2 and Akt signalling pathways (Figure 4-1). Duplicate cultures o f treated cells 
were lysed under non-reducing, denaturing conditions in the presence o f  ICy3 and ICy5 
(80 pmol/pg protein) to rapidly label proteins and limit post-lysis redox modifications. 
Samples were then reduced with DTT prior to 2DE separation. Individual ICy5-labelled 
samples were run with an equal load o f an ICy3-labelled standard pool consisting o f an
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equal mixture o f  all samples (Figure 4-4). This strategy was used to control for the 
apparent dye bias observed for the labelling and separation o f some proteins. Image 
analysis using D eCyder software revealed the dynam ic range o f detection o f  the 
experiments was approxim ately 1 0 0 0  fold between the lowest and highest-abundant 
proteins in the gels. More than 100 differences in labelling using a >1.5-fold cut off, 
were observed both between the cell lines (ErbB-2 dependent) and in response to H2O2 
treatment. A pseudo-coloured and overlaid area o f  the images for the C3.6 samples is 
shown for each tim epoint in Figure 4-5. O f particular note, H2O2 treatment for only 2 
min reduced the labelling o f a number o f proteins, suggestive o f rapid thiol modifications 
that block ICy-dye-labelling (eg. Spots 24 and 27 in Figure 4-5), rather than changes in 
protein expression per se. Such modifications could include disulphide bond formation, 
modification by glutathionylation or oxidation to the sulphenic (R-SOH) acid. Since the 
latter modification is generally unstable, a disulphide may be formed with a nearby thiol 
or the RSOH may be further oxidized to the sulphinic (R-SO 2H) or sulphonic (R-SO 3H) 
acid forms o f  the thiol. In some cases, the change in ICy dye labelling recovered over 
time, indicating reversible modification, perhaps through the activation o f redox defence 
mechanisms. A num ber o f proteins also showed rapid increases in labelling (eg. Spots 25 
and 26 in Figure 4-5), suggesting generation o f  new thiol groups, for example through 
scission o f disulphide bonds, or through labelling o f  isoforms generated after redox- 
dependent shifts in pi, as reported for the peroxiredoxins (W agner et al., 2002;Rabilloud 
et al., 2002a). Some o f  these observations may explain the dramatic changes in free thiol 
content that occur within 2 min o f hydrogen peroxide treatment (Figure 4-3) and the 
activation o f  cellular signal pathway (Figure 4-1).
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Image analysis by DeCyder
(Figure 4-4) Strategy’ for ICy3/5 cysteine-labelling 2D-DIGE to monitor oxidant-dependent 
and ErbB-2 dependent thiol reactivity changes. Duplicate samples of untreated and H20 2 
treated cells were lysed in the presence of ICy3 and ICy5. A standard pool was made from the 
ICy3-labelled samples by mixing equal amounts of all eight samples. 150 pg of this was run 
against 150 pg of each ICy5-labelled sample on each gel, generating 16 images for DeCyder 
image analysis.
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(Figure 4-5) Use of ICy3/5 cysteine-labelling 2D-DIGE to monitor thiol reactivity7 in 
response to H20 2 treatment of mammary luminal epithelial cells. The top images indicate 
merged 2D fluorescence images of standard pool (red/ICy3/mixture of all samples) vs. H20 2- 
treated samples (blue/ICy5) showing differential labelling with time. The lower images show 
enlarged 3D fluorescence profiles of the boxed areas showing some of the changes in detail.
4 .4  A p p lic a t io n  o f  c y s te in e - la b e ll in g  2 D -D IG E  to  s tu d y  p e ro x id e -  
d e p e n d e n t  a n d  E r b B - 2 - d e p e n d e n t  c h a n g e s  in  th io l- r e a c t iv i ty
The experiment in the previous section (section 4.3) was performed on single samples of 
cultured cells for each peroxide treatment condition. However, for statistical validation, 
analysis o f multiple samples for each experimental condition is essential. Thus, the 0 min 
and 20 min timepoints were chosen for a more detailed statistical analysis o f thiol 
labelling in human mammary luminal epithelial cells (HB4a) and ErbB-2 overexpressing 
partners (C3.6). Each condition was run in triplicate and 2-D gels were analysed using 
DeCyder software. Gels were then post-stained with silver-stained or CCB stained. 
Protein features o f interest were picked for identification using MALDI-MS. The 
labelling strategy is outlined in Figure 4-6 and the 24 fluorescent images obtained are 
shown in Figure 4-7. This experiment was repeated twice. In one o f these experiment 
the ICy3/5 labelling was reversed, and CCB used as a post-stain instead o f silver. In the
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other, spots o f interest were excised from unstained gels, using the coordinates o f the 
fluorescent spots, rather than the post-stained spots. Similar changes in ICy3/5 labelling 
were observed in these 3 experiments. In one experiment, 126 significant changes in 
labelling were identified (> 1.5-fold up or down regulated; p <0.05; the statistics used here 
is discussed in Appendix J) (Figure 4-8). O f these, 51 were peroxide-dependent and 90 
were ErbB-2 dependent, with 15 changes displaying dual dependency. Post-staining with 
silver or CCB and matching to the corresponding fluorescent images allowed picking of 
89 different gel features with high confidence. These samples contained a reasonable 
amount o f stained protein that could be used for identification by MS (Figure 4-9).
(Time o f treatm ent 
with 0.5 mM H 20 2)
Labelled with ICy3
Labelled with IC>5
4a (0 min) 4a (20 min) 3.6 (0 min) 3.6 (20 min)
M i x e d  as  an i n t e r n a l  s t a n d a r d
f ff
Gel 1-3 Gel 4-6 Gel 7-9 Gel 10-12
Post Silver-stain 
Pick differentially labelled spots 
Trypsin Digestion 
Identification by M ALDI-M S
(Figure 4-6) Strategy for ICy3/5 cysteine-labelling 2D-DIGE to monitor oxidant-dependent 
and ErbB-2 dependent thiol reactivity changes in HB4a and C3.6 cells. Untreated HB4a and 
C3.6 cells or cells treated with 0.5 mM for 20 min were lysed in the presence of ICy3 and ICy5 
and incubated for labelling. Equal amount of the ICy3 labelled samples were mixed as an 
internal standard and run against the individual untreated or hydrogen peroxide treated samples. 
Each individual sample was run triplicate against the standard pool and a statistical analysis 
performed using Decyder BVA software. Gels were post-stained with silver or CCB and the spots 
of interest were excised for in-gel digestion and subsequent MALDI-TOF-MS analysis.
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(Figure 4-7) Representation of the experimental design and images obtained in the study of 
thiol reactivity in HB4a and C3.6 cells in response to 0.5 mM H20 2 treatment. (A) Randomly 
growing HB4a and C3.6 cells were treated with 0.5 mM H20 2 for 20 min and compared to 
untreated samples. Equal amounts of ICy3 labelled lysates were mixed as an internal standard 
pool and run against ICy5 labelled hydrogen peroxide-treated or untreated samples. Samples were 
run in triplicate to assess reproducibility and for statistical analysis of changes. This represents 12 
gels with 24 images generated. Gel images were processed using the BVA module of DeCyder 
software. 2 representative enlarged images are shown in (B).
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A. Differential labelling between B. Differential labelling between 
HB4a (20’) and HB4a (0) C3.6 (20’) and C3.6 (0)
C. Differential labelling between D. Differential labelling between 
HB4a (0) and C3.6 (0) HB4a (20’) and C3.6 (20’)
(Figure 4-8) Visualisation of spots that display changes in cysteine thiol labelling with H20 2 
treatment and between HB4a vs. C3.6 cells. Representative ICy dye images of H20 2 
treated/untreated HB4a and C3.6 cells are shown. Protein features with altered ICy-labelling are 
labelled with a spot identity number.
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(Figure 4-9) Master gel image of ICy3 labelled standard pool and its corresponding silver 
stained image. The image shown is a merged image of ICy3 labelled HB4a/C3.6 cell lysate pool 
(red spots) and the image of its corresponding silver stained gel (black spots) created using Adobe 
Photoshop software. The arrows indicate the aligned features between significant differentially 
labelled spots and the silver-stained spots. These spots (89) were picked for identification.
4. 5 Id e n t i f ic a t io n  o f  d if f e re n tia l ly  la b e lle d  sp o ts
One o f the most sensitive methods for protein identification in proteomics relies on gel 
based mass spectrometry. Improved mass spectrometers and sample preparation methods 
now make possible the use o f low femtomole amounts o f gel-loaded proteins with a high 
probability of successful identification. Several approaches are used for protein MS- 
identification, with the most commonly used method being peptide mass mapping using 
matrix assisted-laser desorption/ionisation-mass spectrometry (MALDI-TOF-MS) and 
database searching (Chapters 1 and 2).
In this work, a modified porcine trypsin was used to generate tryptic peptides from gel-
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separated proteins. This enzyme efficiently cleaves at the C-terminal side o f lysine and 
arginine residues w ithout giving rise to any autolysis peaks. Proteins were digested 
(procedure described in Chapter 2) and the tryptic digest mixture was analysed by 
MALDI-TOF-M S using an Ultraflex instrument (Bruker Daltronics). Fifty one out o f  the 
89 proteins o f interest (57%) gave well resolved spectra with high signal-to-noise ratios 
and high mass accuracy (within +/- 50 ppm) and consequently the picked proteins were 
identified with high confidence. A typical example o f  a peptide mass spectrum with 
database search results is shown in Figure 4-10. Protein identification was carried out on 
samples from triplicate gels and from the repeat experiments. Many o f the same protein 
identifications were found in the repeated analysis, giving an increased confidence in the 
validity o f the protein identities and changes. However, for the other 38 spots o f interest, 
the signals were low or spectral peaks were poorly resolved and the peptide fingerprints 
did not provide sufficient protein sequence coverage to identify the protein. This problem 
may be caused by insufficient sample, inadequate extraction o f special peptides (e.g. 
hydrophobic peptides), the lack o f tryptic sites, or post-translational modification o f  the 
proteins. In these cases the proteins could not be identified, despite repeat picking, 
digestion and peptide mass fingerprinting.
Identification o f  differentially labelled features from unstained gels was also attempted 
using automated picking methos based on coordinates derived from the fluorescent 
images alone. Although the picking accuracy was good (confirmed by re-scanning o f  
gels), only ~40% o f  the features could be identified with confidence. O f the samples that 
could not be identification, they generally generated low intensity spectra, implying that 
there was insufficient material in these spots. Thus, whilst detection o f these low- 
abundance thiol-containing proteins was possible using the ICy dyes, the steps in the 
processing for MALDI-TOF analysis were insufficiently sensitive to detect the digested 
proteins. This would be due to the labelling o f  very reactive thiols on protein species 
expressed at low levels and affinity purification strategies could be used to enrich them.
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(Figure 4-10) Typical mass spectra and database searching for protein identification by 
peptide mass fingerprinting. Proteins were picked and proteolysed with trypsin (Chapter 2). 
The peptide mixture generated was then analysed by matrix-assisted laser-desorption/ionisation- 
MS (MALDI-TOF-MS). (A) A typical mass spectrum was acquired on an Ultraflex TOF/TOF 
mass spectrometer (Bruker Daltonics). The list of peptide masses was searched against the NCBI 
theoretical peptide fragment database (updated NCBInr. 3.24.2003 or Swiss-prot) using Mascot 
and Protein Prospector. (B) Peptide mass mapping was performed by database searching using 
Mascot (Matrix Science) with a probability score higher than the threshold value (62 in this case) 
meaning the hit is highly significant. (C) Protein Prospector (version 3.4.1) MS-Fit search tool 
(UCSF, USA). The search criteria allowed a +/- 50 ppm mass error and up to 1 missed cleavage. 
Identical search parameters were used for all MS searches. (D) Representation of protein 
coverage, where in the case analysed (Cyclophilin A), the matched peptides represent 44% of the 
sequence of the protein.
Table 4-1A shows the 25 o f the 51 identified proteins which displayed peroxide- 
dependent changes in ICy labelling and includes 10 isoforms which also showed some 
ErbB-2 dependency at the fold cut-offs used. Table 4 -IB shows the 26 identified 
proteins displaying ErbB-2-dependent differences alone (i.e. C3.6 vs. HB4a). Some 
iso forms (such as chaperonin containing T C Pl-p  and cytokeratin 13) formed charge 
trains that could be induced by labelling o f a number o f thiols and implying that 
saturation labelling was not achieved in this experiment. The migration of all o f the 
identified features are shown in a master gel in Figure 4-11 A. Proteins located in the high 
molecular weight, acidic region o f the gel are shown in a zoomed-in area o f the figure 
(Figure 4-1 IB). Examples o f some these changes are represented graphically in Figure 4- 
12. It is important to note that all proteins identified contain at least one free cysteine 
thiol, which helps to validate the specificity o f this labelling technique.
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A
Mowse Est Eat Pred Pred Accession
Spot No Protein Name %Cov Score mass Pi Mass PI No.
769 BiP protein* 35 105/64 72000 6.1 70932 6.2 6470150
1123 Chaperonin containing TCP1-a 27 72/64 60000 6.7 60344 6.8 135538
1242 Chaperonin containing TCPI-p* 50 123/64 55000 6 6 57489 6 5453603
1206 Chaperonin containing TCPI-P* 50 127/64 55000 6.7 57489 6 5453603
1110 Chaperonin containing TCP1-y 36 88/64 57000 6.6 60403 6.1 20455521
1144 Chaperonin containing TCP1-/; 43 124/64 56000 12 58025 6.2 730922
1143 Cytokeratm 10 28 69/64 58000 6 9 58827 5.1 4557697
2276 Glutathione S-transferase * 55 68/64 25000 6.4 24678 6.7 121746
2253 Glutathione S-transferase x chain A 54 71/64 25000 5.7 23225 6.4 494066
2049 Glyceraldehyde-3-phosphate DH* 42 124/64 35000 9 36054 8.6 120649
1088 HSP-73* 46 88/64 70000 6 70898 6.4 123648
2482 Peptxfyt-prolyl cis-trans isomerase A* 65 94/64 15000 8 17881 7.8 13937981
1536 Peroxiredoxin 1* 34 68/64 23000 6.6 22111 8.3 548453
1603 Peroxiredoxin 2* 33 107/64 20000 6 21892 6.7 2507169
2274 Peroxiredoxin 3 (antioxidant protein 1) 33 138/64 26000 6.4 27693 7.7 2607171
2510 Peroxiredoxin 5. chain A* 44 138/64 17000 7.2 16900 7 15826629
2195 Peroxiredoxin 6 (antioxidant protein 2) 68 113/64 26000 6.9 25035 6 1718024
2228 Peroxiredoxin 6 (antioxidant protein 2) 59 98/64 27000 7 25035 6 1718024
2157 Prohibtin 44 68/64 30000 5.6 29804 6.6 4505773
1563 Proteasome p 2 subunit* 38 71/64 22000 7.6 22836 6.5 1709762
2271 RAN small GTPase 67 104/64 25000 7.6 24423 7 5453555
2141 Signal recognition particle receptor p subunit 33 66/64 29000 8.1 29651 9.2 20141812
1302 Splice isoform of Glutaryl-Co A DH 36 87/64 50000 7.3 47356 86 2492631
2224 Triosephosphate isomerase* 61 80/64 28000 7.4 26539 6.5 136060
Average fold-difference * and p-value
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Eat
Pi
Pred
Mass
Pred
P<
Accession
No
4a<20) to 
4a(0)
2095 14-3-3 protein o 31 91/65 30000 4.6 27774 4.7 5454052 1.01
1207 Aldehyde dehydrogenase 6 25 76/64 54000 7.4 56010 6 6 4502041 -1.41
1183 Cytokeratm 6 53 100/64 55000 6.1 53501 5.4 14318422 1.04
1277 Cytokeratm 7* 54 98/64 55000 6.1 51335 6.4 20178293 -1.25
1307 Cytokeratm 13 48 137/64 50000 4.9 49587 49 24234696 •1.05
1298 Cytokeratm 13 45 221/64 50000 4.6 49587 4 9 24234696 -1.01
1295 Cytokeratm 13 31 102/64 50000 4.9 49587 4.9 24234696 1.3
1165 Cytokeratm 13 39 116/64 55000 4.9 49587 4.9 24234696 1.05
1303 Dihydrokpoamlde dehydrogenase 42 110/64 54000 7.5 54151 7.6 118674 -1.04
2262 Glutathione S-transferase a 67 74/64 26000 7 2 24678 6.7 121746 -1.47
2182 HSP-27* 46 115/64 27000 6.6 22783 6 4504517 •1.31
2213 HSP-27* 25 67/60 27000 6.1 22783 6 4504517 1.37
1104 HSP-60 32 140/64 60000 6.4 61055 6.7 129379 -1.26
1060 HSP-60. mitochondrial precusor* 26 81/64 57000 5.7 61213 6.7 129379 1.11
1082 HSP-60. mitochondrial precusor' 40 127/63 57000 5.4 61213 5.7 4504521 •1.03
996 HSP-70* 44 160/64 71000 5.4 70699 5.4 5729877 1.1
1736 Maspm precusor (protease inhibitor 5) 41 67/64 41000 6.6 42229 5.8 453368 -1.28
1729 Maspin precusor (protease inhibitor 5) 56 75/64 41000 6.7 42229 5.8 547892 -1.07
2507 Nucleoside diphosphate kinase A 44 77/64 16000 6.6 17149 5.8 127981 1.27
2248 Protea some alpha 2 subunit 32 63/60 26000 7.4 25899 6 9 4506181 1.13
1204 Protein disulfide-isomerase A3 precursor' 37 261/64 55000 6.5 56783 6 2507461 -1.28
1216 Protein disulfide-isomerase A3 precursor* 34 79/64 56000 6.3 56783 6 2507461 -1.09
1178 Protein disulfide-isomerase ER60 precusor 25 78/64 56000 6.2 56680 6.1 1085373 1.12
2254 Rho-GDP-dissociation inhibitor 1 31 86/64 27000 5 23207 5 4757768 1.33
2518 Ubiquitin-conjugating enzyme E2N 55 114/64 16000 6.4 17138 6.1 2501432 1.01
Average fold-difference 1 and p -va lu e
P-value
3.6(20') to 
3.6(0) P-value
3.6(0*) to 
4a(0) P-value
36(20') to 
4a(20') P-value Function
0.85 -1.16 0.11 -1.71 0 00014 -2 000087 Growth regulation
0 0008 •1.12 0.18 1.43 0.0013 1.81 0.0026 Detox, of aldehydes
0.76 1.11 0.35 1.6 0.014 1.72 0.036 Cytoskeleton
0.01 -1.16 0.00012 1.45 0 000065 1.67 0 00058 Cytoskeleton
0.01 -1.13 0.01 4.16 0.0000039 3.67 0 000098 Cytoskeleton
0.93 -1.11 0.21 3.17 0 000069 288 000031 Cytoskeleton
0.016 -1.06 0.016 5.54 0 0001 4.03 000073 Cytoskeleton
0.012 1.04 0.012 2.29 0.024 2.28 0.0064 Cytoskeleton
0.77 1.18 0.22 -1.84 0 000044 -1.61 0.018 Regulation of cellular redox state
0.0034 -1.12 0.00078 -2.36 0 00000085 -1.8 000065 Regulation of cellular redox state
0.0043 -1.46 0.0011 2.51 0.0023 225 0.0082 Protein folding
0.0038 -1.12 0.009 6.42 0 000091 4 2 0 029 Protein folding
0.09 -1.05 0.45 -1.89 0 000019 •1.58 0.023 Protein folding
0.0034 -1.07 0.009 -1.63 0 00046 -1.82 000008 Protein folding
0.037 -1.04 0.037 0 000016 -1.78 0.0012 Protein folding
0.55 -1.13 0.33 -1.44 0.00015 -1.79 0.028 Protein folding
0.0008 1.08 0.18 1.48 0.0014 2.04 00000041 Growth/Proliferation suppresion
0.053 1.09 0.12 1.4 0.003 1.64 000003 Growth/Proliferation suppresion
0.1 -1.05 0.15 1.89 0.0049 1.42 0.00078 Nucleotide metabolism
0.069 1.07 0.68 -2 0.00013 -212 0.0033 ATP/ubiquitin-dep. Proteolysis
000038 -1.23 0.00062 1.67 0 000032 1.64 0000002 Disulfide bond formation/protein folding
0.013 -1.02 00094 1.66 0 00012 1.66 0000028 Disulfide bond formation/protein folding
0.0021 -1.04 0.0031 1.67 0.0013 1.34 0.0018 Disulfide bond formation/protein folding
0.019 -1.07 0.028 2.01 0.011 1.41 0.017 Inact of NAD PH oxidase/small GTPases
0.00018 1.13 0.0046 1.74 0.0023 1.94 0.00046 Ubiquitin conjugation
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(Table 4-1) Identification of differentially labelled/expressed proteins. (A) Proteins displaying H20 2-induced differential labelling in normal 
(HB4a) and ErbB-2-overexpressing (C3.6) human mammary luminal epithelial cells. (B) Proteins displaying differential labelling between HB4a 
and C3.6 luminal epithelial cells. Proteins were identified by MALD1-TOF peptide mass mapping (see Materials and Methods (Chapter 2)). 
“Proteins identified in two or more independent experiments. Proteins appearing more than once in the tables were identified as isoforms with 
different p/s. The % coverage of analysed peptides, the MOWSE score from Mascot searches and the significance threshold score, the 
estimated mass and p/(from gels), the predicted mass and p/(from the database) and the NCBI gene identifier (Accession Number) are shown for 
each protein. MS spectra, MOWSE score histograms, matching peptides and sequence coverage for all proteins are shown in Appendix C. 
+Average fold-differences from DeCyder analysis show abundance ratios for treated HB4a cells versus untreated (4a(20’) to 4a(0)), treated C3.6 
cells versus untreated (3.6(20’) to 3. 6(0)), untreated C3.6 versus untreated HB4a (3.6(0) to 4a(0)) and treated C3.6 versus treated HB4a (3. 6(20’) 
to 4a(20’)). Proteins displaying an average fold-difference of > 1.5-fold up (+) or down (-) regulation between pairs of conditions where /?<0.05 
and spots matched in all images are shaded grey. N. A. not analysed. Functions were ascribed from the NCBInr database and literature searches.
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AHSP-73 (1088) 
HSP-70 (996) 
HSP-60 (1082) 
BiP protein (769) 
HSP-60 (1104) 
HSP-60, mit. precursor (1060) 
Cytokeratin 6 (1183) 
Protein disulfide-isomerase (1178) 
Cytokeratin 7 (1277) 
Cytokeratin 13 (1165) 
Cytokeratin 13 (1295) 
Cytokeratin 13 (1298) 
Cytokeratin 13 (1307) 
14-3-3 protein a  (2095) 
Rho-GDP-dissociation inhibitor 1 (2254) 
Prohibitin (2157) 
HSP-27 (2213) 
HSP-27 (2182) 
Glutathione-S-transferase it (2253) 
Similar to FU00075 protein (2451) 
Peroxiredoxin 2 (1603) 
Ubiquitin-conjugating enz. E2N (2518) 
Hypothetical protein FU 20972 (2848)
Protein disulfide-isomerase A3 (1216)
Protein disulfide-isomerase A3 (1204)
Chaperonin containing T C P l-a  (1123)
Chaperonin containing TCP1 -y (1110)
Chaperonin containing TCPI-P (1206)
Cytokeratin 10 (1143)
Chaperonin containing TCPI-P (1242) 
Glutaryl-CoA dehydrogenase-splice isoform (1302) 
Dihydrolipoamide dehydrogenase (1303) 
Chaperonin containing TCP1-C (1144)
Aldehyde dehydrogenase 6 (1207)
Maspin precursor (Protease inhibitor 5) (1729) 
Maspin precursor (Protease inhibitor 5) (1736) 
Glyceraldehyde-3-P dehydrogenase (2049)
SRP receptor P subunit (2141)
Triosephosphate isomerase (2224)
Peroxiredoxin 1 (1536)
Peroxiredoxin 6 (antioxidant protein 2) (2195)
RAN small GTPase (2271)
Proteasome ot2 subunit (2248)
Peroxiredoxin 6 (antioxidant protein 2) (2228) 
Glutathione-S-transferase n  (2262)
Proteasome P2 subunit (2248)
Peroxiredoxin 3 (antioxidant protein 1)(2274) 
Glutathione-S-transferase it (2276)
Peptidyl-prolyl cis-trans isomerase A (2482) 
Peroxiredoxin 5, chain A (2510)
Nucleoside diphosphate kinase A (2507)
(Figure 4-11) 2DE migration of proteins identified by MALDI-TOF-MS displaying H20 2- 
induced differential labelling and/or ErbB-2 dependent differential expression (see Table 4- 
1). (A) A silver-stained image of a representative gel is shown. (B) An enlarged image of the 
high molecular weight acidic region is shown.
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(Figure 4-12) Examples of proteins displaying altered labelling following H20 2 treatment 
and/or differential expression between normal (HB4a) and ErbB-2 overexpressing (C3.6) 
cell lines. Proteins were identified from gels by MALDI-TOF-MS as described in Materials and 
Methods (Chapter 2). Graphs were derived from DeCyder image analysis where the standardised 
abundance is the ratio of the volume of a test gel feature versus the volume of the corresponding 
internal standard gel feature. Triplicate data points are shown for the 0 and 20 min experiments 
with lines joining the average values, whilst single data points are shown from the preliminary 
timecourse experiment.
Proteins differentially labelled or expressed in response to H2O2 fell into several 
functional groups. Firstly, molecular chaperones were highly representative. Heat shock 
protein 73/hsc70, the ER chaperone BiP/Grp78, peptidyl-prolyl cis-trans isomerase A 
(cyclophilin A/CypA), signal recognition particle receptor p subunit (SRp) and the 
chaperonin-containing T-complex protein 1 (TCP1) subunits a ,  P, y and are all known
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to be involved in processes such as ATP-dependent protein folding, protein transport, 
degradation o f incorrectly folded polypeptides and prevention o f aggregation o f  newly 
synthesised polypeptides. ICy labelling o f these individual proteins were both increased 
and reduced by H2O2 treatment depending on the particular protein (Table 4-1 A). CypA 
showed the greatest increase in labelling in response to H2O2 . Immunoblotting was used 
to reveal that this was not due to altered protein expression, although the differential 
labelling between cell lines did appear to result from a change in protein expression 
(Figure 4-13A and Figure 4-14).
Reassuringly, a number o f  the identified proteins have known roles as cellular redox 
regulators. This includes two isoforms o f  glutathione S-transferase n , in which labelling 
was both reduced after H2O2 treatment and in the C3.6 cells. Again, no significant 
changes in protein expression level were detected by ID  immunoblotting (Figure 4-14), 
which was suggestive o f a mechanism involving direct oxidative modification. In support 
o f  this, a reduction in ICy labelling o f recombinant GST protein was observed after 
treatment with H2O2 , although a specific site o f modification could not be identified by 
MS (Figure 4-15 and see later). There also appeared to be a shift in the molecular weight 
o f  the H2C>2-treated sample that might be due to oxidation changing the charge and 
therefore the mobility o f the protein. Five o f  the six known mammalian peroxiredoxin 
(Prxn) family members were also identified as targets o f F^C^-induced redox stress in the 
human luminal epithelial cell system. The Prxns are antioxidant enzymes that function 
by reducing hydroperoxides that have been implicated in redox-regulation o f  cell 
signalling (Wood et al., 2003). ICy dye labelling o f  2DE isoforms which corresponded to 
P rxn l, 2, 3, 5 and 6  was increased after H2O2 treatment, whilst the level o f  another 
isoform o f  Prxn6  was reduced (Table 4-1A and Figure 4-12). ID immunoblotting 
showed that overall, Prxn expression did not correlate well with ICy labelling; P rxnl and 
3 levels were increased slightly by H2O2 treatment in HB4a cells in agreement with the 
ICy dye labelling results; whereas Prxn2 decreased in HB4a cells and Prxn5 and 6  levels 
were unaffected (Figure 4-14). These results infer that the labelling changes are not only 
due to changes in protein level, but also due to changes in the reactivity o f  thiols within 
these proteins.
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(Figure 4-13) Validation of differential labelling/expression by ID and 2D immunoblotting.
Expression of selected targets was analysed by ID and 2D immunoblotting using specific 
antibodies. 2D blots of lysates from untreated and H20 2-treated HB4a cells and a mixed lysate 
are shown aligned with the corresponding ICy dye fluorescence images. Average-fold differences 
are taken from Table 4-1 A. Results are shown for (A) Peptidyl-prolyl cis-trans isomerase A 
(CypA) (B) Hsp27 (C) Prohibitin (D) Triosephosphate isomerase (TPI).
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(Figure 4-14) Validation of differential labelling/expression by lD-immunoblotting. Protein 
expression in total cell lysates from H20 2-treated/untreated HB4a and C3.6 cells is compared by 
1D-SDS-PAGE and immunoblotting with specific antibodies. The protein expression profiles are 
compared with the ICy dye labelling ratios from the 2D-DIGE experiment.
113
400 ng Protein
GST Ran
(Figure 4-15) Effect o f H20 2 on thiol reactivity o f recombinant proteins. Recombinant GST 
and Ran (400 ng in urea lysis buffer) were treated with 0.5mM H20 2 for 20 min or left untreated. 
The samples were then labelled with ICy dye (80 pmol/pg), resolved by IDE, detected by 
fluorescence scanning and post-stained with colloidal coomassie blue.
All Prxns contain an active-site cysteine which is oxidized to a sulfenic acid by the 
peroxide substrate which is then converted back to the free thiol via various mechanisms 
include intra- and inter-molecular disulphide bond formation and reduction by the 
thioredoxin system. Previous data have shown that Prxn cysteines can be over-oxidised 
to sulphinic or sulphonic acids, resulting in their detection as proteins with an acidic shift 
on 2D gels (Wagner et al., 2002;Rabilloud et al., 2002a). Whilst it is expected that H2O2- 
dependent oxidation o f Prxn active-site cysteines would block ICy labelling, we 
hypothesise that the increased labelling observed may occur as a result of labelling o f 
other free thiols (present in all Prxns) on a p/-shifted pool o f oxidised protein. However, 
one could also envisage that Prxns may be partially oxidised in resting cells, and that 
activation of cellular antioxidant mechanisms leads to their complete reduction and the
114
creation o f  additional labelling sites that were not present prior to oxidative insult. In 
support o f  the suggestion that there is a shifted pool o f  oxidised peroxiredoxin which can 
be separated from the unmodified protein, we detected 2  isoforms o f peroxiredoxin 6 . 
These hypotheses and the results explain why protein levels seen in immunoblotting do 
not correlate well with the ICy labelling results. However, the nature o f the differences 
between the two isoforms could not be characterised by MALDI-TOF-MS.
Other proteins o f interest modified by peroxide treatment included glyceraldehyde 3- 
phosphate dehydrogenase (G3PDH), triosephosphate isomerase (TPI), prohibitin, and 
Ran (Table 4-1 and Figure 4-13). TPI, Ran and prohibitin expression levels were found 
not to be altered significantly by H2O2 treatment, suggesting that direct oxidative 
modification (Figure 4-14 and Figure 4-13C and D). The observed modulation o f  the 
glycolytic enzymes G3PDH and TPI supports previous data showing that oxidative stress 
can redirect carbohydrate fluxes to generate increased reducing power in the form o f 
NADPH at the expense o f  glycolysis. Thus, it is interesting that these two proteins have 
been identified in other studies as being regulated by oxidative stress (Shenton and Grant, 
2003). Prohibitin can prevent cellular proliferation by binding to the Rb protein thus 
promoting suppression o f  E2F-mediated transcription, and it has been implicated in cell 
cycle regulation, senescence, immortalization and tumourigenesis (reviewed in (McClung 
et al., 1995)). Its oxidative modification may therefore have profound effects on cellular 
proliferation, which was found to be reduced in these cells by H2O2 treatment. The small 
GTPase Ran is known to play a critical role in active nuclear transport (Quimby and 
Dasso, 2003), and its modification may adversely affect protein localisation or be part o f 
a redox protective mechanism. In support o f  the concept that direct oxidative 
modification o f Ran take place, reduced ICy dye labelling o f recombinant Ran protein 
was observed after treatment with H2O2 (Figure 4-15) which was in agreement with the 
observed 2D-DIGE results. SRp is also a small GTPase involved in targeting o f  nascent 
polypeptides to the endoplasmic reticulum translocation machinery (Connolly and 
Gilmore, 1989). Thus, my results suggest that GTPases could be novel targets o f  
oxidative stress and the impact o f redox modification o f these enzymes on protein 
localisation and processing merits further analysis.
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The experimental strategy used here also allowed simultaneous comparison o f the effects 
o f ErbB-2 overexpression on the proteome o f  luminal epithelial cells exposed to 
oxidative stress. In my experiment, 26 gene products were identified (representing 36 
isoforms) that were significantly up- or down-regulated (> 1.5-fold; p  <0.05) in untreated 
or H2C>2-treated normal versus ErbB-2 overexpressing cells (Table 4-1B). The 
differential modulation o f several m olecular chaperones was observed, suggesting that 
ErbB-2 overexpression may alter protein folding/processing and influence the stress 
response. For example, multiple isoforms o f  Hsp27 and PDI/ERp60 were up-regulated in 
the C3.6 cells and these were found to be moderately affected (1.2-1.5-fold) by H2O2 . 
Hsp60 and Hsp70 were down-regulated but unaffected by H2O2 and T C P l-a , TCP1- 
P, SRp and CypA showed both robust ErbB-2- and H2 0 2 -dependent regulation (Table 4- 
1, Figures 4-12 and 4-13 and 4-14). Although the functional consequences o f  these 
changes are unclear, several o f these stress-response proteins have been shown to be 
dysregulated in human cancer and appear to alter the response o f  tumour cells to immune 
surveillance, anticancer drugs and oxidative stress (reviewed in (Sarto et al., 2000b)). In 
support o f our data, Hsp27 is overexpressed in invasive ductal carcinomas o f  the breast 
(Sarto et al., 2000b) and protects cells against oxidative stress through p38-dependent 
phosphorylation and cytoskeletal modulation (Dalle-Donne et al., 2001).
Interestingly, CypA contains only free thiols, and so the increased labelling observed 
suggests that a more complex mechanism o f  redox modulation. One possibility is that 
H2O2 may cleave a disulphide bond between CypA and another protein. In support o f 
this, CypA has been shown to bind to and promote the antioxidant activity o f the 
peroxiredoxins (Lee, 2001). The modulation o f these molecular chaperones by H 2O2 is 
likely to affect protein folding and may trigger the unfolded protein response (UPR) that 
modulates expression o f ER chaperones such as BiP/Grp78 and the protein disulphide 
isomerase PDI/ERp60. Thus H2O 2 may allow cells to tolerate the accumulation o f  
unfolded proteins (Lee, 2001). It is o f  interest that BiP/GRP78 has been shown to play an 
important role in the UPR by providing cytoprotection from H2O2 in a mechanism 
involving activation o f ERK1/2 signalling (Hung et al., 2003). In correlating with 
previous blotting results, H2O2 was found to activate the ERK 1/2 signalling in the HB4a 
and C3.6 cell system.
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Isoforms o f several redox regulatory proteins (GSTti, Prxn3, Prxn6 , Rho-GDP- 
dissociation inhibitor 1 (R hoG D Il) and dihydrolipoam ide dehydrogenase) were also 
altered by ErbB-2 overexpression, although data from ID  immunoblotting o f total protein 
expression did not particularly agree with that from ICy labelling data. Again, this 
indicates that direct oxidative modification which does not alter protein abundance. 
However, the prescence o f differentially labelled multiple isoforms cannot be resolved by 
IDE so the effect on isoform distribution could not be observed. Dysregulated 
expression (mostly up-regulation) o f  Prxns has been observed in human cancers, 
including breast cancer. Such changes have been connected with a protective role against 
anti-tumour agents and oxidants, and have even been reported to promote cell 
proliferation and tumour progression (Noh et al., 2001;Shen and Nathan, 2002). Whilst 
changes in Prxn expression and redox signalling may contribute to the hyperproliferative 
phenotype observed in the C3.6 cells (Timms et al., 2002), down-regulation o f  14-3-3g, a 
negative regulator o f  cell proliferation (Table 4 -IB) could also have an important effect. 
Indeed, and in agreement with our findings, 14-3-3a  expression has been shown to be 
down-regulated in a significant proportion o f primary breast carcinomas examined 
(Vercoutter-Edouart et al., 2001), and it is tempting to speculate that ErbB-2 
overexpression may directly cause this down regulation.
RhoGDI functions to inhibit the activity o f  the Rho-family o f  small GTPases by directly 
preventing the exchange o f  GDP for GTP by guanine exchange factors (GEFs), by 
preventing intrinsic and RhoGAP mediated GTP hydrolysis and by keeping Rho/Rac in 
the cytoplasma (Adra et al., 1997). Thus, RhoGDI can inhibit cell motility by inhibiting 
the activity o f Rho proteins. RhoGDI overexpression has been shown to increase the 
estrogen receptor transcription level (Su et al., 2001) and the expression o f  the estrogen 
receptor directly inhibits breast cancer cell motility and invasion (Lazennec et al., 2001). 
These studies suggest that RhoGDIs play an important role in cancer cell motility. The 
data here in (Table 4-1) show that the observed increased labelling o f RhoGDI in the 
HB4a cells with no significant difference in protein level measured by immunoblotting 
(Figure 4-14). Thus, ErbB-2 signalling could control cell motility via a mechanism 
involving the altered thiol accessibility o f RhoGDI.
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4.6 Identification of ICy dye labelled residues by MALDI-TOF-MS
It was reasoned that it would be possible to identify the specific sites o f cysteine redox 
modification by identifying peptides that were labelled with ICy dye. Therefore all MS 
database searches were conducted with the inclusion o f the ICy3 (510 Da) and ICy5 (508 
Da) modification. However, this search revealed only a few modified peptides with high 
confidence. Two o f  the examples were Prxn6  and GAPDH, which were labelled at Cys90 
and Cys246, respectively (Figure 4-16). W hilst these are not the active site cysteines o f  
these redox-sensitive enzymes (Lind et al., 2002;Wood et al., 2003), they are accessible 
to labelling, corroborating our theory o f  how the labelling o f  some protein isoforms can 
be increased (i.e. an oxidation-dependent shift in pi with labelling o f the shifted form at 
additional sites). It is important to note that the unlabelled forms o f these peptides were 
also identified, suggesting that labelling is sub-stoichiometric or that the dye moiety was 
lost during ionisation. The poor recovery o f  labelled peptides in general may possibly be 
due to their lowered solubility and hence inefficient extraction o f peptides from gel 
pieces. In support o f  this, other work in the laboratory showed that model peptides 
labelled in solution performed well in MALDI-TOF MS. Further refinements to the 
extraction procedures were carried out including extraction o f peptides from gel pieces 
using higher percentages o f acetonitrile (50% or 70%), and trifluoroacetic acid (5% or 
10%), with or without sonication. However, these different extraction strategies did not 
improve the ability to identify dye-labelled peptides.
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Spot 2415/ Pxn-6 Spot 2049/GAPDH
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(Figure 4-16) Identification of ICy-modified cysteine residues by MALDI-TOF-MS.
MALDI-TOF-MS spectra are shown for ICy-modified peptides of Prxn6 and GAPDH from the 
ICy 2D-DIGE analysis. The molecular weights of ICy3-modified peptides are 510 Da higher 
than the corresponding unmodified peptides.
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4.7 Effect of H2O2 on dye integrity
As part o f  the 2D-DIGE analytical strategy, gels were post-stained with silver, which was 
subsequently removed prior to in-gel digestion and MS analysis using 1% H2O2 treatment 
(approximately 300 mM) (Gharahdaghi et al., 1999). However, 1% H2O2 (300 mM) 
treatment might also oxidise and damage the dyes on labelled proteins leading to 
problems in identifying labelled peptides by MS. Based on this hypothesis, the effect o f 
H2O 2 on ICy3/5 labelling was investigated. Firstly, the indicated concentration o f  ICy3 
and ICy5 were treated with 1% H2O2 at room temperature for 10 min, the duration used 
for removing silver stain prior to in-gel digestion. Subsequently, the absorbance at 553 
and 648 nm were recorded for the !Cy3 samples and ICy5 samples, respectively (Figure 
4-17A). Similarly, the fluorescence excitation/emission wavelengths o f 532/580 nm and 
633/680 nm were used to detect fluorescence from the ICy3 and ICy5 samples, 
respectively. Both measurements indicated that 1% H2O2 caused damage to ICy3, 
reducing its absorbance and fluorescence emission by approximately 40%. ICy5 was 
more severely affected and only 10-20% o f  the ICy5 signal remained after treatment. 
MALDI-TOF-M S analysis o f  the H202-treated dyes indicated that the 636 Da ICy5 signal 
nearly disappears, whilst the 638 Da signal o f  ICy3 was no significant change after H2O2 
treatment (Figure 4-17B). According to these observations, the process o f silver 
destaining to improve MALDI-TOF-M S identifications o f  proteins damages the ICy 
molecules, presumably through oxidation and breakage o f  the ring structure o f  these dyes 
and would lead to loss o f  observable dye-modified peptides. For this reason, this step 
was omitted in subsequent analyses or CCB post-staining was used instead. It is 
important to note that the concentration o f  H2O2 used for destaining is >600 times higher 
than that used for induction o f oxidative stress in cells, such that damage to the dyes in 
lysates would not occur.
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(Figure 4-17) The Effect of H20 2 on ICy3 and ICy5 integrity. (A) 60 pi of the indicated 
concentrations of ICy3 and ICy5 were treated with 1% H20 2 at room temperature for 10 min or 
left untreated. The absorbance at 553 and 648 nm were recorded for ICy3 and ICy5 samples, 
respectively. The fluorescence of the H20 2-treated and untreated dyes were measured at 
excitation/emission wavelengths of 532/580 nm and 633/680 nm for ICy3 and ICy5, respectively. 
(B) 1 pmol of ICy3 and ICy5 were treated with 1% H20 2 at room temperature for 10 min. After 
mixing with 1 pi of DHB matrix, spectra were acquired by MALDI-TOF-MS on an Ultraflex 
instrument calibrated with Calmix 2.
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4.8 Analysis of H202-induced and ErbB-2 dependent protein changes by 
NHS-lysine labelling 2D-DIGE.
According to the previous cysteine 2D-DIGE analysis (Table 4-1), two differentially 
labelled isoforms o f  peroxiredoxin 6 were observed that are likely to represent different 
oxidative states; one reduced form and one oxidized (sulfenic/sulfinic/sulfonic) form. In 
order to corroborate this and other findings, lysine 2D-DIGE was applied to analyses 
changes in protein level due to oxidative stress.
Thus, a minimal-NHS-Cy dye lysine labelling 2D-DIGE experiment was performed 
where triplicate cultures o f  HB4a and C3.6 cells were treated with 0.5 mM H2O2 for 20 
and 240 minutes or left untreated. This experimental design would allow the 
simultaneous examination o f  significant changes due to ErbB-2 overexpression and H2O2 
treatment, and provide gels for the excision o f  protein spots for MS identification. Three 
biological triplicate sets o f  samples were run on 9 gels using a Cy2-labelled standard 
consisting o f  a mixture o f all samples, and 27 fluorescent images were captured (Figure 
4-18). DeCyder BVA analysis showed 138 significant changes in labelling across the 
different conditions (> 1.5-fold up or down regulated; p<0.05) (Figure 4-19). O f these, 
117 could be aligned to corresponding CCB stained spots (Figure 4-20) and 53 (45%) o f 
them were identified by M ALDI-TOF-M S representing 38 gene products (Table 4-2). 
The other 64 (55% ) could not be identified due to low sequence coverage or low MS 
signals. Comparison between the ICy and N HS-Cy dye-labelling approaches revealed 18 
common identities, representing isoforms o f  11 individual gene products. In most cases, 
these displayed the same direction o f  altered expression, indicating that the ICy dyes 
were detecting changes in abundance for these proteins.
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(Figure 4-18) Representation of the experimental design and images obtained in the analysis 
of the proteomic response to H20 2 treatment in HB4a and C3.6 cells using NHS-Cy 2D- 
DIGE. (A) Randomly growing HB4a and C3.6 cells were treated with 0.5 mM H20 2 for 20 and 
240 min and compared to the untreated samples. Lysates were prepared and labelled with NHS- 
Cy3 or NHS-Cy5 and compared to an internal standard representing pooled aliquots of each 
sample labelled with NHS-Cy2. Samples were run in triplicate for statistical analysis and to 
assess reproducibility. This represents 9 gels with 27 images generated. Gel images were 
processed using the BVA module of DeCyder software. One of the image sets in (A) are shown in 
(B) with representative enlarged images.
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A. Differential labelling between B. Differential labelling between
HB4a (20) and HB4a (0) HB4a (240) and HB4a (0)
C. Differential labelling between D. Differential labelling between
C3.6 (20) and C3.6 (0) C3.6 (240) and C3.6 (0)
E. Differential labelling between F.
C3.6 (0) and HB4a (0)
Differential labelling between 
C3.6 (20) and HB4a (20)
G. Differential labelling between 
C3.6 (240) and HB4a (240)
(Figure 4-19) Differential protein expression in HB4a vs. C3.6 cells and H20 2-induced 
differences. Representative Cy dye images of H20 2treated/non-treated HB4a and C3.6 cells are 
shown. Protein features with altered expression across the time course or between cell lines are 
labelled with the master spot identity numbers. All of the images in this figure are presented in 
Appendix I with representative enlarged images.
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(Figure 4-20) M aster gel image of NHS-Cy2 labelled standard pool and its corresponding 
colloidal coomassie blue stained image. The image shown is a merged image of the NHS-Cy2 
labelled HB4a/C3.6 cell lysate pool (red) and the corresponding colloidal coomassie blue stained 
gel (blue) created using Adobe Photoshop software. The yellow circled spots indicate aligned 
differentially labelled spots that were excised for further identification.
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Average fold-difference T and p -value
Spot No Protein Name % Cov
Mowse
Score Est mass EsI pi
Pred
Mass Pred pi
Accession
No
4a<20') to 
4a (0) P-value
4a(24(r) to 
4a(0) P-value
3.6(20-) to 
36(0) P-value
3 6(240-) to 
3 6(0') P-value Function
391 2-OGOH 27 104/64 110000 72 114601 6 1352618 -103 079 -1.15 0.17 1 098 -162 00015 TCA cycle eruyme/Oxldative metabolism
1123 Cytokeratm 6A 30 104/64 60000 6 59914 8.1 46812692 1.13 0.014 1.63 0.0011 1.07 0 0061 166 000021 Cytoskeieton
1090 Diiydrotpoyt dehydrogenase 35 100/64 55000 7.8 54713 7» 51095146 -1.09 0 2 -1.35 0038 -1.11 0.12 -1*7 0.0017 Component of pyruvate dehydrogenase
471 Elongation (actor 2* 13 67/64 95000 7.1 96246 6.4 119172 509 0021 4.39 0 00013 6 65 0 00002 3.53 0000096 Protein synthesis
472 Elongation factor 2* 21 75*6 95000 72 96246 6.4 119172 3.19 00069 2 53 0000026 3.12 0 0011 2.7 00018 Protein synthesis
476 Elongation (actor 2* 37 157/64 95000 7.3 96246 6.4 119172 2 24 0.031 1.67 00007 223 000036 162 0 0023 Protein synthesis
406 Elongation (actor 2* 27 83*4 95000 7.4 96246 6.4 119172 -1.34 0026 -1.25 0.01 -1.5 0.011 -1 28 0025 Protein synthesis
487 Elongation (actor 2* 39 169*4 95000 7.5 96246 6.4 119172 -246 000085 -225 0 00013 -3.27 0000059 -293 0000056 Protein synthesis
1345 Enolase alpha* 41 125*4 47000 7.3 47461 7 29792061 1.34 0.033 1.46 0 0042 1.52 0 0062 1.94 00016 Glycolysis
1347 Enolase alpha* 76 226*4 47000 7.5 47481 7 29792061 -1.15 0.028 -1.59 0.0012 -1.26 0.014 -1.62 000099 Glycolysis
994 HSP-60 57 247*4 60000 5.5 61187 5.7 31542947 1.07 048 -1.07 0.5 •1.1 0.36 -1.89 00012 Protein folding
764 HSP-70 protein 9B* 66 317*4 70000 6 73920 5.9 24234666 -1.09 0.015 -122 0.015 -1.11 0.021 -1.78 000018 Protein folding
777 HSP-70 protein 9B* 31 116*4 70000 56 73920 5.6 24234688 1.06 0.71 1.38 0.07 -1.01 0.92 1.7 0.0018 Protein folding
713 HSP-71 55 204*4 70000 6.5 71062 6.7 16741727 1.19 0 063 1.57 0.0038 -1.15 00036 A 2 0.007 Protein folding
1777 Lactate dehydrogenase B* 56 236*4 37000 6 36801 5.7 49259212 -1.04 0.0047 -1.4 0.005 •1.1 0.0017 .1.74 000065 Glycolysis (regeneration of NADH)
725 Lamm A/Ca 57 206/24 70000 6 70903 8.6 27436948 Mi 0.017 •128 0.15 -1.43 0.0027 -1.44 000076 Nuclear protein for mitosis
663 L-ptastm* 56 245*4 70000 5.5 70815 52 4504965 -1.43 0000045 -1.34 0.011 -264 0.0001 •1.4 00038 Actm binding protein
503 NRAS-related protein 32 115*4 65000 6.5 60046 6.2 16356661 -1.03 0.62 -121 0.025 -1.03 0.6 -1.54 00051 Ras oncoprotein
2256 Peroxiredoxin 1* 75 163*4 23000 8.5 22324 8.3 32455266 -4 91 0.027 •5.63 0.00034 -0.54 0000072 •9.83 000000026 Cellular protection from oxidative stress
2263 Peroxiredoxin 1* 74 157*4 23000 8.3 22324 8.3 32455266 6.17 0.014 4.77 0.00019 5.64 0.000077 617 0000059 Cellular protection from oxidative stress
2267 Peroxjredoxm 2 isoform b 37 73*4 20000 5.5 16036 6.1 33186452 11.71 0 0056 938 0000026 8.57 000032 6.8 000032 Cellular protection from oiddative stress
2264 Peroxiredoxln 2* 58 190*4 22000 5.6 21692 5.7 2507169 -9 0.0014 -4.14 00001 -8.15 0.00015 -7.39 00000044 Cellular protection from oxidative stress
2211 Peroxiredoxin 3 isoform b 28 84*4 26000 7 25839 7 32483377 ■4.03 000056 -4.11 000012 -3.04 00000037 -3.83 0 000000088 Cellular protection from oxidative stress
2123 Peroxiredoxln 6* 82 160*4 27000 62 25035 6 1718024 -1.65 0.0073 -1.74 0.0011 -1.41 0.0017 -1.01 0 0048 Cellular protection from oiddative stress
2133 Peroxiredoxin 6* 47 67*4 27000 6 25035 6 1718024 954 00062 9.19 0000063 12.42 000005 13.9 0000036 Cellular protection from oxidative stress
2074 Phosphoglycerate mutase 1 53 102*4 28000 7 26931 6.8 49456447 -1.82 000021 -1.73 000056 -3.77 0.000021 -3.97 0.00005 Glycolysis
2076 Phosphomannomutase 2 35 71*4 28000 6.5 26406 6.4 4557839 -1.48 0.012 -1.51 00089 •1.42 0.0052 -1.65 0.016 Protein glycosylation
1352 Sorting nexin 5 43 100*4 47000 6.6 47072 6.3 23111047 1.19 0 0018 206 0.000027 1.26 0.017 2 5 0000063 intracellular trafficking
762 TNFR 1 asso proteins 43 162*4 70000 8.3 70618 6 1062886 -1.13 00099 -1.33 0.0093 1.04 0.012 •2.11 00014 Cytokine involved inflammatory
B Average fold-difference * and p-value
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Mowte
Score Est mass Est pi
Pred
Mass Pred pi
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3 6 (O’) to 
44(0") P-value
3 6 (20') to 
4a(20') P-value
3.6 (2400 to 
40(2400 P-value Function
1202 Cytokeratin 13A 45 161/64 50000 5 49898 4 9 24234696 163 0 000071 1.54 00016 1.79 00000079 Cytoskeieton
1316 Cytokeratin 17* 54 219/64 40000 5 40520 4.9 47939651 236 0 0036 205 0.019 2.37 0 00095 Cytoskeieton
1541 Cytokeratin 16 44 161/64 45000 4 6 44079 6 417200 -1.56 0.0062 -1.6 0.0041 -1.43 0 006 Cytoskeieton
1545 Cytokeratin 19* 82 325/64 45000 4.9 44079 5 417200 *1*1 000089 -1.82 0.0001 -1.61 0 001 Cytoskeieton
1088 FK506-bindtng protein 4 35 65/64 52000 5.8 52057 5.4 4503729 -1.65 000067 -1.61 0.047 -1 89 00017 Immuno-regulation/protein folding (PPIase)
2221 Flavin reductase (NADPH) 55 65/64 24000 8 22219 7.1 32891807 -1.57 0.0095 -1.29 0.19 -1.32 0 009 Protection from oxidative stress/iron metabolism
1406 Fumarate hydra tase 43 114/64 50000 8 5 54773 8 8 32680021 1.63 0.0028 1.63 00005 1.6 00027 TCA cycle enzyme
1294 Rb-binding protein p46* 44 142/64 50000 5 48132 5.2 4506439 -1.73 00009S -2.35 0.011 -3.41 0.023 Suppression of proliferation
2223 Glutathione S-transferase pi 69 179/84 25000 5.5 24678 5.7 121746 -1.94 000054 -2.05 0.00033 •1.84 0 00014 Regulation of cellular redox state
800 HSP-70 52 136/64 70000 6 70263 5.6 32879973 -1.67 0.0018 -1.77 000044 -1.92 0 0015 Protein folding
713 HSP-71 55 204/64 70000 6.5 71082 5.7 16741727 2.07 000032 1.61 000039 1.1 0.16 Protein folding
2366 Human elF1* 50 75/60 16000 5.5 16433 5.1 7546515 1.51 0.013 1.62 0.00071 1.67 0.00079 Protein synthesis
1688 Isocitrate dehydrogenase 3 30 78/64 40000 6.5 40022 6.5 5031777 1.67 0.0013 1.83 0.0062 1.31 0.0051 TCA cycle enzyme
863 L-plastin* 60 260/64 70000 5.5 70815 5.2 4504965 3.32 0000038 1.79 0 00024 3.19 000045 Actin bundling protein
592 Mito Inner memb Protein* 29 84/64 85000 7 84026 6.1 12803209 , s 0.0074 1.47 0 00049 1.33 0.0017 Unknown
657 Myxovirus resistance protein 1 39 122/64 75000 6 75886 5.6 21619147 -4.88 0.0078 •7.99 0.00041 -6 86 00066 Anti-viral protetn/l F N-induced
666 Myxovirus resistance protein 1 55 222/64 75000 6.3 75886 5.6 21619147 -10.01 0.000026 -6.7 000055 -12.92 0 000024 Anti-viral protein/IFN-induced
2211 Peroxiredoxin 3 isoform b 28 84/64 26000 7 25839 7 32483377 1.74 0.0017 2.3 0.0021 1 n f l 0 00056 Cellular protection from oxidative stress
2123 Peroxiredoxin 6 82 160/64 27000 6.2 25035 6 1718024 -1.99 0.0035 •1.61 000017 -1.16 0.073 Cellular protection from oxidative stress
1025 Protein disulfide-isomerase 63 236/64 57000 4.8 57117 4.8 1085373 -1.51 0.0078 -1.58 000053 -1.41 0 0072 Disulfide bond formation/pro tern folding
1411 Thioredoxin domain containing 4 32 87/64 45000 5 47297 5 37183214 -1.73 0.0042 -2211 0.00037 -2 06 0.0021 Protection from oxidative stress/protein folding
1134 Trp-tRNA synthetase isoform b 26 67/64 50000 6.3 48852 6 47419920 -1.67 0.0012 -1.59 0.0002 -1.7 00021 Protein synthesis
1001 Ub-specific protease 14 37 123/64 60000 5.6 61317 5.6 30583205 -1.59 000028 -1.68 00026 -1.54 0.0059 Unknown
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(Table 4-2) Identification of H20 2- and ErbB-2-dependent differentially expressed proteins. (A) Proteins displaying H20 2-induced 
differential labelling in normal (HB4a) and ErbB-2-overexpressing (C3.6) human mammary luminal epithelial cells. (B) Proteins displaying 
differential labelling between HB4a and C3.6 luminal epithelial cells. Proteins were identified by MALDI-TOF peptide mass mapping (see 
Materials and Methods (Chapter 2)). “Proteins identified in two or more independent experiments. Proteins appearing more than once in the 
tables were identified as isoforms with different p/s. The % coverage of analysed peptides, the MOWSE score from Mascot searches and the 
significance threshold score, the estimated mass and p/ (from gels), the predicted mass and pi (from the database) and the NCBI gene identifier 
(Accession Number) are shown for each protein. MS spectra, MOWSE score histograms, matching peptides and sequence coverage for all 
proteins are shown in Appendix D. tAverage fold-differences from DeCyder analysis show abundance ratios for treated HB4a cells versus 
untreated (4a(240’) and 4a(20’) versus 4a(0)), treated C3.6 cells versus untreated (3.6(240’) and 3.6(20’) versus 3.6(0)) and C3.6 versus HB4a at 
each timepoint(3.6(0’) to 4a(0’), 3.6(20’) to 4a(20’) and 3.6(240’) to 4a(240’)). Proteins displaying an average fold-difference of > 1.5-fold up (+) 
or down (-) regulation between pairs of conditions where /?<0.05 and spots matched in all images are shaded grey. N. A. not analysed. Functions 
were ascribed from the NCBInr database and literature searches.
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The lysine labelling results showed that 30 o f  the 53 identified proteins displayed 
peroxide-dependent changes (Table 4-2A) and the other 23 ErbB-2-correlated changes 
(Table 4-2B). All o f  the identified features are shown in Figure 4-21. As expected, 7 o f  
the 23 ErbB-2- correlated proteins were matched with those from a previous analysis o f  
these cell lines from our laboratory (Gharbi et al. , 2002) where a similar lysine labelling 
2D-D1GE and M ALDI-TOF-M S was used to identify ErbB-2 correlated differential 
expression. These proteins include myxovirus resistance protein 1, HSP-70, L-plastin, 
ubiquintin carboxyl hydrolase 14, FK506-binding protein 4 and cytokeratin 17. Whilst a 
higher overlap o f identifications might be expected from these two studies, differences in 
gel resolution, the fact that not all differentially expressed features were identified and the 
way the cells were grown (serum-starved in the previous study versus grown in the 
presence o f serum in this study) may account for the low overlap.
The differentially expressed proteins identified by N HS-Cy labelling and MS were again 
involved in redox regulation, protein folding, proliferative suppression, glycolysis and the 
cytoskeieton, suggesting that these cellular functions are the m ajor targets o f redox stress 
and ErbB-2 overexpression. In addition, four citrate (TCA) cycle enzymes were 
modulated, including dihydrolipoamide dehydrogenase, which possesses a redox-active 
disulphide bond at its active site, and four proteins involved in protein synthesis. 
Importantly, Prxns 1, 2, 3 and 6 were again identified and three (Prxn-1, Prxn-2 and 
Prxn-6) were identified in doublet spots (Figure 4-21 and Table 4-2A). Interestingly, all 
o f the basic spots o f  the doublets became less intense and the acidic spots more intense 
after hydrogen peroxide treatment. Since M ALDI-TOF-M S and database searching gave 
high confidence hits for both proteins in the spot pairs, this shows that the difference in 
intensity between the two spots is due to a post-translational modification. The study o f  
W agner et al. and Rabilloud et al. (W agner et al., 2002;Rabilloud et al., 2002b) also 
found doublets for the Prxns by 2DE and M ALDI-TOF-M S which changed in a similar 
manner to that observed here following oxidative stress. Further analysis showed that the 
bacic spot is the native Prxn while the acidic spot corresponded to the sulfinic or sulfonic 
form o f each Prxn. Thus, we can infer that the basic spots in the doublet o f Prxn-1, Prxn- 
2 and Prxn-6 are the native forms o f  the enzymes and that the acidic spots in the doublet 
correspond to the sulfenic, sulfinic or sulfonic forms. In addition, elongation factor 2 and
enolase alpha also existed as multiple isoforms, where the more acidic isoforms were up- 
regulated by H2O2 treatment, suggesting that both of them may be oxidized and shifted in 
pi. It is likely that such modifications would affect protein translation and glycolysis, 
respectively. Differences were also detected in the response o f several proteins isoforms 
to H2O2 in the two cell lines. These included Hsp73/71, Prxn-6 and L-plastin (Table 4- 
2A); differences which are likely to reflect their altered abundance in the ErbB-2 
overexpressing cells (Table 4-2B). In summary, these data show the complexity o f the 
response o f epithelial cells to redox stress and the effect that ErbB-2 overexpression has 
on these responses.
NRAS-related protein (503) 
TNFR1 -associated protein, Hsp 75 (762) 
Hsp73/Hsp71 (713) 
MxA, myxovirus resistance protein 1 (668) —. 
MxA, myxovirus resistance protein 1 (657) -—  
Hsp70 protein 9B/mortalin-2 (764) —  
Hsp70 protein 2 (800) —  
H*p73/Hsp71 (777) —  
L-plason (863) —  
Ub-spectfic protease 14 (1001)—  
Protein disulfide-isomerase ERp60 (1025)-— 
Hsp60 mitochondrial precusor ( 9 9 4 )^ "  
FK506-binding protein 4 (1088). 
Cytokeratin 13A(1202) 
Rb-binding protein p46 (1294) 
Cytokeratin 17(1316) 
Cytokeratin 19(1541) 
Cytokeratin 19(1545) 
Isocitrate dehydrogenase 3 (1688) —  
Lactate dehydrogenase B (1777) — ' 
Peroxiredoxin 6 (2123)
Peroxiredoxin 6 (2133) -  
Glutathione S-transferase pi (2223) — 
Peroxiredoxin 3 isoform b (2211) — 
Peroxiredoxin 2 (2267) -  
Peroxiredoxin 2 (2264)
2-OGDH (391)
Elongation factor 2 (471)
Elongation factor 2 (476)
Elongation factor 2 (487)
Elongation factor 2 (468)
Elongation factor 2 (472)
Mito Inner memb. Protein (592)
U m in  A/C (725)
Dihydrolipoamide dehydrogenase (1090) 
Cytokeratin 6A (1123)
Enolase alpha (1345)
Enolase alpha (1347)
Fumarate hydratase (1406)
Sorting nexin 5 (1352)
Trp-tRNA synthetase isoform b (1134) 
Thioredoxin domain containing 4 (1411) 
Phosphomannomutase 2 (2076)
Phosphoglycerate mutase 1 (2074)
Flavin reductase (NADPH) (2221) 
Peroxiredoxin 1 (2256) 
Peroxiredoxin 1 (2263)
Human elF l (2366)
(Figure 4-21) 2DE migration of proteins identified by MALDI-TOF-MS displaying H20 2- 
induced and/or ErbB-2 dependent differential expression (see Table 4-2). An NHS-Cy-dye 
image is shown with the identified proteins.
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4.9 Conclusions
In experiments to assess the response o f epithelial cells to oxidative stress and ErbB-2 
overexpression, the activation o f  certain signalling molecules was firstly examined. The 
results demonstrated that the responses between HB4a and C3.6 cells to hydrogen 
peroxide were significantly different. More proteins and a greater degree o f tyrosine 
phosphorylation were observed in the HB4a versus C3.6 cells. Moreover, the stress 
protein kinase, p38, was fully activated in 5 minutes after H 2O2 treatment in HB4a, but 
not until 20 minutes in C3.6 cells. Both the MAP kinase and PI3Kinase pathways were 
activated after H2O2 treatm ent in both cell lines. Interestingly, MnSOD, which generates 
cellular hydrogen peroxide from superoxide, exhibited lower expression in the C3.6 cells. 
These observations indicate that either proliferative signalling pathways or survival 
pathways are significantly different between the cell lines when exposed to peroxide 
stress, variations that are derived from ErbB-2 overexpression. Indeed, the C3.6 cells 
appeared to be more resistant to FhC^-induced cell death. The Ellman’s test 
demonstrated that the levels o f  total free thiols in cells display a dramatic decrease after 
hydrogen peroxide treatment, consistant with the oxidation o f cellular targets. This 
response was less dramatic in the C3.6 cells, which may indicate that these cells are more 
tolerant to redox stress, and have developed mechanisms for the more rapid removal and 
repair o f  ROS and redox damage.
In order to investigate the molecular changes associated with oxidative stress in more 
detailed, lysine and cysteine 2D-DIGE were used for expression profiling and to examine 
changes in thiol reactivity. This work showed that DIGE analysis could provide a 
sensitive, accurate and quantitative analysis o f differential protein regulation in this 
model cell system. Reproducible and significant differences were detected both between 
the parental and ErbB-2 overexpressing cell lines and in responses to hydrogen peroxide 
treatment.
Cysteine labelling 2D-DIGE using iodoacetylated versions o f the Cy dyes (ICy dyes) 
under non-reduced conditions, was employed to probe for targets o f cellular oxidative 
stress (H2O2 treatment) in HB4a and C3.6 cells. Firstly, a timecourse o f  H2O2 treatment 
was carried out in the two cell lines revealing multiple differential ICy labelling between 
cell lines and with H2O2 treatment. Notably, very rapid (within 2 minutes) changes in
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labelling were observed, indicative o f thiol oxidation rather than changes in protein 
expression. A more detailed study using a 20 minute exposure to hydrogen peroxide was 
then carried out and proteins identified by M ALDI-TOF-M S. In this study, the number 
o f  spots that could be matched between all gels was high, showing the reproducibility o f 
the 2D-DIGE method. These experiments also showed the compatibility o f  ICy dye 
covalent labelling with subsequent identification by MALDI-TOF-MS, although some 
proteins could not be identified in most cases due to low protein abundance. Thus, whilst 
changes in thiol reactivity could be detected at a high level o f  sensitivity, the proteins 
could not be identified because o f  limitations in the sample preparation steps for MS. In 
one o f three repeat experiments, the results showed that 126 gel features were 
significantly differentially labelled with a > 1.5 fold-increases or decreases in labelling 
CP<0.05) between the cell lines or in response to H2O2 treatment. 89 o f  these changes 
could be matched to their corresponding silver stained spots and these were picked from 
gels for MS identification. So far, 51 proteins have been identified using M ALDI-TOF- 
MS. These identified proteins have functions in protein folding, redox regulation, 
cytoskeieton, proliferation and nuclear transport. In addition, 26 o f  these identified 
proteins were ErbB-2-dependent, such as Hsp-27, and some o f them are related to the 
biological functions in cancer cell such as maspin precursor (protease inhibitor 5).
To validate the changes observed by DIGE, some o f  the proteins o f interest were further 
investigated by 1-D and 2-D immunoblotting. The levels o f  many o f the identified 
proteins did not correlate with the changes seen for ICy dye labelling, supporting the 
notion that H2O2 was acting by inducing changes in thiol reactivity instead o f  altering the 
protein level. However, the limited dynamic range o f  ECL used for immundetection and 
the lack o f  resolution o f  differentially charged isoforms by IDE; made it difficult to 
correlate the data well. All o f the proteins identified contain at least 1 free cysteinyl thiol 
group, demonstrating the specificity o f  labelling. However, very few ICy labelled 
peptides could be identified by M ALDI-TOF-M S. This is possibly caused by the low 
solubility o f dye-labelled peptides, the low efficiency o f  peptide extraction or the loss o f 
the ICy dye label during ionization.
M odifications o f  cysteine residues can induce an increase or decrease in ICy dye 
labelling. The absence or reduction in labelling could be caused by glutathionylation or
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oxidise cysteines to sulfenic, sulfinic or sulfonic forms/ the form o f disulphides. In 
contrast, the gain or increase in labelling could have been induced by breakage o f  
disulphides or by peroxide-induced shifts in p /a n d  labelling o f non-oxidised thiols on the 
p / shifted proteins. Support for the latter was seen in results from the lysine-labelling 
2D-DIGE experiments w here doublet spots for peroxiredoxins/ elongation factor 2/ 
enolase were found with the sulfinic/sulfonic acid forms o f  the proteins migrating to 
more acidic p\ but still am enable to ICy dye labelling on additional sites. Finally, the 
identification o f unique and shared gene products using both lysine labelling and cysteine 
labelling strategies helps to better define the biological changes associated with H2O2 
stress and ErbB-2 overexpression and demonstrates the usefulness o f 2D-DIGE for the 
study o f  post-translational modifications. However, in the absence o f a 100% hit rate for 
MS protein identifications, it is still difficult to compare the relative contributions o f  
changes in abundance versus changes in thiol reactivity using these methods.
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Chapter 5 APPLICATION OF CYSTEINE- 
LABELLING 2D-DIGE AS A PROBE FOR GROWTH 
FACTOR DEPENDENT CHANGES IN THIOL 
ACCESSIBILITY AND OXIDATION
5.1 Introduction
In the previous chapter, the potential o f the cysteine-labelling 2D-DIGE method was 
shown in an analysis the cellular targets o f oxidative stress and ErbB-2 overexpression. In 
this chapter, the utility o f  the 2D-DIGE strategy for the analysis o f  EGF-induced changes 
in thiol reactivity and accessibility is assessed. As previously described, the ErbB 
receptor family o f  receptor tyrosine kinases is responsible for transferring extracellular 
stimuli in the form o f  growth factors to downstream intracellular signalling events.
The recruitment and activation o f  effector proteins to the receptor is an important step in 
the initiation o f  various downstream signalling cascades. This process involves a series o f 
protein-protein interactions which include hydrophobic interactions, ionic interactions, 
covalent bond formation/breakage and hydrogen bond formation/breakage. It is possible 
that thiol accessibility could change during the process o f  signal transduction if  specific 
thiol groups are located at the interface between interacting proteins. Thus, by labelling 
cysteinyl thiols with the ICy dye reagents under native conditions, it may be possible to 
monitor the dissociation and association o f  protein complexes, for example, in response 
to mitogen treatment. Thus, the work in this chapter was aimed at testing whether this 
strategy was feasible. It has also been shown that cysteinyl thiol groups play important 
roles in signal transduction through covalent changes in their oxidative status (Chapter 1). 
Indeed, a growing body o f evidence suggests that endogenously generated H2O 2 is 
required for growth factor signalling (see Introduction) (Lee et al., 2000;Park et al., 
2004;Kwon et al., 2004). Thus, the second aim o f this work was to establish whether 
mitogen stimulation produces changes in the redox status o f  proteins and to identify these 
targets using ICy dye 2D-DIGE and MS.
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5.2 ICy dye differential labelling under native conditions and 
identification of EGF-induced changes
In order to apply cysteine labelling 2D-DIGE to study potential changes in thiol 
accessibility, native protein labelling conditions were developed. The normally used urea 
ICy dye labelling buffer replaced by a Nonidet P-40 (NP-40) lysis and labelling buffer 
(1%  NP-40/lOmM  Tris pH 8.0/1 mM EDTA), which contains a mild non-ionic detergent 
that has minimal effect in the conformation o f  proteins. Experiments were performed to 
compare serum-starved HB4a cells with EGF-stimulated cells. A timepoint o f 10 min 
was chosen to examine immediate growth factor signalling events and 1 nM EGF was 
used. This concentration is known to robustly stimulate mitogenic signalling events in 
these cells (Timms et al., 2002). Cells were grown and treated in triplicate and lysed in 
the presence o f ICy dye. ICy3- labelled individual samples were run against an equal load 
o f  ICy5-labelled standard pool consisting o f  an equal mixture o f  all 6 samples. 
Subsequently, urea-containing buffer was added and the samples reduced to improve 
sample solubility prior to 2DE. Although the resulting 2D images could still be scanned 
and analysed by DeCyder, there appeared to be an appreciable level o f precipitation and 
aggregation o f  proteins/dyes particularly across the gel in the 50-60 kDa region and fewer 
spots could be resolved by this native 2D-DIGE labelling compare with denaturing 2D- 
DIGE (Figure 5-1). Two independent experiments were run with 6 gels and 12 
fluorescent images were captured in each. In one o f  these experiments, 10 significant 
changes in labelling were identified (>1.3 fold up or down regulated; p<0.05) (Figure 5- 
2A and B). Post-staining with colloidal coomassie blue or silver and matching o f  the 
patterns to the corresponding fluorescent images allowed the picking o f  6 gel features 
with confidence (Figure 5-2C), and 3 proteins were identified by M ALDI-TOF peptide 
mass mapping with a mass accuracy set at +/-50 ppm (Figure 5-3). These 3 proteins were 
aldehyde reductase, annexin IV and peroxiredoxin 6. All o f  these proteins contained at 
least one cysteine in their protein sequence and displayed reduced ICy dye labelling 
following EGF treatment. This may suggest that these proteins are interacting with other 
proteins to protect their free thiols or are the targets o f EGF-induced generation o f 
oxidants.
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O f note, the post-staining did not produce the apparent precipitation or aggregation in the 
50-60 kDa region (Figure 5-2C), therefore, it must be a dye labelling phenomena and 
possibly due to the aggregation of dyes induced by NP-40 buffer.
This significant precipitation/dye aggregation problem resulted in the loss o f some 
labelled features from the DeCyder analysis. Therefore, an extension of this study was 
performed using ICy labelling buffer with urea instead o f NP-40 to compare EGF treated 
versus untreated HB4a total cell lysates. Under these denaturing conditions, potential 
EGF- induced changes in intermolecular accessibility would no longer be observed, 
however, EGF-induced thiol oxidative changes can still be investigated. The 
experimental design was the same as the previous experiment and ICy3-labelled EGF 
treated/untreated samples were run with against an equal load of ICy5-labelled standard 
pool consisting o f an equal mixture of all samples. The precipitation problem was 
significantly improved and seven changes in labelling were determined by DeCyder 
analysis with the criteria of >1.3 fold up or down regulation with p<0.05 (Figure 5-4). 
Only two changes were found with a 1.5 fold cut-off (data not shown). Post-staining with 
colloidal coomassie blue stain and matching to the corresponding fluorescent images 
allowed picking of three gel features with confidence (Figure 5-4B), and two proteins 
were identified by MALDI-TOF peptide mass mapping (Figure 5-4). These two proteins 
were Rho-GDP dissociation inhibitor (GDI) and peroxiredoxin 6. Both o f them displayed 
reduced ICy dye labelling after EGF treatment.
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B Biological Replicates I
(Figure 5-1) Representation of the experimental design in the study of the thiol reactivity in 
HB4a cells in response to 1 nM EGF treatment using ICy dye labelling under native 
conditions. (A) Serum-starved HB4a cells were treated with InM EGF for 10 min or left 
untreated. Equal amounts of ICy5 labelled cell lysates (in 1 % NP-40 native buffer) were mixed as 
an internal standard pool and run against ICy3-labelled lysates from untreated and EGF treated 
cells. Samples were run in triplicate as biological replicates for statistical analysis and to assess 
reproducibility. This represents 6 gels with 12 images generated. Gel images were processed 
using the B VA module of DeCyder software. All of the images in this figure are also presented in 
Appendix L with representative enlarged images. One of the image sets in (A) is shown in (B) as 
representative enlarged images.
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(Figure 5-2) Visualisation of differential thiol reactivity in EGF treated versus untreated 
HB4a cells labelled under native conditions. (A) Representative ICy dye image of EGF treated 
treated samples. Protein features displaying altered expression levels (> 1.3 fold) after EGF- 
treatment are labelled with a spot identity number. (B) Table showing the 10 differentially 
labelled protein spots with average fold change and T-test /^values. (C) The image is a merged 
image of the ICy5-labelled standard pool (red spots) with the image of its corresponding silver 
stained gel (black spots). The arrows indicate the aligned features between differentially labelled 
spots and the corresponding silver-stained spots. These spots were picked for identification by 
MALDI-TOF MS.
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(Figure 5-3) 2DE migration and identification of proteins displaying EGF-induced 
differential labelling. (A) An ICy-dye image of a representative gel shows the positions of 
aldehyde reductase, annexin IV and peroxiredoxin 6. (B) Proteins (aldehyde reductase, annexin 
IV, Peroxiredoxin 6) displaying EGF-induced differential labelling in HB4a human mammary 
luminal epithelial cells identified from gels by MALDI-TOF-MS. Graphs were derived from 
DeCyder image analysis where the standardised abundance is the ratio of the volume of a test gel 
feature versus the volume of the corresponding standard gel feature. Triplicate data points are 
shown for the untreated and treated experiments with lines joining the average values. 3D 
profiles of the spots and MS spectra are also shown. Details of MS searches are shown in 
Appendix E. (C) Protein table showing MALDI-TOF peptide mass fingerprinting results. The % 
coverage of analysed peptides, the MOWSE score from Mascot searches and the significance 
threshold score, the estimated mass and p/ (from gels), the predicted mass and pi (from the 
database) and the NCBI gene identifier (Accession Number) are shown for each protein. 
f Average fold-differences from DeCyder analysis show abundance ratios for EGF treated HB4a 
cells versus untreated (4a(10’) versus 4a(0)). Proteins displaying an average fold-difference of > 
1.3-fold up (+) or down (-) regulation where p<0.05 and spots matched in all images are shaded 
grey. Functions were ascribed from the NCBInr database and literature searches.
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(Figure 5-4) Visualisation and identification of differential thiol reactivity in EGF treated or 
untreated HB4a cell lysates labelled under denaturing conditions. (A) Representative ICy 
dye image of EGF-treated HB4a cell lysate. Protein features with altered expression levels (>+/- 
1.3 folds; p<0.05) are indicated. (B) Merged image of ICy5 labelled EGF treated and untreated 
HB4a cell standard pool (red spots) and the corresponding colloidal coomassie blue stained gel 
image (black spots). The arrows indicate the aligned features of the significantly differentially 
labelled spots. These spots were picked for identification by MALDI-TOF-MS. (C) Proteins 
(Peroxiredoxin 6 and Rho-GDI) displaying EGF-induced differential labelling in HB4a human 
mammary luminal epithelial cells identified from gels by MALDI-TOF-MS. Graphs were 
derived from DeCyder image analysis where the standardised abundance is the ratio of the 
volume of a test gel feature versus the volume of the corresponding standard gel feature. 
Triplicate data points are shown for the untreated and treated experiments with lines joining the 
average values. 3D profiles of the spots and MS spectra are also shown. Details of MS searches 
are shown in Appendix F. (D) Protein table showing MALDI-TOF peptide mass fingerprinting 
results. The % coverage of analysed peptides, the MOWSE score from Mascot searches and the 
significance threshold score, the estimated mass and p / (from gels), the predicted mass and p/ 
(from the database) and the NCBI gene identifier (Accession Number) are shown for each 
protein. +Average fold-differences from DeCyder analysis show abundance ratios for EGF treated 
HB4a cells versus untreated (4a(10’) versus 4a(0)). Proteins displaying an average fold- 
difiference of > 1.3-fold up (+) or down (-) regulation where p<0.05 and spots matched in all 
images are shaded grey. Functions were ascribed from the NCBInr database and literature 
searches.
5.3 Conclusions
In this chapter, peroxiredoxin 6, aldehyde reductase and annexin IV were identified as 
proteins that display reduced thiol accessibility or reactivity after EGF treatment. This 
may be due to changes in its association o f  the proteins with other intracellular molecules 
following EGF treatment, which would occlude reactive thiol groups or because these 
groups were directly oxidised in response to EGF. However, it is also possible that these 
proteins become degraded or move to an insouluble compartment following EGF 
stimulation. Under denaturing labelling conditions, Rho-GDI and peroxiredoxin 6 also 
showed significant reductions in thiol reactivity, suggesting that cysteine residues in both 
o f  these proteins are covalently modified via an EGF receptor-dependent pathway. 
Aldehyde reductase is an NADP(H)-dependent oxidoreductase implicated in the 
pathogenesis o f various diabetic complications (Yabe-Nishimura, 1998). The enzyme is 
rate limiting in the polyol pathway, where glucose is converted to sorbitol by aldehyde 
reductase, followed by NAD+ dependent conversion to fructose by sorbitol 
dehydrogenase. Under conditions o f  hyperglycemia, the stimulation o f  the polyol
144
pathway leads to an overflow o f  the products and the depletion o f NADP+ and NAD+ in 
cells. The resulting increase in the NADH/NAD+ ratio in these cells leads to a condition 
similar to hypoxia (W illiamson et al., 1993). Thus, numerous aldehyde reductase 
inhibitors are being developed as possible agents for diabetic complications. A study 
from Nishinaka and Yabe-Nishimura showed that intracellular hydrogen peroxide can up- 
regulate the gene expression o f  aldehyde reductase (Nishinaka and Yabe-Nishimura, 
2001) and it is known that hydrogen peroxide can be induced by EGF stimulation via Rac 
and Rho dependent pathways (Lee et al., 2000). These findings imply that aldehyde 
reductase could be regulated by EGF at the transcription level via generation o f 
endogenous H2O2 and could also be modified to a higher oxidative status by hydrogen 
peroxide at the post-translational level. Indeed, Cys-298 o f  aldehyde reductase has been 
reported as a potential redox-sensitive active site cysteine (Srivastava et al., 2003). Both 
o f  these may explain the decrease in ICy dye labelling o f  aldehyde reductase after EGF 
treatment. This finding warrants further investigation, particularly the effect o f  EGF on 
the polyol pathway, although this work is beyond the scope o f  this thesis.
The annexins are a family o f  closely related calcium- and membrane-binding proteins 
expressed in most eukaryotic cell types. Twelve annexin subfamilies have been identified 
in vertebrates which all have similar biochemical functions. The annexins participate in 
the regulation o f  membrane organisation and membrane traffic and the regulation o f  ion 
(Ca2+) passage across membranes and hence Ca2+concentrations within cells (Hayes and 
Moss, 2004;M oss and Morgan, 2004). AnnexinVI has been shown to specifically inhibit 
EGF-dependent Ca2+ influx through the plasm a membrane and Ca2+ release from 
intracellular stores (Fleet et al., 1999). Annexins I & II have been identified as major 
substrates for the tyrosine kinase activity associated with the EGF receptor and their 
reactivity appears to be controlled by phosphorylation following growth factor 
stimulation (Rothhut, 1997). In addition, annexin II was recently identified as an oxidant- 
sensitive protein in HeLa cells. This study showed that oxidants from exogenous H2O 2 or 
generated in response to extracellular growth stimuli increased the incorporation o f  a 
glutathione into a reactive cysteine o f  annexin II (Sullivan et al., 2000). A more recent 
study demonstrated that reversible glutathionylation could regulate annexin phospholipid 
and F-actin binding activity (Caplan et al., 2004). Taken together, these studies suggest
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that the annexins are subject to complex regulation and modification by receptor tyrosine 
kinases, such as the EGF receptor, and oxidants such as EGF-induced hydrogen peroxide 
and could have play an important role in cross-talk between growth factor and Ca2+ 
signalling. Using cysteine labelling 2D-DIGE, it was demonstrated that there was a EGF 
induced decrease in ICy labelling o f  annexin IV. By analogy to Annexin II, this is likely 
to be as a result o f glutathionylation o f the active site cysteines in response to EGF- 
induced oxidant production, which would block ICy dye labelling.
Rho-GTPases regulate many cellular processes including growth and differentiation, 
vesicular transport, reactive oxygen species production, apoptosis, cytoskeletal dynamics 
and cellular motility (Bishop and Hall, 2000). The regulators for these Rho-GTPases can 
mainly be classified into three groups:GDP/GTP exchange factors (GEFs) which 
stimulate the conversion o f Rho proteins from the GDP-bound form to the activated 
GTP-bound form; GTPase activating proteins (GAPs) which stimulate the conversion 
GTP to GDP conversion to inactive Rho-proteins and Rho GDP dissociation inhibitors 
(RhoGDIs) which bind to the GDP-bound forms o f  Rho proteins (Rho, Rac and Cdc42) 
and inhibits GDP dissociation (Van Aelst and D'Souza-Schorey, 1997). Rho-GDI is also 
involved in the translocation o f Rho, Rac and Cdc42 between the cytosol and the 
membrane (Takai et al., 1993). In addition, recent studies indicate that phosphorylation 
o f  Rho-GDI by p21-activated kinase (P ak l) mediates its dissociation from Rac 
(DerMardirossian et al., 2004) and the Pakl can interact with the Grb2 adapter protein 
coupling Rac activation with EGF signalling (Puto et al., 2003). In the work presented 
here, Rho-GDI displayed reduced labelling following EGF treatment, suggesting that the 
single cysteine in Rho-GDI is oxidised by indirect signalling from EGFR. This oxidation 
may occur via EGF-induced hydrogen peroxide in a feedback loop and the oxidation 
event could be one mechanism by which Rho-GDI function is regulated.
Peroxiredoxin 6, which is involved in the defence against cellular oxidative stress, can 
scavenge peroxides and can also reduce peroxidised membrane phospholipids. Thus, 
peroxiredoxin 6 can protect cells against oxidant-induced plasma membrane damage, 
thereby playing an important role in cellular defense against oxidant stress (Manevich et 
al., 2002). From the data in this chapter (Figure 5-3 and Figure 5-4), peroxiredoxin 6 was 
identified as being differentially labelled under both native and denaturing (urea)
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conditions inferring that the changes in thiol reactivity o f  the Prxn-6 are derived from 
covalent modification (such as forming the sulfenic, sulfinic or sulfonic acid) rather than 
the changes in non-covalent association o f  cysteine accessibility. This is highly likely, 
since Prxn-6 was also identified as a proximal target o f  F^C^-elicited redox stress in the 
previous chapter and has been reported to become oxidised following oxidant treatment 
(W agner et a l , 2002). In addition, the study o f  Bae et al. indicated that EGF can induce 
the generation o f  H2O2 (Bae et al., 1997) This infers that the reduced labelling o f Prxn-6 
following EGF treatment is likely to occur as a result o f oxidation o f the thiol group. 
Importantly, the preferred hypothesis for EGF dependent modification o f Prxn-6 is that 
EGF stimulates the generation o f  low concentrations o f hydrogen peroxide which 
oxidises the active site cysteine in Prxn-6.
In this chapter, native denatured labelling o f  the cysteine thiol in proteins was used for 
studying thiol accessibility and cellular redox regulation following EGF stimulation. In 
two independent experiments using triplicate samples, only a small number features were 
detected that displayed significant changes. One possible reason for this observation 
could be the use o f  a sub-optimal labelling buffer that leads to the aggregation o f  dyes 
which generate a strong background and mask a subset o f labelled features for analysis. 
Another possible reason could be that the modifications that occur on proteins o f lower 
abundance cannot be detected by this method. It must be considered also that EGF 
induced H2O2 production will be much lower than exogenously added H2O2 as 0.5 mM, 
this would induce less proteins labelling by ICy dye because only a subset o f  the protein 
was modified by oxidation.
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Chapter 6 Application of cysteine labelling 2D-DIGE to 
analyse changes in plasma fractions following UV 
irradiation
6.1 Introduction
In the previous chapters, the potential utility o f  cysteine labelling 2D-DIGE for the 
identification o f  cellular targets o f  oxidative stress and EGF-induced changes in thiol 
accessibility and modification has clearly demonstrated. In this chapter, the utility o f this 
technique for studying the effects o f  UV irradiation on cysteine thiol modifications in 
purified human plasm a fractions is presented. Transmission o f viruses in human sera 
represents a considerable risk for humans, particularly when the serum is used for the 
production o f  pharmaceutical products such as vaccines and blood clotting agents. 
Therefore, procedures for inactivating different viruses or bacteria in these products are 
mandatory. Conventional disinfection techniques that have been used for pathogen 
inactivation include solvent-detergent treatment (W ainwright, 2002b) and ultra-violet 
irradiation (W ainwright, 2002a). However, it is possible that such treatments may also 
damage the protein components o f  these blood products affecting their potency.
In this work, a human plasma fraction developed by Baxter Healthcare (Vienna, Austria) 
was used to evaluate the potential o f  cysteine labelling 2D-DIGE on detecting UV 
irradiation induced changes. This chromatographically-purified fraction known as FIBA 
is being developed for use as a blood clotting agent for heamophilics and for use after 
serious injury. Baxter Healthcare developed a large-scale UV-C irradiation strategy to 
disinfect any pathogen in these preparations since this method has been shown to remove 
various viruses with high clearance rates (Kurth et al., 1999). However, some reports 
indicate that UV treatment can modify the thiol groups o f  proteins. For example, UV 
irradiation induces a change o f thiol reactivity o f crystallin and the cleavage o f  heavy 
chain subfragment 1 o f myosin (Grammer et al., 1988;El'chaninov and Fedorovich, 
1990). These thiols are all related to protein activity. The aim o f the work presented here 
was to determine if  thiol reactivity is altered in the purified plasma fraction following
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exposure to different doses o f UV-C treatment. In addition, we wanted to identify which 
plasma proteins are the targets o f  UV irradiation induced damage.
6.2 Identification of differentially expressed/labelled plasma proteins 
following UV-irradiation
Cysteine labelling 2D-DIGE was applied to study the effect o f  UV irradiation on thiol 
reactivity in a purified fraction o f  human plasma. Labelling with ICy dyes was carried 
out on denatured, non-reduced samples prepared in ICy urea labelling buffer. 
Experiments were performed on samples subjected to UV irradiation doses o f  0 mJ/cm2, 
20 mJ/cm2, 40 mJ/cm2 and 80 mJ/cm2, in triplicate (Figure 6-1). ICy3 labelled individual 
samples were run on 2D gels with an equal load o f  ICy5-labelled standard pool, 
consisting o f  an equal mixture o f  all samples. Although hundreds o f protein features can 
be separated well by 2D-DIGE, poor focusing o f  some abundant proteins was observed in 
this experiment (Figure 6-1 and 6-2). This might be caused by the plasm a samples 
containing buffer components (NaHCC>3 + NaCl) which interfere with the isoelectric 
focusing.
Twenty-nine protein spots displaying significant changes in labelling between the treated 
and untreated samples were identified (>1.5 fold up or down regulated; p<0.05) with a 
large degree o f  overlap in their regulation at the different UV doses (Figure 6-2). Post- 
staining with colloidal coomassie blue and matching to the corresponding fluorescent 
images allowed picking o f  17 gel features with confidence (Figure 6-3). The fewer 
number o f  post-stainable matching spots might be caused by low abundance proteins that 
cannot be detected by CCB staining but which contain reactive thiol groups. In addition, 
the positively charged ICy dye may induce p i shift in dye-labelled proteins which would 
dilute the signal if  labelling is sub-stoichiometric (see discussion in Chapters 3 and 4). 13 
o f  these 17 proteins were identified by M ALDI-TOF peptide mass mapping using a mass 
accuracy o f  +/- 50 ppm (Figure 6-4). These 13 protein isoforms represented 7 different 
gene products. These gene products were actin, ALB protein (a human albumin fragment 
in serum with a molecular weight o f  48 kDa), complement component C4, kininogen 
precursor, prethrombin 2, retinol-binding protein and serum amyloid P component. The 
3-D spot images, the standardised protein levels and the MALDI-TOF-MS spectra o f
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these proteins are shown in Figure 6-5. O f these proteins, kininogen precursor, multiple 
isoforms of serum amyloid P component and retinol binding protein displayed an 
increase in labelling in response to UV irradiation; conversely, actin, ALB protein, 
complement component C4 and prethrombin 2 showed a decrease in labelling in response 
to UV irradiation (Figure 6-5). Interestingly, several o f the proteins showed dose- 
dependent changes. These data suggest that the blockage o f free thiols due to disulphide 
bond formation/oxidation and the breakage of disulphide bonds/reduction may occur as a 
result o f UV-C irradiation.
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(Figure 6-1) Representation of the experimental design in the study of the thiol reactivity of 
plasma fractions in response to different doses of UV-C irradiation. (A) Plasma fractions 
were treated with 20, 40 and 80 mJ/cm2 of UV-C irradiation and compared to the untreated 
samples. Equal amounts of ICy5 labelled plasma samples were mixed as an internal standard pool 
and run against the untreated and UV-treated samples labelled with ICy3. Samples were run in 
triplicate for statistical analysis to assess reproducibility. Thus 12 gels were run with 24 images 
generated. Gel images were processed using the BVA module of DeCyder software to identify 
significant changes in protein isoform abundance/ ICy labelling. One of the image sets in (A) are 
shown in (B) with representative enlarged images.
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P<0.05; Spot Volumes>50000 
Average fold difference >1.5 or < -1 .5 fold
20 / 0 (20 c h a n g e s )
80 I 0 (29 c h a n g e s )  40 / 0 (23 c h a n g e s)
Master No. (20/0)
14.33
p-value (40/0)
22.61
p-value (80/0) p-value
1168 0.0048 0.0028 25.56 0.0026
1198 15.89 8.8E-07 22.82 3.4E-05 23.82 4.00E-06
905 7.47 1.2E-05 1049 4.1E-05 15.24 1.80E-05
904 4.31 0.0053 8.26 0.0012 15.13 0 00048
1197 8.43 0.0016 11.33 0.00015 14.39 0 00049
909 4.4 0.018 6.58 0.0068 13.41 0.0025
924 3.87 0.0024 6.2 0.00075 9.8 0.00031
914 3.26 0.0047 5.96 0.00067 9.5 0.00031
1219 2.03 0.011 2.74 0.04 9.08 0.0024
907 2.58 0.0058 3.86 0.0013 5.89 0.00049
1005 2.23 0.0092 3.35 0.0019 4.79 0.00063
1072 1.87 0.0015 2.26 0.0006 4.09 8.90E-05
939 2.13 0.035 2.81 0.017 3.98 0.0056
913 1.67 0.007 2.02 0.021 2.75 0.0067
343 2.21 0.00034 2.01 0.0011 2.32 0.00024
11 1.61 0.0059 1.75 0.003 2.13 0.0013
580 1.52 0.0025 1.38 0.0024 1.67 0.0016
542 1.39 0.02 1.2 0.059 1.62 0.0054
1007 1.28 0.09 1.4 0.014 1.57 0.0047
891 -1.13 0 34 -1.25 0.048 -1.57 0.0025
1121 1.26 0.59 1.05 0.69 -1.63 0.0049
573 -1.15 0.0047 -1.5 0.00075 -1 74 3.50E-05
433 -1.7 0 0059 -1.81 0.003 -1.78 0.0069
767 -1.42 0.019 -1.53 0.011 -1.79 0.0033
420 -1.33 0.038 -1.57 00012 -1.86 0.00026
448 -1.2 0.0051 -1.49 0.0009 -1.88 0.0002
1229 -1 21 
-3.99
0.48 -1.96 0 0082 -2.03 0.023
437 0.0036 -3.47 0.0051 -3.55 0.0043
438 -7.11 0.00048 -5.65 0.00087 -6 22 0.00082
(Figure 6-2) Visualisation of differential thiol labelling in UV-treated versus untreated 
plasma fractions. A representative ICy dye image of a UV treated plasma fraction is shown. 
Protein features with altered labelling (>+/- 1.5 fold up or down) across the time course are 
labelled with their spot identity number (top left). The table shows the average fold difference in 
labelling intensity between the treated samples and the untreated sample for 29 spots matched 
across all gels with /^-values from the applied T-test. Green shaded values are >1.5 fold up or 
down regulated. The Venn diagram shows the number of spots and their co-regulation between 
each exposure and the untreated sample.
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(Figure 6-3) Master gel image of ICy5 labelled standard pool and its corresponding colloidal 
coomassie blue stained image. The image shown is an aligned image of the internal standard 
pool labelled with ICy5 (red spots) and the image of its corresponding colloidal coomassie blue 
stained gel (blue spots). The arrows indicate the aligned features of significant differentially 
labelled spots and the corresponding colloidal coomassie blue-stained spots. These spots were 
picked from gels for identification by MALDI-TOF-MS.
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Km inogen precusor (11)
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Com plem ent com ponent C 4 (437)
Com plem ent com ponent C4 (438) 
ALB protein (448)
ALB protein (420)
Prethrom bin 2 (573)
Serum  am yloid P com ponent (924)
Serum  am yloid P  com ponent (907) 
Serum amyloid P com ponent (909) 
Serum am yloid P com ponent (914) 
Serum amyloid P com ponent (913)
Retinol binding protein (1072)
A v e ra g e  fo ld -d iffe re n c e  f  a n d  p  -v a lu e
MowseS Esi. Est. Prod. Prod. Accession UV(20/0 UV(40/0 UV(io/0
No. Protein Namo % Cov core mass pl Mass Pl No. mJ/cm2) P-value mJ/cm2) P-value mJ/cm2) P-value Function
433 Actin 42 92/64 43000 5.5 42188 5.4 156759 -1.7 0.0059 -1.81 ! 0.003 -1.78 0.0069 cytoskeleton protein
420 ALB protein 53 181/64 45000 6 47361 6 27692693 -1.33 0.038 -1.57 0.0012 -1.86 0.00026 similar to human serum albumin
446 ALB protein 31 90/64 45000 5.9 48664 6 27692693 -1.2 0.0051 -1.49 0.0009 -1.88 0.0002 similar to human serum albumin
437 Complomont component C4 35 90/64 46000 7 48037 5.8 40737308 -3.99 0.0036 -3.47 0.0051 -355 0.0043 complement protein
438 Complement component C4 39 113/64 46000 7.5 48037 5.8 40737308 -7.11 0.00048 -5.65 0.00087 -6.22 0.00082 complement protein
11 Kininogen precursor 35 81/64 70000 5.5 71945 6.3 125507 1.61 0.0059 1.75 0.003 2.13 0.0013 Blood coagulation
573 Prethrombin 2 46 94/64 35000 7 5 34245 6.3 809450 -1.15 0.0047 -15 0.00075 -1.74 0.000035 Blood coagulation
1072 Retinol binding protein 75 103/64 21000 55 20959 5.3 230284 1.87 0.0015 2.26 0.0006 4.09 0.000089 Transporting vitamin A from liver to vitamin A dependent tissu-
907 Serum Amyloid P component, chain A 39 90/64 24000 6 23358 6.1 576259 258 0.0058 3.86 0.0013 5.89 0.00049 chaperone; chromatin degradation control
909 Serum Amyloid P component, chain A 39 107/64 24000 5.8 23358 6.1 576259 4.4 0.018 6.58 0.0068 13.41 0.00025 chaperone; chromatin degradation control
913 Serum Amyloid P component, chain A 39 112/64 24000 5.6 23358 6.1 576259 1.67 0.007 2.02 0.021 2.75 0.0067 chaperone; chromatin degradation control
914 Serum Amyloid P component, chain A 33 70/64 24000 5.7 23358 6.1 576259 326 0.0047 5.96 0.00067 9.5 0.00031 chaperone; chromatin degradation control
924 Serum Amyloid P component, chain A 39 78/64 24000 5.5 23358 6.1 576259 3.87 0.0024 6.2 0.00075 9.8 0.00031 chaperone; chromatin degradation control
(Figure 6-4) 2DE migration of proteins identified by MALDI-TOF-MS displaying UV- 
induced changes in thiol labelling. A representative ICy-dye image is shown displaying 
proteins with UV-induced differential labelling. UV-induced differentially labelled proteins were 
identified from gels by MALDI-TOF-MS as described in Materials and Methods. Protein table 
showing MALDI-TOF peptide mass fingerprinting results. The % coverage of analysed peptides, 
the MOWSE score from Mascot searches and the significance threshold score, the estimated mass 
and p/ (from gels), the predicted mass and pi (from the database) and the NCBI gene identifier 
(Accession Number) are shown for each protein. MS spectra, MOWSE score histograms, 
matching peptides and sequence coverage for all proteins are shown in Appendix G. The criteria 
for inclusion was an average fold-difference of > 1.5-fold up (+) or down (-) regulation where 
p<0.05 and spots were matched across all 12 images.
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(Figure 6-5) Examples of protein isoforms identified by MALDI-TOF-MS displaying UV- 
induced thiol labelling changes. Proteins (Kininogen precursor (A), Actin (B), ALB protein 
(C), Serum Amyloid P component (D), Complement C4 (E) and Retinol binding protein (F)) 
display UV-induced differential labelling in plasma fractions and were identified from gels by 
MALDI-TOF-MS. Examples of 3D-images of spots are shown for the untreated (0 mJ/cm2) and 
treated (20, 40 and 80 mJ/cm2) samples. Graphs were derived from DeCyder image analysis 
where the standardised abundance is the ratio of the volume of a test gel feature versus the 
volume of the corresponding standard gel feature. Triplicate data points are shown for spots from 
the untreated and treated samples with lines joining the average values. MS searches are shown in 
Appendix G.
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Kininogen is a thiol protease inhibitor synthesised in the liver and secreted into the 
plasma, where it complexes with prekallikrein and factor XI (Renne et al., 2002). After 
cleavage by kallikrein or factor X lla, the m ature kininogen protein comprising 626 
residues forms a disulphide-linked two subunit protein (Shariat-Madar et al., 2002). This 
cleavage o f kininogen is required for expression o f its procoagulant activity, which is 
contained in the light chain. Here, ICy labelling o f  kininogen displayed a dose-responsive 
increase following UV irradiation, suggesting that the disulphide bridges within the 
whole protein are broken due to UV irradiation, thus increasing the free thiols available 
for ICy labelling (Figure 6-5A). This is the first time that kininogen has been found as a 
potential target o f  UV-induced damage, although further studies are required to assess the 
effects o f UV on its function.
Actin is a major component o f  eukaryotic cells with mainly contractile and structural 
functions. The 2D-DIGE results showed a decrease in labelling o f actin following UV 
exposure. It is the major constitutent o f  the cytoskeleton, forming filaments that are 
regulated by many intracellular signalling pathways and that interact with numerous 
intracellular proteins (Pollard and Cooper, 1986). Some studies have also shown that 
actin is found on the cell surface, in the extracellular matrix, and in serum and other 
biological fluids (Rohr and Mannherz, 1978;Owen et al., 1978;Thorstensson et al., 
1982;Accinni et al., 1983;Moroianu et al., 1993). Normally, actin is released into the 
serum as a consequence o f cell death and/or necrosis and is cleared from the circulation 
by the vitamin D-binding protein (Goldschmidt-Clermont et al., 1986). Monomeric actin 
binds to the vitamin D-binding protein through actin's C-terminal region although the 
intracellular cleavage o f actin results in fragments that do not bind and therefore are not 
cleared as rapidly from the serum (Goldschmidt-Clermont et al., 1986). There are no 
reports o f the direct modification o f  serum actin by UV irradiation and so the results o f  
the study here appear to be novel. Nevertheless, there is one report indicating that one o f 
the major targets o f UV-induced alterations intracellularly is the actin molecule 
(Maekawa et al., 1996) suggesting that serum actin could possibly be modified in a 
similar way. Since actin contains an odd number o f cysteine residues, this implies that at 
least one free thiol exists that could be accessible for UV-induced modification. Such a
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modification may explain the decrease in cysteine labelling after UV irradiation (Figure 
6-5B).
Serum albumin is one o f  the major serum transport proteins which include serum 
albumin, fetoprotein, vitamin D-binding protein and afamin (Schoentgen et al., 
1986;Haefliger et al., 1989;Lichenstein et al., 1994). Albumin is the most abundant 
protein in serum. It binds water, cations, fatty acids, hormones, bilirubin and drugs and 
regulates the osmotic pressure o f  blood (M inton, 1995). Recent studies indicate that UV- 
irradiation o f  a BSA solution in the presence o f  cysteine can alter the protein secondary 
structure o f  BSA. Moreover, UV irradiation also induced changes in album in’s binding 
ability (Samoilova et al., 1987). These reports suggest that the cysteine residues on 
albumin can be modified by UV irradiation and may induce changes in the physiological 
function o f  the protein. The result from this work indicates that the serum albumin 
protein exhibits a UV-C dose-dependent reduction in cysteine labelling suggesting that 
the free thiol in this protein has been oxidised (Figure 6-5C). The observation o f 
peroxide-induced oxidation o f  human serum albumin shown in Figure 3-11 supports such 
a mechanism and may explain the thiol reactivity changes seen under UV irradiation. 
Amyloid P component (AP) was first discovered as a glycoprotein present in all amyloid 
deposits in all types o f amyloidosis, and was later found to be identical to the normal 
circulating plasma glycoprotein, serum amyloid P component (SAP) (de Haas, 1999). 
SAP belongs to the family o f  pentraxins, a superfamily o f plasma proteins characterised 
by their pentameric assembly and calcium-dependent ligand binding. It has been reported 
to bind to glycosaminoglycans, especially heparin, heparin sulfate and dermatan sulfate, 
to mannose terminated glycans, and to glycans with preterminal galactose residues 
(Emsley et al., 1994c). In addition, native SAP is apparently the only protein from serum 
that shows calcium-dependent binding to DNA and chromatin at physiological pH and 
ionic strength (Pepys et al., 1994;Emsley et al., 1994b). SAP also plays an important role 
in pathogen defence in serum and has been shown to bind to lipopolysaccharide (LPS) 
which is the major component o f  the outer membrane o f  Gram-negative bacteria (Preston 
et al., 1996;de Haas et al., 1998). A structural study showed that native SAP contains two 
cysteines which are linked by an intramolecular disulphide bond (Thompson and Enfield, 
1978;Emsley et al., 1994a). Since serum amyloid P component was identified in the
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plasma fractions as a protein whose reactive thiol content was increased by UV 
irradiation (Figure 6-5D). This implies that UV-C exposure breaks the intramolecular 
disulphide bond and increase the content o f available cysteines for ICy labelling. 
Components o f the complement system form a large family o f glycoproteins that have 
important functions in the immune response and host defence (Goldman et al., 1982). 
They are proteolytically activated by cleavage at specific sites to form A- and B- 
fragments (Ogata et al., 1989). The proteins are highly hydrophilic, with a mainly alpha- 
helical structure held together by disulphide bridges (Gennaro et al., 1986). In this study, 
UV irradiation resulted in a significant reduction in the labelling o f complement C4 
protein (Figure 6-5E). Previous work by Livden et al. showed that complement C4 levels 
were significantly reduced under UV treatment for 4 weeks and it is tempting to speculate 
that the reduced labelling o f complement C4 could be caused by the degradation o f  the 
protein in response to UV treatment.
Finally, Serum Retinol Binding Protein (RBP) is the major retinol transporter in plasma, 
binding a single all-trans-retinol molecule as its physiological ligand. RBP is synthesised 
in hepatic parenchymal cells, where the apoprotein is loaded with retinol. Subsequently, 
the retinol-RBP complex is released into plasma and associates with transthyretin 
forming the main transporting complex (Wolf, 1992). 85-90% o f plasma RBP carries 
bound retinol (Blaner, 1989). RBP-mediated retinol transport facilitates the transfer o f 
insoluble retinol from storage sites to peripheral tissues, with the synthesis o f RBP 
regulating retinol release from the liver and controlling the specificity o f  its uptake by 
target cells (Newcomer, 1995a). In addition, it has been shown that RBP protects bound 
retinol from oxidation (Newcomer, 1995b). RBP-target-cell interaction is important for 
its biological function: RBP is recognised by a cell-surface receptor, releasing retinol, and 
losing its affinity for transthyretin. The resulting apo-RBP is filtered by the kidney, 
reabsorbed and catabolised (Wolf, 1992;Sundaram et al., 1998). Interestingly, the amino 
acid sequence o f  RBP contains 6 cysteines which form 3 disulphide bonds without any 
free thiols in the native protein (Rask et al., 1987). In addition, the substitution o f  these 
cysteines with serines induces decreased affinity for retinol and disturbs the 3D structure 
o f the protein (Reznik et al., 2003). As with kininogen and serum amyloid P, the ICy dye 
labelling o f  RBP progressively increased with increasing UV doses (Figure 6-5F),
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consistent with the generation o f free thiol groups. Again, a likely explanation is that the 
disulphide bridges within RBP are broken due to UV irradiation, thus, increasing the free 
thiol content for ICy dye labelling.
6.3 Conclusions
In this chapter, UV-treated human plasm a fractions provided by Baxter Healthcare were 
subjected to cysteine 2D-DIGE and MALDI-TOF-MS analysis. The aim was to 
investigate the effect o f UV-C on plasm a proteins particularly its effect on thiol oxidation 
and may be useful for understanding the possible drawbacks o f UV disinfection o f  serum 
products. By means o f  cysteine 2D-DIGE, 29 protein features out o f 1461 were 
confidently identified as UV-induced changes due to alterations in thiol reactivity or 
protein content o f the samples. Seventeen gel features were aligned to coomassie blue 
stained gels and accurately picked for in-gel digestion and MALDI-TOF-MS 
identification and 13 o f these were identified with confidence. The changes observed 
were classified into two groups, those displaying increased ICy dye labelling and those 
with decreased labelling. None o f  the changes were biphasic. Two serum transport 
proteins, serum amyloid P component (SAP) and retinol binding protein (RBP), and the 
coagulant-related factor, kininogen were found to display dose-dependent increases in 
labelling. One o f  the possible mechanisms for this could be the UV-induced breakage o f 
disulphide bonds and exposure o f  pairs o f  free cysteine thiols for ICy dye labelling. 
Structural studies o f  SAP and RBP support this hypothesis as all o f the cysteines in the 
two native proteins form disulphide bonds. The only mechanism for ICy dye labelling to 
take place therefore is the reduction o f the disulphide bonds to generate free available 
thiols. As the formation/breakage o f disulphide bonds may adversely alter the biological 
activity o f proteins, the evaluation o f  the modifications o f serum amyloid P, retinol 
binding protein and kininogen must be considered in preparations o f blood derived 
products.
In contrast, the serum carrier protein ALB, the cytoskeleton protein actin, the host 
defense protein complement C4 and the coagulant factor prethrombin 2 all showed 
decreased ICy dye labelling with UV-treatment. Possible mechanisms to explain this are 
that the proteins could be degraded by UV as reported by Livden et al. (Livden et al.,
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1987) or available free thiols are modified by UV-induced ROS to form the sulfenic, 
sulfinic or sulfonic forms o f cysteines (Schafer et al., 2001) which would both reduce 
labelling. These modifications might also exert the irreversible loss o f protein activity 
and need to be evaluated before preparing UV-irradiated blood products for therapeutic 
use.
In this 2D-DIGE study, numerous SAP isoforms were identified in a charge train with all 
isoforms showing increase ICy dye labelling with increasing UV dose. This charge train 
might be caused by poor focusing or by labelling o f  multiple isoforms o f SAP. As SAP 
contains only 2 cysteines, the ICy labelled protein would not generate more than 2 shifted 
isoforms indicating the formation o f the charge train is not only due to labelling-induced 
p i  shifts, but also contributed by uncharacterised isoforms o f SAP. It is worth 
mentioning that a lysine 2D-DIGE analysis was also carried out to compare changes in 
protein abundance between untreated and UV-treated (80 mJ/cm2) samples. This analysis 
revealed two consistent differences in repeat experiments, where the abundance o f  two 
protein isoforms was increased by an average o f 2.75 and 10.1 fold, respectively. These 
isoforms represented very low-abundance species and could not be identified by M ALDI- 
TOF-MS. Importantly, they ran at very different p/s and molecular weight than the 
isoforms displaying differential ICy labelling and are therefore unlikely to represent any 
o f  the isoforms identified here. These data suggest that UV induces specific changes in 
the thiol chemistry o f proteins rather than changes in the abundance o f  the whole proteins 
or their degraded products. There are two hypotheses to explain the UV-C-induced 
reduction o f disulphide bonds. One o f  these is that UV-C generates ROS to reduce the 
disulphide bond (Figure 6-6A). The other hypothesis is the disulphide bond absorbs the 
energy directly from UV-C and then the reduction event occurs (Figure 6-6B). The 
wavelength o f  UV-C ranges from 200 nm to 280 nm which overlaps with the absorbance 
spectra o f DNA and RNA, but has little effect on protein (Chin et al., 1995). Therefore, a 
ROS mediated disulphide bond reduction model is the preferred mechanism.
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(Figure 6-6) Possible mechanisms for UV induced ICy dye labelling. (A) Indirect UV-C 
induces the breakage of disulphide bond due to the formation of ROS. (B) Direct UV-C induces 
the breakage of disulphide bond.
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Chapter 7-DISCUSSION AND FUTURE PROSPECTS
The control o f  cell differentiation, proliferation, apoptosis, growth and migration in 
response to extracellular regulatory peptide signals is mediated in a large part by receptor 
tyrosine kinases (RTKs) (Holbro and Hynes, 2004). These receptors transduce signals 
across membranes and stimulate and integrate downstream signal transduction pathways 
which are fundamental to most o f the m ajor aspects o f  cell physiology. As the receptors 
are at the highest level in the initiation o f responses to ligands, their functions are 
frequently taken over in oncogenesis. The activation o f  the RTKs by growth factors is 
tightly controlled in quiescent cells with absence o f ligands, however, the binding o f 
growth factors, which usually mediates the dimerisation o f  the receptors, leads to the 
activation o f the tyrosine kinases, causes inter-subunit phosphorylation and creates 
tyrosine phosphorylation motifs that then act as binding sites for downstream signal 
mediators (reviewed in (Arteaga, 2002)). These mediator proteins play an important role 
in intracellular signalling by recruiting various proteins to specific locations, providing a 
link between molecules o f signalling cascades and RTKs. For example, Grb2 is 
important in the activation o f  downstream signalling pathways such as the 
Ras/Raf/M APK pathway. These mediator proteins contain different motifs that mediate 
protein-protein interactions. Two o f  these motifs, the Src homology 2 (SH2) domain and 
Src homology 3 (SH3) domain can bind to specific phoshorylated tyrosine-containing 
sequences on RTKs and proline-rich sequences, respectively. Thus, as in the case o f  
Grb2 which contains both SH2 and SH3 sequences, it can bring cytoplasmic proteins via 
its SH3 domain to an activated RTK throught its SH2 domain which will bind to the 
phosphorylated tyrosine residues o f  the RTK. At the cellular level, three major signalling 
pathways mediate the downstream effects o f RTK activation. The first pathway involves 
the Ras-Raf-MAP kinase pathway. The second pathway involves phosphatidylinositol 3- 
kinase (PI3K) and Akt. The third pathway involves the stress-activated protein kinase 
pathway, involving Jak/Stat (Bell et al., 2005).
Because o f the critical roles o f  RTKs in cellular signalling processes, their catalytic 
activity is under tight control. This is achieved by several mechanisms, which can be 
briefly summarised as follows: the phosphorylation state o f a RTK can be controlled by
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the activation o f  opposing signals such as protein tyrosine phosphtases (Hunter, 1995). 
Ligand-binding can lead to removal o f  receptors from the cell surface by endocytosis 
(W aterman and Yarden, 2001) and RTKs can be degraded following ubiquitination 
(Shtiegman and Yarden, 2003).
The critical position o f the receptor at the top o f  the signal transduction cascade, means 
that alterations in expression levels, mutations o f the receptor itself or loss o f receptor - 
modifying enzymes, can lead to altered cellular functions and can therefore drive 
deregulated cell growth and contribute to the process o f  transformation (review in 
(Nicholson et al., 2001)). Indeed, many oncogenes, which were discovered because o f 
their altered function or expression in cancers or because they were related to viral 
oncogenes encode RTKs (Baserga, 1994). The era o f  genomics has extended the 
definition o f  those RTKs through gene sequencing projects and many RTKs are now 
known to be mutated or overexpressed in human cancers (Blume-Jensen and Hunter, 
2001;Cox et al., 2005). The deregulation o f the RTKs can also be caused by increased 
stimulation o f RTKs through autocrine growth factor loops (Deuel et al., 1983;Sizeland 
and Burgess, 1992). Recent reports also indicate the increased RTK activity can be 
mediated by deletion or point mutation o f the RTKs (Paez et al., 2004;Mason et al., 
2004;Singh et al., 2005). For example, v-erbB, the oncogenic counterpart o f EGFR, 
transduced as the viral oncogene o f avian erythroblastosis virus. The mechanism o f  v- 
ErbB activation involves deletion o f its ligand-binding domain, resulting in a truncated 
receptor (Downward et al., 1984). Another example is the neu transforming gene, the rat 
homologue o f ErbB-2/HER2, which was identified as having a specific mutation in its 
transmembrane domain that was found to be responsible for its oncogenic potential and 
the constitutive activation o f the kinase (Bargmann and Weinberg, 1988). These 
investigations suggest that these RTKs would be potential targets for human cancer 
therapy and according to the mechanism o f  RTK activation, many possible strategies can 
be used for therapeutic purpose. These include the design o f  antagonists for preventing 
ligands binding to RTKs (Sebti and Hamilton, 2000), the design o f antibodies against 
RTKs (Glennie and Johnson, 2000), the design o f kinase inhibitors for RTKs (Garrett and 
Workman, 1999), the design o f inhibitors for preventing adaptor protein signalling 
(Garbay et al., 2000) and the design o f  inhibitors for preventing receptor dimerisation
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(Berezov et al., 2002a) For example, the humanised monoclonal anti-ErbB-2 antibody 
Trastuzumab (Herceptin) can bind to the extracellular domain o f ErbB-2 and lead to 
down-regulation o f ErbB-2 by inducing receptor internalisation (Kumar et al., 1991) 
whilst small molecule EGFR tyrosine kinase inhibitors such as Gefitinib have been 
developed for non-small cell lung carcinoma therapy (W akeling et al., 1996). Moreover, 
peptides o f 12-30 amino acids which were derived from the potential extracellular 
dimerisation surface o f ErbB receptors can inhibit ErbB-2 dimerisation and growth o f  
cells overexpressing these receptors (Berezov et al., 2002b). However, the development 
o f  cancers is not only due to simple mutations or overexpression, but also the 
contribution o f  the deregulation o f  many biomolecules. The additional molecular 
abnormalities might reduce the therapeutic effect. Thus, combined treatment with 
different target-specific agents is necessary.
Proteomic technologies provide a powerful tool for the detailed comparison o f proteins 
from cells under different growth conditions and have been applied to evaluate the effect 
o f  cancer therapies. For example, a proteomic method combining SDS-PAGE, 
chromatography and mass spectrometry has been used to profile the cellular targets 
affected by the action o f  the EGFR kinase inhibitor gefitinib and the results generated can 
help rational design o f drugs (Brehmer et al., 2005). In addition, the ErbB receptor 
families have been intensively pursued as therapeutic targets owing to the large number 
o f  cancer patients whose tumours show aberrant ErbB family expression. Indeed, the 
ErbB-2 receptor has been shown to be overexpressed in 25 to 30% o f invasive breast 
cancers and provides a useful marker for therapy. This is the reason why the model cell 
lines HB4a and its ErbB-2 overexpressing partner, C3.6 cells, were used to study cancer 
cell signalling in this thesis. Thus, proteomic techniques which can analyse the global 
changes o f  gene products and signalling molecules on a large scale are powerful tools to 
explore cancer-related signalling and to identify potential therapeutic candidates.
Studies on ErbB-2 have mostly focused on its proliferative and anti-apoptotic signalling 
capabilities which have been shown to promote tumourigenesis. However, there is very 
little information about the relationship between ErbB-2 signalling and cellular ROS, 
which can be induced by growth factor stimulation and may play a secondary messenger 
role in normal and cancer cells. With this in mind, another purpose o f  this study was to
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examine the effects o f  ErbB-2 overexpression on the cellular response to oxidative stress. 
This study was thus aimed at elucidating the effects o f  ErbB-2 overexpression and H 2O2- 
induced oxidative stress on protein levels and post-translational modifications using a 
combination o f proteomic and biochemical analysis.
Several techniques have been used for proteomic differential expression studies, 
involving gel-based and non-gel based approaches (see Introduction). In this study, the 
recently developed technique o f  2D-DIGE analysis was employed. This protein tagging 
and detection method uses a panel o f  matched fluorescent dyes to compare different 
samples on the same 2D gel, thus providing increased experimental reproducibility and 
accuracy for statistical analysis o f differential protein expression between biological 
samples. In addition, given the wider linear dynamic range o f  fluorescence detection, this 
technique provides a better strategy for carrying out global expression profiling compared 
to conventional methods. The original 2D-DIGE methodology uses three N- 
hydroxysuccinimidyl (NHS) ester-derivatives o f the cyanine dyes (NHS-Cy2, -Cy3 and - 
Cy5) for covalent labelling o f protein primary amino groups (i. e. lysine £-amino and N- 
terminal a-am ino groups). In this procedure, differentially labelled samples are mixed 
and separated on the same 2D gels generating directly super-imposable 2DE images for 
quantitative analysis (Unlu et al., 1997b). In 2D-DIGE expression profiling, one dye (e.g. 
Cy2) is used to label an internal standard pool o f all samples which is run on every gel 
against the Cy3 and Cy5 labelled test samples (Gharbi et al., 2002;Alban et al., 2003). 
The fluorescence signal from each protein feature (Cy3 or Cy5 labelled) is then compared 
with the co-migrating standard feature (Cy2 labelled) on each gel to give a standardised 
abundance ratio that can be averaged across replicate samples and compared between 
different samples to allow identification o f  significant changes. NHS-Cy dye lysine 
labelling is typically carried out under conditions that limit modification to an estimated 
3-5% o f total protein (minimal labelling). This low stoichiometry is essential to avoid 
sample insolubility and heterogeneous multiple labelling in the molecular weight 
dimension. Overlabelling o f lysine may also block tryptic cleavage sites, hindering the 
downstream identification o f labelled proteins by mass spectrometry.
In order to improve the sensitivity o f  the NHS-Cy dye minimal labelling technique, 
labelling o f  a less prevalent amino acid at higher stoichiometry would be required. Such
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an amino acid is cysteine which can be labelled through alkylation o f its thiol group. To 
this end, a pair o f iodoacetylated derivatives o f  the fluorescent cyanine dye was 
synthesised by our collaborator Dr. Piers Gaffney (LICR and now at Imperial College 
London). These reagents are charge- and size-matched, making it possible to carry out 
accurate protein expression profiling based on cysteinyl thiol labelling 2D-DIGE. In 
addition, cysteinyl thiols are targets o f  stress-induced oxidative modification, then these 
reagents were used to monitor such modifications, based on the fact that the iodoacetyl 
dyes would no longer react with oxidised thiol groups. Thus, the cysteine labelling dyes 
developed and described in this thesis were used to monitor changes in the redox status o f 
protein thiols in response to specific stimuli, such as oxidants (Chapter 4), growth factors 
(Chapter 5) or UV irradiation (Chapter 6), as well as to examine changes in protein 
expression.
Initially, protein labelling using the ICy dyes was characterised and optimised for use in 
2D-DIGE analysis (Chapter 3). These experiments showed that the ICy labelling is rapid 
under non-denaturing or denaturing conditions and that the protein solubility at high 
stoichiometry is better than with lysine labelling. The sensitivity o f the ICy labelling is 
higher than the corresponding silver and CCB stains, though only 50% o f the ICy- 
labelled protein features could be aligned to post-stained silver or CCB features. This 
difference is partly attributed to non free thiol-containing proteins which can not be 
detected by cysteine labelling strategy or proteins that silver-stain/ CCB stain poorly. 
Study o f the dye to protein ratio optimum for labelling showed that 80 pmol o f dye per 
pg o f  total cell lysate, which was chosen for 2D-DIGE experiments, gave a reasonably 
high sensitivity o f  labelling without compromising sample solubility or resulting in 
heterogeneous labelling and formation o f  over-complex spot patterns. Moreover, 
different thiols appeared to display different labelling reactivities although labelling was 
specific for free thiol groups. This could be caused by imcompletely denaturation o f 
proteins or by the adjacent peptide sequences that interfere the dye accessibility. 
Apparent dye bias was observed in a small group o f labelled proteins over 25-30 kDa 
molecular weight range. One hypothesis for this could be that SDS could interact 
differently with the two differentially labelled protein pools and affect their migration in 
gels. However, this could be overcome by using the internal standard labelling strategy.
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Importantly, ICy dye labelling was compatible with MS analysis used to identify the 
differentially labelled proteins o f  interest. Thus, an optimised workflow was established 
for the analysis o f protein expression profiles and redox-dependent thiol modifications. 
Compared to the conventional NHS-lysine labelling strategy o f  2D-DIGE, a drawback for 
the ICy dyes used here is the potential p /  shift o f  ICy-labelled proteins caused by the 
positive charge on the dyes. Although such shifts were not formerly proved, this charge 
difference may lead to the loss o f  accurate experimental p i  information which can help in 
the validation o f MS search results. In addition, given the likely sub- stoichiometric 
labelling, dye-dependent shifts are likely to dilute the total amount o f protein available 
for MS-identification and could partly explain why the “hit” rate for identification o f 
differentially ICy labelled proteins was rather low. Since ICy dye labelling under non­
reducing conditions is not completely dependent on protein amount, but rather reveals the 
total amount o f  free thiol groups that are affected by changes in thiol reactivity, a 
validation step such as immunoblotting or lysine-labelling 2D-DIGE is required to 
discriminate the labelling differences caused by altered thiol reactivity versus altered 
protein expression.
During the course o f  this work, a study based on the use o f a pair o f maleimide Cy dyes 
for cysteine 2D-DIGE labelling was reported by Shaw et al (Shaw et al., 2003). These 
dyes were recently commercialized by GE Helthcare for cysteine thiol “saturation” 
labelling o f  denatured and reduced samples. The evaluation o f this labelling strategy 
showed improved sensitivity and dynamic range for the technique over the commercial 
minimal labelling method based on lysine labelling dyes (Shaw et al., 2003). This 
analytical strategy was recently applied in two separate studies to identify proteomic 
changes in rare samples; between laser micro-dissected normal intestinal epithelium and 
adenoma (Kondo et al., 2003) and between differentially sorted murine bone marrow cell 
populations displaying distinct chemotactic responses (Evans et al., 2004). Comparison 
o f the ICy dye labelling strategy used in this study with that for the maleimide Cy dyes 
revealed some similar findings, including increased sensitivity o f detection o f  thiol- 
containing proteins, increased protein precipitation at high labelling ratios, altered 2DE 
spot patterns compared with minimal lysine labelling, a similar dynamic range o f 
detection (~5000) and some apparent dye bias. However, there are notable differences
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between the two strategies. The maleimide dyes were used for labelling o f  all cysteine- 
containing proteins in pre-reduced samples for sensitive expression profiling, whereas the 
focus here was to label non-reduced samples with a view to following redox-dependent 
thiol-reactivity. This is likely to affect the reactivity and extent o f labelling. As such, we 
opted to use a lower dye to protein ratio and did not see the appreciable sample losses due 
to precipitation that was reported by Shaw et al (Shaw et a l, 2003). The labelling o f  
fully reduced samples for ICy dye 2D-D1GE has yet to be explored. It is also worth 
noting that the maleimide dyes are sulphonated to give them a net neutral charge, and so 
they have the advantage that they should not alter the p /  o f  labelled proteins, unlike the 
ICy dyes, where potential p 1 shifts will add complexity to the analysis. The other 
significant difference is that the current study used iodoacetyl derivatives o f Cy3 and Cy5 
as opposed to maleimides, on the basis o f their expected greater reactivity. This should 
allow efficient labelling at lower temperatures, thereby reducing the risk o f protein 
modification by the breakdown products o f  urea in the lysis buffer.
Although sample solubility is a problem when high stoichiometric labelling o f  either 
cysteine or lysine is carried out, we show that there is a distinct analytical advantage to be 
gained from labelling the lower-occurrence cysteine residues. This advantage was evident 
for example, in the reduction o f  heterogeneous labelling and the ability to monitor redox- 
dependent thiol modifications simultaneously. It is worth noting that our recent 
calculations predict that around 95% o f all human open reading frames encode a 
cysteine-containing protein (R. Jacobs, unpublished data). Although a proportion o f  
these would not be accessible to alkylation, our data showed significant labelling o f  free 
thiols in denatured, non-reduced lysates, with around 5% o f the detectable proteins found 
to be susceptible to changes in labelling in response to oxidative stress. Since 
free/reactive thiol groups play important roles in enzyme catalysis and protein function, 
their redox modification is likely to alter protein function or oxidant-dependent signal 
transduction. Given the importance o f oxidative stress in human disease, further studies 
should be undertaken to assess the functional significance o f these modifications and to 
assess their role in cytoprotection, induced cellular damage and signalling.
In this thesis, the cysteine-labelling 2D-DIGE strategy was used to study the effects o f  
H2O2 and ErbB-2 overexpression in a model cell system consisting o f  immortalised
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HMLECs and to relate these changes to the early stages o f breast cancer progression and 
the response to oxidative stress. These cell lines are an appropriate cell type to use, since 
most breast cancers arise from the luminal epithelium. In addition, the C3.6 cells were 
shown to overexpress surface levels o f  ErbB-2 similar to those observed in certain breast 
cancers (Harris et al., 1999). The intracellular signalling pathways triggered by hydrogen 
peroxide were first examined. In agreement with previous studies (Caselli et al., 
1998;Kwon et al., 2004), cellular phospho-tyrosine levels were increased in both the 
HB4a and C3.6 cells after hydrogen peroxide treatment supporting the notion that H 2O2 
inhibits the activity o f  protein tyrosine phosphatases (PTP) by oxidising the free thiol 
cysteines o f their active sites. Interestingly, more proteins were tyrosine phosphorylated 
and to a greater degree in the HB4a cells versus the C3.6 cells, indicating that ErbB-2 
overexpression can affect the response to cellular oxidative stress. A model o f  the 
signalling role o f  H2O2 in growth factor stimulated cells is shown in Figure 7-1. The 
concentrations o f  free thiols in HB4a and C3.6 cells were reduced by 45% and 23%, 
respectively, after hydrogen peroxide treatment for 2 min, then recovered to ~80 % o f  the 
basal level after 20 min in both cell lines. This implies that C3.6 cells have a higher 
tolerance for peroxide and a more efficient mechanism for its removal which is somehow 
dependent upon ErbB-2 overexpression. In support o f this, HB4a cells activated more 
rapid and stronger signalling responses, such as p38 activation, than the C3.6 cells. Thus, 
the C3.6 defence mechanisms would appear to act upstream o f these signalling events 
and could remove H2O2 before these signalling events are activated. Cells were further 
compared by cysteine 2D-DIGE and fifty-one proteins with significant differential 
labelling were identified by MALDI-TOF-MS. It is important to note that all proteins 
identified contain at least one free cysteine thiol, validating the labelling specificity. 
Those identified proteins that were differentially labelled or expressed in response to 
hydrogen peroxide fell into three main functional groups that included molecular 
chaperones, cellular redox regulators and metabolic enzymes. The experimental strategy 
used also allowed simultaneous detection o f  proteins that were correlated with ErbB-2 
overexpression in luminal epithelial cells. These ErbB-2 overexpression-related proteins 
included cytoskeletal proteins, molecular chaperones, redox regulatory proteins and
174
proliferation regulatory proteins. Importantly, some o f the identified targets were 
differentially regulated by both H2O2 treatment and ErbB-2 overexpression.
GF
Protein-Y Protein-YP
PTEN PTEN
NADPH NADP*
(Figure 7-1) M echanism s for the production, signalling and removal of H 2O 2 in 
grow th factor-stim ulated cells. Stimulation o f cells with a growth factor induces the 
activation o f PI3K which catalyses the conversion o f PIP2 to P I P 3 .  P I P 3  can activate the 
NADPH oxidase (NOX) complex, which results in the production of O2 that can be 
converted to H2O2 through the action of SODs. The H2O2 mediates the inactivation of 
PTPs, PTEN and Prxs by modification o f their active site cysteines to form Cys-SOH or 
intra-/inter-molecules disulphides. The oxidised PTEN and Prxs are regenerated by the 
cellular thioredoxin system.
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The results from this study support the concept that ErbB-2 overexpression has diverse 
effects on the response o f cells to oxidative stress through the regulated expression and 
activity o f  redox-sensitive enzymes and also through changes in stress-inducible proteins. 
The up-regulation o f RhoGDIl in the ErbB-2 overexpressing cells is particularly 
interesting since in other cell systems Rho-GDI has been shown to modulate recruitment 
o f the NADPH oxidase complex to Rho-family GTPases for superoxide ion generation 
(Olofsson, 1999). It is tempting to extrapolate that this interaction also occurs in 
mammary luminal epithelial cells and may alter superoxide ion production and H2O2 
levels. Moreover, the previous observation o f the down-regulation o f  mitochondrial 
superoxide dismutase (MnSOD) in the C3.6 cells (Gharbi et al., 2002;White et al., 2004), 
may also result in alternative regulation o f  intracellular H2O2 levels. These changes may 
at least, in part, account for the altered H202-inducible activation o f E rkl/2  and p38 
MAPK signalling in this cell system, which in turn has direct implications on the stress 
responses o f normal versus tumour cells and the response to chemotherapy and 
radiotherapy which are likely to alter the redox status o f  cells.
Following the identification o f  cysteine-labelling changes, lysine-labelling 2D-DIGE was 
also performed to identify H2O2- and ErbB-2-dependent changes in protein expression 
under the same conditions and to compare the two labelling strategies in a biological 
context. As expected, there was an overlap with previous work from our labortatory 
where the HB4a and C3.6 cell proteomes were compared by lysine labelling 2D-DIGE 
(Gharbi et al., 2002). In both cases, most o f  these proteins displayed the same 
directionality o f up- or down-regulation in C3.6 versus HB4a cells. Comparison between 
the ICy and NHS-Cy dye analysis technologies revealed 11 individual gene products that 
were common to both methods and most o f these displayed similar changes in labelling. 
This data confirms that the ICy dyes could detect changes in the abundance for these 
proteins, whilst the identification o f unique gene products by each method shows the 
usefulness o f applying both labelling strategies in better defining the proteomic changes 
associated with peroxide stress and ErbB-2 overexpression. Despite this, it is still 
difficult to discern the relative contributions o f  changes in protein abundance versus 
changes in thiol reactivity using the ICy dye labelling method alone and therefore, other
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strategies are needed to discriminate between the two. Toward this end, ID and 2D 
immunoblotting were applied. In most cases, changes in abundance were not detected, 
indicating the labelling changes were due to thiol modifications that block (e.g. formation 
o f sulphinic acid or disulphide bonds) or enhance labelling (formation o f free thiols or 
breakage o f  disulphide bonds). On the other hand, the proteins with changes both in 
abundance and in labelling mean that their gene expression are regulated by H2O2 or 
ErbB-2 overexpression.
O f the protein isoforms identified by both labelling methods, peroxiredoxins 1, 2 and 6 
were identified as doublet spots with differing p/s by lysine labelling. Notably, the more 
basic spots in these doublets were all shown to be down-regulated after peroxide 
treatment, whilst the more acidic spots were up-regulated. A similar observation has 
been reported (W agner et al., 2002;Rabilloud et al., 2002b) and was found to be due to 
oxidation o f  the active site cysteine thiols o f these proteins. Such shifts provide an 
explanation for the observed differential labelling by the ICy dyes. Figure 7-2 explains a 
possible model for pi shift-induced differential labelling. Briefly, hydrogen peroxide 
oxidises a specific free thiol cysteine o f a multi-cysteine protein and induces the acidic- 
shift o f the protein. When ICy labelling is performed, the remaining free thiols o f the pi 
shifted protein and the original protein are both labelled resulting in the increased 
detection o f  the shifted isoform and decreased detection o f the original isoform due to 
changes in abundance. This model is made more valid by the fact that Prxns 1, 2, and 6 
also possess free thiols in addition to the reactive site thiol, which is the presumed target 
o f  FhC^-dependent oxidation. Elongation factor 2 and enolase alpha also existed as 
multiple isoforms, where the more acidic isoforms were up-regulated by peroxide 
treatment, suggesting that they may also be oxidised and shifted in pi. These 
modifications may affect protein activity and warrant further investigation. It should be 
noted, however, that the dyes may also shift labelled proteins to more basic isoforms, 
thus, complicating the pattern o f detected isoforms, although such dye-induced shifts 
were not formally proven.
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(Figure 7-2) A possible model for p /s h if t  induced differential ICy dye labelling.
The data from 2D-DIGE protein expression profiling o f the model human luminal 
epithelial cell system presented here was compared to other published proteomic studies 
o f breast and other cancers and some correlations in the datasets were observed. Several 
o f the identified proteins have been shown to be differentially regulated in various human 
cancers and could therefore play important roles in the processes associated with human 
luminal epithelial cell transformation. For example, Hsp27 showed a significant increase 
in abundance in the C3.6 cells compared to the HB4a cells. This chaperone protein has 
been implicated in various cellular processes including stress response and apoptosis and 
has been reported to be overexpressed in various human cancers (Sarto et al., 2000a) 
including breast ductal carcinoma (Wulfkuhle et al., 2002). L-plastin is a member o f the 
plastin family o f actin-bundling proteins. Although it was thought to be specific to 
heamopoietic cell lineages, it has been found overexpressed in malignant human solid 
tumours (Lin et al., 1993;Park et al., 1994). L-plastin is known to regulate cell adhesion 
and motility (Otsuka et al., 2001) and its deregulated expression has been correlated with 
cancer invasion and metastasis (Zheng et al., 1999). Indeed, cancer cells transfected with 
an antisense L-plastin gene were shown to display suppression o f in vivo tumour invasion 
in nude mice. Since L-plastin upregulation was observed in the C3.6 cells, it may thus
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contribute to ErbB-2-dependent tumour invasion. Cytokeratinl7 which is overexpressed 
in squamous cell carcinomas has been shown to be a highly sensitive and specific 
immunohistochemical marker for premalignant and malignant transformation in the 
larynx (Cohen-Kerem et al., 2004). The observation o f increased cytokeratin 17 in the 
ErbB-2 overexpressing cells again supports the notion that it may be involved in ErbB-2- 
dependent malignancy. Thus, the current study using 2D-DIGE can be used for the 
identification o f important putative protein targets that have potential regulatory roles in 
ErbB-2-dependent cell transformation. The proteomic approach undertaken here has 
provided crucial preliminary information regarding the effects o f ErbB-2 overexpression 
in a cellular model, giving rise to many interesting hypotheses which should be followed 
up on and which could provide new insights into the molecular mechanisms associated 
with cancer progression.
Although ICy3/5 labelling could be used to specifically and sensitively detect free thiol 
groups in proteins and investigate redox regulations in cells, it appeared that some low- 
abundance, differentially expressed/labelled proteins were not amenable to mass 
spectrometric identification due to insufficient material. Thus, in the future, enrichment 
strategies should be employed to try and identify these proteins. This could include the 
uses o f  zoom gels or sub-cellular fractionation to increase the loading and analysis o f 
proteome subsets. However, proteins could also be labelled with affinity-tagged cysteine 
dyes, to enable enrichment o f only labelled protein prior to 2DE. Our laboratory has 
recently synthesised such dyes containing a biotin group on the opposite arm to the 
iodoacetamide group and they should allow for recovery o f  purified labelled protein 
using immobilised streptavidin with improved recovery through the use o f  a cleavable 
linker (Figure 7-3). Conditions are currently being optimised in our laboratory for the use 
o f these reagents for 2D-DIGE and subsequent protein identification by mass 
spectrometry.
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N HHydrophilic spacer
(Figure 7-3) The structure of an affinity-tagged cleavable cysteine label (!BCCy3).
In general, the 2D-DIGE analysis in this thesis represents a new technique to help 
understand ErbB-2 dependent cellular transformation and how ErbB-2 affects redox 
responses. However, further work beyond the scope o f this study should be carried out to 
characterise how the identified changes affect cell behaviour, cellular signalling or cell 
morphology. For example, one question would be whether oxidation o f RanGTPase 
affects nucleo-cytoplasmic transport. This could be achieved by proteins known to be 
transported by Ran using immunofluorescence. Others experiments would use RNAi- 
mediated knockdown to alter the expression o f  specific proteins o f  interest (Cullen, 
2002;Famulok and Verma, 2002). This strategy could be applied to this model cell 
system to examine the effects o f particular proteins on cell proliferation and survival in 
the absence or prescence o f oxidative stress. As an inverse strategy, overexpression o f 
the proteins o f interest (such as peroxiredoxin 6) could also be tested for effects on cell 
proliferation and survival, following exposure to oxidative stress.
One o f  the important issues in redox studies is to look for the breakage or formation o f 
disulphide bonds. Whilst the ICy dye strategy used here must be detecting such events,
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an alternative reverse labelling strategy could be applied to more directly assess 
disulphide formation/breakage. Basically, protein samples from ROS treated cells would 
be harvested under anaerobic conditions in lysis buffer containing an alkylating agent 
such as iodoacetic acid (IAA). Those cellular proteins that had not encountered ROS in 
the cell will become irreversibly alkylated on their free thiol groups by IAA. In contrast, 
any protein in which free thiol cysteines have been oxidised in response to the ROS 
stimulation will be resistant to alkylation. Following reduction with DTT, all o f  the 
reversible ROS-modified proteins will now possess free thiols for labelling. This 
technique has been used to study the reversible oxidation and inactivation o f proteins 
including protein tyrosine phosphatases (Meng et al., 2002;Baty et al., 2002). An 
advantage o f this methodology is that it was suitable for conducting in-gel protein 
activity assays to test the effect o f oxidation o f  PTP activity. Thus, the ICy dyes could be 
used for this reverse labelling strategy in the future.
The usefulness o f  the ICy dye labelling strategy was further tested by applying it to 
examine EGF-induced changes in thiol labelling. Native and denatured protein labelling 
were both performed to study potential EGF-induced thiol accessibility and reactivity 
changes o f proteins. There were few significant changes observed in these experiments, 
suggesting that alterations in the accessibility o f  cysteinyl thiols and the redox 
modification o f protein thiols do occur, however, the dissociation/association o f  protein 
complexes or the redox regulation o f  cellular cysteines is not the dominant mechanism o f  
regulation following EGF treatment. Instead, EGF stimulation predominately induces 
downstream signalling or regulates cell functions by mechanisms such as 
phosphorylation o f mediators through kinase action. Nevertheless, the importance o f the 
EGF signalling related dissociation/association o f protein complexes and redox 
regulation cannot be neglected. Notably, Prxn-6 was identified as being differentially 
labelled under both native condition and denaturing condition suggesting that the changes 
in thiol reactivity o f the Prxn-6 are caused by covalent modification (redox reaction) 
rather than by cysteine accessibility. Furthermore, this redox modification o f  Prxn-6 
could be that EGF stimulates the generation o f low concentrations o f intracellular H2O2 
which oxidises the active site cysteine o f  Prxn-6 in cells (see Chapter 5).
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In a different application, ICy 2D-DIGE was used to investigate UV-C induced changes 
in thiol reactivity in human plasma fractions. Although UV-C irradiation did not induce 
significant effects on the blood clotting functions o f  the fractions (data from Baxter 
Healthcare), it did indeed induce thiol reactivity changes in the purified plasma proteins 
in this study. The possible mechanisms for these could involve UV induced breakage o f 
disulphide bonds or direct modification o f  free thiols by UV-C induced ROS. Future 
studies would aim to identify the nature o f  these modifications, try to assess how they 
affect protein function and find out why those identified proteins are more easily 
modified by UV-C than the other proteins. More important than evaluation o f loss o f  bio­
reactivity or change o f the structure o f  these proteins is the question o f whether the 
potential toxicity o f  these modified proteins presents a danger to patients.
In summary, cysteine-labelling 2D-DIGE using the ICy dyes has been optimised and 
evaluated for differential proteomics in this thesis. Using MS, their application has been 
shown in the identification o f targets o f  cellular oxidative stress (Chapter 4), to study 
growth factor-induced thiol reactivity (Chapter 5) and to determine UV-C-induced thiol 
reactivity changes (Chapter 6). In future, cysteine-labelling 2D-DIGE could be applied to 
study other systems and diseases where oxidative stress is thought to play a role. For 
example, this system could be applied to study ischemic reperfusion-injury in cardiac 
cells (Ambrosio et al., 1992;Molyneux et al., 2002;Leducq et al., 2003) or to study 
protein targets o f  radiation (x-ray/y-ray)-induced intracellular oxidative stress that cause 
DNA damage and apoptosis (Nakano and Shinohara, 1994;Risom et al., 2003). In 
conclusion, the cysteine-labelling 2D-DIGE provides an MS-compatible and reproducible 
technique for identifying significant differences in the expression and redox modification 
o f  free thiol-containing proteins in multiple biological samples. This was achieved by 
labelling cysteine thiol groups with a matched pair o f fluorescent alkylating agents.
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Appendix A—Synthesis of Cy dyes
The following describes the synthese o f NHS-Cy3/5 & ICy3/5 dyes which was carried 
out by Dr. Piers Gaffney (Imperial College London).
NHS ester-derivatives o f the fluorescent cyanine dyes Cy3 and Cy5 (NHS-Cy3 and NHS- 
Cy5) for lysine labelling were synthesized in-house following a modified version o f the 
published protocol (Unlu et al., 1997a), and are structurally identical to the commercially 
available NHS-Cy dyes. Briefly, Cy carboxylic acids were prepared from the reactions o f  
1 and 2 (Figure 1A), and these converted to the corresponding NHS-Cy reagents. To 
optimise yields and ensure compound purity, each o f the reported intermediates for NHS- 
Cy preparation was purified before commencing the next step, instead o f  carrying 
through crude material. However, in our hands, the published preparation o f lb  gave poor 
and variable yields; an alternative preparation, that has worked reliably for several 
phenylimido indoline Cy3 and Cy5 precursors, is described for la . Also, in our hands, the 
published preparation o f 2  gave material significantly contaminated with l-[6 - 
hexanoyl(6 -hexanoic acid)]-2-methylene-3,3-dimethyl indolinium bromide. We have 
overcome this by alkylating 2,3,3-trimethyl indolenine with a 6 -bromohexanoate silyl 
ester. The iodoacetyl versions of Cy3 and Cy5 (ICy3 and ICy5) were synthesised via the 
illustrated route starting with the reaction o f  1 and 3 (Fig. 1A) and their structures are 
shown in Fig. IB. All Cy dyes were made as stock solutions in anhydrous 99.8% N,N- 
dimethylformamide and stored at -20 °C.
All reverse phase (RP) chromatography used 100 ml silanised silica, Merck (cat. no. 
1.07719). Normal phase thin layer chromatography (TLC) was run on glass-backed silica 
gel 60 F254, Merck (cat. no. 1.05715) and RP thin layer chromatography (RPTLC) was 
run on glass-backed silica gel 60 F254S, Merck (cat. no. 1.15388).
2-[4-(Phenylimido)butenylidene]-l, 3 , 3-trimethyl indoline, la
2-M ethylene-1, 3, 3-trimethyl indoline (0.177 ml, 1.0 mmol) and malonaldehyde dianil 
hydrochloride (0.354 g, 1. 5 mmol) were dissolved in DMF (1 ml) and to this was added 
TFA (0.084 ml, 1.1 mmol). The mixture was heated at 90 °C for 4.5 h then cooled to RT. 
The reaction was diluted with water (50 ml, plus a little dil. HC1) and applied directly to
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a RP column. The column was first eluted with a gradient o f MeCN - H2O, containing 
1% sat. NaHCC>3, then MeOH; the product, contaminated with dianil, eluted at the end o f 
the gradient. The appropriate fractions were combined and the organic solvents 
evaporated under reduced pressure. The aqueous residue was acidified and re­
chromatographed on a RP column eluted with a gradient o f MeCN - H 2O, containing 
0.5% 4M HC1; the product eluted at 35 - 50% MeCN. The appropriate fractions were 
combined, neutralised with NaHCC>3 and the organic solvents evaporated under reduced 
pressure. Brine was added to the resultant aqueous solution and the product extracted 
into CHCI3 (4 x 30 ml). The combined organic layers were dried (Na2S 0 4) and 
evaporated to dryness to give the title compound as a deep orange/yellow gum (la , 0.185 
g, 61%). RPTLC, MeCN - H20  - AcOH (75 : 14. 9 : 0. 1) R{0. 27.
l-(6-Hexanoic acid)-2-m ethylene-3,3-dim ethyl indolinium bromide, 2
First 6 -bromo-/er/-butyl dimethylsilyl hexanoate was prepared: 6 -bromohexanoic acid (7. 
941 g, 40.7 mmol) was taken up in THF (100 ml) to which was added Et3N (6.81 ml, 1.2 
eq.). Dropwise addition o f tert-butyl dimethylsilyl chloride (6.136 g, 40.7 mmol) 
followed, with vigorous stirring, and the reaction continued for 1 h. The suspension was 
then filtered, rinsing the salts with dry ether, and the filtrate evaporated to dryness to give 
crude 6 -bromo-/er/-butyl dimethylsilyl hexanoate (12.781 g) which was used without 
further purification. 2, 3, 3-Trimethyl indolenine (2. 258 g, 14. 2 mmol) was dissolved in 
6 -bromo-ter/-butyl dimethylsilyl hexanoate (6.574 g, 21.3 mmol, 1.5 eq.) and the mixture 
stirred at 100 °C overnight. The next day the reaction was allowed to cool when lightly 
coloured crystals formed in the dark red gummy mother liquor. The mixture was 
mobilised by the addition o f a little DCM (ca. 5 ml) then diluted by the gradual addition 
o f EtOAc (100 ml) with constant swirling. The solids were filtered off, rinsing with more 
EtOAc, to give the title compound as a pale pink powder (2, 0.777 g). The filtrate was 
evaporated to dryness and taken up in MeOH (20 ml) to which was added TFA (0.163 
ml, ca. 0.1 per silyl ester). A fter 1 h the solvent was stripped off and the EtOAc 
precipitation repeated to give a second crop o f the title compound (2, 0.755 g, total ca. 
30%).
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l-(6-A zidohexyl)-2-m ethylene-3,3-dim ethyl indoline, 3
2, 3, 3-Trimethyl indoleneine (3.20 ml, 20 mmol) was dissolved in 1, 2-dichlorobenzene 
(40 ml) and to this was added 1, 6 -dibromohexane (9.24 ml, 60 mmol). The stirred 
reaction was heated at 110 °C overnight and the next day the solvent was stripped off in 
vacuo (oil pump, oil bath 60 °C) to leave a dark lilac oil. This residue was dissolved in 
CHCI3 (100 ml), washed with dilute hydrobromic acid (20 ml 48% HBr + 180 ml water) 
and the aqueous layer was extracted with further CHCI3 (2 x 50 ml). The combined 
organic layers were dried (M gS04) and evaporated to dryness leaving a dark oil (8.00 g). 
To the residue were added DCM (100 ml) then silanised silica (100 ml) and the solvent 
stripped off in vacuo. The silica was placed in a large sinter funnel and washed with H2O 
- MeCN - AcOH (500 ml, 74 : 25 : 1 v/v/v). The filtrate was concentrated on a rotary 
evaporator, basified with Na2CC>3 (aq.), then saturated with NaCl. This was extracted 
into CHCI3 (4 x 50 ml), dried (M gS04) and the solvent evaporated to give crude l-(6 - 
bromohexyl)-2-methylene-3, 3-dimethyl indoline (3.71 g) which was used without 
further purification.
The crude bromide was dissolved in DMF. To this solution was added N aN 3 (2.28 g, 3 
eq.) and the reaction was stirred vigorously for 2 days at RT. The solution was then 
diluted with water (200 ml), buffered with a little NaHCC>3 (aq.), then saturated with 
NaCl. The turbid solution was extracted with EtOAc (200 ml) and the organic layer was 
washed with NaHC0 3  (aq.) then brine. The aqueous layers were combined and extracted 
with further EtOAc (100 ml). This organic layer was also washed with NaHC 0 3  (aq.) 
then brine. The combined organic layers were washed with water, containing a little 
NaHC0 3  (3 x 100 ml), and finally brine. This was dried (M gS04) and the solvent 
evaporated to give the crude title compound (3, 3.272 g, ca. 57%). The neat oil 
decomposes significantly overnight, even at -20 °C.; it may be stored for months in the 
fridge in acidified chloroform (3 g in 50 ml CHC13 plus 2 ml AcOH).
Ar-(6 -Azidohexyl)-A’-m ethyl Cy5 chloride, 4a, and  A -(6 -azidohexyl)-A^-propyl Cy3 
chloride, 4b
l-(6-Azidohexyl)-2-methylene-3, 3-dimethyl indoline (3, 0.376 g, 1.32 mmol) and 2-[4- 
(phenylimido)butenylidene]-l, 3, 3-trimethyl indoline ( la , 0.401 g, 1.33 mmol) were
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dissolved in acetic anhydride (2.5 ml). After stirring for 30 min the solvent was 
evaporated under high vacuum and the residue applied to a RP column. This was eluted 
with a gradient o f  MeCN - H20 , containing 1% AcOH; the product eluted in 60 - 70% 
MeCN. The appropriate fractions were combined and the solvent evaporated at reduced 
pressure. The residue was taken up in CHCI3 and washed with a mixture o f brine and 
NaHC0 3  (aq.). The aqueous layers were washed with further CHCI3 (3 or 4 times), until 
the colour was almost completely extracted, the combined organic layers were dried 
(Na2S 0 4) and evaporated to dryness to give N-(6-azidohexyl)-N'-methyl Cy5 chloride (4a, 
0.538 g, 77%). TLC, pre-dip plate, MeOH - CHC13 - AcOH (10 : 89.9 : 0.1) Rf 0.37; 
RPTLC, MeCN - H20  - AcOH (80 : 19.9 : 0.1) Rf 0. 27. Similarly, l-(6-azidohexyl)-2- 
methylene-3, 3-dimethyl indoline (3, 0.381 g, 1.34 mmol) and 2-[2-
(phenylimido)ethylidene]-l-propyl-3, 3-dimethyl indoline (lb , 0.418 g, 1.37 mmol) were 
reacted in actetic anhydride (2.5 ml). After RP chromatography and extraction, this gave 
A-(6 -azidohexyl)-A’-propyl Cy3 chloride (4b, 0.533 g, 73%). TLC, pre-dip plate, MeOH 
- CHCI3 - AcOH (10 : 89.9 : 0.1) Rf 0. 15; RPTLC, MeCN - H20  - AcOH (70 : 29. 9 : 
0.1) R{ 0.15.
A-(6-Aminohexyl)-AT-methyl Cy5 iodide, 5a, and 7V-(6-aminohexyl)-A’-propyl Cy3 
iodide, 5b
jV-(6-Azidohexyl)-7V,-methyl Cy5 chloride (4a, 0.264 g, 0.50 mmol) was dissolved in 
THF (4 ml). To this solution was added triphenyl phosphine (0.199 g, 0.76 mmol) then 
water (1 ml) and the reaction was stirred overnight in the dark. The following day the 
solvent was stripped off and the residue was applied to a RP column. This was eluted 
with a gradient o f MeCN - H20 , containing 1% AcOH; the product eluted in 30 - 50% 
MeCN. The appropriate fractions were combined and the solvent evaporated at reduced 
pressure. The residue was taken up in CHC13 and washed with a mixture o f KI (50% aq.) 
and a little NaHC0 3 . The aqueous layers were washed with further CHCI3 (2 or 3 times), 
until the colour was almost completely extracted, the combined organic layers were dried 
(Na2S 0 4) and evaporated to dryness to give N-(6-aminohexyl)-N'-methyl Cy5 iodide (5a, 
0.214 g, 72%). TLC, pre-dip plate, MeOH - CHC13 - AcOH (10 : 89. 9 : 0.1) R{ 0.07. 
Similarly, A-^-azidohexyO-A^-propyl Cy3 chloride (4b, 0.261 g, 0.49 mmol) was reacted
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with triphenyl phosphine (0.196 g, 0.75 mmol) in THF (4 ml) and water (1 ml). A fter RP 
chromatography and extraction, this gave N-(6-aminohexyl)-N'-propyl Cy3 iodide (5b, 
0.291 g, 99%). TLC, pre-dip plate, MeOH - CHC13 - AcOH (10 : 89.9 : 0.1) Rf base-line.
-/V-(6-Iodoacetamidohexyl)-AP-methyl Cy5 iodide, 6a, and /V-(6-iodoacetamidohexyl)- 
/V-propyl Cy3 iodide, 6b
A-(6-Aminohexyl)-7V’-methyl Cy5 iodide (5a, 0.150 g, 0.25 mmol) was evaporated from 
dry MeCN ( 3 x 2  ml), the residue was taken up in DCM (0.75 ml) and to this was added 
iodoacetic anhydride (0.099 g, 0.31 mmol, 1.2 eq.). The reaction was stirred for 2 h then 
the solvent was evaporated. The residue was taken up in CHCI3 and washed with KI 
(50% aq.), containing a little N aH C 03, dried (Na2 S 0 4) and evaporated to dryness. This 
material (0.210 g) was triturated with EtOAc and evaporated to dryness to give the crude 
product (0.188 g). This material is contaminated with iodoacetic acid/anhydride: crude 
product (0.072 g) was applied to a RP column which was eluted with a gradient o f MeCN 
- H20 , containing 0.5% KI (50% aq.) and 10 drops/100ml dil. H2SO4 (20% aq.); the 
product eluted in 65 - 70% MeCN. The appropriate fractions were combined and the 
MeCN evaporated under reduced pressure. The aqueous solution was extracted with 
CHC13 (4 x 20 ml), the combined extracts dried (Na2 S0 4 ) and evaporated to dryness to 
give pure N-(6-iodoacetamidohexyl)-N'-methyl Cy5 iodide (6a, 0.052 g). TLC, pre-dip 
plate, MeOH - CHC13 - AcOH (10 : 89. 9 : 0.1) 0.23. Similarly, A/-(6 -Aminohexyl)-/V'- 
propyl Cy3 iodide (5b, 0.163 g, 0.27 mmol) was reacted with iodoacetic anhydride (0.110 
g, 0.31 mmol, 1.2 eq. ) in DCM (0.5 ml). Initial work-up gave the crude product (0.211 
g). After RP chromatography (0.056g) o f  this material gave the pure N-(6- 
iodoacetamidohexyl)-N-propyl Cy3 iodide (6b, 0.046 g). TLC, pre-dip plate, MeOH - 
CHC13 - AcOH (10 : 89.9 : 0.1) 0.15.
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(Appendix A) Synthesis and structure of the iodoacetyl cyanine dyes. (A) Scheme for 
synthesis of ICy3 and ICy5. (B) ICy5 and ICy3 (compounds 6 a and 6 b respectively from the 
synthetic scheme) showing chemical formulas, molecular weights and the excitation/emission 
wavelengths used for detection.
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Appendix B~Quantitative determination of free thiol 
content in standard proteins and in total cell lysates
Free thiol groups can be determined with Ellman’s reagent (Zahler and Cleland, 1968). 
Aliphatic sulphydryls can cleave the disulphide-bridge o f DTNB (5, 5’-dithiobis (2- 
nitrobenzoic acid)). The resulting TNB2' (2-nitro-5-thiobenzoate) anion has a bright
  9
yellow colour, whilst DTNB has a faint yellowish colour. Thus, TNB ' has a distinct 
spectrometric property for detection. The advantages o f this reagent are that it is water- 
soluble, it may be used at neutral pH with few side reactions and its reaction with thiols is 
fast. The reagent has been used not only in the study o f thiol chemistry, but also for the 
analysis o f  biological samples and in enzymology for many years (Brocklehurst et al., 
1972;Gergel' and Cederbaum, 1997;Riener et al., 2002). According to the examination o f 
ICy cysteine-labelling o f standard proteins presented in Figure 3-4 o f this thesis, the 
fluorescence intensities o f  the ICy-labelled standards did not correlate with the number o f 
free thiols on the proteins, even though they were present at equimolar amounts. 
Therefore, Ellm an’s tests were performed to determine the free thiol number in each 
standard protein. The results showed that 0.61, 1.67 and 0.53 mol/mol o f free thiols were 
present in BSA (1 free thiol), Ova (4 free thiols) and a-C rys (1 free thiol), respectively 
Figure Appendix B l). This suggests that these standard proteins were all partially 
oxidised before performing the labelling test. However, these values alone cannot explain 
the variable fluorescence intensities between these labelled standards. Thus, it would 
appear that labelling does not depend upon thiol content alone, but also on the reactivity 
and/or accessibility o f specific thiol groups.
In sections (3.2.4) and (4.2), Ellman’s reactions were also applied for determining the 
average free thiol number per protein molecule from human luminal epithelial cells. For 
this, 200 pg o f cell lysate was diluted to 900 pi with sodium phosphate buffer and an 
absorbance (412nm) o f 0.4 units was obtained for the HB4a lysate using the Ellman’s 
reagent (Figure Appendix B2). It is important to note that the absorbance was linear over 
a whole range o f  different lysate amounts. According to the equation ([SH] = [A412 
(sample)-A412 (reference)] / 13650), 27 nmols o f thiol groups were present in this 
sample. The average molecular weight o f a human protein, was then calculated to be 48
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kDa, by averaging the predicted molecular weights o f  all known human sequences in the 
SwissProt/ TrEM BL & NCBI databases accessed using the international protein index 
(IPI) (calculated by Richard Jacob, LICR, UCL). Thus, 200 pg o f  cell lysate is 
approximately equal to 4.2 nmol o f protein molecules and so there were 6.4 moles free 
thiol/ mol o f protein.
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(Figure Appendix B l) Quantitative determination of free thiol content in standard proteins 
(BSA, OVA and a-Crys). 100 pi o f  standard proteins (BSA, OVA and a-Crys) were prepared at 
the indicated molar amounts and diluted with 100 pi o f  0.01 M DTNB (Ellman’s reagent) and 
2800 pi o f  0.1 M sodium phosphate buffer (pH 8.0). The mixture was incubated in the dark for 15 
min and then the absorbance measured at 412 nm in a 1 cm cuvette. A reference solution was 
prepared containing 100 pi o f  0.01 M DTNB and 2900 pi o f  0.1 M sodium phosphate buffer (pH 
8.0) and the absorbance measured. The concentration o f  sulphydryl groups was calculated using 
the following equation; [SH] = [A412 (sample)-A412 (reference)] / 13650.
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(Figure Appendix B2) Quantitative determination of free thiols (Ellman test). (A) HB4a and 
C3.6 cell lysates were freshly prepared in ICy lysis buffer and the protein concentration 
determined. The indicated amounts o f  total protein in 100 pi were then diluted with 2900 pi o f  
0.1 M sodium phosphate buffer (pH 8.0) containing DTNB (Ellman’s reagent) at a final 
concentration o f  0. 33 mM. Samples were mixed well, and incubated in the dark at room 
temperature prior to measurement o f  the absorbance at 412 nm.
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SIS ISB 1 I M . 7B 11 1 7 . SB 1 * 9 9 .1 * B .B * 1 B *■1**1 — 1 1 ■ 1 C « ; N t l M  |B>
1 **  - BBS 1 44B 74 1**9  11 1 4 * 9 .7 * - a  a * B B SNIBSrBlVBNCTV I
* « t BN* ISSN.BN ftftJ I .ft l l B S f . f l -B .B S B ft M i r s t A N B i t m i i . v
M S * 74 i m , n U N  *7 11NB.N1 -B .B 1 B B r m a n r v  *
ITS - H I I 9 M .N I I f  11 BB I t l l . B I • *  BB B ft BBM1 6T7B4 T6IPBBFB N
» t t IS * 1 * 1 * 4 * U SB .B N U SB .N B N .B f 1 B MBIT 1 rM*9NB . L
SB* - SB* i n  »4 B S B .tS BSB.7B -B .B S B B B W B  B
1 HXL3LVAAFIL LLL3AARAEE EDKKEDVGTV VG IDLGTTY3 CVGVTKNGPV
5 1 EIIAM OQOIIR ITPSY V A FTP EG FRLIG PA A KNGLTSMPEN TV FDAKFLIG
1 0 1 RTVMDPSVQQ D IK F L P F K W EKKTKPYIQV DIGGGQTKTF A PEEISA K V L
1 5 1 TKMKE TAEAY L GKKVTHAW TVPAYFNDAQ PQATKDAGTI AGLHVKRI  IN
2 0 1 EPTAAAIAYG LDKFEGEKNI LVFDLGGGTF DV3LLTID NG VFEW ATNGD
2 5 1 THLGGEDFDQ PV HEHFIKLY KKKTCKDVPK DNRAVQKLPR EVEKAKRALS
3 0 1 SQ H Q A R IEIE SFY EGEDFSE TLYRAKFEEL MHDLFRSTHK PVQKVLEDSD
3 5 1 L K K SD ID EIV LV G G STRIPK I0Q LV K EFFN G K EPSR C IN P DEAVAYGAJLV
4 0 1 QAGVLSGDOD TGDLVLLDVC PLT LG IETV G GVHTKLIPRN T W P T K K S Q I
4 5 1 ESTASOUQPT VT1KVYEGER PLTKDMKLLG T FD L T G IPP A PR G V PQ IEV T
5 0 1 F E l& V N G IL R VTAEWCGTGN K M K iu m 'D g M RLT PEE IER KVNI'AEKFAE
5 5 1 ED KKLKIRlt* TRNELESYAY KLGGKLSSED KETMEXAVEE
6 0 1 KIEWLESHQD AD1EDFKAKK K IL E E IV Q P I ISKLYCSAGP PPTGEEDTAE
6 5 1 KI*EL
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Spot 1123 Chaperonin containing TCP1-a
•000
•000
4000
2000
S t * r t - E n d O b s e r v e d M r ( e x p t ) M r ( c a l c ) D e l t a M i s s S e q u e n c e
64 - 73 1 1 0 6 .6 5 1 1 0 5 .6 5 1 1 0 3 .6 1 0 .0 3 0 K .LLE V E K PA A K .V
•  5 - 102 1 0 1 4 .9 4 1 8 1 3 .9 3 1 8 1 4 .0 0 - 0 . 0 7 0 K . E V G D G T T SW IIA A E L L K  . M
112 - 122 1 2 2 9 .7 0 1 2 2 8 .6 9 1 2 2 8 .6 6 0 .0 3 0 K .IH P T S V IS G Y R .L
131 - 1 43 1 7 6 2 .9 3 1 7 6 1 .9 4 1 7 6 1 .8 9 0 .0 3 0 R . Y IH U fL  1VH TO IL UK . D
190 - 199 1 1 4 6 .6 4 1 1 4 3 .6 3 1 1 4 5 .6 4 - 0 .0 1 0 R .YPVM SVM ILK.A
234 - 2 43 1 1 9 4 .6 5 1 1 9 3 .6 4 1 1 9 3 .6 1 0 .0 3 0 K . IACLDFSLQK. T
248 - 264 1 9 2 3 .0 0 1 9 2 1 .9 9 1 9 2 2 .0 8 - 0 . 0 9 1 K . LG V Q W I TDPEKLOg 1 R . f
444 - 4 66 2 3 5 3 .2 2 2 3 5 2 .2 2 2 3 5 2 .2 9 - 0 .0 7 0 R . SLLVIPMTLAVMAAQDSTDLVAK. L
469 - 480 1 4 1 1 .7 4 1 4 1 0 .7 3 1 4 1 0 .6 6 0 .0 7 0 R.AFHNEAQVVPER.K
469 - 481 1 5 3 9 .8 4 1 3 3 8 .8 3 1 3 3 8 .7 6 0 .0 8 1 R . AFHHEAQVlfPERK . H
500 - 510 1 1 8 8 .6 3 1 1 8 7 .6 4 1 1 8 7 .6 5 - 0 .0 1 0 K .Q A C V FE P TIV K .V
516 - 526 1 2 0 5 .7 3 1 2 0 4 .7 3 1 2 0 4 .6 8 0 .0 4 0 K .F A T E A A IT IL R . I
1 HEGPLSVrGD RSTGETIRSQ NVIUAA5IAN IVKSSLGPVG LDKHLVDD1G
31 DVTITNDGAT ILKLLEVEHP AAKVLCELAP LQDKEVGDGT T SW IIA A E L
101 LKNAEELVKQ KIHPTSVISG YRLACKEAVF YI1IEH1.IW T DELGRDCLIN
1 51 AAKTSHSSKI IGtNGDFFAN KWDAVLAIK YTDIRGQPRY PVMSVM1LKA
2 01 HGR3QHESHL ISGYALNCW G3QGHPKRIV NAKLACLDFS l q k t k h k l g v
2 31 gW ITDPEK L D Q IR0PE3DI TKEPIQKILA TGANVILTTG GIDDHCLKYF
301 VEACAHAVRR VLKRDLKRIA KASGATILST LANLEGEETr EAAHLGQAEE
331 WQERICDDE LILIKNTKAR T3A 3IILR G A NDFHCDENEP 3LHPALCWK
4 01 RVLESKSWP GGGAVEAAL3 IYLENYATSH GSREQLAIAE FARSLLVIPM
4 5 1 TLAVHAAQDS TDLVAKLRAP HMEAQVHPlk KNLKUIGLDL SNGKPRONKQ
301 AGVFEPTIVK VKSLKFATEA A IT ILR ID D L IKLHPESKDD KHGSYEDAVH
3 31 3GALNP
P r o b a b i l i t y  H o u s e  S c o r e
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Probability Based House Score
Spot 1242 Chaperonin containing TCP1-p
W 7 274
3 0 5 2  M g
U « r l U 4 99am ft*4 ** 1 1 N 1 U H iaa Ic f t tm c a
13 - » 1 9 1 7 .4 ) 1914.42 1914.44 0 .4 4 0 0LTS*I(*UUG44.VK.S
71 • M 1744.44 1747.44 1747.41 0 42 I K 0 1WD4PAAJCVT VMS,9 9
40 • 111 7244.14 7247.14 7247.11 0 .4 0 4 •  V9O4CV«0«T YYVTVUUUU10. K
111 1 u 1114.74 1110.71 l l l i . 0 1 •4 .4 7 1 It KIMPQTUJMMR t
1*4 • I N 1241.77 1240.72 1240 72 0 .4 0 0 K 1K7Q T I LA4V9 K
m • K4t 1741 . r r 1744.44 1700 41 0 .4 4 1 o m o u o u i r n m . t
i n 144 •  74 .44 M l .  14 0 4 9 .1J 0 .4 4 0 k uwumtva . l
141 - 241 1211.74 1214.70 1210 . 70 -0 . #0 0 K OSCOLEAIMIIK.K
994 - 111 2041 IT 7044.44 7040 01 0 .4 7 1 it i M f u » m p u r u » «  i
994 141 11J4 .1 1 1124.14 1124.11 *4.44 • R . t t i o c r i f l t . l
m 441 2047.14 2 0 4 4 .1 ) 2044.12 0 .4 1 0 ft LOLVYCttflAirrMPELVK.L
m - 111 1414.14 1411.44 1411.07 0 .4 2 0 II I  14SW A I Q€ACT m o . 4
m - 441 1114.41 1111.44 1111.09 -4 .4 7 0 0 . 11 MBJU CVI.AQTW . 0
J H 441 1912.44 1411.44 1911.40 0 .4 0 1 ft UJ»Ol.CVLA0YVK»&ft. V
« i« - 441 2 )4 7 .2 4 2 )4 4 .1 9 2 )4 4 .1 9 0 40 0 0 NL7TIIAMU6T7SA4LVA0UI A
144 - 441 7747.11 7 7 4 7 1 4 7749.14 *4 .40 0 0 in  9 1 T lAMMCTOtAftl VAQi R A Ow»4*tlo« (7)
144 m 444 1144.47 1141.04 1 )4 1 .4 0 *4 .42 • It 404*144 TTOI.I W  1 O alcJotiatt t l j
141 • l i t 2 0 4 4 .4 ) 2 0 4 0 .4 ) 2040 02 0.41 0 0 Cbt 1G4MOUGI TEST9VK K
141 111 1147.44 1141.47 1141.91 0 4 7 4 0 fOlMAAUUUVILO V
1 ASLSLAPVNI FKAGADEERA ETARLTSFIG A1AIGDLVKS TLGPKGHDKI
51 LLSSGRDASL KVTNDGATIL KNIGVDNPAA KVLVDMSRVQ DDEVGDGTTS
101 VTVLAAELLR EAESLIAKKI HPQTIIAGWR EATKAAREAL LSSAVDHGSD
151 EVKFRQDLMH IAGTTLSSKL LTHHKDHFTK LAVEAVLRLK GSGNLEAIHI
2 01 IKKLCGSLAD SYLDEGFLLD KKIGVNQPKR IENAKILIAN TGHDTDKIKI
251 FGSRVRVDST AKVAEIEHAE KEKHKEKVER ILKHGINCFI HRQLIYNYPE
301 QLTGAAGVMA IEHADFAGVE RLALVTGGEI ASTFDMPELV KLGSCKLIEE
351 VHIGEDKLIH FSGVALGEAC TIVLRGATOQ ILDEAERSLH d a l c v l a q t v
401 KDSRTVYGGG CSEMLMAHAV TQLANRTPGK EAVAHESYAK ALPIG.PTI LA
4 51 DNAGYDSAJDL VAQLRAAHSE GNTTAGLDMR EGTIGDMAIL GITESFQVKR
501 QVLLSAAEAA EVILRVDNII KAAPRKRVPD HHPC
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2  0 9 7  18 1
1200
Spot 1206 Chaperonin containing TCP1-(3
S t a r t - Emi I k » r « t 4 N » < » x p t) Mi ( f a l e ) f t a l t a M laa StftM KC*
11 24 1 7 7 5 .5 5 1 7 7 4 .5 4 1 2 7 4 .3 9 ' f t . 0 3 1 K .M * ) E E 3 U T U  I
» - 3ft 1 5 1 7 .9 4 1 3 1 4 .9 4 1 3 1 4 .0 9 •  . • 3 0 f t . LTS7IQ4IAIGftLVK. S
97 - 71 154ft.7 ft 1 5 4 7 .7 5 1 3 4 7 .7 9 -ft .ftS 0 ft . ftftSLMVTMDOAT ILK . ft
57 - 71 1 5 * 4 .7ft 1 5 4 3 .7 5 1 3 ft) .7 ft - • . f t ) 0 ll.ftftSLMVTMD4ATlLK.ft O x id a t io n  (Hi
• 9 - l i f t 77ftft.71 2 7 4 7 .2ft * * • 7 .1 3 •  . • 4 0 ft VftftftrVbDOTT SVTVLftftELLJt. C
17* - 1 M 1 7 9 1 .7 ft 179ft ■ 7ft 1 7 9 0 .7 7 •  . • 4 0 K ■ IftftftT I lftUftlt. 1!
151 - lftft • 7 f t . 57 • 4 9 .5 4 • 4 9 .5 3 f t . 03 0 K.LAVlAVUk.L
t o * • 707 1 4 4 7 .»4 1 4 9 1 .* 3 1491 as - f t . f t ) 1 ft. LKOSCMLEAtMIIK. ft
t i l 707 1 9 5 1 .7 5 1 7 5 f t .74 1 7 3 0 .7 0 •  - • 4 0 K .C Sem X ftlM lIK .K
M l • 7 7 1 1 9 1 7 . ftft 1 9 1 1 .«9 1 9 1 1 .9 3 -ft.ftft 0 f t . LSeSLftDSTLDEGTLLftft. ft
> •4 - 777 2 9 4 1 .0 7 7 0 4 4 .0 7 2 0 4 0 .0 4 ■ •ft) 1 r  . u M u m u a n u B . i
7 ft) - * 7 3 12ft7 .4 4 1Z 41 .C 3 l f f t l . f t f t - • ■ • 3 1 K . VAE lCMftEXCK. H
177 - 541 * • 9 7 .1 0 2 0 9 4 .1 7 2 0 9 4 .1 2 •  . • 4 0 II. LftLVTftfteiASTTftKPELVK. L
57ft - 5ft7 1 5 5 f t .4 9 1 5 7 9 .4 ft 1 ) 7 9 .4 5 f t .f t ) 0 ft GATftftlLDCACft S
M l - 401 1 5 5 4 ,* 4 1 5 5 1 , ft) 1 5 5 3 . ft* ft .ft l 0 ft SLMftftl CVLAftTVR ft
444 » 445 7 3 4 7 .7 4 7 3 4 4 .7 4 7 3 4 4 .1 9 •  .f t ) 0 ft MLftTI lADMACYD&AftLVAfttJl .A
444 44 5 7 3 4 3 .7 4 7 3 4 7 .2 4 2 3 4 7 . 1ft ■ -■7 0 ft .MLFTI IAOMftCYDSAftLVAftLJI .*  O x id a t io n  (II)
4ftft - 4*0 1 3 3 ft .4 5 1 3 2 9 .4 4 1 3 2 9 .6 9 f t .f t ) 0 ft . A&MSEbNI TA.G1.DK* . E
4ft 1 - 4*ft 2 0 0 9 .1 0 7 0 0 0 .0 9 2 0 0 0 .0 2 •  . • 7 0 f t . E S T ISm ftlL C IT E SrfV ft. ft
4ftl - 499 2 f t2 5 .0 ) 7 0 7 4 .0 4 2 0 7 4 .0 1 •  . f t ) 0 ft ESTlG SH ftlLClTEsrW K .K  O x id a t io n  IB)
1 A SL SL A PV N I FKAGADEERA E T A R L T S r iG A1A 1G D LV K S TLGPKGHDKI
51 LLSSGRDASL KVTMDGATIL KNIGVDNPAA KVLVDHSRVQ DDEVGDGTTS
101 VTVLAAELLR E A E SL IA K K I K PQ TIIAG VR EATKAAREAL LSSAVDHGSD
151 EVKFRQDLHN IAG TTLSSK L LTHHKDHFTK LAVEAVLRLK G SG NLEA IH I
201 IKKLGGSLAD SYLDEGFLLD KKIGVNQPKR IE N A K IL IA N TGHDTDKIKI
251 FGSRVRVDST AKVAEIEHAE KEKHKEKVER IL K H G IN C F I NRQLIYNYPE
301 QLFGAAGVHA IEHADFAGVE RLALVTGGEI ASTFDH PELV KLGSCKLIEE
351 VH IG EDK LIH F3GVALGEAC TIVLRGATQQ ILD EA ER SLH DALCVLAQTV
401 KDSRTVTGGG CSEHLHAHAV TQLANRTPGK EAVAHESYAK A LRM LPT1IA
451 DNAGYDSADL VAQLRAAHSE GKTTAGLDMR EGTIGDM AIL GITESFQVKR
501 QVLLSAAEAA E V IL R V D N II KAAPRKRVPD HHPC
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Spot 1110 Chaperonin containing TCP1-y
0 5  355
P ro b a b ility  fcned Nowie Score
2283 104
2050 990
2496.299
800 1000 1300
i r 
1400 1600 1600 2000 2200 240
l u r l  - tMi 9w»tT»4 Nri»k»«) Mr IrAle) 9*11 a Niaa t  >6»wr»
n  - n 1139.34 1119.33 1119.41 -9.99 1 K.KtfgxsaiNMM.T
U  - 11 1129.39 1119.39 1119.49 -9 .1 1 9 U - K 1 UVgWAAK . 1
M - u 1931.91 1931.94 1932.01 -9.94 1 U.ligvgMrjuuuMllil*.T O m i a a i i e n  ill
»  • u 933. M •14.13 914.41 -9.99 9 K-9UE1S9.T
i m  i n 1109.39 1193.39 1193.3? 9.91 9 K i u m n s n . i l
129 - 119 1134.9? 1213.4? 1211.44 9.99 1 K ALDMUSTLKX .I
1M  - m 1347.73 1349.71 1344.79 •9.94 9 ft-VSSL4CiriALMVK.il
391 - 11C 1429.92 1477 91 1427.74 4.97 9 K.IPeSItEDSCVLft.4
3M  -  249 1179.99 1279 49 1279.71 -4.41 9 a r v L L ftssm x  k
IN  - 199 3923.92 7924 92 2974.91 -9.11 1 k (.rsijTBir rm rrD rrs , i
2*3 - 199 1403.71 1492 71 1497 79 9.47 9 K 9IS9UMJNTLMB A
199 - 199 1419.79 1419.79 1419.79 -9.99 4 K I.ISOIAgKYIKR A OKIdac ion  it)
131 -  131 7494.30 7493.79 2493.11 -9.41 1 n rvxayrrmr®PVUTGAM.;.*IK.r
139 - 379 1949.93 1949.94 1947.99 9.13 1 K. 1 M>CY77r 1T9CMDVK. A
429 - 439 1337.40 1339.39 1334.49 -4.41 4 K AMTOVlUKTYJt.A
429 - 439 1133.39 1132.39 1132.42 -4.94 4 K.MmAKtgvrix-A Cm m»t ion (I)
439 449 1199.71 1143.71 1143.49 9.91 4 ft.AVA94LEVlMl.f
430 491 1111.41 1111.41 1112.49 -9.94 4 ft. ILI«MCSASTIft.L
491 - 391 1234.4? 1231.44 1231.79 -4.94 4 KEL0XVE7LAVKL
399 - 319 1193.44 1194.41 1194.71 -9.99 4 K TAVETAVU-Lft.l
1 HHGHRPVLVL SQNTKRESGR KVQSCNIHAA K T IA D IIR T C LGPKSHHKHL
9 1 LDPHCGIVHT NDG NAILREI gVQNPAAKSN IEISR T Q D E E V G D G TTSV II
1 0 1 LAGEHLSVAE HrLEOQHHPT WISAYPKAJL DDM1STLKKI S IP V D IS D S D
1 9 1 H H L N IIN S S I TTKAISRW SS LACHIALDAV KHVQFEENGR KEIDIKKYAR
2 0 1 V E K IP G G IIE DSCVLRGVHI NKDVTHPRHR RYIK NPRIVL LDSSLEYKKG
2 9 1 ESQTDXEITR EEDFTRILQH EEEYIQQLCE D IIQ L K P D W XTEKGISDLA
3 0 1 QHYLMRANIT AIRRVRKTDN NRIARACGAR IVSRPEELRE DDVGTGAGLL
3 9 1 EIK K IG DEYF TFITDCKDPK ACTILLRGA3 K EILSEVERN LQDAMQVCRW
4 0 1 VtLDPQLVPG GGASEHAVAH ALTERS KAMT GVEQWPYRAV AQALEVIPRT
4 9 1 LIQMCGASTI RLLTSLRAKH TQENCETGGV NGETGTLVDM KELGIWEPLA
5 0 1 VKLQTTKTAV ETAVLLLRID DIVSGHKKEG DDQSRQGGAP DAGQE
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Spot 1144 Chaperonin containing TCP1-C,
I M 6 .2 S 3
91 7 306
1 116 Kf.4
Probability  Based dowse Score
. i "  k; <•
i m  s i
I 191 654 . 4:.* -i9
1 34 8 741
221 1 .105
176 2 063
2 564 106
240 8  170
S(4lt ti.o ■4*«tl«4 Mils**!) Met C*l£) 0*11 a Mias itflttS L t
14 - M 1*94.47 1994.41 1234 . 70 4.14 * R. A9AALAVMlVAAft.fi
rt - n 409.43 7*9.42 799.44 -0.03 0 r  w g rv to .7
4 4 - 9 4 1344.74 1347.73 1347.74 -0.01 1 K HLVSGAGDIKLTK. ft O x id a tio n  (I)
74 - 14* 2344.43 2943.43 2343.33 4.09 0 K VJlTA0OOITGDCTISllVl.IIGEi.LK. 0
124 134 1474.44 1079.43 1473.39 4.04 • R.ALOrUECVR.V
1M - 174 7794.24 72*3.27 77*9.73 0.03 * I  m U lJ W lT U W li I U » .K
174 - 1*9 1119.24 7149.19 2149.92 4.17 1 k KgprpiptrMir twoBt it
244 - 249 1191.49 11*4.43 1190.94 0.09 • K.TEVMSOPra.S
244 294 1743.4* 1742.44 1742.42 4.07 1 K.TEV iscrm sieEi.E
771 - *M 743.47 747.44 742.90 *0.03 1 K.KI IKLK.it
*7* - 2*3 1444.97 1444.91 1444.92 4.09 1 k . vrooioKcrwiogK .«
244 -  293 *04.31 9*3.91 993.92 •0.01 • r  c rw  IWQK r,
2*4 - 349 1742.79 1241.74 1241.44 0 09 • K .« n m L M L » .i
30* 312 797.42 794.42 794.49 -4.03 * K.ECrVALR.K
317 - 321 799.14 7*4.79 7*4.34 -4.09 1 R.MKR.L
317 - 321 721.27 774.74 770.33 -4.07 1 R. RIMER. L O x id a t io n  ( I )
334 - 343 744.34 793. 33 743.42 -0.04 0 K.rTrm.c
344 344 444.4* 439.44 439.49 -4.01 * K.HTLTQIK.D
3*1 - 3*7 794.42 737.41 797.44 o u t 1 R.4U.RAVK.H
431 - 447 1749.13 1747.12 1747.93 4.09 0 R . Agi wgATAOAl-t 112* -V
444 - 443 1742.04 1741.44 1740 93 4. 12 0 K. VLAMSGTOi ge T1VK. 1
1
SI
101
151
201
251
301
351
401
451
501
AVKTLNPKAE
DIKLTKDCNV
LKQADLYISE
RTSLRTKVHA
DTSLIRGLVL
AEEREKLVKA
DALSKEGTVA
YTLGEEKFTF
DDGCWPGAG
QNSGFDLQET
QLLHSCTVIA
VARAQAALAV 
LLHEHQIQHP 
GLHPRIITEG 
ELADVLTEAV 
DHGARHPDMK 
EPKFIEPPVK 
LRRAKRRHME 
IEKCNNPRSV 
AVEVAKAEAL 
LVKIQAEHSE 
TNILLVDEIH
NISAARGLQD 
TASLIAKVAT 
FEAAKEKALQ 
VDS1LAIKKQ 
KRVEDACILT 
KIIELKRKVC 
RLTLACGGVA 
TLLIKGPNKH 
IKHKPSVKGR 
SGQLVGVDLN 
RAGHSSLKG
VLRTNLGPKG
AQDDITGDGT
FLEEVKVSFE
DEPIDLFMIE
CNVSLEYEKT
GDSDKGFWI
LNSFDDLSPD
TLTQIKDAVR
AQLGVQAFAD
TGEPHVAAEV
THKHLVSGAG 
TSNVLIIGEL 
BDFETLIDVA 
IMEMKHKSET 
EVMSGFFYKS 
HQKGIDPFSL 
CLGHAGLVYE 
DGLRAVKNAI 
ALLIIPKVLA 
GVVDNYCVKK
226
lite
rs 
(a 
u )
Spot 1143 Cytokeratin 10
6000
m -
4000
JL .
2000
x ;
0
S ta r t r n a O b serve* H r< e x » t) M r<r a l e ) S a l t  a M ias Sequence
41 - 39 1 7 0 7 .6 4 1 70 6 .6 4 1 7 0 6 .7 6 0 .0 7 0 k . e s L o c e rs s tc rs s o s rs n . 6
60 - 86 2 3 4 2 .9 9 2 34 1 .9 6 2 3 4 1 .9 8 0 .0 1 0 R . £SSGC£CF££SSCG¥GCL&£F S M S n t . £
166 - 177 1 3 8 1 .6 9 1 3 8 0 .6 9 1 3 8 0 .6 4 0 .0 3 0 R.ALEESm rELECK. I
178 • 184 9 9 3 .3 9 9 9 4 . 38 9 9 4 .3 1 0 .0 7 1 K.IKEM YEK.H
706 • 226 2 3 6 7 .4 7 2 3 6 6 .4 6 2 3 6 6 .2 6 0 .2 1 0 K . MQU.MLTTDNAJIlU.QIDMAJt. L
236 - 24S 1 2 3 4 .6 8 1 23 3 .6 7 1 2 3 3 .6 7 - 0 .0 0 1 R . LKYEHEVAIR. Q
323 - 333 1 3 6 3 .7 3 1 3 6 4 .7 2 1 3 6 4 .6 3 0 .0 9 0 R . SQYEQUkEQWR . K
323 - 334 1 4 9 3 .7 3 1 49 2 .7 4 1 4 9 2 .7 3 0 .0 2 1 R . 3QYKQLAEQKHK.0
371 - 366 1 7 9 7 .0 0 1 7 9 6 .0 0 1 7 9 6 .0 0 -0 .0 1 0 R . MVQALEJELQSQLALK. Q
387 - 399 1 3 9 0 .7 8 1 38 9 .7 7 1 3 6 9 .6 7 0 .1 0 0 K . QSLEASLAETEGA. ¥
423 - 439 2 0 8 2 .9 4 2 0 8 1 .9 3 2 0 8 1 .9 6 - 0 .0 3 0 r .a e t e c q m t e y q q l l d ik . i
440 - 430 1 4 3 4 .7 3 1 4 3 3 .7 2 1 4 3 3 .7 6 - 0 .0 4 1 K .IRLEM E1Q TTR.S
443 430 1 16 3 .6 1 1 16 4 .6 0 1 1 6 4 .3 8 0 .0 2 0 R.UEM EIQTYR.S
1 HSVRYSSSKH YSSSRSGGGG GGGGCGGGGG VSSLRISSSK GSLGGGFSSG
31 GFSGGSFSRG SSGGGCFGGS SGGYGGLGGF GGGSFRGSYG S33FGGSYGG
101 SFGGGSFGGG SFGGGSFGGG GFGGGGFGGG FGGGFGGDGG LLSGNEKVTH
151 QNLNDRLASY LDKVPALEES HYELEGKIKE WYEKHGNSHQ GEPRDYSKYY
201 KTIDDLKMQI LNLTTDNANI LLQIDHARLA ADDFRLKYEM EVALRQSVEA
231 DINGLRRVLD ELTLTKADLE HQIESLTEEL AYLKKNHEEE MKDLRNV3TG
301 DVNVEHNAAP GVDLTQLLNN HRSQYEQLAE QHRKDAEAWF NEKSKELTTE
351 IDNNIEQISS YKSEITELRR NVQALEIELQ SQLALKQSLE ASLAETEGRY
401 CVQLSQIQAQ ISALEEQLQQ IRAETECQNT EYQQLLDIKI RLENEIQ1YR
431 SLLEGEGSSG GGGRGGGSFG GGYGGGS3GG GSSGGGYGGG HGG3SGGGYG
301 GG3SGGGSSG GGYGGGSSSG GHGG33SGGY GGGSSGGGGG GYGGGSSGGG
331 333GGGYGGG SSSGGHKSSS SGSVGESSSK GPRY
Probability Based Dowse Score
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Spot 2276  Glutathione S-transferase
Probability Based House Score
697304
J L
1 0 4 5 3 6 0
s t a r t Ind O k i t r r t * Nrieiqpt» M r< c a lc ) O a lta M is * StfMDCf
J» - 43 1733 .70 1732 .70 173 7 .0 3 -0 .0 7 0 K . rrWTVETWQKCSl.K A
44 - 53 1130.61 1133.01 1 13 3 .3 7 0 .0 4 0 k .a s c ivcgi f k . f
54 - 6 * 1003.90 1002.97 1007 .94 0 .0 3 0 K.rQDODI TI YQSRTILR.M
74 - 80 7 31 .47 7 30 .42 7 3 0 .4 3 -0 .0 1 0 K.TLOLYCK.O
•  1 - 2117 .01 211 6 .0 0 7 1 1 3 .9 7 0 .0 3 0 K . DOQEAALVeMVroCVEOLR. c
•1  - 99 213 2 .9 8 2131 .97 2 1 3 1 .9 7 -0 .0 0 0 It. DQQEAALVBMVM9CVEPLR . C Oxidation (Hi
102 - 114 1334 .77 1533 .76 1 53 3 .7 7 -0 .0 1 0 R.YI SL IYTWYEAG1C. P
102 - 119 2 135 .07 2 13 4 .0 0 2 1 5 4 .0 3 0 .0 1 1 K.YISLIYTMYEAGKDDYVX.A
120 - 139 2 12 0 .2 3 2 12 3 .2 3 2 1 2 3 .1 5 0 .0 9 0 K.ALPGQLKPFETLL SQHQGGK. T
100 - 207 1 903 .99 1902 .90 190 2 .9 0 -0.00 0 K AfLASPEYVMLPIH&M&K,0
1 PYTWYFPVR GRCAALPMLL ADQGOSWKEE WTVETVQEG SLKASCLYGQ
51 LPKFQDGDLT LYQSNT1LRH LGRTLGLYGK DQQEAALVDH VNDGVEDLRC
1 01  KYISLIYTNY EAGKDOYVKA LPGQLKPFET LLSQHQGGKT FIVGDQISFA
1 51  DYNLLDLLLI HEVLAPGCLD AFPLLSAYVG RLSARPKLKA FLASPEYVNL
2 01  PINGNGKQ
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Spot 2253 Glutathione S-transferase
637 2  U
Probability Based rtOMse Score
919 4 33  1057.4 73
|9 IS  .477
7 »
. . . .
MOO O  90 IS 00 17 90 20 00 22 50 25 00 27 50
m t
S t a r t - End O b served M r »' e x p t  ) M r ( c a l c ) D e l t a HISS Sequence
1 - 11 1 3 3 7 .7 8 1 3 3 6 .7 8 1 3 3 6 .7 2 0 .0 6 0 - . P PY T W Y F P V U . C
S3 - 70 1 8 8 3 .9 9 1 8 8 2 .9 8 1 8 8 2 .9 4 0 .0 4 0 K . rQ D G D LTL Y Q SH T IL A .lt
73 - 100 2 8 4 9 .2 1 2 8 4 8 .2 1 2 8 4 8 .3 9 - 0 . 1 8 1 R . TLGL YGKDQQEAALVDMVWDGVEDLR . C
82 - 100 2 1 1 7 .0 7 2 1 1 6 .0 6 2 1 1 3 .9 7 0 .0 9 0 K . DQQEAA1VDMVHDGVEDLR. C
101 - 113 1 7 6 3 .7 8 1 7 6 4 .7 8 1 7 6 4 .8 8 - 0 .1 0 1 M .CKY1SL1YTMYEAUK.D
103 * 120 2 1 3 3 .0 2 2 1 3 4 .0 1 2 1 5 4 .0 3 - 0 .0 4 1 K . Y1SLIYTKYEAGKDDYVK.A
121 - 140 2 1 2 6 .1 6 2 1 2 3 .1 3 2 1 2 3 .1 3 - 0 . 0 0 0 K.ALPGQLKPFETLLSQHQGGK. T
191 - 208 1 9 0 4 .0 1 1 9 0 3 .0 1 1 9 0 2 .9 8 0 .0 2 0 K.ATLASPEYVXLPIHGM GK. Q
191 - 2 09 2 0 3 2 .1 2 2 0 3 1 .1 1 2 0 3 1 .0 4 0 .0 7 1 K.ATLASPEYVHLPIHGH&KQ. -
1 PPYTWYFPV RGRCAALFUL LADQGOSRKE EWTVETVQE GSLKASCLYG
51 QLPKFQDGDL TLYQSHTILR HLGRTLGLYG KDQQEAALVD MVNDGVEDLR
101 CKYISLIYTH YEAGKDDYVK ALPGQLKPFE TLLSQNQGGK m v G D Q is r
151 ADYNLLDLLL IHEVLAPGCL DAFPLLSAYV GRLSARPKLK AFLASPEYVM
201 LPINGNGKQ
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Spot 2049 Glyceraldehyde-3-phosphate DH
615 319
'2 .'
Hi e
P robability  Based House Score
*00 *00 1000
-------- 1---------r—
1200 1400 IS M 1*00 2000 e a se
S t a r t -  End O b served M r( r x j i t  ) M r ( c a lc ) D e l t a M is s Sequence
6 -  13 0 0 5 .6 2 0 0 6 .4 2 8 0 6 .6 2 - 0 .0 1 0 K.VGVMGPGR.I
21 -  27 6 9 6 .3 0 6 9 3 .2 9 6 9 3 .3 4 - 0 .0 3 0 R .AAIM SGK.V
36 -  61 6 8 8 .3 2 6 8 7 .3 1 6 8 7 .3 7 - 0 .0 6 0 K . PHGTVK.A
6? -  80 1 6 1 3 .9 1 1 6 1 2 .9 0 1 6 1 2 .8 9 0 .0 1 0 K . LV ING tfP I T1FQER . D
6? -  06 2 0 6 1 .1 1 2 0 6 0 .1 0 2 0 4 0 .1 0 - 0 .0 0 1 K . LV IM G K PITirQ ERD PSK . I
106 -  117 9 0 9 .6 6 9 0 0 .4 3 9 0 8 .4 8 - 0 .0 5 0 K . AGAMLQGOAK.lt
1 60 -  165 7 3 9 .3 2 7 3 0 .3 2 7 3 8 .3 5 - 0 .0 4 0 K .X D M S L K .I
166 -  162 1 0 3 3 .8 5 1 8 3 2 .8 6 1 8 3 2 .9 1 - 0 . 0 7 0 K.IISM ASCTTM CLAPLAK.V
201 -  215 1 6 1 1 .7 6 1 4 1 0 .7 4 1 4 1 0 .7 0 - 0 . 0 5 0 R . GALQNIIPASTGAAK.A
220 -  227 • 6 9 .6 6 8 6 8 .4 5 8 6 8 .5 0 - 0 .0 5 0 K .VIPELM G K .L
220 -  236 0 1 1 .3 0 8 1 0 .3 0 0 1 0 .4 1 - 0 .0 3 0 K.LTGNAPR.V O x id a t io n  (H)
2 3 3 -  268 1 3 3 0 .9 2 1 3 2 9 .9 2 1 3 2 9 .7 9 0 .1 3 0 R . VPTAHVSWDLTCR. L
2 33 -  260 7 8 1 .3 3 7 8 0 .3 6 7 8 0 .4 0 - 0 .0 6 1 K .T D D IK K .V
266 -  271 • 2 9 .6 0 8 2 8 .3 9 8 2 8 .4 3 - 0 .0 4 0 K.QASEGPLK.G
310 - 323 1 7 6 3 .7 9 1 7 6 2 .7 0 1 7 6 2 .8 0 - 0 .0 2 0 K.L1SVYDMEFGYSMR.V
1 MGKVKVGVNG 
51 STHGKFHGTV 
101  VFTTMEKAGA 
151  SCTTHCLAPL 
201  GALQNIIPAS 
251  KPAKYDDIKK 
301  IALNDHFVKL
FGRIGRLVTR
KAENGKLVIH
HLQGGAKRVI
AKVIHDNFGI
TGAAKAVGKV
w k q a s e g p l
ISWYDHEFGY
AAFHSGKVDI 
GHPITIFQER 
ISAPSADAPH 
VEGLMTTVHA 
IPELHGKLTG 
KGILGYTEHQ 
SHRWDLHAH
VAINDPFIDL
DPSKIKUGDA
FVMGVNHEKY
ITATQKTVDG
MAFRVPTAHV
WSSDFNSDT
MASKE
NYMVYMF QYD 
GAEYWESTG 
DNSLKIISNA 
PSGKLURDGR 
SWDLTCRLE 
HSSTFDAGAG
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Spot 1088 HSP-73
Probability Based ttowse Score
91 7 299
1 0 7  746
6 9 7 .2 1 7
I2 7 S S 9 8
16946^
1361 7 9 6
H> 57.001
1592999
2284  1 82
1 8 7 1 9 3 7
2 4 3 3 2 7 1
790
i i i . i i  
1000
1 ' 1 T" T" 
1250
i i , -  i i ■ t t i t i 1 -  | r i--- 1— ■— t - t
2000 2 290 2500 2 750
m t
S t a r t  - End O b se r v e d N r< * x » t> M r ( c « l c ) » « l t « H i s s S f « W M r
37  - 42 1 4 0 7 .7 4 1 4 0 6 .7 4 1 4 0 6 .6 9 0 . 0 4 0 R . TTPSYVAFTOTER. L
57  - 71 1 6 6 3 .7 6 1 6 6 4 .7 3 1 6 6 4 .7 0 - 0 . 0 3 0 K.M(JV6JUr TOTVFBAX.lt O x id a t io n  (8 )
1 1 3  - 1 2 6 1 6 3 2 .0 2 1 6 3 1 .0 2 1 6 3 1 .7 0 0 . 0 4 0 K SFYPEFVSSHVLTK.M O x id a t io n  I I )
1 2 7  - 1 3 7 1 2 6 0 .6 0 1 2 6 7 .6 7 1 2 6 7 .6 3 0 . 0 2 1 X.MKZIAEAY1.GK.T O x id a t io n  (X)
1 3 6  > 1 5 5 I N I . 01 1 9 0 1 .0 0 1 9 0 0 .9 9 0 .0 1 0 K . IVTMfcWIYPAXFMDSOR 0
1 6 6  - 171 1 1 2 2 .7 3 1 1 9 0 .7 2 1 1 9 0 .6 7 0 . 0 5 0 K.DACTIACJMVIII.I
1 7 2  - 1 6 7 1 6 3 9 .0 3 1 6 3 0 .9 2 1 6 3 0 .0 9 0 . 0 4 0 R. IIHEPTAAAIAYliLDK.K
1 7 2  - 16 6 1 7 0 0 .0 0 1 7 0 7 .0 0 1 7 0 6 .9 0 0 .0 1 1 R . IIREPTAAAIAYCLOKX. V
2 2 1  - 3 7 6 1 6 9 1 .7 4 1 6 9 0 .7 4 1 6 9 0 .7 7 0 . 0 7 0 K . STAGDTM.BGCDrOMR -M
2 3 7  - 2 4 6 1 2 3 1 .6 6 1 2 3 0 .6 5 1 2 3 0 .6 1 0 .0 4 0 R .HVMKt lA l^ K  .K O x id a t io n  (HI
2 5 2  - 2 3 7 7 0 5 .1 3 7 0 4 .3 4 7 0 4 .3 3 0 .0 1 0 R.DISEM K.R
2 6 3  - 271 0 3 3 .3 9 0 3 4 .3 0 0 3 4 .4 0 • 0 . 0 2 1 R.TACCRAK.R
3414 - 3 1 1 1 4 0 0 .7 9 1 4 7 9 .7 0 1 4 7 9 .7 5 0 . 0 4 1 R.ARFEFXNAOLTR.G
3 0 2  - 3 1 1 1 2 3 3 .6 7 1 2 5 2 .6 7 1 2 5 2 .6 1 0 . 0 6 0 R .FFEIMADI l t r . g
3 2 6  - 342 1 0 3 0 .0 6 1 0 3 7 .0 3 1 0 3 7 .0 1 0 . 0 4 1 K . U>KS01M >tVl.V665TR. X
3 4 6  - 3 5 7 1 4 5 0 .7 7 1 4 4 9 .7 6 1 4 4 9 .0 0 - 0 . 0 3 1 K.IQKLLQMTIIGK.E
3 4 2  - 3 3 7 1 0 0 1 .3 3 1 0 0 0 .3 3 1 0 0 0 .3 6 - 0 . 0 2 0 k . u  g o m r c H .E
3 6 2  - 364 2 2 6 0 .1 9 2 2 3 9 .1 0 2 2 5 9 .1 4 0 . 0 4 0 K . S IMP&EAVAXG6AVQAAU.SOMC. S
4 2 4  - 4 4 7 2 7 7 4 .3 6 2 7 7 3 .5 5 2 7 7 3 .3 2 0 . 2 3 0 K QrQTFTTYSDHQPGVLIQVYEGER.A
4 2 4  - 300 7 6 3 . 32 7 6 2 .3 1 7 6 2 .3 9 - 0 . 0 7 1 K .S T G K E R K .I
5 4 2  - 550 1 3 1 9 .6 0 1 3 1 0 .5 9 1 3 1 0 .3 9 0 . 0 0 0 K.NSLESYAFXHK.A O x i d a t i o n  (X)
1 RSKGPAVOID LGTTY3CVGV F O H G K V Z IIA  HDOCNRTTPS YVAFTDTERL
5 1  IGDAAKHQVA MMPTHTVFDA KPL IG P P F D D  AW QSDHKHR P FK W N PA G R
1 0 1  PKVQVEYKGE TK STY PEEV S S M V IT K M K F I  AEAYL6KTVT M AW TV PAZF
1 5 1  MDSQROATKD AGTIAGLMVX R I I  Mi: PT  AAA LAY6J_J>KXVG A Z R N V L IFbL
2 0 1  G G G TFD V 3IL T Z Z P G IF E V K  STAGDTHL&G EDFDKRHVHH F LAEFKPKHK
2 5 1  KDISEMXRAV PRLRTACERA K R TLSS ST Q A  3 IE ID 3 L Y E G  ID F Y T 3 IT R A
1 0 1  RFEELMAD1.F R C TtD PV EK A  LRPAKLDKSQ IK D IV tV U U S  T R 1PK IQ K L L
3 5 1  QDFFMGKZLN K SIN PDEA VA YGAAVQAAIL SGDKSZNVQt* LLL LD V TPL3
4 0 1  LCIZTAGGVH T V L IK F N T T I PTK QTQTTTT YSDHOPGVLI QVYXGERAHT
4 5 1  KDNNLLGKFE L T G IP P A P R G  V P Q 1E V T F D I DANCILNV3A VDKSTUKEHX
5 0 1  ITIT N D K G R L SK ZD IERH V G  EAEKYKAZDE KQFDKV33KM SLESYATMCK
5 5 1  ATVZbEKLQG K IK IE D K C 'K I LDKCNZIIM W  LDKNQTAZKZ ZFZHQQKZLE
6 0 1  K V C N P IIT K L  TQ8AGGHPGG HPGGFPGGGA P PSG G A 3SG P T IE E V b
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Spot 2482 Peptidyl-prolyl cis-trans isom erase A
100
—
1 I I *---1--- 1---*---1--- 1--- *---1--- »--- 1--- 1---»--- 1---1--- •--- »---*---1---*--- »--- 1--- «--- 1--- *---•--- *---«---1---«--- 1---1--1— "I----1----1----1--1—
730 1 000 1 230 1 500 1 730 2 000 2 230 2 500 2 730
ma
S ta r t - f  r.d Otoaerved H r< e x » t > H r < c a lc ) 9 « l t a Mill Sequence
1 - 1# 1 946 .06 1 9 4 3 .0 3 1 9 4 4 .9 9 0 .0 6 0 - .  VHPWFF9IAVDGEPLGR. V
19 - 30 1 379 .11 1 3 7 0 .8 0 1 3 7 0 .7 3 0 .0 5 1 R.VSFELFAJHCVFK.T
31 - 30 7 37 .34 7 36 .33 7 3 6 .3 3 •0 .9 7 0 K .TA IH T8.A
49 - 34 7 6 3 .3 3 762 . 32 7 6 2 .3 2 - 0 .0 0 0 K.CSCFHR.I
S3 - 68 1614 .83 161 3 .8 1 1 6 1 3 .7 3 0 .0 0 0 R . 1IPGFMCQGGDFTR. H O x id a tio n  (■)
76 - 90 1031 .96 103 0 .9 3 1 0 3 0 .9 0 0 .0 5 1 K.SlYliUdtLDEMFILK.M
■3 - *0 1134.61 1 133 .60 1 13 3 .3 7 0 .0 4 0 K .F rD K K rilX .H
11# « 130 1513 .84 1 3 1 4 .8 3 1 3 1 4 .7 9 0 .0 4 1 K . TEVLDGKMWFCK. V
131 - 143 1305 .79 1 3 0 4 .7 9 1 3 0 4 .7 4 0 .0 3 1 K.VKE GUT WEAKER. F
131 - 143 1391 .76 132 0 .7 3 13 2 0 .7 3 0 .0 7 1 K.VKEtM llVEAHER.r O x id a tio n  (B)
131 - 143 1517.74 1 33 6 .7 3 1 33 6 .7 3 0 .0 0 1 k .vice oral w e a k e r  . F 2 O x id a tio n  (It)
133 * 143 1270 .64 1 2 7 7 .6 3 1 2 7 7 .5 7 0 .0 5 0 K.EGMH WEAKER. F
133 - 143 1294 .38 1 2 9 3 .3 7 1 2 9 3 .5 7 0 .0 0 0 K.EGKMWEAKER.r O x id a tio n  (B)
133 - 143 1310 .34 1309 .34 1 3 0 9 .3 6 - 0 .8 3 0 K.EGKN WEAKER, r  2 O x id a t io n  (B)
134 164 1247 .64 124 6 .6 3 1 2 4 6 .6 2 0 .0 1 1 K . KITIADCGQIE ■
1 VHPTVFFDIA VDGEPLGRVS FELFADKVPK TAENFRALST GEKGFGYKGS
31 CFHRIIPGFM CQGGDFTRKN GTGGKSIYGE KFEDEHFILK HTGPGILSHA
101 NAGPNTNGSQ FFICTAKTEW LDGKHWFGK VKEGMNIVEA MERFGSRNGK
151 TSKKITIADC GQLE
763 .3 2 7
1379.306
3 4 7 4 3 1
6 9 6 3 2 1
Pr a b i l i t y  Eased
150&794
U S 4 6 1 1  1294 3 7 79 0 7 4 8 0
1 041 5 8 3
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Spot 1536 Peroxiredoxin 1
3000
2000
1 000
0
S t a r t _ End O b se rv ed M r ( e x » t ) M r ( c a l e ) D e l t a M ic e S equence
8 - 16 9 8 0 .6 0 9 7 9 .5 9 9 7 9 .5 2 0 .0 6 0 K. IGKPAPHFK .A
1 21 . 128 8 9 4 .4 7 8 9 3 .4 7 8 9 3 .4 2 0 .0 4 0 K .A D E G IS F R .6
129 - 136 9 2 0 .4 8 9 1 9 .4 7 9 1 9 .3 0 - 0 . 0 3 0 H . G L F 1 ID D K .6
1 29 - 140 1 3 3 9 .9 2 1 3 5 8 .9 2 1 3 5 8 .7 9 0 .1 3 1 R . G L F IID D K G IL R . Q
1 32 - 138 8 1 9 .3 6 8 1 8 .3 3 8 1 8 .4 1 - 0 . 0 6 0 R .S V D E TLR .L
1 32 - 168 1 9 9 6 .9 9 1 9 9 3 .9 9 1 9 9 6 .0 3 - 0 . 0 4 1 R . SVDETLRLVQAFQFTDK. M
169 - 190 2 4 0 7 .3 8 2 4 0 6 .3 8 2 4 0 6 .1 6 0 .2 1 0 K . MGEVCPAGWKPCSDTIKPDVQK. S
1 MSSGNAKIGH PAPHFKATAV MPDGQFKDIS LSDYKGKYW FFFYPLDFTF
51 VCPTEIIAFS DRAEEFKKLN CQVIGASVDS HFCHLAUVNT PKKQGGLGPM
101 NIPLVSDPKR TIAQDYGVLK ADEGISFRGL FIID DK G ILR QITVNDLPVG
151 RSVDETLRLV QAFQFTDKHG EVCPAGWKPG SDTIKPDVQK SKEYFSKQK
1 196 7 5 2
30 60 70
P robability  8*sed tows* Scor*
6*9: ~
197.1 m •  IT *  I
ttoia m
1 420699 M - 171
2107.902
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Spot 1603 Peroxiredoxin 2
6 6 * 7  51
- s . :  v
Probability Based Nowse Score
J0 2 1 4 7 L  !2 1 L771
L j ,
730 1 000 1250 1500 1 730 2 000 2 250 2500 2 750
mfc
S t a r t tm End O b s e r v e d M r ( e x p t ) M r( c a l c ) D e l t a M i s s S e q u e n c e
1 - 7 7 0 6 . 3 0 7 0 5 . 2 9 7 0 9 . 3 2 - 0 . 0 3 0 - .N A S G U A R .I
8 - 1 6 9 7 2 . 6 4 9 7 1 . 6 3 9 7 1 . 9 4 0 . 0 9 0 R . IGKPAPDFK. A
1 7 - 26 9 7 8 . 9 9 9 7 7 . 3 4 9 7 7 . 5 2 0 . 0 2 0 K.ATAWDGAFK.E
1 7 - 29 1 3 3 4 . 7 9 1 3 3 3 . 7 4 1 3 3 3 . 7 2 0 . 0 1 1 K . ATAWDGAFKEVK. L
1 1 0 - 1 1 9 1 1 7 9 . 7 4 1 1 7 8 . 7 3 1 1 7 8 . 6 3 0 . 1 0 1 R . RLSEJDYGVLK. T
1 1 1 - 1 1 9 1 0 2 3 . 4 7 1 0 2 2 . 4 6 1 0 2 2 . 9 3 - 0 . 0 6 0 R.LSEDYGVLK.T
1 2 0 - 1 2 7 9 2 4 . 4 9 9 2 3 . 4 8 9 2 3 . 4 3 0 . 0 4 0 K . TDEGIAYR. G
1 2 8 - 1 3 9 8 6 2 . 4 2 8 6 1 . 4 1 8 6 1 . 9 0 - 0 . 0 8 0 R . GLFIIDGK.G
1 4 0 - 1 9 0 1 2 1 1 . 7 7 1 2 1 0 . 7 6 1 2 1 0 . 6 7 0 . 1 0 0 R.QITVMDLPVGR.S
— 3~hASGllARlCK P a P d E K A Y A V  V D T 33t f W W K L  ' S B Y K i S K T W E T F V P n i F T F V
51  C PTEIIA FSN  RAEDFRKLGC EVLGVSVDSQ FNHLAUINTP RKEGGLGPLN
1 0 1  IPLLGDVTRR LSEDYGVLKT DEGIAYRGLF IIDGKGVLRQ ITVWDLPVGR
1 51  SVDEALRLVQ AFQYTDEHGE VCPAGWKPGS DTIKPNVDDS KEYFSKHN
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Spot 2274 Peroxiredoxin 3
• 000
5000
4000
5000
2000
1 000
0
S t a r t - End O b s e r v e d M r ( e x p t > M r ( c a l r ) D e l t a M i s s S e q u e n c e
1 - 7 7 0 6 . 3 0 7 0 5 . 2 9 7 0 5 . 3 2 - 0 . 0 3 0 - .MASGNAR.I
8 - 1 6 9 7 2 . 6 4 9 7 1 . 6 3 9 7 1 . 5 4 0 . 0 9 0 R.IGKPAPDPK.A
17 - 26 9 7 8 . 5 5 9 7 7 . 5 4 9 7 7 . 5 2 0 . 0 2 0 K.ATAWDGAFK.E
17 - 2 9 1 3 3 4 . 7 5 1 3 3 3 . 7 4 1 3 3 3 . 7 2 0 . 0 1 1 K.ATAWDGA1KEVX.L
11 0 - 1 1 9 1 1 7 9 . 7 4 1 1 7 8 . 7 3 1 1 7 8 . 6 3 0 . 1 0 1 R . RL SEDYGVLK. T
11 1 - 1 1 9 1 0 2 3 . 4 7 1 0 2 2 . 4 6 1 0 2 2 . 5 3 - 0 . 0 6 0 R.LSEDYGVLK.T
12 0 - 1 2 7 9 2 4 . 4 9 9 2 3 . 4 0 9 2 3 . 4 3 0 . 0 4 0 K.TDEGIAYR.G
1 2 8 - 1 3 5 8 6 2 . 4 2 8 6 1 . 4 1 8 6 1 . 5 0 - 0 . 0 8 0 R.GLFIIDGK.C
14 0 - 15 0 1 2 1 1 . 7 7 1 2 1 0 . 7 6 1 2 1 0 . 6 7 0 . 1 0 0 R . QITVMDLPVGR. S
1 MASGKARIGK PAPDFKATAV VDGAFKEVKL SDYKGKYWL FFYPLDFTFV
51 CPTEIIAFSN RAEDFRKLGC EVLGVSVDSQ FNHLAVINTP RKEGGLGPLN
101 IPLLGDVTRR LSEDYGVLKT DEGIAYRGLF IIDGKGVLRQ ITVKDLPVGR
131 SVDEALRLVQ AFQYTDEHGE VCPAGVKPGS DTIKPNVDDS KEYFSKHN
120 14040 80
Probability Based House Score
100
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Spot 2510 Peroxiredoxin 5
§000
5 000
4 000
3000
2 000
1 000
0
m 2
S ta r t Cad Observed N r(e x » t> N r ( c a lc ) D a l ta H is s Sequence
1 -  15 1 5 5 7 .5 5 1 0 5 6 .5 4 1 0 5 6 .6 2 - 0 .0 8 1 -  HAAAVGRLLRA
74 -  53 1 5 7 1 .5 5 1 02 0 .3 7 1 02 8 .5 2 0 .0 3 0 X . GYAWMSX7K. 0
74 -  91 1 9 3 4 .7 5 1 93 3 .7 7 1 9 3 3 .9 7 - 0 .1 9 1 X . CTAWXCETKOL SL DDF X . 6
54 -  91 9 5 2 .4 9 9 3 1 .4 5 9 5 1 .4 3 0 .0 2 0 X . DL SLDDfK. G
54 -  93 1 1 3 7 .3 6 1 13 6 .3 6 1 1 3 6 .5 7 - 0 .8 1 1 x.DLsLoorxex.y
ISO -  144 1 73 3 .5 4 1 7 3 2 .5 3 1 7 5 2 .9 2 - 0 .0 9 0 K . H&GL&HHHXALLSDLTK. Q
ISO -  144 1 7 6 9 .9 3 176 5 .9 2 1 76 8 .9 1 0 .0 1 a X . N&GL&HNMLALL SOL TK. Q
171 - 154 1 4 6 7 .5 4 1 46 1 .8 3 1 46 1 .7 8 0 .5 3 0 X . DYGVLLE6S6UU.R • 6
1SS -  196 1 2 8 5 .7 9 1 28 4 .7 8 1 2 8 4 .7 4 0 .0 4 0 R & LF IID P H G V IK .H
157 -  257 1 2 0 4 .7 3 1 2 8 3 .7 2 1 2 0 3 .6 5 0 .0 7 0 K.MLSVMDLPV6K.S
705 -  214 •3 3 .4 3 8 3 2 .4 3 •3 2 .4 3 - 0 .0 0 0 R.SVEETLR.L
249 -  2S3 7 1 4 .3 2 7 1 3 .3 1 7 1 3 .3 4 - 0 .0 2 a K.EYFQK.V
1 MAAAV GRLLR ASVARHVSAI PUGISATAAL RPAACGRTSL TNLLCSGSSQ
51 AKLFSTSSSC HAPAVTQHAP YFKGTAWHG EFKDLSLDDF KGKYLVLFFY
101 PLDFTFVCPT EIVAFSDKAN EFHDVNCEW AVSVDSHFSH LAUINTPRKH
151 GGLGHMHIAL LSDLTKQISR DYGVLLEGSG LALRGLFIID PNGVIKHLSV
201 MDLFVGRSVE ETLRLVKAFQ YVETHGEVCP ANWTPDSPTI KPSPAASKEY
251 FQKVNQ
M I S  10
Probability Based tto*se Score
.4 : h r
mss
10 2 1 5 78
13421 fl 15 19 8471 137 5 6 4 1 7 5 4 8 5 6
19 54.782 21 3 9  8 ©
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Spot 2195 Peroxiredoxin 6
40 00
20 X
0
•  X  O X  1 0 X  12 X  1 4 X  1 * X  18 X  2 0 X  22 X  2 4 X  2 < X
mk
S t a r t  -  End O k s n v r d M r(cx » t> Hr ( c a l c > O e l t a U M S e q u e n c e
X -  11 2 0 9 8 .1 4 2 0 9 7 .1 4 2 8 9 7 .0 9 0 . 0 3 0 -  PSeCLLSBVAFlirtJUfTTVf*. X
41 -  » 1 3 0 9 .6 9 1 3 9 4 .6 0 1 3 9 4 .6 9 0 .0 3 0 R . Of TFVCTTELSWt. A
S )  -  62 1 0 4 9 .9 6 1 0 4 4 . 90 1 0 4 4 .6 0 - 0 .0 2 1 R -AAKLAPKFAK. R
4 7  -  63 1 0 0 7 .0 9 1 0 9 6 .0 4 1 0 9 6 .6 8 0 .0 4 0 R . LMLSIOSVEONLMTVK. P
84  -  94 1 9 0 9 .7 9 1 9 0 1 .7 1 1 3 0 1 .6 6 0 .0 9 0 K.0  IRATMCEEPTRK. L
9 1  -  1 * 9 1 0 8 9 .6 1 1 0 8 4 .6 1 1 0 0 4 .3 0 0 .0 9 0 K .L »rPIX »»R .R
10« - 191 1 9 1 9 .0 9 1 9 1 1 .8 9 1 9 1 1 .8 3 0 .0 1 0 R . El-AILt a a  BPAEX. D
108  194 1 6 6 9 .0 1 1 8 8 4 .0 0 1 8 8 3 .0 9 0 .0 1 1 8 EUtlLLtMLPPAEXPEX.G
1 0 8  194 1 9 0 0 .9 3 1 8 9 9 .9 2 1 8 9 9 .9 9 • 0 .0 7 1 R . ELA ILLMLBPAEXDE3C . C O x id a t io n  iHi
1 3 2  -  140 1 0 0 7 .9 7 1 0 4 6 .9 7 1 0 0 6 .3 3 0 .0 2 0 R.WTVFGPOX.K
1 3 2  -  141 1 1 3 9 .6 8 1 1 3 4 .6 7 1 1 3 4 .6 4 0 .0 3 1 R .w r v r o r o x K .L
144  -  194 1 1 9 1 .7 1 1 1 9 4 .7 0 1 1 9 6 .6 7 0 .0 4 0 K.LSILXPATT6R.8
1 9 9  -  181 9 0 6 .4 7 9 4 3 .4 6 9 0 9 .4 6 0 .0 0 0 R .H TPEILRV
1 6 2  -  172 1 2 0 0 .7 9 1 1 0 0 .7 3 1 1 0 0 .7 1 0 .0 3 0 R W1SLQL TALK k
1 6 2  -  1 7 3 1 3 9 6 .0 0 1 3 5 3 .7 0 1 3 5 9 .0 1 - 0 ,0 2 1 R W lSLfLTAKER.V
1 7 4  -  181 9 1 3 .4 7 9 1 4 .4 7 0 1 4 .4 0 - 0 .0 2 0 R.VATOVOWK.P
189  -  106 1 0 9 0 .0 0 1 8 9 8 .8 9 1 0 7 8 .6 0 0 .0 » 0 k . b c e  s v w i . r  r i  M B M  . x
1 8 2  - 108 1 0 4 9 .8 4 1 8 4 4 .8 4 1 6 4 4 .8 7 • 0 .0 4 0 | . i M m n M M  ■ x O x id a t io n  IK)
182  100 1 9 9 7 .9 4 1 9 9 6 .9 3 1 9 3 6 .0 7 • 0 .0 4 1 R . BCOSVMVLPTirEXZJUK. L
1 PGGLLLGDVA PHFEANTTVG RIRFHDFLGD SDJGILFSHPR DFTPVCTTEL
51 GRAAKLAPEF AKRNVKLIAL SIDSVEDHLA WSKDINAYNC EEPTEKLPFP
1 0 1 IIDDRNRELA ILLGMLDPAE KDEKGHPVTA RWFVFGPDK KLKLSILYPA
1 5 1 TTGRHFDEIL R W ISLQ LTA EKRVATPVDW KDGDSVMVLP TIPEEEAKKL
2 0 1 FPKGVFTKEL PSGKKYLRYT PQP
64 3.2 57
1----- 1----- 1----- I----- 1
80 100 120 
P ro b a b ility  Based Mowse Score
1 0 0 7574 1191 709
. '.s-
6 7 9 2 9 2
8 4 2  5 10
1 2 5 7 6 9 2
697.29 9 06 .410
7713 M 12614 -
: : ;  . os
1 5 8 2 7 1 7 20911 42
1 8 9 7 0 4 81277.746 1475.784
165 3.673
24 2 7  5 20 2 62  9 367
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Spot 2228 Peroxiredoxin 6
25 00
20 00
1500
1000
500
0
1 90 1000 1290 1 500 1790 2000 22 90 25 00 27 90 5000 52 90
m*
S t u t . ( M O b s e r v e d M r < e x » t ) M r < o o lc > O s l t a M is s S e q u e n c e
1 - 7 1 7 0 9 0 . 1 6 7 0 9 7 . 1 3 7 0 9 7 . 0 9 0 . 0 7 0 . rG M X I. W W APW UUrTTVCR. I
7 2 - 4 0 7 3 0 0 . 1 3 7 7 9 9 . 1 3 7 7 9 9 . 1 6 - 0 . 0 4 1 i .  n w n — w i n  r a w . i
« • 3 7 1 3 9 3 . 6 0 1 3 9 4 . 6 7 1 3 9 4 . 6 3 0 . 0 2 0 K . DrTPVCTTELUR A
4 1 - S3 1 6 6 3 . 0 0 1 6 6 4 . 0 0 1 6 6 4 . 0 2 0 . 0 6 1 R . o r  TPVC T TEL KRAAK. L
6 7 - 0 3 1 0 9 7 . 0 4 1 0 9 6 . 0 3 1 6 9 6 . 0 0 0 . 0 3 0 K LIA LSIBSVEO HUUISK .D
1 0 6 - 1 7 1 1 7 9 9 .0 1 1 7 9 0 . 0 0 1 7 9 7 . 9 7 0 . 0 4 1 R KRELAILl. GMLDPAEK. D O x id a t io n  IR)
1 0 0 - 1 7 1 1 3 7 0 . 0 7 1 3 7 7 . 0 6 1 3 7 7 . 0 7 0 . 0 4 0 R . F 1 A III . GMI.DPAFK. 0  O x id a t io n  (!)
1 3 7 - 1 4 0 1 0 0 7 .6 1 1 0 0 6 . 6 0 1 0 0 6 . 3 3 0 . 0 3 0 R . WTVTGFDIC.lt
1 6 7 - 1 7 7 1 7 0 0 .7 1 1 1 9 9 . 7 0 1 1 9 9 . 7 1 - 0 . 0 1 0 R.W XSLQ LYA EX .K
1 0 7 ISO 1 0 4 3 . 0 7 1 0 4 4 . 0 4 1 0 4 4 . 0 7 - 0 . 0 1 0 K .D bD SV M V LPTlF K lU U t.K  O x id a t io n  (■)
1 PGGLLLGDVA PHFEANTTVG RIRFHDFLGD SWGILFSHPR DFTPVCTTEL
51 GRAAKLAPEF AKRNVKLIAL SIDSVEDHLA WSKDINAYNC EEPTEKLPFP
101 IIDDRNRELA ILLGMLDPAE KDEKGMPVTA RWFVFGPDK KLKLSILYPA
151 TTGRNFDEIL PW ISL Q L TA EKRVATPVDV KDGDSVMVLP TIPEEEAKKL
20 1 FPKGVFTKEL PSGKKYLRYT PQP
9 1 7 2 8 9
75 100
P ro b a b ility  Based House Score
10117 S3
1391676
1 7 9 6 0 7 8
2 0 9 8 1 6 1
1 4 2 8 9 0 7
23 0 Q 134
256 3 9 31
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Spot 2157 Prohibitin
I
Probability Based House Score
1077216
9 17  2 82
1 604914
149.4 B 1154.9 9S 237 1 279
26 1914 »
R M 1000 1300 1400 Woo to n 3000 3200 2400 3000 mk
S t a r t _ End O bserved M r (e x p t ) H r  < c a lc ) D e l t a H i s s S equence
12 - 33 2 3 7 1 .2 8 2 3 7 0 .2 7 2 3 7 0 .2 4 0 .0 3 0 K . r  GLA1AVAGGWRSAL YWDAGHK. A
94 - 103 1 3 9 6 .8 9 1 3 9 5 .8 9 1 3 9 3 .8 4 0 .0 5 0 R .IL FR P V A S Q LP R .I
106 * 117 1 4 4 4 .7 0 1 4 4 3 .6 9 1 4 4 3 .6 3 0 .0 4 0 R .lF T S ie E D Y D E R .V
106 - 128 2 6 3 9 .4 1 2 6 3 8 .4 0 2 6 3 8 .3 7 0 .0 2 1 R . I F T S I G E D Y D E S V L P S I T T E I L * . S
134 - 143 1 1 4 9 .6 3 1 1 4 8 .6 3 1 1 4 8 .5 8 8 . 0 4 0 R .FD A CELITQ R.E
220 - 239 1 9 9 8 .1 0 1 9 9 7 .0 9 1 9 9 7 .0 8 0 .0 1 0 K . AAELLAMSLATAGDGLIELR. K
240 - 233 1 6 0 6 .9 1 1 6 0 3 .9 1 1 6 0 3 .8 4 0 .0 7 1 R . KLEAAEDIAYQLSR. S
236 - 272 1 8 3 3 .0 0 1 8 3 3 .9 9 1 8 3 4 .0 3 - 0 .0 3 0 R . HITYLPAGgSVU.Ql.PQ. -
1 HAAKVFESIG KFGLA1AVAG GWNSALYHV DAGHRAVIFD RFRGVQDIW
51 GEGTHFLIPW VQKPIIFDCR SRPRNVPVIT GSKDLQNVNI TLRILFRPVA
101 SQLPRIFTSI GEDYDERVLP SITTEILKSV VARFDAGELI TQRELVSRQV
151 SDDLTERAAT FGLILDDVSL THLTTGKEFT EAVEAKQVAQ QEAERARFW
201 EKAEQQKKAA IISAEGDSKA AELIAN SLAT AGDGLIELRK LEAAED1AYQ
251 LSRSRMITYL PAGQSVLLQL PQ
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Spot 1563 Proteasome p2 subunit
1420806
240 7.199
2 364038
2109.033
1776.036
S ta r t -  En6 Observed N r(e M V t) N r <c a lc ) D e lta N is s Sequence
1 -  19 2 1 5 5 .0 7 215 4 .0 6 2 1 3 4 .0 7 -0 .9 1 0 -  . KE YLIGIQ& PD YVLVA SDB.V O x id a t io n  (H)
69 -  85 1898 .81 1 89 7 .8 1 1 8 9 7 .9 1 - 0 .1 0 1 K.HRM GYTLSPTAAAJfFTR.R
71 - 85 1 6 1 1 .9 3 1 61 0 .9 2 1 6 1 0 .7 7 0 .1 3 0 R . NGYELSPTAAAMFTR. R
l i t -  133 1 00 0 .3 8 9 9 9 . 17 9 9 9 .3 0 0 .9 7 0 R.YYTFT1SR.K
154 9 9 5 .5 0 9 0 4 .4 9 9 8 4 .3 7 - 0 .0 8 1 R . ERAVF.U.R . K
163 -  169 9 1 9 .4 5 9 1 8 .4 4 9 1 8 .4 5 - 0 .9 1 0 K .C L E E L Q K .R
171 -  181 1 3 0 6 .8 5 130 5 .6 4 1 3 0 3 .7 4 0 .0 9 0 R .F IL H L P T F S V R . I
171 -  165 1 776 .84 1 7 7 3 .0 3 1 7 7 3 .9 3 -0 .9 1 1 R .F ILM LPTrSVR IIDK . M
1  M E Y L IG IQ G P D Y V LV A SD R V A A SN IVQ M K D DHDKMFKMSE K IL L L C V G E A
5 1 G D T V Q F A E Y I QKNVQLYKMR N G Y E L S P T A A A N F T R R N L A D C L R SR T P Y H V
1 0 1 N L LLA G Y D EH EGPALYYM DY L A A L A K A PF A AH G YG AFLTL S IL D R Y Y T P T
1 5 1 IS R E R A V E L L R K CLEELQ K R F I L M L P T F S V  R II D K N G I H D L D N IS F P K Q G
2 0 1 S
240
|'ir ■] >u>m
Spot 2271 RAN small G T P ase
2900
20 00
921508 1244.744
7 5E 401
697 .201
979.600
132&74Z
1511951 1785 109
S ta r t _ En4 Observed M r< e x p t) N r ( c a lc ) • e l t a Mrss S e q u e n c e
13 - 23 1 91 3 .3 9 1914 .37 1 014 .37 0 .0 0 0 K . LVLVUDtrtil UK. t
31 - 37 960 .31 9 39 .39 9 3 9 .4 7 0 .0 3 0 M. HL TbKt £K . K
M • 39 1009 .61 1 997 .69 1 097 .37 0 .0 3 1 R.NLT6EFKKK.Y
39 - 3C 2 9 3 2 .3 0 7 031 .79 2 03 1 .1 0 0 .7 0 a K . YVATLUVEVHPLVTHTRR.0
37 - 71 1689 .98 1688 .99 168 8 .8 3 0 .1 3 i R . CP IKTNWDTAUQFK . T
77 - 93 7 2 6 7 .1 0 7 76 6 .0 9 2 26 6 .0 4 0 .0 3 0 R . D6TYIQAQCAI DfTDVTSR■V O x id a tio n  (H)
109 - 106 9 22 .30 9 21 .49 9 2 1 .4 6 0 .0 4 0 K HVPWWKB D
111 - 127 1 97 1 .2 3 1970 .22 1970 .03 0 .1 9 l R VCEHIPIVI. CC9KVDIK . 9
133 - 140 7 3 9 .4 0 7 37 .39 7 3 7 .4 2 - 0 .0 3 0 k . s rv n o t.K
143 - 132 1 2 1 4 .7 0 1213 .69 121 3 .6 0 0 .0 9 0 K . MLQYYDISAX. S
1 MAAQGEPQVQ FKLVLVGDGG T GKTTFVKRH LTGEFEKKYV ATLGVEVHPL
51 VFHTHRGPIK FHVWDTAGQE KFGGLRDGYY IQAQCAIIMF DVTSRVTYKH
1 0 1 VPNWHRDLVR VCEHIPIVLC GHKVDIKDRK VKAKSIVFHR KKHLQYYDIS
1 5 1 AKSNYNFEKP FLULARKLIG DPNLEFVAMP ALAPPEWMD PALAAQYEHD
2 0 1 LEVAQTTALP DEDDDL
■i—i—i—i—i—i—r“ i—i
75 100
P r o b a b i l i ty  Based house S core
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Spot 2141 Signal recognition particle receptor p
8 4 1 5  10
M M
221 L1Q8
9 IT I H
2ft 2 1 I 44
1995 1 14
2297307
1023476
21 1 5.1 92
10774 14
142 C
16 8 5 023
M
79) 1000 129) 1500 179 ) 2000 2 2 9 )
-I---- 1---- r - r —,----r —l----1----1— i---- 1----r r ! I----1-  T 1----1----1---- I-'T—
2 5 U  2750  3000  3250
m  k
s t « r t  e * 4 O k M IT H 4 >  < •i*9* ) D « l t « M iaa I t f M O H
•  -  27 2 0 3 1 .2 2 2 0 3 0 .2 1 2 0 3 0 .0 2 0 .1 0 1 ■ .  M M M U m  <jrru> n o .«
1  -  » 2 0 * 1 .1 4 2 0 3 0 .1 3 2 0 3 0 .0 3 0 .1 * 1 R. RVAMOOAWrTtOPYLOTtR 0
• 4  - M 0 1 3 .4 0 0 3 4 .4 8 0 1 4 .3 0 0 .0 2 0 i . u r a . n .1
1 U  -  170 2 2 0 7 .3 1 2 2 0 * . 30 2 2 0 4 .2 0 0 .1 0 1 R.evnwoen.rovi.iRsiMH.RH
1*1 -  17* 2 * 1 3 .1 0 2 * 1 2 .1 3 2 9 1 2 .2 0 - 0 .0 * 1 R.rvm v*enY*vi.iR9MH.R.o o«»d*t»o« m>
1*4  -  17* 1 0 4 0 .0 3 1 0 3 0 .0 3 1 0 4 0 .0 0 • 0 .0 9 0 K. RVOE21X0VI.ISSMBLK. R
102 - l tB 7 7 4 .3 4 7 7 3 .3 1 7 7 3 .3 0 - 0 .0 0 0 K.fRUNOK.S
1 M  - 1*7 0 * 4 .CO * 0 0 .3 * * 0 0 .9 0 0 .0 2 0 K l.IW Q IER  f
200 20* 7 4 3 .4 2 7 4 4 .4 1 7 4 4 .4 1 0 .0 0 0 K .o j n u . v
204  -  227 2 1 4 3 .2 * 2 1 4 4 -2 4 2 1 4 4 .1 1 0 .1 * 1 R. VTRSOAPSTLRSSSTAPOOLSR. K
2 0 4  - 227 2 1 4 4 .0 4 2 1 4 3 .* 4 2 1 4 4 .1 1 - 0 .1 9 1 ». VTRSAARSTLRSSSTAMOLfiK. K
1
3 1
201
2 3 1
H ASADSRRVA  
LVFW KLIRSR  
1 0 1  AVYRVNNNRG 
1 5 1  EVKDVAEFLY  
LHTLRVTRSA  
GRGDVGSADI
DGGGAGGTFQ
RSSORAVLLV  
N S L T L ID L P G
QVLIDSHGLK
A P S T L D S S S T  
QDLCKVLAKI
PYLDTLRQEL
GLCDSGKTLL  
HZ3LRLQ FLE  
N T P S F L IA C N  
APAQLGKKGK
A
Q QTDPTLLSV
FVRLLTGLYR
R F K S SA R A IV
KQDIAMAKSA
E FE FSQ LP L K
W A V L A V L L T  
D T Q T S IT D 3C  
F W D S A A F Q R
KLIQQQLEKE
VEFLECSAK G
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Spot 1302 Splice isoform of Glutaryl-Co A DH
«00
I 0 23 3 06
971334
1344971
1 133377
I 646 376
1430790
3311105
S t a r t _ E n d O b s e r v e d H r < e x R t> H r ( c a L c ) D e X ta H i s s S e q u e n c e
1 - 9 9 8 8 . 3 6 9 8 7 . 3 3 9 8 7 . 3 6 - 0 . 0 1 1 MALRGVSVR L
3 - 1 3 9 8 6 . 6 3 9 8 3 . 6 3 9 8 3 . 6 0 0 . 0 4 1 K . GVSVRLLSR.0
7 9 - • 8 1 1 9 6 . 7 6 1 1 9 5 . 7 3 1 1 9 5 . 7 2 0 . 0 3 1 R.LM PRILUUIR N
7 9 - 8 8 1 2 1 2 . 7 2 1 2 1 1 . 7 1 1 2 1 1 . 7 2 - 0 . 0 1 1 R . LHPRILLAMR. H O x id a tio n  ( I )
9 3 - 1 1 1 1 8 0 2 . 0 4 1 8 0 1 . 0 3 1 8 0 0 . 9 3 0 . 0 8 0 R.EIISEM G ELCVLG PTIK .G  O x id a t io n  (8 )
1 1 2 - 1 2 8 1 7 0 0 . 9 0 1 6 9 9 . 8 9 1 6 9 9 . 8 4 0 . 0 6 0 K . GYGCAGVSSVAYGLLAR. E
1 1 2 - 1 3 2 2 2 2 7 . 9 7 2 2 2 6 . 9 6 2 2 2 7 . 1 1 • 0 . 1 4 1 K . GYGCAGVS SVAYGLLAKKLER . V
2 0 3 - 2 1 0 8 8 3 . 3 9 8 8 2 . 3 8 8 8 2 . 4 4 - 0 . 0 6 0 K .STTUM TK.T
2 1 1 - 2 2 7 2 0 0 7 . 0 9 2 0 0 6 . 0 8 2 0 0 6 . 0 1 0 . 0 7 0 K . W ITBSPM AD LFW V AR. C
2 1 1 - 2 2 7 2 0 2 3 . 0 6 2 0 2 2 . 0 3 2 0 2 2 . 0 0 0 . 0 3 0 K . t v i t n s p m a d l f v w a r . c O x id a t io n  (B)
229 • 2 3 4 9 0 9 . 2 8 9 0 8 . 2 7 9 0 8 . 3 3 - 0 . 0 8 0 R .C T D G C IR .6
2 3 3 - 2 4 3 1 0 3 0 . 3 3 1 0 4 9 . 3 3 1 0 4 9 . 3 7 • 0 . 0 4 1 R . GEL LEKCKR . 0
2 3 3 - 2 4 3 1 0 6 6 . 6 1 1 0 6 3 . 6 0 1 0 6 3 . 5 6 0 . 0 4 1 R.GFLLEXGMR.C O x id a tio n  (H)
2 4 1 - 249 9 4 4 . 4 7 9 4 3 . 4 6 9 4 3 . 3 0 - 0 . 0 4 1 K . GKRfrL SAPR . I
2 9 3 - 3 1 3 2 1 0 8 . 1 8 2 1 0 7 . 1 7 2 1 0 7 . 0 3 0 . 1 4 0 R . YGIAWGVLGASEFCLHTAR. Q
3 2 9 - 3 3 3 8 7 1 . 3 6 8 7 0 . 3 3 8 7 0 . 3 3 0 . 0 2 1 R.R Q LIQ X K .L
3 3 4 - 3 3 3 2 2 2 3 . 2 3 2 2 2 4 . 2 3 2 2 2 4 .1 7 0 .0 6 0 K . lA M tl TEITLGLHACLQLGR . L
1  M ALRGVSVRL L SR G PG LH V L  R T W S S A A Q T  EKAGRTQ SQL A K S S R P E F D U
5 1  Q D PLV LEEQ L  T T D E I L I R D T  FRTYCQERLM  P R IL L A H R N E  V F H R E IIS E M
1 0 1  G E L G V L G P T I K G YGCAGVSS V A Y G LL A R E L  E R V D S G Y R SA  M SVQSSLVM H
1 5 1  P IY A Y G S E E Q  RQKYLPQLAK G E L LG C F G LT  E P N S G S D P S S  M ETRAHYNSS
2 0 1  NK SY T LH G TK  TW ITNSPM AD L F W W A R C E D  G C IR G F L L E K  G M R G LSA PR I
2 5 1  Q G K F SL R A SA  T G H IIM D G V E  V P E E N V L P G A  SS L G G P F G C L  NNARYGIAW G
3 0 1  V L G A SE F C L H  TARQYALDRM QFGVPLARHQ LIQ K K LADM L T E IT L G L H A C
3 5 1  LQLGRLKDQD K AAPEM VSLL KRNNCGKALD IARQ ARDH LG  G N G ISD E Y H V
4 0 1  IRH AM NLEAV N T Y E G T H D IH  A L IL G R A IT G  IQ A F T A S K ______________________
i i ■> 1 i" 1 'r i
7 5
Probability Based House Score
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Spot 2224 Triosephosphate isom erase
tsi
1107.9 89
9 17336
823.4 54 14 1 4 8 24
;■ ' . <*>
1137 604
' ' ;
t o o M i l i t *  P w t j  H e w  sc<r t
1 000
■ 1 T~ ",
1500 —r i t —• 2000 2 500 3000 3 500
a t
S ta r t - End Okaarved H r<ex»t> H r < c a lc ) D e l ta M ias Sequence
6 - 13 9 5 4 .5 2 9 5 3 .5 1 9 5 3 .4 8 0 .0 4 0 K.FFV&GNVK.N
1 * • 32 1 54 2 .8 9 154 1 .8 8 1 54 1 . 0 .0 1 1 R . KflSLOIX 16U.MUUC. V
19 - 32 1 41 4 .8 2 1 4 1 3 .8 2 1 4 1 3 .7 0 0 .0 3 0 K . 0 SL GEL IGTLMAAK . V
59 - 68 1 13 7 .6 0 1 1 3 6 .6 0 1 1 3 6 .3 6 0 .0 3 0 K . IAVAAQHCYK.V
69 - 84 1 62 1 .8 5 1 62 0 .8 4 1 6 2 0 .8 2 0 .0 2 0 K .VTMGAETCC1SFGM1X.0
69 - 84 1 6 3 7 .7 9 1 63 6 .7 9 16 36.81 -0 .0 3 0 K .VTHGATTCEISPGM1K. D O x id a t io n  (H)
85 - 98 1 5 8 6 .7 9 1 5 8 5 .7 8 1 5 8 5 .7 3 8 .0 5 0 K.DCGATVWLCMSER.R
99 - 112 1 6 1 4 .8 3 1 6 1 3 .8 2 1 6 1 3 .8 2 0 .0 1 1 R M W  CE SDE1 I  M)K . V
to o - 112 1 45 8 .7 7 1 43 7 .7 6 1 4 3 7 .7 1 0 .0 3 0 R.MVrCCSDELIGQX.V
113 - 130 1 88 7 .9 9 1 8 0 6 .9 8 1 8 0 6 .9 7 0 .0 2 0 K.VAH8LAEGLGVIACIGEK.L
162 - 148 8 5 0 .5 0 •4 9 .4 9 8 4 9 .4 6 8 .0 3 0 K .W IE g T K .V
160 - 174 1 60 2 .9 7 160 1 .9 6 1 6 0 1 .0 8 0 .0 8 0 K . W IA Y E F W A I6TC K . T
1 APSRKFFVGG NWKMNGRKQS LGELIGTLHA AKVPADTEW CAPPTAYIDF
5 1  ARQKLDPKIA VAAQHCYKVT HGAFTGEISP GMIKDCGATW WLGHSERRH
1 0 1  VFGESDELIG QKVAHALAEG LGVIACIGEK LDEREAGITE KWFEQTKVI
1 5 1  ADNVKDUSKV VLAYEPW AI GTGKTATPQQ AQEVHEKLRG ¥LKSNVSDAV
2 0 1  AQSTRIIYGG SVTGATCKEL ASQPDVDGFL VGGASLKPEF VDIINAKQ
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Spot 2095  14-3-3 protein a
■fM
100
4000 Probability Based novse Score
MOO
2000
1000
mft
S ta r t  -  End O k t r r v d M r ( e * * t ) Mr < c « lc ) B e ltd H i f i Sequence
I t  -  I t 0 1 6 .4 9 0 1 9 .4 9 0 1 9 .4 1 0 .0 3 0 K.LAEQAER.X
19 -  32 1 60 9 .0 7 1604 .06 1 6 0 4 .7 2 0 .1 4 1 R . YEDMAAFMKGAVEK . G O x id a tio n  (M)
42 -  49 9 0 7 .9 3 9 0 6 .5 2 9 0 6 .9 2 0 .0 1 0 r . a u .s v A n c .il
90 -  56 7 29 .36 720 .36 7 2 0 .3 9 - 0 .0 4 0 K . RWGGQR . A
90 -  60 1 21 3 .7 0 1 21 2 .6 9 1 2 1 2 .6 5 0 .0 4 1 k .v w g g o r a a w r .v
97 -  60 1 30 7 .0 0 1306 .00 1 3 0 6 .7 6 0 .0 3 1 R AAHRVLSSIEQK. S
61 -  60 9 0 3 .9 6 9 0 2 .5 5 9 0 2 .5 1 0 .0 4 0 R.VLSSIEQK.S
61 -  77 1 09 2 .7 3 1091 .72 1 0 9 1 .9 0 - 0 .1 0 1 RVLSSIEQKSMEEGSEEK.6
70 -  09 1005 .49 100 4 .4 0 1 0 0 4 .5 0 - 0 .0 3 1 K . tPEVREYR. E
110 -  117 034 . 30 0 3 3 .3 7 0 3 3 .3 5 0 .0 2 0 K.EAGDAESR.V
123 -  129 9 4 0 .4 5 9 4 7 .4 5 9 4 7 .4 2 0 .0 3 1 K.MKGDTCR.r O x id a tio n  (H)
149 -  160 1 30 6 .7 0 130 5 .7 7 1 3 0 5 .6 5 0 .1 3 1 R SAYQEAHDISKK.E O x id a tio n  ( I )
161 -  169 1 05 4 .9 9 1 05 3 .5 9 1 0 5 3 .5 3 0 .0 6 0 K EMPPTMPIR.L
161 -  169 1 07 0 .6 0 106 9 .5 9 1 0 6 9 .5 2 0 .0 7 0 K.EHPPTHPIR.L O x id a tio n  (H)
219 -  224 1 20 5 .7 5 1 20 4 .7 4 1 2 0 4 .6 5 0 .1 0 0 K .B STLU Q U .R . D O x id a tio n  (H)
1 MERASLIQKA KLAEQAERYE DMAAFMKGAV EKGEELSCEE RHLLSVAYKN
5 1  WGGQRAAWR VLSSIEQKSM EEGSEEKGPE VREYREKVET ELQGVCDTVL
1 0 1 GLLDSHLIKE AGDAESRVFY LKMKGDYYRY LAEVATGDDK KRIIDSARSA
1 5 1 YQEAMDISKK EMPPTHPIRL GLALNFSVFH YEIANSPEEA ISLAKTTFDE
2 0 1 AMADLHTLSE DSYKDSTLIM QLLRDNLTLW TADNAGEEGG EAPQEPQS
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Spot 1207 A ldehyde d eh yd rogen ase  6
6 3 1 J 09
i l l !
»l&34
P robab ility  Based House Score
r  . i ;
o u o  7 <T. 2 1 4 B ;> .3- ’ oi91 9453
16 30.829W - ; >
14 16761
22 8 3 I 911794805 io i n  821
too too 1000 1 200 — I--------- <--------- r—1400 lew 1 400 2 OW 2 200
m *
S t a r t - End O b se rv ed H r ( e x p t ) H r ( c a l c ) D e l t a M is s S equence
34 - 44 1 4 1 6 .7 6 1 4 1 5 .7 5 1 4 1 5 .6 0 0 .0 7 0 K .IF IH M E V K E S K .S
99 - 109 1 3 0 6 .8 0 1 3 0 3 .7 9 1 3 0 3 .7 4 0 .0 5 0 f t . LLHQLADLVER. 0
143 - 130 9 3 7 .4 9 9 5 6 .4 8 9 3 6 .4 4 0 .0 4 0 R . YFAUVADK . I
133 - 1 67 1 3 3 7 .7 0 1 3 3 6 .6 9 1 3 3 6 .7 2 - 0 . 0 3 0 K . T IP TD D O W C FTR . H
390 - 339 1 6 3 0 .0 3 1 6 2 9 .8 2 1 6 2 9 .8 0 0 .0 2 0 R.VFVEEtJVYSEFVR.R
340 - 350 1 2 5 7 .6 0 1 2 5 6 .6 7 1 2 5 6 .6 9 - 0 . 0 2 1 K . KRPVGDPFDVK. T
341 - 350 1 1 2 9 .6 4 1 1 2 0 .6 3 1 1 2 0 .5 9 0 .0 4 0 K.RPVGDPFDVK.T
407 - 421 1 6 8 1 .9 6 1 6 8 0 .9 6 1 6 8 0 .9 8 - 0 . 0 3 1 R . lA K LLIFG P V Q P ILK  . F
410 - 421 1 3 6 9 .8 8 1 3 6 8 .8 8 1 3 6 8 .7 7 0 .1 1 0 K .E E IF G P V Q P IL K .F
494 - 431 9 7 3 .3 2 9 7 2 .5 1 9 7 2 .5 6 - 0 . 0 5 1 K .S IE E V IK R .A
4 39 - 446 1 5 5 0 .7 9 1 5 5 7 .7 9 1 5 5 7 .7 7 0 .0 2 0 R . AHSTDYM .TAAVFTK.il
4 02 - 4 07 6 3 7 .3 2 6 3 6 .3 1 6 3 6 .2 6 0 .0 3 0 K.HSGHGR.E O x id a tio n  (H)
408 - 501 1 6 1 4 .7 0 1 6 1 3 .7 7 1 6 1 3 .7 8 - 0 .0 1 0 R . EL GEYALAEYTEVK. T
507 - 312 6 4 3 .3 1 6 4 2 .3 1 6 4 2 .3 3 - 0 . 0 3 1 K .LG DKHF. -
1 HATANGAVEN GQPDGKPPAL PR PIR N LEV K FTK IFIH NEW HESKSGKKF A
51 TCNPSTREQ I CEVEEGDKPD VDKAVEAAQV AFQRGSPHRR LDAL3RGRLL
1 0 1 HQLADLVERD RATLAALETM DTGKPFLHAF F ID L E G C IR T LRYFAGtfADK
1 5 1 IQGKT1PTDD M W CFTRHEP IGVCGAITPW NFPLLHLVtfK LAPALCCGNT
2 0 1 MVLKPAEQTP LTALYLGSLI K EA G FPPG W N IV PG FG PT V G A A IS SH P Q I
2 5 1 NK IAFTG STE VGKLVKEAAS RSNLKRVTLE LGGKNPCIVC AOADLDLAVE
30 1 CAHQGVFFNQ GQCCTAASRV FVEEtJVYSEF VRRSVEYAKK RPVGOPFOVK
3 5 1 TEQGPQIDQK Q F D K IL E L IE 3GKKEGAKLE CGG3AHEDKG L F IK P T V F S E
4 0 1 VTDNMPIAKE E IF G P V Q P IL K F K SIE E V IK RANSTDYGLT AAVFTKNLDK
4 5 1 ALKLASALES GTVHINCYNA LYAOAPFGGF KMSGMGRELG EYALAEYTEV
5 0 1 KTVTIKLGDK HP
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Spot 1183 Cytokeratin 6
(2 3  : 0
8 2 7 4 0 7
611211
14 19 785
79 IPO
f r c f c a o i i i t a  no*** S c o r t
i  91 : ■
1129600
781 323 ;o4> >M
76V MO 1184647
; . 6 S M
221 L1 fl
g |  u o f :4v
2268178I S 3 i 7 «
1701 896 184 7 8 98 19 560  56 211 91 '*4 23 4 0 1 90
I t M t  - I M H M « n < 4 « * < •> * « » ■ r i c * U > N 1 U Hi m U f m c i
• 2  * » l 9 1 1  *9 9 1 9  m 9 1 9  81 " 9  9 8 9 ¥ 5TT4O PO 30 1
39  • 81 8 1 0 .4 * 8 8 9 .4 9 0 0 9 .4 * - 0 . 0 1 9 i . u u i r s i . v
• 2  8 8 * 9 0  ** *0 9  39 7 0 9  30 - 8  8 1 9 0  0 0 3 3 0 T 0  «
8 * 1  - l * t 0 * 7 .8 1 8 * 0  40 0 * 8 .8 * - 0 . 0 * 4 K . I 8 0 1 H . V
1 M  19 8 1 1 8 1  9 9 1 1 8 0  4 ) 1 1 0 9  4 3 0 . 0 9 1 k v a n  z o o m  a
1 1 *  - I I P 9 0 0  41 9 0 3  4* 9 0 4 .  48 - 0 . 0 8 0 0  n i H M i  H
m  - i t * 1 0 8 3  98 1 9 8 8  >8 1 9 8 4  33 9 . 0 1 0 1  0L E T IS 0X X  L
1 8 0  I P ? * 0 1 8  18 * 0 1 1  11 * 0 1 1  9 * 8  0 0 8 8  I tfU M ffl U M Q M V X M V  N
M l  I I P 1 3 9 * .7 * 1 3 9 1 .3 1 1 3 3 1 4 7 9 . 0 8 9 I t . I D B K m  IK X
M l  * 1 * I4 P O  IP 1 8 7 9  77 1 8 * 9  78 0  9 1 1 ¥ T 0 W m  IK * 0
* 0 8  l i t 1 4 9 8 .1 9 1 4 9 3 .7 * 1 8 9 4 .7 8 - 0 . 0 4 1 K . n n E m i n  1
t n  -  i t # 1 8 1 9  19 1 4 1 8  70 1 8 1 9  79 9  0 8 9 0  U 0 T N 1 0 U  0
* 8 1  - t l > * 1 0 9 .0 0 * 1 0 0 .0 0 * 1 0 0 .0 1 0 . 0 3 0 k . u m i m s v n o o o s i . i
* 1 9  I T * * 1 9 9  91 n i 8  9 9 * 1 * 4  9 0 9  0 9 0 9  n .  9 3 0 1 3O T W 01  V M M  3 0 « 1
1 1 1  - 9 P * 1 1 * 0 .7 1 1 1 1 0 .7 0 1 1 1 9 .0 0 0 . 0 8 0 i . a H O t i u m i
1 08  1 9 4 1 0 7 9  9* 1 0 7 9  31 1 9 7 9  30 0 - 9 1 9 K 8 0 7 1 * 1 8 8 *  S
I M  - >88 1 0 0 0  M 9 0 0  99 4 9 9  48 9  0 1 0 k  ftO M U O U K  k
3 30  181 1 3 4 4  T l 1 9 0 3  79 1 3 8 3 .0 7 0 . 0 3 0 R OSLXA01 8 0 8 X 0 0  Q
I  I P  -  18P 1 0 3 8 .0 0 1 9 3 9  0 3 1 9 4 6  0 1 0 0 9 1 R 8 4 1 * 0 8 1 8 0 8 * 0 O 6 0 U H S  .R
M 3  - 1 1 1 1 1 * 9  4 0 1 1 * 0 .3 9 1 1 * 0 .0 1 - 0 . 0 * 1 P v E U IK U L H k X .l
M l  - 4 9 8 9 1 9  49 9 1 0  49 9 1 9  41 9  9 8 B ¥  AK0BM8X 0
M 4  1 9 8 8 1 3 .1 7 0 1 4 .1 8 0 3 4 .4 0 - 0 . 0 9 1 k 8891 1 0 m  . 9  C« i d a t  xam  1*1
*98 4 0 * 1 1 9 9  90 1 1 1 *  37 1 1 4 *  43 0  9 7 9 R r Y P d J W R *  L
>84 - 4 0 * 1 1 0 9 .3 0 1 1 0 0 .4 9 1 1 8 9 .3 8 - 0 . 0 3 4 1  n p i M O t . L  JK tPM K lO ft (0 )
4 0 1  8 1 * m i  n 1 2 7 4  n 1 * 7 9  79 9 9 1 9 R U L > l I l A m  I
8 0 4  - 8 1 8 8 i 0 0 , * » 1 4 0 4 - 7 9 1 9 0 4  8 0 - 0 . 0 1 B i . u u n i i n u  l
4 94  394 1 1 7 1 .9 9 1 1 7 * 4 0 1 1 7 *  8 3 0  0 0 0 R i v s n i a r i f i .
1 FSA PSR ISA B  
51  C S R IS S S S F S  
1 0 1  VDPNIQAVRT 
1 5 1  KTARSNH&NH 
3 0 1  EDEINKRTEM 
2 5 1  EEIRELQSQI 
3 0 1  SHYQIKYEEL 
3 5 1  SLEAAIA6AE  
4 0 1  VKLAJLD1EIA 
451  LT3PGL3YSL  
SOI VLPK
FGPPASTPAS
RVGSSHFRGG
QEKEQIKTLN
FESYXNNLRR
EHEFVLIKKD
SDTSWLSMD
QSLAGKHGDD
QRGELA1KD8
TYRKLLEGEE
GS3FGSGAGS
TH SIRVT0K 3  
LGGGYGGA3G 
NKFASPIDKV  
QLETLGQEKL 
V6EAYHNKVE 
HSRSLDHDSI 
LRRTKTEISE  
MAKL3ELEJLA 
SRLESGB'JNM 
33 F 3 R T 3 S 3 R
YKVSTSGPRA 
HGGITAVTVN 
RfLEQQMKML 
KLEAELGMHQ 
LESRLEGLTD 
IAEVKAOYED 
MNRNI3RL0A  
LuPAKQDMAR 
3 IHTKTTSGY 
AWVKKIETR
F3SRSYTSGP  
QSLL3PLVLE  
ETKBSLLOOO 
GLVEDPKNKY 
EINFLRQLYE 
IARR3RAEAE 
EIEGLKGOPA 
QLREYQELMM 
AGGLS3AYGG 
DGKLVSESSD
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Spot 1277 Cytokeratin 7
14 5 3 921
1341763
1 2 7 7 7 3 0
102 3484
679.460
1196618
9 11415
7 7 1 3 4 8
1
1847.763 2012085
i ,i n
---1---1---1---r-- 1--- 1--
750
i— i— ,— p— .— . 
1000
— i— i— i— i— 
1 250
T-----,---- 1---- 1---- r—
1 500 1750 2000 2 250 2 500
i-----1---- r-  T----,---------- 1---- r
2750 3 000 
m
S ta r t  - EMI OfeacrvcO Mr ( e a p t  > Mr<c a lc ) M a lta M ia* S o fM D T f
S3 - i t 1 1 0 4 .6 3 1 1 0 3 .6 1 1 1 0 3 .5 7 0 .0 4 0 R.SAYCOMVflACIR.E
70 -  M 1 0 1 4 .3 6 1 0 1 3 .3 3 1 0 1 3 .3 1 0 .0 4 0 H. LDAt>PSL0* .9
102 - 100 0 7 7 .4 3 0 2 6 .4 2 0 2 6 .4 7 - 0 .0 0 0 x .r o s r iM K .v
111 - 117 9 0 6 .4 4 9 0 5 .4 4 9 0 S .4 6 0 .0 3 0 n.rLEQOHX.L
111 -  122 1 4 9 0 .7 6 1 4 0 9 .7 3 1 4 0 9 .0 1 - 0 .0 4 1 RrLEOO OKLLZTK.tr
133 -  133 1 0 4 3 .5 0 1 0 4 4 .5 0 1 0 4 4 . 56 0 .0 2 0 K .tm iy f .o K N
137 - 149 1 4 4 2 .0 4 1 4 4 1 .0 3 1 4 4 1 .7 9 0 .0 4 0 l . L » i r U | U S U . G
ISO -  107 1 9 S J .9 7 1 9 3 2 .9 0 1 9 3 3 .0 7 - 0 .0 7 1 R , {*LE6L«V M «l(L£6£l.lt, S
100 -  177 1 2 1 3 .SO 1 2 1 7 .SO 1 2 1 2 .5 3 o.os 0 R .9W D W E 0FK .0 Ok lOat io n m
100 -  190 1 2 7 0 .7 1 1 2 1 9 .7 0 1 2 1 9 .6 4 0 .0 6 0 R.M UM ErW LM .K
100 -  199 1 3 4 0 .7 0 1 3 0 7 .7 6 1 3 4 7 .7 4 0 .0 7 1 R . TAXtMKrWl K* 0
715 236 1 4 1 8 .7 3 1 4 1 7 .7 2 1 4 1 7 .7 2 0 .0 0 0 K .VDALMOeiMS'LR . T
I M  -  2 7 3 2 7 3 9 .0 2 2 2 3 0 .0 1 2 2 1 0 .1 1 - 0 .0 9 1 R . SLMLDCIIAZVKAQYUMAK. C O x id a t io n  IB)
337 •  M l 1 0 1 7 .9 6 1 0 1 1 .9 5 1 0 1 1 .9 6 - 0 .0 1 1 K. LEAAIAXAZXRCri A l K. 0
334 - 343 1 1 0 6 .6 2 1 1 0 3 .6 1 1 1 0 9 .6 0 0 .0 1 0 K (lEELEAALQS .A
354 -  JOS 1 3 0 3 .7 0 1 3 0 4 .7 3 1 3 0 4 .7 3 0 .0 2 1 K.tCELZAALQROK t
304 -  370 0 3 5 .1 9 0 3 4 .3 0 0 3 4 .4 0 - 0 .0 2 1 R.AKQOMAR.Q O x id a t io n  (Ml
374 -  302 1 1 2 6 .3 7 1 1 2 3 .3 7 1 1 2 3 .3 4 0 .0 3 0 R.EYOELMSVK.L
174 -  102 1 1 4 2 .S 3 1 1 4 1 .3 3 1 1 1 1 -3 3 - 0 .0 1 0 R.CY9EUISVK.L O x id a t io n  10)
303 -  393 1 2 7 7 .7 3 1 2 7 6 .7 2 1 2 7 6 .7 0 0 .0 2 0 K . LALMIELATYR . K
303 -  394 1 4 0 3 .7 7 1 4 0 4 .7 6 1 4 0 4 . OO - 0 .0 4 1 K. LALD IE LATYRK . L
i  h s i h f s s p v f
S I  VRSAYGGPVG 
1 0 1  KFASriDKVP  
1 S 1  QLUULQVDGG 
2 0 1  VDAAYHSKVE 
2 3 1  NSRSLDLOGI 
3 0 1  LRNTRNEISE 
3 3 1  RJLKQECLEAA 
4 0 1  SP.LAGDGVGA 
4 51  LLKAYSIRTA
TSRSJLirSGR  
AGIREVTINQ 
FLEgQHKLLE 
RLEAELRSHg 
L E AKVDALMD 
1AEVKAQYEC 
HNPAIQRLQA 
LQRAKgDNAR 
VNISVHNSTG 
3ASRR3ARD
GAGVRLSSAR
SLLAPLRJ.DA
TKWTLLgEQK
DW EDFKNKY
EllfFLRTLNE
MAKCSRAEAE
EIDNIKNGRA
QLREYgELHS
GS3SGGGIGL
PGGLGS3SLY
OPSLgRVRQE
SAKSSRLPDI
EDEINRRTAA
TELTELGSG1
a w y g t k f e t l
Kl PA M A FA F 
VKLALDIEIA  
TLGGTHGSNA
GLGASRPRVA
ESEQIKTLNN
FEAgiAGLRG
EJfEFWLKKD
SDTSW LSHD
QAQAGKHGDD
ERGELALXDA
TYRKLLEGEE
LSFSSSAGPG
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3000
2000
1 000
n t
S ta r t  - End • k t t r v r l Hr < vx*t > Hr < r a le  t * # l t  4 Ml**
S -  IT 2 1 4 7 .0 9 2 1 4 * .* 2 2 1 4 3 .* 3 * .* 7 * o . L * 9 sso sY * e6 ro « escg L ee< « . e
104 - 114 1 1 2 0 .4 3 11 1 9 .4 4 1 1 1 9 .9 3 * .1 1 • K. IIMAM-MMt.L O x id a tio n  ( ! )
111 - 111 0 2 3 .4 3 0 2 2 .4 2 0 2 2 .4 1 - * .* 1 • R.LA9XLKK. V
194 -  111 81 * 1 . 7* 13** . 1* 1 3 M .4 1 * .1 0 • i . i i t t M i D u a m .  1
IS* -  149 9 * 7 .9 4 * • * .9 1 9 M .9 4 - * , n 1 8 . 1 8 W M 8 .4
141 -  ISO 071 49 0 7 0 ,4 3 0 7 0 .4 2 * .* 3 • k osfasteh  o
131 -  1ST * 1 3 .4 3 * 3 4 .4 2 9 1 4 .4 1 * .* 1 •
1W  - ITS 1 1 4 4 .4 9 1 1 4 1 .4 0 1 1 4 3 .4 2 * .* S • K. ILIATIEMMR.V
1 H  104 1 0 4 2 .4 7 1 * 4 1 .4 4 1 0 4 1 .9 * * .* • 0 i . v n j i u u . i
101 -  1*1 0 1 9 .3 * 0 1 4 . 1* 0 1 4 .4 9 • * .* 4 • 0 . LAV99T R . 1-
991 -  940 2 1 1 7 .0 7 2 1 9 * .* 1 2 1 9 * .0 * * .* 1 • II. ioi m g i  r si HrriAYMK i
949 -  972 2 * 1 9 .1 9 2 4 1 0 .1 1 7410 2* - * .1 9 •
2*1 -  2*9 11 1 2 .3 7 1 1 3 1 .3 4 1 1 3 1 .9 * *.** • * BAZEwntax s
10* - 310 2 * 3 2 .0 4 2 0 3 1 .* 9 2 * 9 1 .0 2 * .* 3 1 K. SSELHKEVSnrrAMlQTllt. I
11* - )M 1 0 1 7 .3 3 1 0 1 4 .9 3 1 * 1 4 .9 * " * .* 4 1 K. 7EITEl.lt*. T
127 -  149 1 0 1 0 .1 9 1 0 1 7 .1 4 1 * 1 * .* * * .1 * 0 ■ a g u z i u i N i i  o K  i
197 -  142 1014 - 01 1 0 1 1 .0 0 1 * 1 2 .9 * * .* 9 0 R.TtOCLEIElOSfLSMC A O x id a tio n  <*)
17* -  309 1 443 .71 1 4 4 4 .7 0 1444 3* * ,1 4 * * . S D E C l i g n i  M
39* -  406 1 3 7 * .SC 1 17* . 04 1 1 7 0 .7 2 * .1 4 1 K.TBLEQCIATTBS
39* ■ 4*4 1 1 2 2 .4 0 1 1 2 1 .4 7 1 1 2 1 .9 7 * .1 0 0 R.LEQEIATYA.S
41* -  49* 1 4 * 0 .0 2 1 4 * 7 .0 1 1 4 * 7 .4 0 * .1 3 0 R.MlCrrSlAASVSMI.S O x id a tio n  ( ! )
1 HSLRLQSSSA SYGGGFGCGS CQLGGGRGVS TCSTRFVSGG SAGGYGGGVS
5 1  CGFGGGADSG FGGGYGGGLG GGYGGGLGGC FGGGFAGGFV DFGACDGGLL
1 0 1  TGNEKITMQM LKDRLASYLE KVRALEEAMA DLFVKIRDWM LKQSPASPER
1 5 1  DYSPYYKTIE ELRDK1LTAT IEMNRVILEI DMARLAVDDF RLKYENELAL
2 0 1  RQSVEADING LRRVLDELTL SKTDLEMQLE SLMEELAYMK KNHEEEHKEF
2 5 1  SHQWCCVKV EMDATPGIDL TRVLAEMPEO YEAKAERNPP DAEEWFMAKS
3 0 1  AELNKEVSTM TAMIQTSKTE ITELRRTLQC LEIELOSQLS MKAGLENTVA
3 5 1  ETECPYALOL Q Q I0G L I3S I EAQL3ELRSE MECQMQEYKH LLDIKTRLEQ
4 0 1  EIATYRSLLE GQDARMGFP SSAGSVSPRS TSVTTTSSA3 VTTTSNA3GR
4 5 1  RTSDVRRP
Spot 1307 Cytokeratin 13
84 2 5 10
P r o b a b i l i ty  Based M o w  S core
21 1 i'<'
'  S2«
93 5 429
-» . • - i
1041671
1488740 2283 I 55
, V.1SI 1987.0 32 26 1 9,1 18
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Spot 1298 Cytokeratin 13
*■ 4 4 — A i r
0 0  1 2 0  160 2 0 0  2 4 0
P ro fcab i1l t y  b a sed  ttowse S c o re
769.296 
663.401
30 1 0 4  10
2900 2790  3000
m  it.
» 4 t l - CM ■ 4W H I4 * 1 1 6 1 * 0  * 1 1 0 * 1 0 *911 . M l* * ll**4*C 4
> *7 7146 99 7 1 4 ) 9* 7 4 4 ) .9 ) * .* 7 • * t * » t t ) W t 4 W « 4 W » < M *  •
186 - 111 1179 69 1119 i* 1119 » •  *4 • a iD 4 * a jM t i  o iK M tio a  III
1*6 — 171 19*9 *3 19*9 *7 19*7 9* •  *4 M *  IIM *H JM 4A )nC 9 V
I N — 171 1974 91 1 97) 91 1 9 7 ).9 7 -* .* T 1 K l W W I 4 * 3 W n i  V ■jilCMtlc-O iBl
m - 171 ♦73 4) *77 4 ) •7 7  4 ) - * .* 7 • » LAS1UK V
18) - 1 7 ) 8*8* 6 ) 1*77 4 ) 1*77 47 *  *7 1 * U 5 1 U M I  *
8*4 - 8 » 13*1 6 ) 13** 67 IM *  6 ) - *  *7 • * t u c u i M m  i
8 6) - 1 )7 17*7 99 17*4 9* 17*4 *7 •  •* 1 * 4 » 4 $ m * i 5 r r n i  r
8)8 - 1 )7 9 )5  41 9 )4  41 974 41 - * .* * • *  4T5WW »
■ 64 * 844 714*.77 7147 74 7167 79 •  *4 1 8 U tftT liaM W llB IM nft L
87* - 144 8*47 6 ) 1*41 47 1*41 W •  *4 • •  v n e iM M *  i
8*5 - 191 •  ») 17 •  >* 47 •  71 47 - 4 * 1 • •  LAW9949 L
197 - 7*1 174* 7 ) 1747 74 1747 69 * .* 4 t * i n t * u u  *
1*4 - 7*1 1 * * 7 .) ) 1**4 54 ■9*4 )1 * .* > • 1 1 B C U U  *
7*7 - 787 17*1 67 174* 67 17**.68 •  *6 • * 4 S V U 7 I M 1  1
7*1 - 7 1 ) 1 8 )7 .7 4 1M 4 7) I M 4  71 •  *4 i * 4 5 V H 4 IH U *  V
714 - 777 1*1» )9 1*16 V* 1*14 9* * * 1 • » vLMSin.6*: f
773 - 7*7 1 *7) 9* 1*74 *9 1*74 * ) •  94 1 •  v u M f i r t n w i  a
7 7 ) - 7*1 1*41 91 1*4* 9* 1*4* *4 •  *4 1 * A M M t l l M M ll  a  0 1 lA * tlo t, lill
778 - 7*1 1 9 )7  74 1*54 74 t* M  *4 ♦  44 1 •  m o H i i u i a i i  a  1 0 a i « « i o *  Hi
m - M7 1*77.97 1*77 94 1*77 94 4 M • a  n * 4 * 7 in * $ * i9 a c  *  0 i» a » tio ®  m
>41 - 7 ) ) 1449 7* 144* 69 144* 44 •■ •7 • a  M u a r a m n i
m 4*4 1 )3 9  74 177*. 7) 1 7 7* .77 * .* 7 1 8 M 8 « I U m t
w - 4*6 1177 4* 1471 99 1871 97 •  *7 • a i K c u m  )
414 - 479 i m  74 8791 7 ) 1)91 49 * * 4 • K M « m 5 4 « S V 5 f*  5
616 - 4 7 9 14** 71 1 4 * 7  7 * 1 4 * 7  4 * •  *7 • a *14*955A45V5C* 5  0a M a t io n  III
1 K SLRLQ SSSA SYGGGFGGGS CQ1.GGGRGVS TC STRrV SG G SAGGYGGGVS
5 1 CGFGGCADSG FGGGYGGGLG GGYGGGLGGG FGGGFAGGFV DTGACDGGLL
1 0 1 TCNEKITMQN LNDRLASYLE KVRALEEAMA DLEVKIRDVH LKQSPASPER
1 5 1 d y s p y y k t i e ELPDKILTAT IEM H R V IL EI DMARLAVODF RLKYENELAL
2 0 1 RQSVEADIHG LRKVLDELTL SK T P L E H 0IE SLNEELAYHK KNHEEEHKEF
2 5 1 SNQW GQVNV EMPATPGIDL TRVLAEMREQ YEAHAERNRR DAEEYFHAKS
3 0 1 AELNKEVSTN T AH IQ TS KTE ITELRRTLQG L E IE L Q SQ L S MKAGLEHTVA
3 5 1 ETECRYALQL Q Q IQ G L IS S I EAQLSELRSE HECQNQEYKH LLDIKTRLEQ
4 0 1 E IA TY R SLLE GQDAKMIGFP SSAGSVSPRS T S V T T T S 3A 3 VTTTSNASGR
4 5 1 FTSD V FPP
697.2 55 1039.636
7 0 9 2  52
967600
11 30635
0 7 9 7 6 1
1924.9141659838
22 9 9 1 30  1--
685.275
250
144
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Spot 1295 Cytokeratin 13
S 4 : ' ;
9 l 7 2 67
1077 187
P r o b a b i l i ty  B<«?d rtouse S co re
■/-: : w.
7 8 1 2 *
1379802
762.373 1025 460
I; ?: ? 46
130 5 744
2146877
1449696
1788004
aao
---1--------- V
1000
—i----------1------
1200 1400
---- 1---------- ’
1600
--------1—
1800 2000 2 200
m b
S t a r t _ End O b ie rre d N r f r x p t > M r (c a lc ) D e l ta M s ** Sequence
9 - 27 2 1 4 6 .8 8 2 1 4 9 .9 7 2 1 4 9 .9 9 '0 .0 6 0 R . LQSSSASYGCCr GGGSCQl.GGGR.0
124 - 139 1 3 0 1 .6 7 1 3 0 0 .6 6 1 3 0 0 .6 9 0 .0 1 0 R .AL EEAMADLEVK. I
1S1 - 157 9 3 5 .4 0 9 3 4 .3 9 9 3 4 .4 1 - 8 .0 2 0 l . n s n n . T
174 - 194 1 0 4 2 .9 9 1 0 4 1 .9 8 1 0 4 1 .9 9 -6 .0 1 0 R . V I I  K IDMAJt . l
199 - 191 8 3 9 .4 3 8 3 4 .4 3 8 3 4 .4 2 0 .0 0 0 R . LA VB Dr*. L
192 - 201 1 24 8 .7 1 1 2 4 7 .7 0 1 2 4 7 .6 9 0 .0 2 1 R . LKYEMELALR. Q
194 - 201 1 0 0 7 .4 9 1 0 0 6 .4 8 1 0 0 6 .5 1 - 9 .0 3 0 K . YENEIALR. Q
202 - 213 1 3 9 7 .7 2 1 3 9 6 .7 1 1 3 9 6 .7 1 0 .0 0 1 R. QSVEADIHGLRR .v
291 - 299 1 1 3 2 .9 5 1 1 3 1 .9 4 1 1 3 1 .5 0 0 .0 4 0 R.BAEZVFKAK.S
927 - 342 1 8 1 7 .9 7 1 8 1 6 .9 7 1 8 1 6 .9 6 8 .0 1 0 R.TLQ6LE1ELQSQLSMX.A
327 - 342 1 8 3 4 .0 0 1 6 3 3 .0 0 1 9 3 2 .9 6 0 .0 4 0 R . T i.Q G i.rm  gsQi s tw .A  o x id a t io n  (N)
343 - 399 1 4 4 9 .7 0 1 4 4 8 .6 9 1 4 4 8 .6 6 9 .0 3 0 R . AdJEMTVAE IE C R . I
398 - 406 1 1 2 2 .5 8 1 1 2 1 .5 8 1 1 2 1 .5 7 9 .0 1 0 R.LEQEIATYR.S
416 • 429 1 4 0 8 .7 4 1 4 0 7 .7 3 1 4 0 7 .6 6 0 .0 9 0 X .N1GFPSSAGSVSPR. s O x id a t io n  ( ! )
1 HSLRLQSSSA  
5 1  CGFGGGAPSG 
1 0 1  TGNEKITNQN 
1 5 1  DYSPYYKTIE  
2 0 1  RQSVEADIHG  
2 5 1  SNQW GQVNV  
3 0 1  AELNKEVSTN 
3 5 1  ETECRYALQL 
4 0 1  E IATYRSLLE  
4 5 1  RT3DVRRP
SYGGGFGGGS 
FGGGYGGGLG
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LRRVLDELTL
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TAHIQT3KTE
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Spot 1165 Cytokeratin 13
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842 5 10
Probability Based nowse Score
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1 132 314
124 8 7 86
102 3 4 25
2283.1 94
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1 * 6  4 0 4 1 3 7 9 . 0 0 1 1 7 0 . 0 0 1 J 7 0 .  72 * . * • 1 K . I I I U 0 E 1 A I 7 H .S
3 * 0  4 0 4 1 1 3 3 . 6 3 1 1 3 1 . 4 6 1 1 2 1 . 9 7 * . * 7 • I . U * U ! H I  5
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1 MSLRLQSSSA 
51  CGFGGGADSG 
1 0 1  TGNEKITMQN 
1 5 1  DYSPYYKTIE 
2 0 1  RQSVEADING 
2 5 1  SNQWGQVNV 
3 0 1  AELNKEVSTN 
3 5 1  ETECRYALQL 
4 0 1  E1ATYRSLLE 
4 5 1  RTSDVRRP
SYGGGFGGGS 
FGGGYGGGLG 
LNDRLASYLE 
ELRDKILTAT 
LRKVLDELTL 
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TAMIQTSKTE 
Q Q IQ G LISSI 
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DMARLAVDDF
3LNEELAYMK
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Spot 1303 Dihydrolipoamide DH
1 0 -
73 100
P r o b a b i l i t y  B ased flowse S co re
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- . 7 . 1  n  ■ 
790 1 ooo 1 250 1 500
■ ■ 1 ' r  
1 790 2 000 2 290 2 300
s t a r t  - EM B bM IT V d N 1 U ■AM S a f a m c B
M  - 4 4 1 1 4  -40 1 1 1 . 4 4 7 1 1 .4 1 - 4 . 4 7 9 R A M L O l  V
« ?  - T t 7 4 4 .1 4 7 4 4 .9 4 7 4 4 .1 4 - 4 . 0 4 4 i . m m i
7 1  -  • • 1 4 1 4 .4 1 1 4 1 9  4 4 1 4 1 4 .4 4 - 4 - 4 4 9 k  . w t i K T a j w c i i a i
u s  -  i n 4 4 4 .7 5 554 24 5 9 4 .2 4 - 4 . 9 4 9 K OF ASH . 6
1 1 1  - 4 1 7 9 7 4 .1 9 9 1 9 .2 4 9 1 9 .4 4 • 4 . 4 4 4 I . G t B S C V I .L
1 14  -  117 9 M  17 9 1 5 . 4 4 9 1 5 . 4 4 4 . 4 7 9 •  ■ OKIMSEVV L Qv i Om i o * <■»
1 ) 1  IA J 1 1 7 4 .1 0 1 1 7 4 .4 9 1 1 7 4 .4 5 4 . 4 4 9 K .JU .ftM lJJM aj'K .f
1 1 1  -  l « 9 7 7 .4 4 9 1 1 . 4 1 9 7 1 . 1 7 • 4 . 9 9 4 K WWMGYWC I
1 4 1  -  1 7 1 1 1 4 4  59 1 1 0 )  54 1 1 4 1 .5 5 4 . 4 4 0 K A 4 4 0 T Q V I4 T K .4
1 1 4  -  1 1 4 1 9 4 4 .1 9 1 9 4 9 .1 7 1 9 4 5 .4 4 4 . 9 9 4 X JW V 1U U 971I1V K U S W |K .L O B ite iA o a  44)
7 44  -  1 4 7 1 0 4 4  94 1 4 4 9  54 1 4 4 5 .4 # * 4 .4 1 1 K 0 7 9 4 1 1 0 *  4
7 4 1  140 1 5 1 1 .1 5 H U  r* 1 5 1 7 .1 1 * 4 . 4 7 7 0 C O O R im n  1 1 4 4 5 4 4 4  .A
T t l  - MO 1 1 4 4 .9 9 1 1 4 9 .9 1 1 1 4 9 .9 # - 4 . 4 1 9 s .  i w s m u t w a . i
141 -  115 1 7 1 7  90 1 1 1 4 .9 1 1 7 1 4 .4 9 4  49 9 K AEV1 YCOVLLVf 144  9
114 ISO 4 4 4 .1 1 4 4 1 . 1 4 4 4 1 . 2 4 - 4 . 4 1 9 i . i r m . i
T t l  -  114 1 9 4 7 .4 4 1 9 4 4 .4 1 1 5 4 4 .4 1 9 . 9 1 9 4 .  W G 4R FI4IX 1.D 44 6
1 4 1  - 145 1 9 1 9  90 1 4 1 1 .9 9 1 9 7 4 .0 7 4 . 0 9 0 K im i^ A lM W A A ftC L A M R A
1 4 1  -  1 4 9 1 9 9 9 .4 4 1 9 9 4 .4 4 1 9 9 4 .4 7 • 4 . 4 9 9 K. 1PI1Y 1IU W A 69H L A M K  .A • ^ n U t i o n  (4 )
149 -  117 1 9 4 1  40 1 9 4 0 - 7 9 1 5 4 4 .7 4 4 . 9 4 1 0 SC r0L K E F41C W  V
421 4 7 1 9 4 9 .4 9 9 0 4 .4  7 9 4 4 . 4 5 4 . 4 7 4 i . t v r u i n i . i
4 4 1  -  4 4 9 1 9 7 4 .1 9 1 9 9 1 .7 4 1 9 7 1 .7 1 9 .4 9 9 I . V C O I K P T l W f  1
4 4 4  545 1 4 4 1  53 1 4 0 4  57 1 4 4 4 .5 1 4 . 4 1 4 K . c n u i s n i  s
l H03W3RVYCS
31 PGGYVAAIKA
1 0 1 AHGKDFASRG
1 3 1 MGYGKITGKN
2 0 1 V33TGALSLK
2 3 1 VGIDHEISKM
3 0 1 A E V IT CDVLL
3 3 1 YA1GDWAGP
4 0 1 UVGKSEEQLK
4 3 1 LGAHILGPGA
301 A SF G K SINF
LAKRGHFNFI 
AQLGFKTVCI 
1EMSEVRLNL 
QVTATKADGG 
KVPEK H W IG
f q r i l q k q g f
VCIGRRPFTK
KLAHKAEDEG
EECIEY K V G K
GERVNEAALA
SHGLQGLSAV  
EKKETLGCTC 
DKHHEQKSTA 
TQVIDTKNIL  
AGVIGVELGS 
KFKLNTKVTG 
HLGLEELGIE  
IICVEGHAGG  
FPPAAMSRAK  
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PLRTTADQPI
LNVGC1PSKA
VKALTGGIAH
IA T G SEV T Pr
VWQRLGADVT
ATKKSDGKID
LDPRGRIPVN
AVHIDYNCVP
TNADTDGHVK
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VSIEAASGGK
TR FQ T K IPR I
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Spot 2262 Glutathione S-transferase
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P robab ility  Based Nowse Score
75 1 328
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i -, 4 K * r  i : . >
1883 963 2154.922
1025 528
1077252
1337 853
2126.082
r  n : ■ r168 1 781 ,70*187
HO 1000
— 1-------------1-------------i------------- 1-------------!—
1200 1 400 1 600 1600
----------1-------------■-------------1------------ 1-------------i---------
2000 2 200 2 400
mk
S ta r t _ End Observed M r(e x p t) H r (c a lc ) D e lta H i s s I/i n i *»
1 - 14 1601 .78 1680 .77 1 68 0 .8 8 -0 .1 1 1 .MPPYTWYTWRCR. C
2 - 12 1 337 .83 133 6 .8 3 1 33 6 .7 2 0 .1 3 0 H.PPYTW YFPVR.6
31 - 43 1733 .84 173 7 .8 4 1 7 3 2 .8 3 -8 .0 7 0 K . rrWTVETVQKOSLK .A
46 - 35 1136 .61 1133 .60 1 1 3 5 .5 7 0 .0 3 0 K.ASCLY&QLPK.F
M - 71 1 883 .96 1882 .96 1 8 8 2 .9 4 0 .0 1 0 K . rQDUOLTl.YQSRT IL R . X
72 - 02 1214 .64 121 3 .6 3 1 21 3 .6 9 - 0 .0 7 1 R.HLGRTL&LY&K.D
S3 - 101 2 11 6 .9 0 711 3 .8 9 2 1 1 3 .9 7 -8 -0 8 0 K . DQQUUU.VSMVMDGVKD1.R . C
83 - 101 2 1 3 2 .8 7 2 13 1 .8 6 2 1 3 1 .9 7 -0 .1 1 0 K.DQQEAALVDMVMDGVEDLR.C O x id a t io n  (H)
104 - 121 215 4 .9 2 215 3 .9 1 2 1 5 4 .8 5 -0 .1 4 1 K . Y I SI. I  YTmrEAUKDOYVK. A
122 - 141 2 12 6 .0 8 212 3 .0 7 2 1 2 3 .1 5 - 8 .0 8 0 K . ALPGQLKPrZTlXSQHQCGK. T
192 • 209 1 90 3 .9 2 1 9 0 2 . 9 1 1 9 0 2 .9 8 -0 .0 8 0 K .ATLASPEYVRLPIMUNUK. Q
1 K P P Y T W Y F P  VRGRCAALRH LLADQGQSRK EEW TVETW Q EGSLKASCLY
S I  GQLPKFQDGD L T L Y Q SV T IL  RHLGRTLGLY GKDQQEAALV DHVNDGVEDL
1 0 1  R C K Y IS L IY T  MYEAGKDDYV KALPGQLKPF ETLLSQMQGG K T F IV G D Q IS
1 5 1  FADYIfLLDLL LIHEVLAPGC L D A F PL L SA Y  VCRLSARPKL KAFLASPEYV
2 0 1  MLPINGMGKQ
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■ 1 ■
•00 •1000 1200 1400 1000 i«oo 2000 2200 2400
S t a r t - End O b s e rv e d M r ( e x p t ) N r ( c a l c ) D e l t a M is s S eq u en ce
6 - 12 8 3 1 .5 3 8 3 0 .5 2 8 3 0 .5 0 0 .0 2 0 R .V P E S L L R .6
13 - 20 9 6 1 .4 9 9 6 0 .4 8 9 6 0 .4 5 0 .0 4 0 R.GPSW DPFR.D
21 - 27 9 6 0 .4 9 9 5 9 .4 8 9 5 9 .4 2 0 .0 6 0 R.DW YPKSR.L
80 - 89 1 0 7 5 .6 5 1 0 7 4 .6 4 1 0 7 4 .5 7 0 .0 7 0 R .Q L S S G V S E IK .H
97 - 1 12 1 7 8 4 .8 2 1 7 8 3 .0 2 1 7 8 2 .9 2 0 .1 0 0 R . VSLDVMHFAPDEL1VK. T
124 - 1 3 6 1 6 5 5 .7 9 1 6 5 4 .7 8 1 6 5 4 .7 4 0 .0 3 1 K . HEERQDEKCY1SR. C
128 - 1 36 1 1 0 4 .6 1 1 1 0 3 .6 0 1 1 0 3 .5 0 0 .1 0 0 R .Q D E M 6X IS R .C
172 - 1 88 1 9 0 6 .1 4 1 9 0 5 .1 3 1 9 0 4 .9 8 0 .1 4 0 K . LATQ SM EITIPVTFESR  .A
189 - 1 98 9 4 1 .5 2 9 4 0 .5 1 9 4 0 .5 0 0 .0 1 0 R.AQLGGPEAAK.S
1 MTERRVPFSL LRGPSWDPFR DWYPHSRLFD QAFGLPRLPE EWSQWLGGSS
5 1 WPGYVRPLPP AAIESPAVAA PAYSRALSRQ LSSGVSEIRH TADRWRVSLD
1 0 1 VHHFAPDELT VKTKDGWEI TGKHEERQDE HGYISRCFTR KYTLPPGVDP
1 5 1 TQVSSSLSPE GTLTVEAPMP KLATQSHEIT IPVTFESRAQ LGGPEAAKSD
2 0 1 ETAAK
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2200 2400
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S t a r t - End O b ser v ed Mr <e x p t ) Mr( c a l c ) b e l t  a M is s S eq u e n c e
5 - 1 2 9 8 7 53 9 8 6 .5 2 9 8 6 .6 0 - 0 . 0 8 1 R . RVPPSLLR.6
6 - 1 2 8 3 1 4 7 8 3 0 .4 7 8 3 0 .3 0 - 0 . 0 4 0 R .V P F S L L R .G
6 - 2 0 1 7 7 3 9 7 1 7 7 2 .9 6 1 7 7 2 .9 4 0 . 0 2 1 R .VPFSLLR9PSW DPFR.0
1 3 - 2 0 9 61 4 5 9 6 0 .4 4 9 6 0 .4 5 - 0 . 0 0 0 R .GPSW DPFR.D
2 1 - 27 9 6 0 48 9 5 9 .4 7 9 5 9 .4 2 0 .0 4 0 R . DWYPHSR. L
28 - 37 1 1 6 3 74 1 1 6 2 .7 3 1 1 6 2 .6 1 0 .1 2 0 R . LFDQAF GLPR. L
1 2 8 - 1 3 6 1 1 0 4 52 1 1 0 3 .5 1 1 1 0 3 .5 0 0 .0 1 0 R .Q D EH G Y1SR .C
1 7 2 - 188 1 9 0 6 09 1 9 0 3 .0 9 1 9 0 4 .9 8 0 .1 0 0 K . L A T Q S M E IT IP V T F E S R . A
1 89 - 1 9 8 9 4 1 50 9 4 0 .5 0 9 4 0 .3 0 - 0 . 0 0 0 R .AQLGGPEAAX. S
1 MTERRVPFSL LRGPSWDPFR DWYPHSRLFD QAFGLPRLPE EUSQULGGSS
51  UPGYVRPLPP AAIESPAVAA PAYSRALSRQ LSSGVSEIRH TADRURVSLD
1 0 1  VNHFAPDELT VKTKDGWEI TGKHEERQDE HGYISRCFTR KYTLPPGVDP
1 5 1  TQVSSSLSPE GTLTVEAPMP KLATQSHEIT IPVTFESRAQ LGGPEAAKSD
2 0 1  ETAAK
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P r o b a b i l i t y  Based Bowse Score
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• 1  T f 1 7 4 4  « I M S . 79 I M S  71 4 . 4 1 • 3  T V 11E 4M V S 79  7
• t  -  i t t M 4 4  I I I M 4 . I I 3 1 * 4 .9 4 - 4 . 4 7 4
i n  -  i n 1 4 M .S 1 I N I . 31 1 N 7 . S I - 9 . 4 9 1 I . I U J B N E I  Z
I N  1 4 * § 7 7  IS 4 7 4  . 41 4 7 4  4 4 - 4  4 1 • 4  4 4 1 * 9 * 1 9  •
w  -  1 1 * i s a a  n I N I .  74 I M )  7 * 4 .4 1 4 «  V L K N U I I N N I . r
i n  m l l l l  M 1 4 3 1 .  f t 1 9 9 1 .9 9 9 . 4 4 1 K T U N a c u z a v M  1
I N  - » 1 I S M  N 1 4 1 7 .4 4 1 * 7 1  * 4 - 4 . 4 4 1 4  T U M L C iltM M K T M  4  O » l 4 4 t l 0 «  (Him - » i 1 1 1 1 . 79 1 3 4 * .7 9 1 3 4 4 .7 0 9 . 4 3 4 1  N I M i r t l T M . f i
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t * a  -  m I I S I  IS l i l t . 91 l i f t  7 4 - 4  4 1 1 4 IMVM 4*M W *  *
M l  -  I M • 3 7 . 4 4 4 1 4 .  34 1 3 9 .  31 9 .4 1 • A A 9 G T C M I.S
m  i n M l  11 4 4 4 .1 1 M 4 . 4 9 4 . 4 9 i 9  iru rC M K JC  9
h i  -  m IAA » 4 4 1 .1 1 4 * 9 .9 1 •  4 4 4 ft VWCVIVTR 3
M S  - >11 1 * 3 1 .  M 1 4 3 4 .9 7 1 * 9 9 .9 9 4 . 4 7 I K VSCVXVTK4MMBXX *
m s  wm 1 1 4 1  M 1 4 4 1 .1 4 1 4 4 S  9 9 4 . 4 1 1 9  V M V SV T K M M L L R  «  Ok H K I M  <*>
i n  -  m • 4  3 44 4 4 9 .4 7 9 4 9 .1 9 - 4 . 4 3 1 I . U M i i . l
I M  -  4 1 7 1 1 3 3 .4 4 1 9 1 9 .4 3 1 9 9 9 .9 9 9 . 4 4 4 i v u T 9 v n n . i i
m  -  m I M  41 9 9 4 .4 9 9 9 9  SO H I , 4 4 • K VTIOIRATK *
A M  -  4 4 4 1 * 1 4 .1 7 1 * 4 3 .4 * 1 * 4 3 .9 9 9 . 4 * 9 9  -* 4 W E * * m .e 6 * C A L L B . C
M )  -  4 7 4 141  41 4 4 4 .4 4 9 4 4 .9 1 - 4 , 4 1 1 K K t U I U l . T
44 7  -  4 4 1 1 7 1 1 .4 4 1 9 1 4 .4 4 1 9 1 4  4 1 - 4  4 7 4 •  9 4 JH v r* ^ i r v t *  i
1 HLRLPTVFRO 
3 1  VAVTMGPKGP 
1 0 1  VAJOIT1IEEAG 
1 5 1  VIAELKKGSK 
2 0 1  VKDGKTLKDE 
2 5 1  ISSX Q SIV PA  
3 0 1  KAPGF GDHRX 
3 5 1  TKDDAHLLKG 
4 0 1  VAVLKVGGTS 
4 3 1  LD3LTPANED 
30 1  VGYDAHAGDT 
33 1  KEEKDPGHGA
HRPVSRVLAP
TV IIEQ SV G S
DGTTTATVLA
PV TTPEEIA Q
LEIIEGM KFD
LELAMAHRKP
NQLKDKAIAT
KGDKAQIEKP
DVEVWEKKDP
Q K IG IE IIK R
VNBVEKGIID
HGGHGGGHGG
HLTRAYAKDV 
PKVTKDGVTV 
RSLAKEGEEK 
VAT1SANGDK 
RGYISPYFIH  
LVIIAEDVDG  
GGAV7GEEGL 
IOEIIEQLDV  
VIDAL MATRA 
TLKIPAHTIA  
PTKWRTALL 
GUI
KFGADARALM
AKSIDLKDKY
ISKGAMPVEI
EIGNIISDAJ!
TSKGQKCEFQ
EAL3TLVLNF
TLNLEDV0PH
TT3EYEKEKL
A V E EG IV L G G
K H A G VEGSLI
DAAGVA3LLT
LQGVDLLADA 
KNIGAKLVQD 
KPGVMLAVt A 
KKVGRKGVIT 
DAYVLLSEKK 
LKVGLQWAV 
DLGKVGEVIV 
HERLAKLSDG 
GCALLRCIPA 
VEKIHQSSSE  
TAEVW TEIP
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Spot 1060 H SP-60
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, H i 656 1194 J33
97 I 362 221 * OS. «] •
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1758S62 2 » e  I S32<BI 07 2303 14
S t a r t End ■ k t e n t l M r(rx*t > H r< r* lc> D e l t a ■ i s a S eq u en ce
I M — 141 0 3 3 .4 4 0 3 4 .4 3 034 .4 4 - 0 .0 1 0 K .U W V I I R  ,*
141 - I M 1 4 0 0 .9 7 1 3 * 9 .9 4 1 3 * 9 .9 0 0 .0 4 1 R.RfiUMUIVMVIAELK.K Ox 1 Oat VO ft (0)
I M - 221 1 9 3 0 .9 1 1 9 3 7 .9 1 1 9 3 7 .9 4 - 0 .0 3 1 K TLKDELIIIEGKXFPR . 6 O x id a t io n  |B)
« T - 249 1 4 0 1 .7 0 1 4 0 0 .4 9 1 4 0 0 .7 4 - 0 .0 3 0 k . r e r  v m y v l l  vck . k
149 - 7*0 2 1 4 3 .1 9 2 3 4 4 .1 9 2 1 4 4 .1 1 0 .0 4 0 R. K9LVIIACBV»CC*LSTI.VUni-L
*91 - 101 1 1 3 1 .7 3 1 1 3 2 .7 3 1 1 3 2 .7 4 - 0 .0 1 1 r . lkv clqw a vk  . a
*91 - 301 9 1 2 .3 9 9 1 1 .3 0 9 1 1 .3 0 - 0 .0 0 0 K .VKLIJVVAVK A
10* - 109 0 1 1 .3 0 0 1 * .1 7 0 1 7 .1 0 - 0 .0 1 0 K. AR6PCM0I. K
171 - 107 2 0 3 0 .0 7 2 0 3 7 .0 4 2 0 3 7 .0 2 0 .0 3 0 r  . i  g o i iz o L o v r r s r iK K . i
171 - 309 2 2 9 3 .1 4 2 2 9 4 .1 1 2 2 9 4 .1 3 - 0 .0 2 l R . I «B i  m u « T  t  SZTEKEX. L
190 « 1*4 0 4 1 .1 1 0 4 2 .3 0 0 4 7 .3 0 0 .0 1 1 K.LMBRLAK.L
441 - 470 * 4 1 .4 1 9 4 0 .4 4 9 4 0 .4 1 0 .0 3 1 K .ICIEIIK K .T
474 ~ 401 0 4 4 .3 0 0 4 1 .4 9 0 4 3 .4 9 0 .0 1 0 K. 1PAMTIAK .9
1 HLRLPTVFRQ HRPVSRVLAP HLTRAYAKDV KF GAD ARAL M LQGVDLLADA
51 VAVTHGPKGR TVIIEQSVGS PKVTKDGVTV AKSIDLKDKY KNIGAKLVQD
101 VANNTNEEAG DGTTTATVLA RSIAKEGFEK ISKGAHPVEI RRGVHLAVDA
151 VIAELKKGSK PVTTPEEIAQ VATISANGDK EIGNIISDAH KKVGRKGVIT
201 VKDGKTLHDE LEIIEGMKFD RGYISPYFIN TSKGQKCEFQ DAYVLLSEKK
251 ISSIQ SIV PA LEIANAHRKP LVIIAEDVDG EALSTLVLHR LKVGLQWAV
301 KAPGFGDHRK NQLKDHAIAT GGAVFGEEGL TLNLEDVQPH DLGKVGEVIV
351 TKDDAHLLKG KGDKAQIEKP IQEIIEQLDV TTSEYEKEKL HERLAKLSDG
401 VAVLKVGGTS DVEVNEKKDR VTDALNATRA AVEEGIVLGG GCALLRCIPA
451 LDSLTPANED QKIGIEIIKR TLKIPAMTIA KNAGVEGSLI VEKIHQSSSE
501 VGYDAHAGDF VNHVEKGIID PTKWFTALL DAAGVASLLT TAEWVTEIP
551 KEEKDPGHGA HGGHGGGHGG GHF
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41 * 7 2 1 3 4 4 .7 1 1 3 4 3 .7 0 1 3 4 3 .7 1 - 0 .0 1 0 R.TVIIEQSW6SPK.V
9 7 - 12 1 2 9 6 0 .1 6 2 3 5 9 .1 6 2 3 9 9 .2 4 - 0 . 0 9 0 K . LVgDVAJMTKtUtUDGT TTATVLAK . S
1 3 4 » 141 8 9 3 .4 4 0 5 4 .4 3 8 9 4 .4 6 - 0 . 0 3 0 K . GAKFVEIR. i)
1 4 3 - 1 5 7 1 5 7 2 .9 6 1 5 7 1 .9 5 1 5 7 1 .9 0 0 . 0 5 1 R . IJVHLA VftAVIAELKX. Q O xidation  (Hi
204 - 2 2 1 1 9 3 8 .9 7 1 9 3 7 .9 6 1 9 3 7 .9 4 0 . 0 2 1 K . TLEMXE1IECMKFDR . 0 O x id ation  |R|
2 7 7 - 2 3 3 1 3 0 9 .7 4 1 3 8 8 .7 4 1 3 8 8 .7 0 0 . 0 4 0 r  . c i r i s p v r i i r r s * . e
m - 2 4 9 1 6 0 1 .0 1 1 6 0 0 .8 8 1 6 0 8 .7 4 0 . 0 6 0 K. CErOOAWLLSEX. K
2 9 1 - 2 6 8 1 9 1 9 .1 0 1 9 1 8 .0 9 1 9 1 0 .0 6 0 . 0 3 0 k . i s s iQ s iv p a iE iJ u u m a .K
2 4 9 - 2 9 0 2 3 6 5 .  34 2 3 6 4 .3 5 7 3 4 4 .3 3 0 . 0 2 0 R. K2LVIIAEDVDCEJU. ST1VLKR. L
2 9 1 - 301 9 1 2 .5 0 9 1 1 .3 8 9 1 1 .5 6 - 0 . 0 0 ■ K.V6MJWAVK.A
302 • 3 0 9 0 3 3 .4 0 0 3 7 .3 9 8 3 2 .3 8 0 . 0 1 0 K .A P G rC O n .K
302 - 3 1 0 9 4 1 .4 7 9 6 0 .4 7 9 6 0 .4 8 - 0 . 0 1 l K .A F C rC M M .V
371 - 3 8 9 2 2 9 3 .2 3 2 2 9 4 .2 2 7 2 9 4 .1 3 0 . 0 7 i R . 1 OE1 1E9LWTTSEXEKEK. L
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4 4 1 - 4 7 0 9 4 1 .5 9 9 4 0 . 39 9 4 0 .6 1 - 0 . 0 2 1 K .I 0 I E 1 I K R .7
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Spot 1736 Maspin precusor
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»0 1000 1X0 1400 <aoo 1000 2000 2200 2400 i i o
mt
< l « l t - Em I O b a r iv r d M r (« x » t ) M r ( c a l c ) Dr I t « M ia s •zI•
2 - 2 2 2 2 1 9 .9 9 2 2 1 0 .9 9 2 2 3 9 .0 9 - 0 . 1 1 0 a . I>4HOOi4L«UUI14t AVllLt'K . 0
33 - 0 * 1 0 7 0 .9 2 1 0 2 9 .9 1 1 0 2 9 .9 2 - 0 . 0 1 0 K . CDTAMFIG9VI HTEMVK . D
72 - 04 1 2 3 3 .9 4 1 2 5 2 .9 3 1 2 5 2 . SO 0 . 1 3 0 K . OVPfbPQTVTSOVHK. L
•  3 — 9 2 9 4 4 .3 4 9 4 3 .3 4 9 4 3 .3 0 0 . 0 3 0 K .L S SrY SL K .L
1 4 3 - 1 2 3 3 3 4 2 .2 4 2 3 4 3 .2 4 2 3 4 5 .0 2 - 0 . 0 4 0 K OI TDCKFFHIIADKSVNDQTK T
1 ( 1 - 1 7 0 1 7 3 9 .2 1 1 7 3 0 .0 0 1 7 3 7 .9 2 0 . 0 4 1 K . ILWMJUtXrVtilOMK. K
3 2 1 • 2 2 9 1 1 0 1 .7 0 1 1 0 0 .2 9 1 1 0 0 .6 2 0 . 0 7 0 K . I  I t l  l’FQHK . H
2 ) 2 - 2 3 * 1 2 1 4 .7 * 1 2 1 3 .7 9 1 2 1 3 .2 9 0 . 1 0 0 K.HLSHTILLPK t> O x id a t io n <11
2 3 4 - 2 7 3 2 2 2 2 .2 7 2 2 2 1 .0 2 2 2 2 2 .0 3 - 0 . 1 2 0 K. OL»SESLSO«TKPSniUUU(-V O x id a t io n  I Hi
300 - 3 12 1 9 1 7 .2 2 1 9 1 6 .0 7 1 * 1 2 .0 1 0 . 0 2 0 K. HirSEOTSOFSOKSETK.6
100 - 3 1 2 1 9 3 4 .0 0 1 9 3 2 .9 9 1 9 3 2 .0 0 0 . 1 0 0 K.MirSEOTS&fStHtSKTK.O O x id a t io n  ( I )
3 2 7 m 3 43 2 0 1 7 .0 2 2 0 1 2 .0 3 2 0 1 3 .9 3 0 . 1 0 0 K.VCLEITEDOODSIEVPSAK. I
331 - 324 1 7 1 6  01 1 7 1 5 .0 2 1 7 1 4 .8 7 0 . 1 3 0 K.DELMOONPFIYIIR.M
3 7 0 3 7 2 0 3 0 .4 2 0 3 7 .4 2 0 3 7 .4 7 - 0 . 0 2 0 K . a i i r r s K . r
1 HGQNSMDALQ LAHSAFAVDL FKQLCEKEPL GNVLFSPICL STSLSLAOVG
51 AKGDTANEIG QVLHFEHVKD VPFGFQTVTS DVMKLSSFYS LKLIKRLYVD
1 0 1 KSLNLSTEFI SSTKRPYAKE LETVDFKDKL EETKGQINNS IKDLTDGHFE
1 5 1 NILADNSVND QTKILWNAA YFVGKWMKKF PESETKECPF RLNKTDTKPV
2 0 1 QMMNMEATFC NGN ID S INC K IIELPFQNKH LSMFILLPKD VEDESTGLEK
2 5 1 IEKQLNSESL SQWTNPSTMA NAKVKLSIPK FKVEKHIDPK ACLENLGLKH
3 0 1 IFSEDTSDFS GMSETKGVAL SNVIHKVCLE ITEDGGDSIE VPGARILQHK
3 5 1 DELNADKPFI YIIRHNKTRN IIFFG K FCSP
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S t t f t  -  Em I 0 4 a « r * » 4 M r < « x » n N r < t a l c > f t o l t * N iM S o o o o n e o
49  64 1 9 7 9 .9 9 1 9 4 9 .9 9 1 9 4 9 .9 2 0 .0 3 0 K . C D  TAME I c g v u r o w x . D
• 0  * 7 9 4 4 .4 9 9 4 3 .4 7 9 4 3 .3 0 0 .0 3 0 K.LSSFTSLX.L
9 7  -  199 1 4 2 4 .7 7 1 4 2 3 .7 4 1 4 2 3 .7 4 0 .0 3 0 X . S U L S T E r iS S m .B
1 3 9  -  1S9 2 3 4 4 .1 3 2 3 4 3 .1 4 2 3 4 9 .0 9 0 .0 6 0 K. OLn>&KTF-MILAIlHSVmi0 TK . t
1 9 9  -  179 1 2 9 3 .7 4 1 2 9 2 .7 9 1 2 9 2 .7 9 0 .0 0 0 X. ILWXAAYFVGK. •
1 9 9  -  1 7 3 1 7 3 9 .9 9 1 7 3 7 .9 9 1 7 3 7 .9 4 0 .0 2 1 K. ILWlUAYTVGXtfNK. X
192  -  1 9 9 1 9 4 3 .4 9 1 9 4 2 .4 7 1 0 4 2 .3 3 —0 . 0 4 1 K . E ( m U 9 . 7
2 1 4  -  224 1 1 9 1 .4 4 1 1 9 9 .4 4 1 1 0 0 .4 2 0 .0 3 0 K. IEELPFQMK.H
2 2 9  -  2 3 4 1 1 9 9 .4 4 1 1 9 7 .4 4 1 1 9 7 .4 9 - 0 .0 6 0 K .M -SW ILLPK .B
2 2 9  -  2 3 4 1 2 1 4 .7 4 1 2 1 3 .7 3 1 2 1 3 .4 9 0 .0 4 0 K.KLSMTILU'K.D O x id a t io n  (B)
2 4 9  -  2 49 2 2 2 2 .9 9 2 2 2 1 .9 7 2 2 2 2 .0 3 - 0 . 0 9 0 K. QLMVESLSVVnWSTIUJMkX .V O x id a t io n  (9)
2 9 9  -  311 1 9 1 7 .9 9 1 9 1 4 .9 9 1 9 1 4 .9 1 0 . 1 7 0 K. HirKEOTSM-SOtSZTK. G
2 9 9  -  311 1 9 1 7 .7 9 1 9 1 4 .7 7 1 9 1 4 .9 1 - 0 ,0 4 0 k  . M ir s z o is o r s G M s e n t . o
2 9 9  -  311 1 9 3 3 .9 9 1 9 3 2 .9 7 1 9 3 2 .9 0 0 .0 6 0 K .M i r s a m o r s a r a n c . G  O x id a t io n  <a>
3 2 2  -  349 2 9 1 4 .9 2 2 9 1 9 .9 1 2 9 1 9 .9 9 - 0 .0 3 0 K .V d tlT tD G G D S ltW U U t. 1
J44 -  399 1 7 1 9 .9 9 1 7 1 4 .9 7 1 7 1 4 .9 7 0 .9 1 0 K. J>ELJWU>NW 1Y11K . M
349 -  371 9 3 9 .4 7 9 3 7 .4 4 9 3 7 .4 7 - 0 .0 1 0 t . u n r a t . F
3 4 9  -  379 1 3 2 9 .4 4 1 3 2 9 .4 4 1 3 2 9 .4 4 - 0 .0 0 1 r  N i i r r a c r c s 2 . -
1 HDALQLANSA FAVPLFKQLC EKEPLGNVLF 3PICLSTSLS LAQVGAKGDT
51 AMEIGQVLHF EMVKDIPFGF QTVTSDVNKL SSFYSLKLIK PLYVDKSLML
101 SIEFISSTKR PYAKELETVD FKDKLEETKG QINNSIKDLI DGHFENILAD
151 NSVNDQTKIL WNAAYFVGK WMKKFPESET KECPFRLHKT DTKPVQHHNM
201 EATFCHGNID SINCKIIELP FQMKMLSMFI LLPKDVEDE3 TGLEKIEKQL
251 HSESLSQWTH PSTNANAXVK LSIPKFKVEK MIDPKACLEN LGLKHIFSED
301 TSDFSGNSET KGVALSNVIH KVCLEITEDG GD SI EVP GAR ILQHKDELMA
351 DHPFIYIIRH NKTRIIIIFFG KFCSP
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Spot 2507 Nucleoside diphosphate kinase A
MOO
2000 P robab ility  Based house Score
1 344 921
919 422 1 493930
1 70 7 931
2066 093
S ta r t - End Observed M rte x p t) H r<c a lc ) D e lta H is a Sequence
1* - 26 8 28 .48 8 2 7 .4 7 8 2 7 .9 1 -0 .0 4 0 R .G L V 6E IIK .R
19 - 27 9 84 .67 9 83 .66 9 8 3 .6 1 0 .0 3 1 R .H .V G E IIK R .F
39 - 49 170 7 .9 3 1706 .94 1 70 6 .9 3 0 .0 2 1 R.LVGLKTMOASEDLLK.E O x id a tio n  (R)
40 - 49 1 19 7 .6 8 1196 .67 1 1 9 6 .3 7 0 .0 9 0 K.FMQASEDLLK.E O x id a tio n  ( I )
40 - 36 2 8 6 6 . 09 2063 .09 2 0 6 3 .0 2 0 .0 7 1 K . FMQASEDU KEHYVDLK . D
67 - OS 2 14 8 .2 0 2147 .19 2 1 4 7 .0 5 0 .1 4 0 K . YMHSGPWAMWEGLMWK. T 2 O x id a tio n
89 - 109 1786 .03 178 3 .0 4 178 4 .9 1 0 .1 3 0 R . VHLCETMPADSUPGTIR. G
89 - 10S 1 00 2 .0 7 1001 .06 1 00 0 .9 0 0 .1 6 0 R-VMHiEtKPADSKPGTIR.tr O x id a tio n  (H)
106 - 114 1 09 1 .3 9 1030 .38 1 03 0 .4 9 0 .0 9 0 R.GDFCIQV6R.K
1 MANCERTFIA IKPDGVQRGL VGEIIKRFEQ KGFRLVGLKF MQASEDLLKE
51 HYVDLKDRPF FAGLVKYMHS GPWAMVWEG LHWKTGRVM LGETHPADSK
1 01 PGTIRGDFCI QVGRNIIHGS DSVESAEKEI GLUFHPEELV DYTSCAQNUI
1 5 1 YE
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Spot 2248 Proteasome alpha 2 subunit
679330
2000
697 322
1300
737 3 27
769 365
2299 32$I 195364 2027 3 25
S t A r t - End Obeer* ed M r< e x p l> K r (C d lC ) D e l t a K ie s Sequence
4 - 17 1478 78 1 4 7 7 .7 7 1 4 7 7 .7 1 0 .0 7 0 R.GYSFSLTTFSPSGK.L
18 - 38 2027 13 2 0 2 6 .1 2 2 0 2 6 .1 3 - 0 .0 3 0 K . LVQLEXALAAVAGCAPSVG1K. A
S3 - 39 893 43 8 9 4 .4 2 8 9 4 .4 4 - 0 .0 2 0 K .S IL Y D E R .S
70 * 83 1564 75 1 5 6 3 .7 4 1 5 6 3 .7 5 - 0 .0 1 0 K . HI6LVYSCMGPDYR.V
171 - 173 637 31 6 3 6 .3 0 6 3 6 .3 3 - 0 .0 3 0 K . T lX E K .it
171 - 176 793 41 7 9 2 .4 0 7 9 2 .4 3 - 0 .0 3 1 K . TFXEKH. Y
919 - 226 943 54 9 4 2 .5 3 9 4 2 .3 5 - 0 .0 2 1 R.KLTPTEVK.P
220 - 226 787 38 7 8 6 .3 7 7 8 6 .4 5 - 0 .0 8 0 R.LTPTEVK.D
220 - 233 1304 83 1 3 0 3 .8 2 1 3 0 3 .8 2 0 .0 0 1 R.LTPTEVKDYUU1IA. -
1 AERGYSFSLT TFSPSGKLVQ IEYALAAVAG GAPSVGIKAA NGWLATEKK
51 QKSILYDERS VHKVEPITKH IGLVYSGMGP DYRVLVHRAR KLAQQYYLVY
1 0 1 QEPIPTAQLV QRVASVMQEY TQSGGVRPFG VSLLICGUNE GRPYLFQSDP
1 5 1 SGAYFAWKAT AMGKNYVNGK TFLEKRYNED LELEDAIHTA ILTLKESFEG
2 0 1 QMTEDNIEVG ICNEAGFRRL TPTEVKDYLA A IA
40 50 60
P robab ility  Based dowse Score
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Spot 1204 Protein disulfide-isomerase A3 precusor
1277 760
107377 1163*30
P r o b a b i l i ty  rWwse S co re
1 107 393
1 83 8 995
23990471994017
no i000 1250 1500 1750 2000 2250 2500 2750 2000
■  ft
S ta r t  - End Observed H r < e x p t ) M r ( c a lc ) D e l ta M rs * Sequence
21 - 38 1 9 9 4 .0 9 1 9 9 3 .0 8 1 99 2 .9 6 0 .1 2 0 R . L V A A S D V L X L T D D H F E S R . I
63 - 73 1 19 1 .6 3 1 1 9 0 .6 4 1 1 9 0 .3 9 0 .0 3 0 R . L A F E Y E A A A T R . L
103 - 119 1 65 2 .0 3 1 6 3 1 .8 2 1 6 5 1 .7 6 0 .0 7 1 K . I  r K D W K A U A Y D & P R . T
176 - 183 1 17 9 .6 6 1 1 7 8 .6 5 1 1 7 0 .5 8 0 .0 7 1 K  . A A S M L K D H Y R  . F
259 - 271 1 6 1 9 .8 2 1 61 8 .8 2 1 6 1 8 .7 8 0 .0 4 0 K . D L L I A Y Y D V D Y Z K . H
297 - 304 8 7 7 .4 7 8 7 6 .4 6 8 7 6 .4 8 * 0 .0 2 0 K . L M F A V A S R . K
336 - 344 1 1 7 2 .6 0 1 1 7 1 .6 0 1 1 7 1 .3 3 0 .0 6 0 K . F V H Q E E F S R . D
352 - 363 1 5 1 5 .8 7 1 51 4 .8 6 1 5 1 4 .7 5 0 .1 1 1 R . F L Q D Y F D G M L K R . Y
380 - 395 1 83 3 .0 4 1 83 2 .0 3 1 8 3 1 .9 0 0 .1 3 0 K . V W A E M F D E I V N N E M K  . D
434 - 448 1 6 8 0 .6 9 1 6 7 9 .6 8 1 6 7 9 .7 5 -0 .0 6 0 k . m d a t a m d v p s p f e v r . o  O x i d a t i o n  ( B )
449 - 460 134 1 .7 1 1 3 4 0 .7 0 1 3 4 0 .6 8 0 .0 2 0 R . C r P T l Y F S P A M K . K
462 - 466 5 99 .44 5 9 8 .4 3 5 9 8 .3 8 0 .0 5 1 K . L M P K K . Y
472 - 482 1 3 7 0 .8 2 1 3 6 9 .8 1 1 3 6 9 .6 9 0 .1 2 0 R . E X S D F I S X L Q K . E
403 - 496 1 57 9 .9 2 137 8 .9 1 1 9 7 8 .8 3 0 .0 9 0 R . E A T m P P V I Q C E K P K . K
403 - 497 1 7 0 7 .8 4 1 7 0 6 .0 3 1 7 0 6 .9 2 - 0 .0 9 1 R . E A T H P P V I Q E E K P K K . K
1 HRLRRLALFP GVALLLAAGP LVAASDVLEL TDDHFES R I3 DTGSAGLHLV
51 EFFAPRCGHC KPJLAPEYEAA ATRLKGIVPL AKVDCTANTN TCNKYGVSGY
1 0 1 PTLKIFRDGE EAGAYDGPRT ADGIVSHLKK QAGPASVPLR TEEEFKKFIS
1 3 1 DKDASIVGFF DDSFSEAHSE FLKAASHLRD MYRr AHTNVE SLVNEYDDNG
2 0 1 EGIILFRPSH LTNKFEDKTV AYTEQKHTSG KIKKTIQENI FGICPHHTED
2 5 1 NKDLIQGKDL LIAYYDVDYE KNAKGSNYWR NRVHHVAKKF LDAGHKLHFA
3 0 1 VASRKTFSHE LSDFGLESTA G E IPW A IR T AKGEKFVKQE EFSRDGKALE
3 3 1 RFLQDYFDGM LKRYLKSEPI PESNDGPVKV W AENFDEIV NMEMKIVLIE
4 0 1 FYAPHCGHCK NLEPKYKELG EKLSKDPNIV 1 AKMDAIAHD VPSPYEVRGF
4 5 1 PTIYFSPAMK KLHPKKYEGG RELSDFISYL QREATHPPVI QEEKPKKKKK
5 0 1 AQEDL
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Spot 1216 Protein disulfide-isomerase A3 precusor
: r,.
PrtfMfeWiUi e« M  Scot*
-h. ;  *,
1277 715
. \*y » r
. M . r>2
i "7 ■i< x7;
. ■45SI
1 X 3  711
996.514 I 71 7 828
; :? a ; ;
i 5 y ,i;
2X4 361
190 1000 r  i ■ ■ ■ 1280 1800 1180 2000 2280 2800 2180
S t a r t - C M D k H r t e l H M eiqpt) N r ( r a l c ) D e l t a H i 90 S e q u e n c e
* 3 -  73 1 1 9 1 .6 9 1 1 9 0 .6 1 1 1 9 0 .3 9 0 . 0 2 0 R.LAJPKXEAAATR.L
9 5 -  1 0 4 1 0 0 4 .3 0 1 0 0 3 .3 0 1 0 0 3 .3 6 0 . 0 2 0 K . YGVS6YPTLK. I
1 03 -  1 1 9 1 6 3 9 .0 9 1 6 3 1 .0 1 1 6 3 1 .7 6 0 .0 3 1 X . IFRDCEEAGAYDCPB. V
108 -  1 1 9 1 9 3 6 .9 9 1 9 3 3 .3 9 1 2 3 3 .3 1 0 . 9 9 0 R . DCrCAQAYD6PR. T
9 1 3 -  9 9 6 1 4 9 7 .7 3 1 4 2 6 .7 9 1 4 2 6 .7 0 0 .0 2 1 K. I'EBKTVAYTCPJt N
9 91 -  304 0 7 7 .4 3 0 7 6 .4 4 0 7 6 .4 0 - 0 . 0 4 0 i . u n n n . R
306 -  3 9 9 9 3 7 3 .3 3 9 3 7 4 .3 9 2 3 7 4 .3 0 0 .0 2 0 X . TFSMEL SOPOLE S TAGS IP W A IR . T
336 -  344 1 1 7 9 .4 0 1 1 7 1 .4 7 1 1 7 1 .3 3 - 0 . 0 6 0 K.FVHOECrSR.D
336 -  344 1 1 0 0 .9 6 1 1 9 7 .3 9 1 1 0 7 .3 3 0 . 0 2 0 x .r v M g E c r s s .D  o x i d a t i o n  (X)
3 39 -  3 6 9 1 3 3 9 .6 7 1 3 3 0 .6 7 1 3 3 0 .6 9 0 . 0 2 0 X.riQOn'OGHLX.K
3 39 -  3 6 3 1 3 1 3 .7 0 1 3 1 4 .7 0 1 3 1 4 .7 3 0 .0 3 1 St.FLQDH'OtlfLKR.Y
3 67 -  3 7 9 1 3 6 0 .6 3 1 3 6 7 .6 3 1 3 6 7 .6 6 - 0 . 0 3 0 K,SEPIPESHDCPVK,V
300 -  39  3 1 0 3 3 .0 1 1 0 3 2 .0 1 1 0 3 1 .9 0 0 .1 1 0 x . v w a r h t w  r v n o K  - D
4 3 8 -  4 4 0 1 6 6 4 .9 0 1 6 6 3 .7 9 1 6 6 3 .7 3 0 .0 4 0 K . MBATAHOVFSPXCVR . 0
4 3 4 -  4 4 0 1 6 0 0 .0 4 1 6 7 9 .0 4 1 6 7 9 .7 5 0 .0 9 0 KHDATAXDVPSPYIVR & O x id a t io n  (H)
4 4 9 -  4 6 0 1 3 4 1 .7 0 1 3 4 0 .6 9 1 3 4 0 .6 0 0 .0 2 0 B.GPPTIYPSPAHX.K
4 7 9 -  4 0 9 1 3 7 0 .7 9 1 3 6 9 .7 2 1 3 6 9 .6 9 0 . 0 3 0 X . FLVDf ISYI QR.F
4 0 3 •  4 9 6 1 3 7 9 .9 4 1 3 7 0 .0 4 1 3 7 0 .0 3 0 .0 1 0 R . EATRPPV1QECKTK. K
1 KRLRPLALFP GVALLLAAAR LAAA5DVLEL TDDNFESRIS DTG3AGLHLV
31 EFFAPWCGHC KRLAPEYEAA ATRLKGIVPL AKVDCTANTN TCNKYGVSGY
1 0 1 PTLKIFRDGE EAGAYDGPRT ADGIV3HLKK QAGPASVPLR TEEEFKKFIS
131 DKDASIVGFF DDSFSEAHSE FLKAASNLRD NYRr AHTNVE SLVNEYDDNG
201 E G IIL F P P S H LTNKFEDKTV AYTEPKHTSG K IK K F IjG N I FGICPHHTED
231 NKDLIQGKDL LIAYTDVDYE KNAKGSNYVR NRVHHVAKKF LDAGHKLHFA
301 VASRKTFSME LSDFGLESIA G E IP W A IR T AKGEKFVNQE EFSRDGKALE
351 RFLQDYFDGN LKRYLKSEPI PESNDGPVKV W AEM FDEIV HHLMKDVLIE
401 FYAPHCGHCK NLEPKYKELG EKLSKDPNIV I AKKDATAMD VPSPYEVRGr
4 31 PTIYFSPAMK KLNPKKYEGG RELSDFISYL QREATHPPVI QEEKPKKKKK
501 AQEDL
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Spot 1178 Protein disulfide-isomerase ER60 precusor
r t ct: at:: 1 Ba:cd rtoM:c : : j- c
m i i n
TS9295
600
—i------------'
BO
r -  ■ p  
1000
■ --  r  r : ; 
1300 1400 10)0
i 5 
ISO
i' 1 1 I i 
2000 2200 2400
m *
S t a r t  - End Observed N r ( r x p t ) M r ( c a lc ) D e l t a M is s Sequence
63 - 73 1 1 9 1 .6 2 1 1 9 0 .6 1 1 1 9 0 .5 9 0 .0 1 0 R.LAPEYEAAATR.L
95 - 104 1 0 8 4 .5 7 1 0 8 3 .5 6 1 0 8 3 .5 6 0 .0 0 0 K . YGVSGYPTLK. I
105 - 119 1 6 5 2 .8 4 1 6 5 1 .8 3 1 6 3 1 .7 6 0 .0 7 1 K.JFRDGEEAGAYDGPR. T
259 - 271 1 6 1 9 .7 9 1 6 1 8 .7 9 1 6 1 8 .7 8 0 .0 1 0 K . DLL LAYYDVDYEK. M
352 - 363 1 5 1 5 .7 8 1 5 1 4 .7 7 1 5 1 4 .7 5 0 .0 2 1 R . FLOOWTDGHLKR . Y
434 - 448 1 6 6 4 .8 3 1 6 6 3 .8 2 1 6 6 3 .7 5 0 .0 7 0 K.MDATAHDVPSPYEVR. 6
434 - 448 1 6 8 0 .7 0 1 6 7 9 .6 9 1 6 7 9 .7 5 - 0 .0 5 0 K .MDATAMDVPSPYEVR. 6 O x id a t io n  (H)
449 - 460 1 3 4 1 .6 8 1 3 4 0 .6 7 1 3 4 0 .6 8 - 0 .0 0 0 R . GFPTIYFSPAHK. K
472 - 482 1 3 7 0 .7 0 1 3 6 9 .6 9 1 3 6 9 .6 9 0 .0 0 0 R.ELSDF1SYLQR.E
403 - 496 1 5 7 9 .8 2 1 5 7 8 .8 1 1 5 7 8 .8 3 - 0 .0 1 0 R . EATMPPVIQEEKPK. K
1 HRLRRLALFP 
51 EFFAPWCGHC 
101 PTLKTFRDGE 
151  PKDASIVOrr 
201  EGIIL.FRPSH 
251  NKDHOGXDL 
301 VASRKTrSHE 
351  RFLQDYFD6H 
401 FYAPOCGHCX 
451 PTIYFSPJUOC 
501  AQCDl
GVALLL AAAP. 
KRLAPEYEAA 
EAGAYDGPRT 
rPSFSElHSE 
LTNKFEDKTV 
LIAYYDVDYE 
LSDFGLESTA 
LKRYLK3EPI 
NLEPKYKELG 
KLNPKKTEGG
LAAASDVLEL
ATRLKGIVPL.
ADOIVSHLKK
FLKAASNLRD
1TTEPKHTS0
KNAKGSNTVR
G E IPW A IR T
PESNDGPVKV
EKL3KDPNIV
RELSOFISYL
TDDNFE3P.I3 
AKVDCTANTN 
QAGPA3VPLR 
NYRFAHTNVt 
KIKKF100NI 
NRVBHV AKXF 
AKGEKFVHOE 
WAENFDEIV 
IAKMDATAW 
QREATHPPVI
DTGSAGLBL'
TCNKYGVSG’
TEEEFKKF1
SLVNEYDl»N<
rClCPHHTE
LDAGHKLNF
IFSPDGKAL
NNENKDVLI
VPSPYEVRGI
QEEKPKKKKI
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Spot 2254  Rho-GDP-dissociation inhibitor 1
15
10
5
0
25 7550
Probab ility  B*sed Score
1 454775
/' 47
1751 k  m
907418
It 77204
14 , 80S1195 703
1364.191
1868 7 58 2045-883
> iH''H
790
• ■ . 
1000 1290 1900 790 2000 2290 2500 2790
It
S ta rt _ Kiut Observed H r(e x » t) H r ( r o le ) » e l t « H is s S e q u e n c e
34 - 43 1 2 *2 .7 3 1201.72 1201 62 0 .1 0 0 K SIQEIQELDK.0
ISO - 111 1454 .77 1433.77 1453 76 0 .0 1 1 k  . g s rv i kt c vrvK . i
l i t - 137 1132 .42 1131.41 1131 61 0 .0 1 1 K .V M R i.ivsaw .y
l i e - 137 1148 .59 1147.50 1147 40 - 0 .0 2 1 R VMREJVSGMK V O x id a tio n  (B)
131 - 137 743 .34 742 .33 762 39 -0 .0 6 0 S . I I V S M . T
128 - 134 900 .49 979 .40 979 49 -0 .0 1 0 K.TIOKTTB.K
139 - 193 1401 .00 1400.00 1600 76 0 .0 4 1 K . lDKID¥HVbSIbPR.A
139 - 153 1417.01 1414.81 1616 75 0 .0 6 1 KIDKTDOfVfcSY&PRA O x id a tio n  <H|
143 - 133 1245.41 1244.60 1244 35 0 .0 3 0 K.TDtMVSSYGPR.A
143 - 152 1241 .50 1260.50 1260 34 0 .0 3 0 K.TDZHVbSybVR.A O x id a tio n  (B)
193 - 147 1751 .05 1750.04 1750 83 0 .0 1 0 R .AEEYEFLTPVEEAPK. 6
193 • 173 2396 .09 3295 .00 2295 11 -0 .0 3 1 R.AEXYZTLTPVECAPKCMUUt.O O x id a tio n  (X)
111 “ 199 3344 .19 3363 .10 3343 11 0 .0 8 1 R. r  TDDDKTOMLSimniLT IK . X
1 MAEQEPTAEQ LAQIAAENEE DEHSVNYKPP AQKSIQEIQE LDKDDESLRK
5 1 YKEALLGRVA VSADPNVPNV WTGLTLVCS SAPGPLELDL TGDLESFKKQ
1 0 1 SFVLKEGVEY RIKISFKVNR EIVSGMKYIQ HTYRKGVKID KTDYMVGSYG
1 5 1 PRAEEYEFLT PVEEAPKGML ARGSYSIKSR FTDDDKTDHL StfEWMLTIKK
2 0 1 D¥KD
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Spot 2518 Ubiquitin-conjugating enzyme E2N
1000
769330
1213321
9 85 3 27
2006073
2093 0681763 934
2463081
S t a r t _ End O b s e r v e d Hr< e x p t > H r ( c a l c ) B e l t s H i s s S e q u e n c e
• - 14 8 8 7 . 3 6 0 8 6 . 3 3 8 8 6 . 3 2 0 . 0 3 1 R .I IK Z T Q K .L
15 - 24 1 0 3 6 . 7 0 1 0 3 3 . 6 9 1 0 3 3 . 6 3 0 . 0 6 0 R LU L EPV PG IK . A
15 - 33 2 0 0 6 . 0 7 2 0 0 3 . 0 7 2 0 0 3 . 8 3 0.02 1 h . Luusevro  i  k a c f d e s x a r  . y
31 - 33 2 1 9 6 . 2 4 2 1 9 3 . 2 3 2 1 9 3 . 0 7 0 . 1 6 0 R . YFHW IAGPQDSPFE& GTFK. L
51 - 68 1 7 6 3 . 9 3 1 7 6 2 . 9 3 1 7 6 2 . 8 9 0 . 0 4 0 K . LEIFLPKEYFW AAPK. V O x i d a t i o n  (H)
34 • 70 2 0 1 9 . 0 3 2 0 1 8 .0 4 2 0 1 8 . 8 3 - 8 . 0 1 1 K ■ l.ELFLPEEYTMAAPKVR . F O x i d a t i o n  (H)
75 - 82 9 8 5 . 5 3 9 8 4 . 5 2 9 8 4 . 3 0 0.02 0 K. IYKPHVDK. L
73 - 83 1 3 1 1 . 8 3 1 3 1 0 . 8 2 1 310 .71 8.12 1 K. I YKPSVDKl GH . I
86 - 92 8 7 4 . 3 4 8 7 3 . 3 3 8 7 3 . 3 0 0 . 0 3 0 R .I C L D U K .B
1 4 6 - 1 3 2 8 3 4 . 3 9 8 5 3 .3 8 8 3 3 . 4 0 - 0 . 0 2 0 R .l.Y A H H M l. -  O x i d a t i o n  (1 )
1 MAGLPRRIIK ETQRLLAEPV PGIKAEPDES NARYFHWIA GPQDSPFEGG
51 TFKLELFLPE EYPMAAPKVR FMTKIYHPHV DKLGRICLDI LKDKUSPALQ
1 0 1 IRTVLLSIQA LLSAPNPDDP LANDVAEQUK TNEAQAIETA RAUTRLYAMH
1 5 1 HI
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Appendix D—Spectra, MOWSE scores, matched peptide and 
sequence coverage of identified proteins (Table 4-2)
Spot 391 2-OGDH
I i i r75 100
Probability Based ttowse Score
1 126 63 6
I 1 1237/724 } . * £ : £ *  2012 .03
1 '  1660.051 1 0 5  084 *
U W I - En4 IM »rvM Mr<#vpt> I r i r i l c ) M 1 U M in
a? i n 2112.14 M il .I T M i l .  01 4.19 • 4 . 4TAAiyurrfctA¥tS9t*L3*. 4
12) - ITS 14S2 SI 1491 99 1191.44 4.44 • % LVtfrMLAVQSl.lt A
ITT - IN 1 4 7 1 .il I4 7 4 .i t 1474.49 4.12 4 l i m r 4 L M 5 K M ¥
i t s  - IM 91§4 - 19 9149.19 9149.17 -4 .44 4 K. VTMLTTTTr ISO** SALFUI. K
214 - 2)1 M l .33 947 34 947.44 4.44 4 i  F E c n n  K
278 - 111 134 3 94 1344 94 I344.4T 4.13 4 R PW .W CIV I IPAi K T
797 - 119 9174.14 9777.IS 9177.14 4.41 1 K .v i iM is E in rD iv iw a ra  t
i l l IM 1111.13 1414.44 1414.49 4 .49 4 * LJTVLAJfVlU K
T23 - 11A 134171 1349 71 1942.74 4 44 • N.EEEflFCirPSK L
30# - see 1979.79 1974.77 1714.47 4 .14 4 ic. m v w v m  r
STS - i n 193.34 994.37 994.34 -4 .41 t l . U L t U U l . R
145 " • 31 •44.34 443.34 •49.34 4.44 • R. flLLPf It K
•  51 - IM 1194.71 1413.77 149947 4 .1 4 4 0  HPLIiriFK S
• ?■ - IM l 44 7.49 1444.49 1444.74 4 . IS • ■. S S F 1 U  IrTMTIW ■ 9 ONidM
90# •14 ♦29 43 924.41 924.17 '4 .4 4 4 K.VYYPiTK.E
9)1 - •IT 1444.49 1439 44 1434.9T 4.12 • •  XEQLSPm'M.LLK E
« « •  - ■41 IT74. 94 1777 09 1771.74 4.11 • it rvMAxi JM c or m . ■
912 972 1409.79 1401. 74 1401.47 4.19 • k . aoorY&yVKM. L
911 - IM 1447 43 1444 44 1444.37 4 .44 • 4.AKPWYA44 4
:** ; (tec i on ( t )
S I
111
1 9 1
211
tSitoi
1SS
411
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SCI
341
i l l
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1 1 1
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• • I
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■ S I  
n il
■FfttLftTCJUUCBOTsanvEE493LAAVAHA6SLDAM.DS3 LPLJtE 1X RfcL KPTLLAPLVPWDYVIMJIPL£«YH**1M*
KJCV K SILLBGprpiupssFr
V W S L V C Y R I  NQFEYEEEX9 8N4CPSTSLT 
v o v a l a e t n aIPNMHLOHTQHW7AQCXIP0
NCWPPPDVLP
■ K T L i i r t r t c  LLFCYOIVYY 
A n  A M c y r r n
L A F L T A 3Q T V  
N Y C A 4L EN P K  
osi.vTAcrriv 
V P AP X I33T 1*  
ENAYCONIOV 
a n » r E E r L t »
M ia R l .« V lA B
VTPEMXTLSL 
DJLAEAOCOIV 
FTPVAWWIIA 
H - ^ m t n v t r n  
K TIiK IC EIA F 
r r ‘ iiT M i*?w v  rOCLLKEGXa 
AFYTVCN33L 
riCP<K*AK¥V
p l it ia w  rr> im
3L L A JU > tA A S
4 L T 4 E R JU R &
RVQCmiVK
KTTSgNfcFAA svHKswpirr i'n v r w a  a v  
w u r m M i  
EFNFITIDLEO 
EI WECTW i  
v m m / g i r  
VANF3MLE AA 
Y E T F B L 8 D L F  
PX F W V lfSP D P FTOTLBYKgX 
Aft&VCD£3(ILM
a s s v p v e w t t
IRI-3GQPVE* 
SEY'TVL SFEA 
PC4K 5IV U X P 
Q€.YI>CJf¥VW
HVOOVAITR1
A R T F g g i l tC Y
ftNTMA&APPC
I S I I I i Y Q X I
cgvmgicFET
EWBVl IPAL 
c i n m i A A
PFW aC K TK A
3YTTH0TVHV
EAWTVCKVA
Ht^KFVLg#CT
iK jn a r * 8 F « p
XIKWL9VHLK
-iTraiisHifVL
aLRJU3FMAL
K IT M V F I
r< i* v iP E t* c p
c i L s m r i L
3APVAAEFFL 
T A Y ISFLFLS “•HITVAgLPFL 
r r r  j u m ja a a  
P0XB0FTKEE 
KT11 PICS SEN 
PEOaGPVKYN 
EOTY CdPrEO
w s M o x o n r
AEVN5TFNKP
AELLVJKKJW
«3rrTLPoopp
TPtfE IIV W PT
BtsNiviMcrrc
VLNEASFGDF
89ARPERFLQ
V L P N p x iA P r
A A ^FEK V K A
U-KEVOKYPN
AAAPATOnCK
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Spot 1123 Cytokeratin 6A
- > ;
• : :
Probability Basw now* Score
r i r  i
v;; •>, •
m  b<
i > * -  :
»  9 .M  3 1163 9R S
14B7.»
; 991 826
1 S74 0641 329.772
i 940 992
2 13 3.678
EDO too 1000 1200 1400 1600
i . , . i 
1600 2000 2200
S t u t  - e n d Observed M r(e x » t) H i ( c a l c ) O e ltn m > 9 Seijuence
59  - 6 7 8 8 1 .4 7 8 9 0 . 46 8 8 0 . 4 7 - 0 . 0 0 0 R. SLYCLfrCSK. 0
6 9  - •  3 1 3 9 8 .8 3 1 3 9 7 .8 2 1 3 9 7 .7 3 0 . 0 7 0 R.niSG6SC41SBGYBSX.A
1 7 3  - 1 7 9 8 2 7 . 4 3 8 2 6 .4 2 8 2 6 . 4 2 0.00 0 K . FASFIOK . V
3 0 7  - 9 3 1 1 8 9 1 .0 3 1 8 9 0 .8 1 1 8 8 9 .9 6 0 . 0 3 0 R . gm KPI FEQYI Km R . R
2 2 3  - 2 3 1 1 0 1 6 .3 1 1 0 1 5 .3 0 1 0 1 5 .3 3 - 0 . 0 3 0 R . QLDSIVOER. 6
2 4 0  - 2 4 9 1 1 8 1 .6 0 1 1 9 0 .5 9 1 1 8 8 .3 4 0 . 0 3 0 r CHQDivrorKK
2 6 0  - 2 7 0 1222.68 1 2 2 1 .6 7 1 2 2 1 .6 2 0 . 0 3 a R.TJUUSmrVTLK.K
2 0 7  - 298 1 4 0 7 .8 0 1 4 0 6 .7 9 1 4 0 6 .7 0 0 . 0 9 0 K. AMLTD£INTLR. A
3 2 6  - 3 3 7 1 3 2 9 .7 7 1 3 3 8 .7 6 1 3 2 8 .7 3 0 . 0 3 0 R.KLDIDSIIATVK.A
3 30  - 34* 1 1 0 7 .5 8 1 1 0 6 .5 7 1 1 0 6 .5 4 0 . 0 4 0 K.AQYEBJAOR.S
3 5 *  - 3 6 8 1 1 6 3 .3 9 1 1 6 4 .3 8 1 1 6 4 .3 0 0.00 0 K. YKEXQVTAGR. H
4 3 3  - 4 6 3 1 2 6 3 .7 3 1 2 4 2 . 7 3 1 2 6 2 .4 9 0 . 0 4 0 x . u L m u m . K
5 3 3  - 5 4 9 1 4 4 7 .8 2 1 4 4 6 .9 2 1 4 4 6 .7 7 0 . 0 3 0 R.AI666LSSVGG6SSTIK. X
1 JL3TSTTIRSH S 33R R G F 3A N SARL.PGVSRS G F 3S V 3V 3R S RGSGGLGGAC
3 1 GGAGFGSRSL YGLCGSKRIS IG G G SCA1SG GYGSR1GG3Y GFGGAGSGFG
1 0 1 FGGGAGIGFG LGGGAGLAGG FGGPGFPVCP PGGIQEVTVN QSLLTPLNLQ
1 S 1 IDPTIQ R V R A EEREQIKTLW N K FA SFID K V RFLEOQNKVL ETKWTLLQEQ
2 0 1 GTKTVRQMLE PLFEQYIHM L RRQLDSIVGE RGRLDSELRG MQDLVEDFKN
2 5 1 KYEDEINKRT AAEHEFVTLK KDVDAAYHNK VELQAKADTL TDEIHFLRAL
3 0 1 YDAELSQHQT H IS D T S W L S HDNNRMLDLD SIIA E V K A Q Y EEIA Q R SPAE
3 5 1 AESRYQTKYE ELQVTAGRHG DDLRNTKOEI AEINRHIQRL RSEIDHVKKQ
4 0 1 CANLQAAIAD AEQRGEHALK DAKNKLEGLE DALQKAKQDL ARLLKEYOEL
4 5 1 HNVKLALDVE IATYRKLLEG EECRLNGEGV G O V N ISW Q S TV3SGYGGAS
5 0 1 GVGSGLGLGG G SSY3YG 3G L GVGGGFSSSS GRAIGGGLSS VGGGSSTIKY
5 5 1 T T T SS SSR K S YKH
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Spot 1090 Dihydrolipoamide DH
2900
2000
1900
1000
900
0
1000 1900 2000 2900 3000-------------------------------------------------------------------------------------------BLtL
S ta rt - Em* Observe* Mr(ex»t> M r(c a lc ) O e lta Mies Sequence
71 - 77 734.33 733.39 733.41 -0 .0 7 0 X.AAOLGCTC.T
e« - 100 1819.92 1818.92 1918.86 0 .0 6 9 X. HeTL&GTCLMVCdPSK.A
101 - 119 1771.07 1770.06 1770.83 0 .0 4 0 K.Ai.i.imsMTY]*UKGK.D O xid ation  (HI
144 - 134 1127.69 1126.68 1126.63 8 .0 3 8 K.ALTGCIAMLfK.Q
177 - 743 1*06 .24 1*93.73 1903.08 0 .1 6 a k -HWTGACVicvxtGSWQH.L O xid ation  (E)
246 - 270 2314.42 2913.42 2313.28 9 .1 3 0 a . LUU»Vt*VKf-LGMtf(e6V&U8KlSK. H
246 - 270 7330.30 7329.30 7529.28 0 .0 2 9 a . i GADVTAvrn.cHVccvcr&KrisK.h O x id ation  (0)
312 - 326 1717.99 1716.98 1716.09 0 .0 9 0 K .AEVITCWLIVCIOR. K
332 - 343 1367.94 1366.93 1566.83 0.11 9 a . m «  en .e iE Lbw *. 6
330 - 376 1993.17 1994.16 1994.07 0 .1 0 a K lPimiuDWAUHlJUfK A O xidation  (H)
416 - 420 1981 .8* 1380.87 1580.76 0 .1 7 1 K. SEFQIKEFCIEYK.V
432 - 439 909.46 900.46 908 .43 0.01 8 K.rpraaHSR.A
4*4 - 906 1324.79 1323.79 1323.73 0 .0 5 9 a VOtitMPTLSEAFR.E
307 - 316 1007.34 1006.34 1006.31 0 .0 3 a i . u a u n t K . s
1 KYRRKGKYSG KHQSVSRVYC 3LAKRGHFNR ISHGLQGLSA VPLRTYADQP
S I IDADVTVIGS GPGGYVAAIK AAQLGFKTVC IEKHETLGGT CLM VGCIPSK
1 0 1 ALLVMSHYYH HAHGKDFASR G IE H 5E V PLN LDKHHEyKST AVKALTGGIA
1 5 1 HLFKQNKW H VNGYGKITGK NQVTATKADG GTQVIDTKNI LIA TG SE V T P
2 0 1 F P G IT ID E D T rV SSTG A LSF K K V PE W fW I GAGVIGVELG SWQRLUADV
2 3 1 TAVEFLGMVG GVGIDMEISK NFQRILQKQG FKFKLNTKVT GATKKSDGKI
3 0 1 DVSIEAASGC KAFVITCDVL L V C IG R R PFT KNLGLEELGI ELO PR G RIPV
3 5 1 N TRFQ TKIPH IY A IG D W A G PMLAHKAEDE GIICVEGHAG GAVHIDYNCV
6 0 1 PSVIY TH PEV AW GKSEEQL KEECIEYKVG KFPFAAMSRA KTNAPTDGKV
4 5 1 KILGQKSTDR VLGAHILGPG AGEHVNEAAL ALEYGA3CED I APVCHAHPT
5 0 1 LSEAFREANL A A SFG K SIN F
75 100
Probability Based tlowse Score
2564.161
2408 12 5 3347.331
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Spot 471 Elongation factor 2
300-
760376
6905 3 6
1308 674
Start - End Observed Mr(expt) Hr(oalc) Delta Hiss Sequence
1 - 9 1091.59 1090.58 1090.58 0.01 0 - .VHFTVDQIR.A
299 - 307 1084.59 1083.58 1083.54 0.04 0 K.VFDAIMNFK.K
299 - 307 1100.54 1099.54 1099.54 -0.00 0 K .VFDAIMNFK.K Oxidation (H)
308 - 313 705.34 704.33 704.37 -0.04 1 K.KEETAK.L
409 - 414 760.38 759.37 759.37 -0.00 0 R.FYAFGR.V
419 - 425 1107.66 1106.65 1106.63 0.02 0 R.VTSGLVSTBLK.V
498 - 505 890.54 889.53 889.50 0.03 0 K.FSVSPWR.V
572 - 579 922.44 921.44 921.46 -0.02 0 K . SDPWSYR. E
638 - 646 1138.51 1137.50 1137.51 -0.01 0 K .YEWDVAEAR.K
676 - 687 1308.67 1307.67 1307.65 0.02 0 K . D SWAGF QWATK. E
727 - 738 1378.66 1377.66 1377.71 -0.05 0 R.CLXASVLTAQPR.L
785 - 800 1799.98 1798.97 1798.89 0.08 0 K.AYLPVHESFGFTADLR.S
845 - 857 1444.78 1443.77 1443.76 0.01 1 K .EGIPALDHFLDKL.-
1 VNFTVDQIRA IHDKKANIRN HSVIAHVDHG K3TLTD SLV C K A G IIA SA RA
5 1  GETRFTDTRK D E Q E R C IT IK  S T A IS L E Y E L  SEN D LN FIR Q  SKDGAGFLIN
1 0 1  L ID SPG H V D r SSEVTAALRV TDGALVWDC VSGVCVQTET V L R Q A IA ER I
1 5 1  KPVLMHNKHD RALLELQLEP EELY Q TFQ RI V E N V N V IIST  YGEGESGPHG
2 0 1  N IH ID P V L G T  VGFGSGLHGB AFTLKQFAEH YVAKFAAKGE GQLGPAERAK
2 5 1  KVEDHHKKLW GDRYTDPANG K FSK SA T SPE GKKLPRTFCQ L IL D P IF K V F
3 0 1  DAM H FKK EE T A K L IE K L D I KLDSEDKDKE GKPLLKAVKR RVLPAGDALL
3 5 1  Q H IT IH L P 3 P  VTAQKYRCEL LYEGPPDDEA AHGIKSCDPK GPLMMYISKH
4 0 1  VPTSDKGRFY A F6RVFSGLV STGLKVRIHG PNYTPGKKED L Y L K PIQ R T I
4 5 1  LHHGRYVEPI EDVPCGNIVG LVGVDQFLVK T G T IT T FE H A  HNMRVMKFSV
5 0 1  SPW RV A V EA  KNPADLPKLV EGLKRLAKSD P H V Q C IIE E S  G EH IIAG AGE
5 5 1  LH LEICLK D L EE D H A C IPIK  K SD PW SY R E TVSEESNVLC LSKSPNKHNR
6 0 1  LYMKARPFPD GLAEDIDKGE V3ARQELKQR ARYLAEKYEW DVAEARKIUC
6 5 1  FGPD GTGPNI LTDITKGVQY L N E IK D S W A  GFQHATKEGA LCEENBRGVR
7 0 1  FDVHDVTLHA DAIHRGGGQI IPTARRCLYA SVLTAQPRLH E P IY L V E IQ C
7 5 1  PE Q W G G IY G  VLNRKRGHVF EE3QVAGTPH FW K A Y LPV R  ESFG FTAD LR
8 0 1  SNTGGQAFPQ CVFDHBQILP GDPFDNSSRP 3Q W A E T R K R  KGLKEGIPAL
8 5 1  DHFLDKL
1420 717
Probability Based House Score
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50 60 70 80
P robab ility  Based Mouse Score
1274.805
968  48
•4c:iy?
. - - 4 * * 4
;.<o 2408 058
1494 886 •96' • -6
1000 1500 2000 2500 3000
m /2
Start - End Observed Hr(expt) Mr (calc) Delta Miss Sequence
20 - 31 1307.72 1306.71 1306.63 0.07 0 R.NMSVIAHVDHGK.S
120 - 143 2576.18 2575.17 2375.30 -0.13 0 R.VTDGALVWDCVSGVCVQTETVLR. Q
287 - 298 1494.89 1493.88 1493.80 0.08 0 R.TFCQLILDPIFK.V
299 - 307 1084.65 1083.64 1083.54 0.10 0 K.VFDAIMNFK.K
400 - 408 1006.54 1005.53 1005.49 0.04 1 K.MVPTSDKGR.F O x id a tio n  (H)
409 - 414 760.37 739.36 759.37 -0.01 0 R.FYAFGR.V
413 - 423 1107.70 1106.70 1106.63 0.06 0 R.VFSGLVSTGLK.V
438 - 448 1402.89 1401.89 1401.80 0.09 1 K .KEDLYLKPIQR.T
439 - 448 1274.80 1273.80 1273.70 0.09 0 K.EDLYLKPIQR.T
498 - 503 890.53 889.52 889.50 0.02 0 K.FSVSPWR.V
572 - 579 922.49 921.48 921.46 0.03 0 K.SDPWSYR.E
605 - 624 2143.16 2142.15 2142.07 0.08 1 K . ARPFPDGLAEDIDKGEVSAR. Q
667 - 675 1063.63 1062.62 1062.57 0.05 0 K . GVQYLNE IK. D
727 - 738 1378.82 1377.81 1377.71 0.10 0 R.CLXASVLTAQPR.L
767 - 784 1962.01 1961.01 1960.97 0.03 0 R . GHVFEE S QVAGTPMFWK . A
785 - 800 1800.03 1799.02 1798.89 0.13 0 K. AXLPVMESFGFTADLR. S
1 VNFTVDQIRA 
3 1  GETRFTDTRK 
1 0 1  LIDSPGHVDF 
1 3 1  KPVLHHNKKD 
2 0 1  NIHIDPVLGT 
2 3 1  KVEDHHKKLV 
3 0 1  DAMHFKKEE 
3 3 1  Q H ITIH LPSP 
4 0 1  VPTSDKGRFY 
4 3 1  LHHGRYVEPI 
3 0 1  SPWRVAVEA 
3 3 1  LHLEICLRDL 
6 0 1  LYHKARPFPD 
6 3 1  FGPDGTGPNI 
7 0 1  FDVHDVTLHA 
7 3 1  PEQW GGIYG 
8 0 1  3NTGGQAFPQ 
8 3 1  DNFLDKL
IHDKKANIRN
DEQERCITIK
SSEVTAALRV
RALLELQLEP
VGFG3GLHGV
GDRYTDPANG
TAKLIEKLDI
VTAQKYRCEL
AFGRVFSGLV
EDVPCGNIVG
KNPADLPKLV
E E D H A C IP IK
GLAEDIDKGE
LTDITKGVQY
DAIHRGGGQI
VLNRKRGHVF
CVTDHWQILP
HSVIAHVDHG
STAISLFYEL
TDGALVWDC
EELYQTFQRI
AFTLKQFAEH
KFSKSATSPE
KLDSEDKDKE
LYEGPPDDEA
STGLKVRIHG
LVGVDQFLVK
EGLKRLAKSD
KSDPWSYRE
VSARQELKQR
LNEIKDSW A
IPTARRCLYA
EESQVAGTPM
GDPTDNSSRP
KSTLTDSLVC
SENDLNFIKQ
VSGVCVQTET
V EN VNVIIST
YVAKTAAKGE
GKKLPRTFCQ
GKPLLKAVHR
AHGIKSCDPK
PNYTPGKKED
TGTITTFEHA
PH V Q CIIEES
TVSEESNVLC
ARYLAEKYEW
GFQVATKEGA
SVLTA0PRLH
FWKAYLPVK
SQWAETRKR
KAGIIASARA
SKDGAGFLIN
VLRQAIAERI
YGEGESGPHG
GQLGPAERAK
LILD PIFK V F
RVLPAGDALL
GPLHHYISIW
LY LK PIQ RTI
HNHRVHKFSV
GEHIIAGAGE
LSKSPNKHNR
DVAEARKIBC
LCEENHRGVR
EPIYLV EIQC
ESFGFTADLR
KGLKEGIPAL
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P robability  Based Mouse Score
1594  731
nrimmt) Mr(e«lc) B«lt« Him tmwct
n  1M .M  704. r» - •
1107.42 1104.1
ii74.<a?io.! 1279. 47 1170.702790.91 >790.49
1014.70 1414.70
1904.79 1909.79 1999.70
1949.74 1941.79 1941.77 
2149.11 2142.11 2142.07
1190.92 1197.91 1197.91
1900.09 1907.42 1907.09
1970.00 1977.09 1977.71
1001.09 1000.04 1000.07
1077.04 1070.04 1070.07
1799.07 1790.04 1790.09
wivotno
x»vpc8Hiv«.vw»gn.v*. iTOTXTT1
V Ok10*11ob (H)
CT.XOSVLVO029I
4 Oxidation (I)
1 VNFTVDQIRA 
51  GETRTTDTRK 
1 0 1  LXDSPCHVDF 
1 5 1  KPVLHHNKHD 
2 0 1  NIHIDPVLGT 
2 5 1  KVEDHHKKLH 
3 0 1  DADMFKKEE 
3 5 1  Q H ITIH LPSP 
4 0 1  VPTSDKGRFY 
4 5 1  LHHGRYVEPI 
5 0 1  SPWRVAVEA 
5 5 1  LHLEICLKDL 
6 0 1  LYHKARPFPD 
6 5 1  FGPDGTGPNI 
7 0 1  FDVHDVTLHA 
7 5 1  PEQWGGIYG 
8 0 1  3NTGGQAF PQ 
8 5 1  DMFLDKL
IKDKKANIBN 
DEQERCITIK 
SSEVTAALRV 
RAJLLELQLEP 
VGFGSGLHGB 
GDRYFDPANG 
TAKLIEKLDI 
VTAQKYRCEL 
AFGRVFSGLV 
EDVPCGHIVG 
KNPADLPKLV 
EEDHACIPXK 
GLAEDIDKGE 
LTDITKGVQY 
DAIHRGGGQI 
VLNRKRGKVF 
CVTDHBQILP
KSVIAHVDHG
STAISLEYEL
TDGALVWDC
EELYQTFQRI
AFTLKQFAEH
KFSKSATSPE
KLDSEDKDKE
LYEGPPDDEA
STGLKVRIHG
LVGVDQFLVK
EGLKRLAKSD
KSDPWSYRE
VSARQELKQR
LNEIKDSW A
IPTARRCLYA
EESQVAGTPM
GDPFDNSSRP
KSTLTDSLVC 
SENDLNTIKQ 
VSGVCVQTET 
VEN VNVIIST  
YVAKFAAKGE 
GKKLPRTFCQ 
GKPLLKAVHR 
AMGIK3CDPK 
PNYTPGKKED 
IG I1T T FE H A  
PH V Q CIIEE3  
TVSEESHVLC 
ARYLAEKYEW 
GF QWATKEGA 
s v l t a q p r l h
FWKAYLPVH
3QW AETRKR
KAGIIASARA 
SKDGAGFLIH 
VLRQAIAERI 
YGEGESGPKG 
GQL GPAERAK 
LILD PIFK V F 
RCLPAGDALL 
GPLHHYI3KM 
LYLK PIQRTI 
HMKRVXKFSV 
GEHIIAGAGE 
LSKSPNKHNR 
DVAEARKIWC 
LCEENHRGVR 
EPIYLVEIQC 
ESFGFTADLR 
KGLKEGIPAL
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P r o b a b ility  Based Mouse Score
■ 420 554
v .  4 jr.
1 0 7 7 1 3 0
2211  104
::c44-3
2 3 1 4  171
24C6
:• . 4 -  - v .
2 6 -8 :c4 2 9 5 0  671 3 200  114
S t* r t  -  End Observed Mr{ex p t) Mr (c a lc ) B e lt* M iss Sequence
1 -  9 1091.30 1990.39 1090.30 -0 .4 8 0 - VNTTVDQIR.A
142 -  179 2220.14 2219.13 2219.13 -0 .8 2 0 B . ALLEL QLEPEELYQTPQR. I
297 -  294 1494.47 1493.44 1493.90 -9 .1 4 0 R.TTCQLILOPXFK.V
297 -  397 2574.57 2373.56 2373.32 4.24 1 R. TFCQLI LOP I FKVYDAQQfFK. K O xidation  (H)
299 -  347 1084.44 1983.45 1043.34 -0 .0 9 0 K . VFDA OfHTK . K
299 -  397 1100.44 1999.43 1099.34 -0 .0 9 0 K.VFDAUQfPK. K O xidation  (H)
399 -  313 70S.34 704.37 704.37 9.00 1 K.HB1AX.L
344 - 343 2023.47 2022.06 2022.09 -0 .03 0 R. CELLYEGPPDDEAAMGIK. S O xidation  (1)
400 - 409 1006.41 1903.41 1003.49 -4 .4 9 1 K.MVPTSRKCR.r O x idation  (1)
409 - 414 740.40 759.40 759.37 0.83 0 i . r n n i t . v
413 -  423 1107.33 1106.34 1106.63 -0 .1 0 0 R.VTSGLVSIGLK V
424 - 437 1332.64 1331.63 1331.70 -0 .4 7 1 K.VRJM6PMYTPGK.K
439 - 449 1274.30 1273.39 1273.70 -0 .1 3 0 K.EDLYLKPIQR. T
439 -  433 2109.14 2104.13 2109.11 9.42 1 K EDLYUCPIQRTILMIGR. Y 2 O xidation  (I)
491 -  494 1615.69 1614.49 1614.76 -8 .4 7 0 K. TGTITTFEHAJOWR . V
498 - 505 090.45 089.44 809.50 -0 .0 6 0 K.PSVSPWR.V
403 - 424 2143.94 2142.03 2142.97 -0 .0 4 1 K.ARPFPDGLAEDIDKGEVSAR. Q
434 - 444 1139.43 1137.44 1137.31 -0 .0 7 0 K. YTVWJJBAR . ■
447 - 473 1043.40 1062.47 1062.37 -0 .1 0 0 K. GVQYL9EIK. D
474 - 447 1308.63 1307.64 1307.63 -0 .41 0 K.OSWACrgHATK.E
747 - 794 1961.93 1960.94 1960.97 -0 .0 3 0 R . GMVFEESgVAGTPMFWK .A
747 -  784 1977.99 1976.99 1976.97 0.02 0 R . GMVFEES(JVAGTPMFWK . A O xidation  (I)
795 - 900 1799.01 1790.00 1799.99 -0 .8 9 0 K . AYLPVMESFGPTADLR - S
1 VHFTVDQIRA IHDKKANIRN HSVIAHVDHG KSTLTDSLVC KAGIIASARA
51 GETRTTDTRK DEQERCITIK 3TAI3LFY EL 3ENDLNFIKQ SKDGAGFLIN
10 1 LIDSPGHVDr 3SEVTAALRV TDGALVWDC VSGVCVQTET VLRQAIAERI
15 1 KPVLHHNKHD RALLELQLEP EELYQTFQRI VENVNVIIST YGEGESGPHG
20 1 NIHIDPVLGT VGFGSGLHGB AFTLKQFAEH YVAKFAAKGE GQLGPAERAK
25 1 KVEDHHKKL9 GDRYFDP1NG KF3K3AT3PE GKKLPRTFCQ LILD PIFK V F
30 1 DAOQO'KKEE TAKLIEKLDI KLDSEDKDKE GKPLLKAVHR R9LPAGDALL
35 1 QHITIH LPSP VTAQKYRCEL LYEGPPDDEA AMGIKSCDPK GPLHHYISKM
401 VPTSDKGRFY AFGRVFSGLV STGLKVRIMG PHYTPGKKED LYLKPIQRTI
451 LIWIGRYVEPI EDVPCGNIVG LVGVDQFLVK TGTITTFEKA HNMRVHKFSV
501 SPWRVAVEA KNPADLPKLV EGLKRLAKSD PHVQCIIEES GEHI IAGAGE
99 1 LHLEICLKDL EEDHACIPIK KSDPWSYRE TVSEESNVLC LSKSPNKHNR
6 0 1 LYHKARPFPD GLAEDIDKGE VSARQELKQR ARYLAEKYEW DVAEARKI9C
69 1 FGPDGTGPNI LTDITKGVQY LREIKD SW A GFQWATKEGA LCEENHRGVR
70 1 FDVHDVTLHA DAIHRGGGQI IPTARRCLYA SVLTAQPRLH EPIYLVEIQC
7 9 1 PEQWGGIYG VLNRKRGHVF EESQVAGTPM FWKAYLPVH ESFGFTADLR
8 01 SNTGGQAFPQ CVFDHVQILP GDPFDNSSRP 3QWAETRKR KGLKEGIPAL
8 9 1 DNFLDKL
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P r o b a b i l i ty  Based Mouse Score
-ciJje
1799 885
4 j4  > ,
T '4C ,4
•;-r re:54: 5: 4 -3'o
2 576  176
: 4
•:,r- sic-56' ~C6
: : r : _-r-DC' b-12
Z4J- 462
750 1000 1250 1500 1750 2000
t a r t  -  EjuL O bserved ■ r(o a lc ) » * lt« M il l Sequence
1 -  IS 1412.92 1811.91 1411.49 0.42 1 - MVXFTVDQIRAIKDK.X 2 O xidation  (1)
2 -  i t 1091.34 1090.93 1090.90 -0.42 0 M.VWTVDQIR .A
7J -  M 2244.02 2203.01 2243.10 -9.49 0 X. STAT SLrYTL SFXDLXrXX. Q
121 - 144 2374.10 2573.17 2979.30 -0.13 0 4 . VTDGALVWDCVSCVCVgTETVLR. Q
143 - 140 2224.12 2219.11 2219.19 -0.44 0 R . AU.ELQLEPEELYQTrQA. I
227 - 23S 1004.32 1043.91 1009.32 -0.01 0 k  . g r i a o v u . r
227 - 233 1102.49 1101.44 1191.52 -0.04 0 K.grAOorvAK.r O xidation  (I)
2t a  - 799 1494.41 1493.00 1493.99 9.40 0 R .r rc g L iL O P irR .v
244 - 394 1494.79 1493.70 1493.40 -0 .42 4 R.TPCQLILOPirX.?
>00 - 304 1004.33 1003.93 1003.34 9.00 0 K . VTDA DOIT K ■ K
300 - 304 1100.33 1099.59 1099.94 0.91 0 K.vroAocxrx.x o x id a tio n  txj
392 - 400 1039.34 1430.33 1030.52 0.41 0 K. 6PLMCrTSX.il
392 - 400 1071.32 1079.91 1070.91 -0.01 0 K.CPLMGTXSK.M 2 O xidation  (I)
410 413 740.34 739.33 799.37 -0.42 0 R.rXRTGO.V
414 - 424 1107.42 1104.41 1104.03 -0.02 4 R.VTSU.VST6LK.V
429 - 434 1077.33 1074.93 1074.53 -0.01 0 R . UCGPMYTP&K. X
429 - 434 1093.91 1092.30 1092.33 -0.03 0 R. DlfiPlfYTPGK. X O xidation  (B)
439 -  449 1402.79 1401.79 1441.40 -0.42 1 X KEDIY1KPIQR. T
440 - 449 1274.49 1273.49 1273.79 -0.92 0 K.EDLYLXPIQR.T
437 -  401 2739.33 2754.33 2790.43 -0.10 4 R. YVEPIEDVPCGMTV6LV0VDQTLVX. T
499 -  304 490.49 449.40 409.90 -0 .42 0 B.FSVSPWR.V
340 -  371 1439.73 1434.72 1434.40 0.49 0 K.OLEEOKACIPZE.R
340 - 372 1347.71 1344.70 1900.77 -0.07 I K. DLXEONACIPIKK. S
373 - 340 922.44 921.43 921.44 -0.02 0 K SD PW SYRE
404 419 1343.73 1342.73 1942.77 -0.04 0 X AUPt PDGLAEDIDK. 6
404 - 423 2143.02 2142.02 2142.07 -0.03 1 X. AOPTPOCLAEOIOKSBVSAR. Q
439 -  447 1130.30 1137.90 1137.51 -0.01 0 K.YZVPVAEAA.K
449 -  447 2104.00 2103.00 2104.03 -0.13 0 X . nrCPOPOCTGPtflLTRITX. 6
444 -  474 1043.34 1042.99 1002.97 -0.02 0 X. GVQYIXEIK.D
477 -  444 1300.44 1307.44 1307.45 -0.01 0 X. DSWAGFgVATK.E
724 -  739 1370.70 1377.70 1377.71 -0.01 0 R.CLXASVLIAQPR.L
744 - 743 1941.94 1940.99 1940.97 -0.02 0 r  . bNvrecsgvAOTnrvvx. a
744 - 743 1977.91 1974.91 1974.97 - 0 .0 0 0 R.&Kvrc£sgvA&Tnarwx.A O xidation (0)
744 - 401 1799.40 1790.90 1790.09 -0.01 9 X. AXLPVKSP 6PTA01R. S
444 - 430 1444.44 1443.79 1443.74 0.03 1 KEUXPALOHTLDKL
1 MVHFTVDQIR ADCDKKJLNIR NHSVIAHVDH GK3TLTDSLV CKAGIIASAR
31 AGETRFTDTR KDEQERCITI KSTAISLFYE LSEVDLH71K QSKDGAGFLI
101 NLIDSPGHVD rSSEVTAALR VXD GULL VWD CVSGVCVQTE TVLRQAIAER
131 IXPVLKHNKH DRALLELQLE PEELYQTFQR IVENVNVI13 TTGEGE3GP1
20 1  GNI1IDPVLG TVGFGSGLHG VAFTLKQFAE MYVAKFAAKG EGQLGPAERA
25 1  KRVEDKKKKL WGDRYFDPAN GKFSK3AT3P EGKKLPRTFC QLILDPIFKV
301 FDA D U E KKE ETAKLIEKLD IKLDSEDKDK EGKPLLKAVH RRVLPAGDAL
351 LQHITIHLPS PVTAQKYRCE LLYEGPPDDE AAHGIKSCDP KGPLMNYISK
401 EVPTSDKGRF YAFGRVFSGL VSTGLKVRDf GPVYTPGKKE DLYLKPIQRT
45 1  ILHHGRYVEP IEDVPCGMIV GLVGVDQFLV KTGTITTFEH AHNMRVHKFS
501 VSPWRVAVE AKKPADLPKL VEGLKRLAKS DPMVQCIIEE SGEHIIAGAG
551 ELHLEICLKD LEEDHACIPI KKSDPWSYR ETVSEESNVL CLSKSPNKHN
601 RLYHKARPFP DGLAEDIDKG EVSARQELKQ RARYLAEKYE VDVAEARKHf
6 31  CFCPDGTGP* ILTDITKGVQ YLMEIKDSW ACTQWATKEG ALCEENHRGV
7 01  RFDVHDVTLH AOAIHRGGGQ IIPTARRCLY ASVLTAQPRL KEPIYLVEIQ
7 3 1  CPEQWGGIY GVLNRKRGMV FEESQVAGTP MFWKAYLPV MESFGFTAOL
8 01  RSNTGGGAFP QCVFDHWQIL PGDPFDKSSR PSQWAETRK RKGLKEG1PA
8 51  LDNFLRKL
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Spot 1345 Enolase alpha
M I
705 3 25
1 143 5 *
40 >0 100 
P r o b a b i l i t y  B ased Mows* S c o re
120 140
2033.20* » 1 M W
f U l U m  Him I, , —
S tu rt -  E n d O b s e r v e d Mi Ie x y t 1 Mr ( c a lc ) » « l ta Ml 00 S lf M t C t
» -  14 7««.30 7 *5 .3 7 765.37 0 .01 0 P.ELFPSR.C
IS  -  27 1406.73 1403.73 1403.71 0 .0 4 o ft. bNPTVZVDLETSK. 6
3 7 - 4 9 1003.11 1004.10 1003.94 0 .1 7 0 ft. AAV9SGAST6IYEM.El.lt - 0
71 -  7 * 039 .3 * 490.35 090 .35 0 .0 0 0 K.T1APALVSK.K
103 - 110 1319.94 1310.94 1510.02 0.11 0 i  i w n m i — t i  I
1*2  -  17* 1924.09 1923.00 1922 . 97 0 .1 0 0 K.LAMOEFMILPVtjAAMFlt. E O x id ation  SHl
1*2 - 170 1940.13 1939.12 1930.97 0 .1 3 0 K. UtMQEFMI LFVCAJUIER . 0 2 O xid ation  («)
103 -  102 1143.60 1142.59 1142.61 -0 .0 2 0 R. IGAEVYMMLK.M
202 -  220 1960.97 1939.96 1939.92 0 .0 4 0 K. DATHVOI>eC6fA2MlL33IK . E
23* * 232 1340.06 1339.03 1339.70 0 .0 7 0 k . w i  a M n m . s
23* -  252 1356.02 1535.01 1555 .77 0.04 0 K. wibHOVAASLtEfi. S O x id atio n  ( I )
23* -  2*1 000.36 799.33 799 .30 -0 .0 2 0 K.YOLOriC.S
2*9 -  200 1423.75 1424.74 1424.72 0.02 0 P.Y1SPDQLA9LYX.S
306 -  323 2033.21 2032.20 2032.03 0.13 o K. r  TASAG1QWGODL 7VTSPK. R
3*3 - 357 1633.97 1632.97 1632.01 0.15 0 K.VMQIGSVTESLQACK.L
406 -  411 006.49 003.49 003.44 0.04 o K.YHQLLR.l
1  S IL K IH A R E I  
5 1  NDKTRYHGKG 
1 0 1  NKSKFGAKAI 
1 5 1  VINGGSHAGN  
2 0 1  KDATNVGDEG 
2 5 1  FRSGKYDLDF 
3 0 1  GAWQKFTASA 
3 5 1  ESLQACKLAQ  
4 0 1  ERLAKYNQLL
FDSRGHPTVE
VSKAVEHINK
LGVSLAVCKA
KLAMQEFMIL
G FA PN IL E H K
K SP D D PSR Y I
G IQ W G D D LT
ANGHGVHVSH
R IEEELG SK A
VDLFTSKGLF  
TIA PALV SK K  
GAVEKGVPLY  
PVGAANFREA  
EGLELLKTAI 
SPDQLADLYK  
VTM PK R IAKA 
R SG E T E D T FI  
KFAGRNFRNP
RAAVPSGAST
LNVTEQEKID
RHIADLAGN3
HPIGAEVYHM
GKAGYTDKW
S F IK D Y P W S
VNEKSCNCLL
ADLW GLCTG
LAK
GIYEALELRD  
KLHIEHDGTE  
E V IL PV P A F N  
LKNVIKEKYG  
IGMDVAASEF 
IEDPFDQDDW  
LKVHQIGSVT  
QIKTGAPCRS
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P r o b a b ility  Based flows* Score
1 117.592942 5 2*
1023 4 17
1675 * 77
1431.792
2211 101
2 564 4 44
240* 0 56 > V4'269* 5 36 3 064 4 031*93 *36
1000
T -  ,
1500 2000 2500
S t a r t I M a t i M f t t * U tlC ftiC f M 1 U l i M U f M M *
f t • 1ft M f t i  .ft* t i f t f t .  M 914ft.f tft 4 . f t l ft i . i i f M i i i v i i i t n i f t m  a
« • - • • l l l l . M n i t  t f t l l l f t  19 • .ftl • ft jb * r tj» t9 w v ii v
» • f t t o n . f t * l f t t *  ft* i  r i f t  • * f t . f t t ft * r i m u f t n * c » « i c *  t
S* • f t lft*i ftft 1 4 t f  11 lftft*  • • - f t .  f t l ft * r i m u f t T s i i f ! * ( • .  i  i t )
ft* - M * M . M **T. ftl f t * 9 . t t f t . f t t ft f t . i s r a c r i K . i
I t t -  I M I t 1 4 . ftft 1 1 * 1 . 41 1 1 1 1 .1 f t 9 .9 4 ft K . tf trV W tM K  .ft
I M -  I M m i  i t m i  i * 9 9 9 4  -ftft ft, 19 * ft, r a m t a n f t n  n f t i x t i
Iftft - I M I M f  1 1 1S4II 91 I M l  74 ft.ftft • «  i M i w t r n c i  ?
lftft I M ft l i f t  #7 1 SI 7 ft] 1 *1 7  7 4 f t.ftft • ft ■ ! «  TftTDTIM ft T Q t l f t f t t l o n  rftj
m 144 1 9 1 1 .1 1 1 1 1 9 .9 1 191 *  4ft ft.ftft ft r l i i m n i r t  m
*«* - S f tl I M S . S l i f t i t . M I f t l l .41 f t . f t t ft ft.MAlULUt.K
M l - f t * 1144ft .ftft 1 4 4 4 .4 1 • •4 f t -4ft f t. f tl ft f t l t M f t l l l J *
m - 9* 4 f t f t f t . l t S t l . M •f tf t .  f t f t . f t l ft ft i f tM r t f f t t i t  »
r w J f t t 1411  IS 149ft M 14Sft 7ft f t . f t l ft •  i m t i z o m s  *
it* - SM 1 T 4 1 .M 1 1 4 9 .ftft 174*  ftft ft. 44 ft ■ » c r « r t M v  l M i a i . t
l i f t I M 171ft . ftft 1 1 9 9 .9 1 171ft.ftft f t . f t t ft K M O M M f t V I M i a i . l  :«i4attM |«)
i«ft - I l l S I M . 41 1 1 1 4 .4 9 1 1 1 4 .4 f t ft.ft* ft ft. ftftVtftlftVtfft .4
M t -  i t s !••* . n I f t f tl  ftft 1 4ft4 1* ft.ftft ft ft i f t i f i i a r M . i
T fft l i t f t l f t  fft I S M  f t I S M  11 4 * 4 ft
4«9 41 9 I 9 f t t .1 1 l f f t f t  M 19*4  4 9 f t .M ft it — m i v m *  v
i l l -  f tM » 1 4 7 .1 4 9 3 4 4 .1 1 9 * 4 4 . a* -ft.ftf t ft ft 9 S M  Y S f t C S f t f t i V i r |L » . 1
41 1 -  ft 41 UM .IS 1 1 9 1 .4 f t 1 1 * 4 .4ft 4 . f tl * ft. lnW V M M ft.V
•  I t - ftftl S M I * • f t f t .4* • • 4  4 4 ft.ftft ft ft W V M M I V
1 4 ? * 1 4 ) t i t  I S S ftl *1 M l  1* - f t . f t l ft •  r w e r r r r *  i
I M I M 1117  ft? 1 l i f t  f tl I t * *  7ft •  .f t* l p: n m n m i  « t  ■
i l l I M 1 4 7 1 .ftft 1 4 7 4 .4 1 1 C 7 S .I1 4 .  *4 ft n . r i t w i t H U  w a t  t
M l - M l I I M . 4 4 1 * 9 9 . ftft 1 * 1 1 .ftft M l • f t. f t l f t  B M M P . 9
ft* ft - l i f t I M S  4 1 l i f t * ,  f tl l f t f t  .4 9 ft.ftft ft ft. V M I  IVNftVM 71 •  . f
1 f t -  S ftl • i t  SI ftftl fft *41 I f *.*• • ft niisM m  •
M l ! M ff tM  Sft lf tf t?  *1 94*7 ftft • i  ft* * k  i i m m j t M f t n f w i f m u  7
M t S ftl • 1 1 .4 4 f t l f t .  41 • 1 0  41 •  .ftl • k .  m i m m  . k
ftlf t I M * .  • « ISftft.ftft 1*44 .44 f t .M • 1 7 t t l 9 C M . v m N l . f t
1
SI
HAPGSVSDZE 
PEITEKLMAT 
101 CAIGGT3EQ3 
1S1 NDLniAVC&G 
701 JUSAIGCMWN
»S1 n n i n n
301 HLLEQVAPKC 
331 TATDWRGNP 
401 PJHMNSLCVM 
4 SI GGNMKKLENC 
301 PTTLNIl.EE I 
S S I  PV L P L ID A IQ  
601 PEDLVEVKPK
imELPEArAK 
GDLDQDGRIS 
3V0T0H3TSE 
IVLCKMIMLS 
IGAEDLKEOK 
LNKLSPEZLL 
DFEGVPAWI 
KLNLAFIAML 
PRVMKLYSDL 
NTAVEL6KNQ 
UOCQKVNDDI 
PGSINYDLLK
HvrrvrACL*
VDTDGWGYIS 
FDEFIXIFBG 
EEKYAFVMf I 
VPDtlDfcHTI 
PTLVLGLLU'J 
LRHANTHLEN 
DNS GL RE KM 
FMRYPALHKP 
SDALV1FULY 
AKFSLVU1UG 
rvmrvMETLM 
TENLNDDEKL 
GKGHKFV
EHEL HDLFKA
LKSTDVAKTF
MKALEMDPDC
N K K X LTPPTI 
V I KIULTAD I
A O C N K IM rs
IQ R A E C R L O O
ENQD1DWGAL
EKXKVPVDWH
QDLMEGMRTL
E A E K S S S IS S
NNAKYAISMA
ACLPLPGYRV
RJCAUnOCEGI 
RHVIPBHPNT 
0ENLKLALN3 
ELSRHUULA 
TDIKDSKAYY 
1EPLGCFQFV 
E&E TREEPTr 
RVMKPPYPKL 
TLALlUgLBR 
PKDPX1STSL 
RKIGAPVYAX
286
Appendix J: Statistical treatment of DeCyder data in this thesis
Statistical analysis is an essential process what is used to determine the reliability of data 
obtained using DeCyder gel analysis. In general, to compare mean differences between 
two groups of data that have some correlations, one can run an independent samples 
student t-test. In contrast, when comparing means of 3 or more variables, the Analysis of 
variance (ANOVA) test is suitable for making this comparison and is used to replace 
multiple t-tests. In this thesis, although one or more than one triplicate test groups are 
being compared to triplicate control groups, the statistical analysis in was performed 
between two groups at a time (e.g. when comparing a hydrogen peroxide treated to non­
treated HB4a cells) to test the significance. This strategy prevents the exclusion of some 
spots of interest that can happen when using ANOVA, where the differences are not 
consistent across all groups of conditions. For example, the identified proteins such as 
Lamin, flavin reductase, HSP-71 and peroxiredoxin 6 in Table 4-2 would be omitted in 
an ANOVA analysis used to look for H202 AND cell-line specific changes. Thus, the 
student t-test was chosen and applied in all 2D-DIGE experiments.
As Students t-test provides a method to make statistical comparisons of the means from 
two different groups, all protein identification tables in this thesis show a series of 
labelling/expression changes between two individual treatment comparisons (e.g. 
comparison of plasma fractions exposed to UV 80 mJ/cm2 versus 0 mJ/cm2; UV 40 
mJ/cm2 versus 0 mJ/cm2; UV 20 mJ/cm2 versus 0 mJ/cm2 in Chapter 6). The 
experimental t-test values are calculated by using the following equations:
texp value= | X a -X b  | /S a b  x (l/nA + l/nB) 1/2
where Xa and Xb are the means of A and B groups, respectively; Sab is the standard 
deviation of used values; nA and nB are the number of measurements in group A and 
group B, respectively.
The texp value can be compared with the ttheo (theoretical) value, which corresponds to the 
given degrees of freedom N (N= nA + nB -2), and the confidence level chosen. Tables of 
ttheo values can be found in statistical textbooks. If texp > ttheo then the Ho (null hypothesis
i.e. any differences, discrepancies, or suspiciously outlying results are purely due to 
random and not systematic errors) can be rejected. An erroneous rejection of H0 
constitutes a type 1 error (i.e. false positive), whereas an erroneous acceptance of H0 
constitutes a type 2 error (i.e. false negative).
All significance tests provide results within a predefined confidence level %  (CL%). 
Confidence levels normally used are 90%, 95% and 99%, with 95% being the most 
popularly used value in biological analyses. A CL of 95% means that in the case of 
rejecting Ho, there is a 95% or more certainty that the result is true, i.e. a < 0.05 chance of 
a false positive. In addition, a CL of 95% is generally considered as a compromise 
between two types of errors due to decreasing CL to 90% significantly increase the type 1 
error, while increasing CL to 99% obviously increases the type 2 error.
The p-value is the probability of a type 1 error happening and this value provides 
information for the user to judge the acceptance or the rejection of the null hypothesis Hq. 
For example, using a CL of 95% is the criteria for acceptance in one statistical analysis 
which means the probability of a type 1 error happening is 5% i.e. p  = 0.05. While an 
experimental /?-value of 0.09 means that Ho must be retained otherwise there is a higher 
risk of accepting a high probability of a type 1 error occuring.
All protein identification tables in this thesis which show expression/labelling changes as 
average ratios between two conditions include the /7-value for those comparisons. Protein 
features were selected for identification where /?-values were less than 0.05 and average 
fold-changes were > + or -  1.5 fold (except + or -  1.3 in the EGF stimulation 
experiments in Chapter 5). However, in a few cases (such as Lamin, flavin reductase, 
HSP-71 and peroxiredoxin 6 in Table 4-2), not all of the /7-values of each comparison 
fulfilled the p  < 0.05 criteria. For these cases, the average ratios of expression/labelling 
changes together with /7-values are still listed in the tables.
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